(lp1
(dp2
S'mc_entities'
p3
(lp4
(lp5
Vhttp://dbpedia.org/resource/The_Needles
p6
aVhttp://dbpedia.org/resource/Diameter
p7
aa(lp8
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p9
aVhttp://dbpedia.org/resource/Administration_%28law%29
p10
aa(lp11
Vhttp://dbpedia.org/resource/Injection_%28medicine%29
p12
aVhttp://dbpedia.org/resource/Ribosome
p13
aVhttp://dbpedia.org/resource/Blood_flow
p14
aa(lp15
Vhttp://dbpedia.org/resource/Injection_%28medicine%29
p16
aVhttp://dbpedia.org/resource/Volume
p17
aasS'mc'
p18
(lp19
Vneedle diameter
p20
aVrate of administration
p21
aVinjection site blood flow
p22
aVinjection volume
p23
asS'q_entities'
p24
(lp25
Vhttp://dbpedia.org/resource/Factors_of_production
p26
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p27
aVhttp://dbpedia.org/resource/Intramuscular_injection
p28
asS'url'
p29
S'http://www.pharmacology2000.com/General/Introduction/questions2/intro2.htm'
p30
sS'qtext'
p31
S'Most important factor influencing drug absorption rate following intramuscular injection:'
p32
sS'mcwordcount'
p33
I11
sS'QID'
p34
S'Q0#7'
p35
sS'qwordcount'
p36
I10
sS'qno'
p37
S'7'
sS'correct'
p38
I2
sS'qset'
p39
S'0'
sa(dp40
g3
(lp41
(lp42
Vhttp://dbpedia.org/resource/Weak_acid
p43
aVhttp://dbpedia.org/resource/Acid_dissociation_constant
p44
aa(lp45
Vhttp://dbpedia.org/resource/Acid_dissociation_constant
p46
aa(lp47
Vhttp://dbpedia.org/resource/Weak_acid
p48
aVhttp://dbpedia.org/resource/Acid_dissociation_constant
p49
aa(lp50
Vhttp://dbpedia.org/resource/Acid_dissociation_constant
p51
aa(lp52
Vhttp://dbpedia.org/resource/Weak_acid
p53
aVhttp://dbpedia.org/resource/Acid_dissociation_constant
p54
aasg18
(lp55
Vweak acid (pKa 7.4)
p56
aVweak base (pKa 8.4)
p57
aVweak acid (pKa 8.4)
p58
aVweak base (pKa 6.4)
p59
aVweak acid (pKa 6.4)
p60
asg24
(lp61
Vhttp://dbpedia.org/resource/Drug
p62
aVhttp://dbpedia.org/resource/Ionization
p63
aVhttp://dbpedia.org/resource/Property
p64
aVhttp://dbpedia.org/resource/Intestine
p65
aVhttp://dbpedia.org/resource/Blood_plasma
p66
asg29
S'http://www.pharmacology2000.com/General/Introduction/questions2/intro2.htm'
p67
sg31
S'Drug with this ionization property most likely to diffuse from intestine (pH 8.4) to blood (pH 7.4)'
p68
sg33
I30
sg34
S'Q0#11'
p69
sg36
I21
sg37
S'11'
p70
sg38
I3
sg39
S'0'
sa(dp71
g3
(lp72
sg18
(lp73
V1%
p74
aV10%
p75
aV50%
p76
aV90%
p77
aV99%
p78
asg24
(lp79
Vhttp://dbpedia.org/resource/Weak_acid
p80
aVhttp://dbpedia.org/resource/Organic_acid
p81
aVhttp://dbpedia.org/resource/Acid_dissociation_constant
p82
aVhttp://dbpedia.org/resource/Percentage
p83
aVhttp://dbpedia.org/resource/Ionization
p84
asg29
S'http://www.pharmacology2000.com/General/Introduction/questions2/intro2.htm'
p85
sg31
S'Weak organic acid, pKa 6.5. Percent ionization at pH 7.5'
p86
sg33
I10
sg34
S'Q0#13'
p87
sg36
I11
sg37
S'13'
p88
sg38
I3
sg39
S'0'
sa(dp89
g3
(lp90
(lp91
Vhttp://dbpedia.org/resource/Extreme_weather
p92
aVhttp://dbpedia.org/resource/Drug
p93
aVhttp://dbpedia.org/resource/Instability
p94
aVhttp://dbpedia.org/resource/Stomach
p95
aa(lp96
Vhttp://dbpedia.org/resource/Liver
p97
aa(lp98
Vhttp://dbpedia.org/resource/Drug
p99
aVhttp://dbpedia.org/resource/Metabolism
p100
aVhttp://dbpedia.org/resource/Gut_flora
p101
aa(lp102
Vhttp://dbpedia.org/resource/Tablet
p103
aa(lp104
Vhttp://dbpedia.org/resource/Patient
p105
aasg18
(lp106
Vextreme drug instability at stomach pH
p107
aVhepatic "first-pass" effect
p108
aVdrug metabolized by gut flora
p109
aVtablet does not dissolve
p110
aVpatient non-complance
p111
asg24
(lp112
Vhttp://dbpedia.org/resource/Systemic_lupus_erythematosus
p113
aVhttp://dbpedia.org/resource/Availability
p114
aVhttp://dbpedia.org/resource/Drug
p115
asg29
S'http://www.pharmacology2000.com/General/Introduction/questions2/intro2.htm'
p116
sg31
S'Dramatic decrease in systemic availability of a drug following oral administration is most likely due to:'
p117
sg33
I22
sg34
S'Q0#15'
p118
sg36
I16
sg37
S'15'
p119
sg38
I1
sg39
S'0'
sa(dp120
g3
(lp121
sg18
(lp122
Vless than 1%
p123
aV5%-15%
p124
aV30%
p125
aV> 50%
p126
aV> 90%
p127
asg24
(lp128
Vhttp://dbpedia.org/resource/Percentage
p129
aVhttp://dbpedia.org/resource/Drug
p130
aVhttp://dbpedia.org/resource/Enantiomer
p131
aVhttp://dbpedia.org/resource/Concentration_%28game%29
p132
asg29
S'http://www.pharmacology2000.com/General/Introduction/questions3/questionset3.htm'
p133
sg31
S'Percentage of all drugs that exist as enantiomeric pairs:'
p134
sg33
I16
sg34
S'Q1#0'
p135
sg36
I9
sg37
S'0'
sg38
I3
sg39
S'1'
sa(dp136
g3
(lp137
(lp138
Vhttp://dbpedia.org/resource/Enantiomer
p139
aa(lp140
Vhttp://dbpedia.org/resource/Metabolism
p141
aa(lp142
Vhttp://dbpedia.org/resource/Isomer
p143
aa(lp144
Vhttp://dbpedia.org/resource/Morphine
p145
aVhttp://dbpedia.org/resource/Nature
p146
aasg18
(lp147
Vcardiotoxicity is probably associated with both enantiomers of bupivacaine
p148
aVRopivacaine is less cardiotoxic compared to bupivacaine because it is metabolized faster
p149
aVcisatracurium is an atracurium isomer that doesn\u005c
p150
aVboth l- and d- morphine occur in nature
p151
asg24
(lp152
Vhttp://dbpedia.org/resource/Enantiomer
p153
aVhttp://dbpedia.org/resource/Subtraction
p154
aVhttp://dbpedia.org/resource/Anesthesia
p155
asg29
S'http://www.pharmacology2000.com/General/Introduction/questions3/questionset3.htm'
p156
sg31
S'Examples of enantiomeric differences important in anesthesia:'
p157
sg33
I36
sg34
S'Q1#3'
p158
sg36
I7
sg37
S'3'
sg38
I2
sg39
S'1'
sa(dp159
g3
(lp160
(lp161
Vhttp://dbpedia.org/resource/Electrostatics
p162
aa(lp163
Vhttp://dbpedia.org/resource/Covalent_bond
p164
aa(lp165
Vhttp://dbpedia.org/resource/Hydrophobe
p166
aasg18
(lp167
Velectrostatic
p168
aVcovalent
p169
aVhydrophobic interactions
p170
asg24
(lp171
Vhttp://dbpedia.org/resource/Binding_energy
p172
aVhttp://dbpedia.org/resource/Formwork
p173
aVhttp://dbpedia.org/resource/Alpha_helix
p174
aVhttp://dbpedia.org/resource/Receptor_antagonist
p175
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p176
aVhttp://dbpedia.org/resource/Type_theory
p177
aVhttp://dbpedia.org/resource/Chemical_substance
p178
aVhttp://dbpedia.org/resource/Force
p179
aVhttp://dbpedia.org/resource/Chemical_bond
p180
asg29
S'http://www.pharmacology2000.com/General/Introduction/questions3/questionset3.htm'
p181
sg31
S'The binding of the activated form of phenoxybenzamine (alpha-receptor antagonist) with the alpha receptor is an example of this type of chemical force/bond:'
p182
sg33
I4
sg34
S'Q1#6'
p183
sg36
I25
sg37
S'6'
sg38
I1
sg39
S'1'
sa(dp184
g3
(lp185
(lp186
Vhttp://dbpedia.org/resource/Median_lethal_dose
p187
aa(lp188
Vhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p189
aVhttp://dbpedia.org/resource/Binding_selectivity
p190
aa(lp191
Vhttp://dbpedia.org/resource/Median_lethal_dose
p192
aasg18
(lp193
VED50/LD50
p194
aVpotency/selectivity
p195
aVEC50/LD50
p196
aVTD50/ED50
p197
aVED50
p198
asg24
(lp199
Vhttp://dbpedia.org/resource/Definition
p200
aVhttp://dbpedia.org/resource/Therapeutic_index
p201
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions1/dyn1.htm'
p202
sg31
S'Definition: Therapeutic Index'
p203
sg33
I5
sg34
S'Q3#0'
p204
sg36
I4
sg37
S'0'
sg38
I3
sg39
S'3'
sa(dp205
g3
(lp206
(lp207
Vhttp://dbpedia.org/resource/Propranolol
p208
aa(lp209
Vhttp://dbpedia.org/resource/Iron
p210
aVhttp://dbpedia.org/resource/Coordination_complex
p211
aa(lp212
Vhttp://dbpedia.org/resource/Erythromycin
p213
aVhttp://dbpedia.org/resource/Macrolide
p214
aa(lp215
Vhttp://dbpedia.org/resource/Phenylalanine
p216
aa(lp217
Vhttp://dbpedia.org/resource/Peptide
p218
aasg18
(lp219
Vpropranolol
p220
aViron-complex with its binding protein
p221
aVerythromycin-macrolide antibiotic
p222
aVphenylalanine
p223
aVpeptide
p224
asg24
(lp225
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p226
aVhttp://dbpedia.org/resource/Endocytosis
p227
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions1/dyn1.htm'
p228
sg31
S'Most likely to be transportred into cells by endocytosis:'
p229
sg33
I10
sg34
S'Q3#2'
p230
sg36
I9
sg37
S'2'
sg38
I1
sg39
S'3'
sa(dp231
g3
(lp232
(lp233
Vhttp://dbpedia.org/resource/Area
p234
aa(lp235
Vhttp://dbpedia.org/resource/Subtraction
p236
aVhttp://dbpedia.org/resource/Concentration
p237
aa(lp238
Vhttp://dbpedia.org/resource/Permeability_%28electromagnetism%29
p239
aVhttp://dbpedia.org/resource/Coefficient
p240
aa(lp241
Vhttp://dbpedia.org/resource/Area
p242
aVhttp://dbpedia.org/resource/Permeability_%28electromagnetism%29
p243
aVhttp://dbpedia.org/resource/Coefficient
p244
aasg18
(lp245
Varea/thickness
p246
aVdifference in concentration
p247
aVpermeability coefficient
p248
aVarea x permeability coefficient/thickness
p249
aVthickness
p250
asg24
(lp251
Vhttp://dbpedia.org/resource/Passive_voice
p252
aVhttp://dbpedia.org/resource/Flux
p253
aVhttp://dbpedia.org/resource/Molecule
p254
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions1/dyn1.htm'
p255
sg31
S'Driving force for passive flux of molecules down a concentration gradient:'
p256
sg33
I11
sg34
S'Q3#3'
p257
sg36
I11
sg37
S'3'
sg38
I1
sg39
S'3'
sa(dp258
g3
(lp259
(lp260
Vhttp://dbpedia.org/resource/Transport
p261
aa(lp262
Vhttp://dbpedia.org/resource/Endocytosis
p263
aa(lp264
Vhttp://dbpedia.org/resource/Exocytosis
p265
aa(lp266
Vhttp://dbpedia.org/resource/Lipid
p267
aVhttp://dbpedia.org/resource/Diffusion
p268
aasg18
(lp269
Vcarrier transport
p270
aVpassive diffusion
p271
aVendocytosis
p272
aVexocytosis
p273
aVlipid diffusion
p274
asg24
(lp275
Vhttp://dbpedia.org/resource/Neurotransmitter
p276
aVhttp://dbpedia.org/resource/Chemical_synapse
p277
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions1/dyn1.htm'
p278
sg31
S'Elaboration of vesicular content (neurotransmitter) into the synaptic cleft is an example of:'
p279
sg33
I8
sg34
S'Q3#5'
p280
sg36
I15
sg37
S'5'
sg38
I3
sg39
S'3'
sa(dp281
g3
(lp282
(lp283
Vhttp://dbpedia.org/resource/Amine
p284
aa(lp285
Vhttp://dbpedia.org/resource/Amine
p286
aa(lp287
Vhttp://dbpedia.org/resource/Amine
p288
aa(lp289
Vhttp://dbpedia.org/resource/Quaternary_ammonium_cation
p290
aasg18
(lp291
Vprimary amine
p292
aVsecondary amine
p293
aVtertiary amine
p294
aVquaternary amine
p295
asg24
(lp296
Vhttp://dbpedia.org/resource/Amine
p297
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions1/dyn1.htm'
p298
sg31
S'Permanently charged amine:'
p299
sg33
I8
sg34
S'Q3#8'
p300
sg36
I3
sg37
S'8'
sg38
I3
sg39
S'3'
sa(dp301
g3
(lp302
(lp303
Vhttp://dbpedia.org/resource/Urine
p304
aa(lp305
Vhttp://dbpedia.org/resource/Jejunum
p306
aVhttp://dbpedia.org/resource/Ileum
p307
aa(lp308
Vhttp://dbpedia.org/resource/Stomach
p309
aasg18
(lp310
Vurine
p311
aVbreast milk
p312
aVjejunum,ileum contents
p313
aVstomach contents
p314
aVvaginal secretions
p315
asg24
(lp316
Vhttp://dbpedia.org/resource/Acid
p317
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions1/dyn1.htm'
p318
sg31
S'Most acidic'
p319
sg33
I11
sg34
S'Q3#9'
p320
sg36
I2
sg37
S'9'
sg38
I3
sg39
S'3'
sa(dp321
g3
(lp322
(lp323
Vhttp://dbpedia.org/resource/Stomach
p324
aa(lp325
Vhttp://dbpedia.org/resource/Small_intestine
p326
aa(lp327
Vhttp://dbpedia.org/resource/Kidney
p328
aa(lp329
Vhttp://dbpedia.org/resource/Muscle
p330
aa(lp331
Vhttp://dbpedia.org/resource/Liver
p332
aasg18
(lp333
Vstomach
p334
aVsmall intestine
p335
aVkidney
p336
aVmuscle
p337
aVliver
p338
asg24
(lp339
Vhttp://dbpedia.org/resource/Primary_school
p340
aVhttp://dbpedia.org/resource/Ribosome
p341
aVhttp://dbpedia.org/resource/Drug_metabolism
p342
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions2/kin2.htm'
p343
sg31
S'Primary site for drug metabolism:'
p344
sg33
I6
sg34
S'Q4#0'
p345
sg36
I5
sg37
S'0'
sg38
I4
sg39
S'4'
sa(dp346
g3
(lp347
(lp348
Vhttp://dbpedia.org/resource/Mitochondrion
p349
aVhttp://dbpedia.org/resource/Fraction_%28mathematics%29
p350
aa(lp351
Vhttp://dbpedia.org/resource/Cell_membrane
p352
aa(lp353
Vhttp://dbpedia.org/resource/Golgi_apparatus
p354
aa(lp355
Vhttp://dbpedia.org/resource/Fraction_%28mathematics%29
p356
aa(lp357
Vhttp://dbpedia.org/resource/Nucleolus
p358
aasg18
(lp359
Vmitochondrial fraction
p360
aVcell membranes
p361
aVgolgi bodies
p362
aVmicrosomal fraction
p363
aVnucleolus
p364
asg24
(lp365
Vhttp://dbpedia.org/resource/Drug
p366
aVhttp://dbpedia.org/resource/Mixed_media
p367
aVhttp://dbpedia.org/resource/Function_%28mathematics%29
p368
aVhttp://dbpedia.org/resource/Oxidase
p369
aVhttp://dbpedia.org/resource/Cytochrome_P450
p370
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions2/kin2.htm'
p371
sg31
S'Drug mixed-function oxidase (p450) mainly localized:'
p372
sg33
I9
sg34
S'Q4#1'
p373
sg36
I8
sg37
S'1'
sg38
I3
sg39
S'4'
sa(dp374
g3
(lp375
(lp376
Vhttp://dbpedia.org/resource/Monoamine_oxidase
p377
aa(lp378
Vhttp://dbpedia.org/resource/Redox
p379
aasg18
(lp380
Vamine oxidase
p381
aVepoxidation
p382
aVN-oxidation
p383
aVS-oxidation
p384
aVdeamination
p385
asg24
(lp386
Vhttp://dbpedia.org/resource/Cytochrome
p387
aVhttp://dbpedia.org/resource/Cytochrome_P450
p388
aVhttp://dbpedia.org/resource/Redox
p389
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions2/kin2.htm'
p390
sg31
S'Cytochrome-P450 INDEPENDENT oxidation'
p391
sg33
I6
sg34
S'Q4#4'
p392
sg36
I3
sg37
S'4'
sg38
I0
sg39
S'4'
sa(dp393
g3
(lp394
(lp395
Vhttp://dbpedia.org/resource/Phencyclidine
p396
aVhttp://dbpedia.org/resource/Structure
p397
aa(lp398
Vhttp://dbpedia.org/resource/Heart
p399
aVhttp://dbpedia.org/resource/Depression_%28mood%29
p400
aa(lp401
Vhttp://dbpedia.org/resource/Ketamine
p402
aVhttp://dbpedia.org/resource/Ketamine
p403
aVhttp://dbpedia.org/resource/Receptor_antagonist
p404
aasg18
(lp405
Vrelated to phencyclidine structurally
p406
aVsignificant cardiac depression
p407
aVsignificant respiratory depression
p408
aVflumazenil (Romazicon) is a specific ketamine (Ketalar) antagonist
p409
asg24
(lp410
Vhttp://dbpedia.org/resource/Ketamine
p411
aVhttp://dbpedia.org/resource/Ketamine
p412
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p413
sg31
S'Ketamine (Ketalar):'
p414
sg33
I22
sg34
S'Q8#0'
p415
sg36
I5
sg37
S'0'
sg38
I0
sg39
S'8'
sa(dp416
g3
(lp417
(lp418
Vhttp://dbpedia.org/resource/Anesthesia
p419
aa(lp420
Vhttp://dbpedia.org/resource/Swallowing
p421
aVhttp://dbpedia.org/resource/Cornea
p422
aVhttp://dbpedia.org/resource/Reflex
p423
aa(lp424
Vhttp://dbpedia.org/resource/Amnesia
p425
aa(lp426
Vhttp://dbpedia.org/resource/Redox
p427
aVhttp://dbpedia.org/resource/Muscle
p428
aVhttp://dbpedia.org/resource/Limb_%28anatomy%29
p429
aa(lp430
Vhttp://dbpedia.org/resource/Likelihood_function
p431
aVhttp://dbpedia.org/resource/Emergence
p432
aVhttp://dbpedia.org/resource/Syndrome
p433
aasg18
(lp434
Vdissociative anesthesia
p435
aVswallow and corneal reflexes present
p436
aVamnestic effects
p437
aVreduced muscle limb tone
p438
aV80% likelihood of emergence syndrome
p439
asg24
(lp440
Vhttp://dbpedia.org/resource/Ketamine
p441
aVhttp://dbpedia.org/resource/Ketamine
p442
aVhttp://dbpedia.org/resource/Pharmacology
p443
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p444
sg31
S'Ketamine (Ketalar) pharmacology:'
p445
sg33
I19
sg34
S'Q8#3'
p446
sg36
I5
sg37
S'3'
sg38
I2
sg39
S'8'
sa(dp447
g3
(lp448
(lp449
Vhttp://dbpedia.org/resource/Highland_Clearances
p450
aVhttp://dbpedia.org/resource/Sodium_thiopental
p451
aVhttp://dbpedia.org/resource/Sodium_thiopental
p452
aasg18
(lp453
Vrapid onset
p454
aVrapid initial redistribution phase
p455
aVlow clearance compared to thiopental (Pentothal)
p456
asg24
(lp457
Vhttp://dbpedia.org/resource/Pharmacokinetics
p458
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p459
sg31
S'Etomidate (Amidate) pharmacokinetics:'
p460
sg33
I14
sg34
S'Q8#7'
p461
sg36
I5
sg37
S'7'
sg38
I1
sg39
S'8'
sa(dp462
g3
(lp463
(lp464
Vhttp://dbpedia.org/resource/Analgesic
p465
aa(lp466
Vhttp://dbpedia.org/resource/Acts_of_the_Apostles
p467
aVhttp://dbpedia.org/resource/Interaction
p468
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p469
aVhttp://dbpedia.org/resource/System
p470
aa(lp471
Vhttp://dbpedia.org/resource/Redox
p472
aVhttp://dbpedia.org/resource/Metabolism
p473
aa(lp474
Vhttp://dbpedia.org/resource/Redox
p475
aa(lp476
Vhttp://dbpedia.org/resource/Electroencephalography
p477
aVhttp://dbpedia.org/resource/Activation_energy
p478
aVhttp://dbpedia.org/resource/Consistency
p479
aVhttp://dbpedia.org/resource/Epilepsy
p480
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p481
aasg18
(lp482
Vexcellent analgesic
p483
aVprobably acts by interacting with GABA-ergic receptor systems
p484
aVreduction in cerebral metabolism
p485
aVreduce cerebral blood flow
p486
aVEEG activation, consistent with possible epileptogenic activity
p487
asg24
(lp488
Vhttp://dbpedia.org/resource/Pharmacology
p489
aVhttp://dbpedia.org/resource/Central_nervous_system
p490
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p491
sg31
S'Etomidate (Amidate) pharmacology: CNS actions'
p492
sg33
I26
sg34
S'Q8#8'
p493
sg36
I8
sg37
S'8'
sg38
I4
sg39
S'8'
sa(dp494
g3
(lp495
(lp496
Vhttp://dbpedia.org/resource/Redox
p497
aVhttp://dbpedia.org/resource/Basal_metabolic_rate
p498
aa(lp499
Vhttp://dbpedia.org/resource/Intracranial_pressure
p500
aa(lp501
Vhttp://dbpedia.org/resource/Electroencephalography
p502
aVhttp://dbpedia.org/resource/Observation
p503
aasg18
(lp504
Vreduced cerebral metabolic rate
p505
aVincreased cerebral blood flow
p506
aVincreased intracranial pressure
p507
aVEEG changes observed
p508
asg24
(lp509
Vhttp://dbpedia.org/resource/Propofol
p510
aVhttp://dbpedia.org/resource/Propofol
p511
aVhttp://dbpedia.org/resource/Central_nervous_system
p512
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p513
sg31
S'Propofol (Diprivan): organ system effects -- CNS'
p514
sg33
I14
sg34
S'Q8#12'
p515
sg36
I10
sg37
S'12'
p516
sg38
I3
sg39
S'8'
sa(dp517
g3
(lp518
(lp519
Vhttp://dbpedia.org/resource/Sodium_thiopental
p520
aVhttp://dbpedia.org/resource/Sodium_thiopental
p521
aa(lp522
Vhttp://dbpedia.org/resource/Propofol
p523
aVhttp://dbpedia.org/resource/Propofol
p524
aasg18
(lp525
Vthiopental (Pentothal)
p526
aVpropofol (Diprivan)
p527
aVetomidate (Amidate)
p528
asg24
(lp529
Vhttp://dbpedia.org/resource/Pain
p530
aVhttp://dbpedia.org/resource/Intravenous_therapy
p531
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p532
sg31
S'More likely to be associated with a painful IV administration:'
p533
sg33
I12
sg34
S'Q8#16'
p534
sg36
I10
sg37
S'16'
p535
sg38
I1
sg39
S'8'
sa(dp536
g3
(lp537
(lp538
Vhttp://dbpedia.org/resource/Kappa_Alpha_Psi
p539
aa(lp540
Vhttp://dbpedia.org/resource/Sigma_receptor
p541
aasg18
(lp542
Vkappa
p543
aVmu
p544
aVsigma
p545
asg24
(lp546
Vhttp://dbpedia.org/resource/Opioid_receptor
p547
aVhttp://dbpedia.org/resource/Analgesic
p548
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p549
sg31
S'Opioid receptor subtype most likely associated with analgesia and respiratory depression'
p550
sg33
I3
sg34
S'Q8#18'
p551
sg36
I11
sg37
S'18'
p552
sg38
I1
sg39
S'8'
sa(dp553
g3
(lp554
(lp555
Vhttp://dbpedia.org/resource/Fentanyl
p556
aVhttp://dbpedia.org/resource/Fentanyl
p557
aasg18
(lp558
Vsufentanil (Sufenta)
p559
aValfentanil (Alfenta)
p560
aVfentanyl (Sublimaze)
p561
asg24
(lp562
Vhttp://dbpedia.org/resource/Ionization
p563
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p564
sg31
S'Most likely to be un-ionized (uncharged) at physiological pH:'
p565
sg33
I12
sg34
S'Q8#23'
p566
sg36
I11
sg37
S'23'
p567
sg38
I1
sg39
S'8'
sa(dp568
g3
(lp569
(lp570
Vhttp://dbpedia.org/resource/Fentanyl
p571
aVhttp://dbpedia.org/resource/Fentanyl
p572
aasg18
(lp573
Vfentanyl (Sublimaze)
p574
aVsufentanil (Sufenta)
p575
aValfentanil (Alfenta)
p576
asg24
(lp577
Vhttp://dbpedia.org/resource/Short_film
p578
aVhttp://dbpedia.org/resource/Duration_%28music%29
p579
aVhttp://dbpedia.org/resource/Agent_%28economics%29
p580
aVhttp://dbpedia.org/resource/City_block
p581
aVhttp://dbpedia.org/resource/Physiology
p582
aVhttp://dbpedia.org/resource/Single_%28baseball%29
p583
aVhttp://dbpedia.org/resource/Performance
p584
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p585
sg31
S'Extremely short duration of action may make this agent preferable to block physiological responses to a single, brief intervention such as performing a retrobulbar block'
p586
sg33
I12
sg34
S'Q8#24'
p587
sg36
I26
sg37
S'24'
p588
sg38
I2
sg39
S'8'
sa(dp589
g3
(lp590
(lp591
Vhttp://dbpedia.org/resource/Fentanyl
p592
aVhttp://dbpedia.org/resource/Fentanyl
p593
aasg18
(lp594
Valfentanil (Alfenta)
p595
aVremifentanil (Ultiva)
p596
aVfentanyl (Sublimaze)
p597
aVsufentanil (Sufenta)
p598
asg24
(lp599
Vhttp://dbpedia.org/resource/Opioid
p600
aVhttp://dbpedia.org/resource/Anesthesia
p601
aVhttp://dbpedia.org/resource/Ester
p602
aVhttp://dbpedia.org/resource/Hydrolysis
p603
asg29
S'http://www.pharmacology2000.com/General/Pharmacokinetics/questions6/kin6.htm'
p604
sg31
S'Unique among the various opioids use in IV anesthesia because of its susceptibility to ester hydrolysis:'
p605
sg33
I16
sg34
S'Q8#25'
p606
sg36
I16
sg37
S'25'
p607
sg38
I1
sg39
S'8'
sa(dp608
g3
(lp609
(lp610
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p611
aasg18
(lp612
Vbeta-adrenergic receptor
p613
aVmuscarinic cholinergic receptor
p614
aVsteroid receptor
p615
asg24
(lp616
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p617
asg29
S'http://www.pharmacology2000.com/General/Pharmacodynamics/questions1/questionset1.htm'
p618
sg31
S'Example(s) of an intracellular receptor:'
p619
sg33
I7
sg34
S'Q9#5'
p620
sg36
I8
sg37
S'5'
sg38
I2
sg39
S'9'
sa(dp621
g3
(lp622
(lp623
Vhttp://dbpedia.org/resource/Norepinephrine
p624
aa(lp625
Vhttp://dbpedia.org/resource/Growth_hormone
p626
aa(lp627
Vhttp://dbpedia.org/resource/Corticosteroid
p628
aa(lp629
Vhttp://dbpedia.org/resource/Vitamin_D
p630
aasg18
(lp631
Visoproterenol
p632
aVnorepinephrine
p633
aVgrowth hormone
p634
aVcorticosteroids
p635
aVvitamin D
p636
asg24
(lp637
Vhttp://dbpedia.org/resource/Agent_Orange
p638
asg29
S'http://www.pharmacology2000.com/General/Pharmacodynamics/questions1/questionset1.htm'
p639
sg31
S'Example of an agent that activates cytokine receptor:'
p640
sg33
I7
sg34
S'Q9#6'
p641
sg36
I8
sg37
S'6'
sg38
I2
sg39
S'9'
sa(dp642
g3
(lp643
(lp644
Vhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p645
aVhttp://dbpedia.org/resource/Curve
p646
aa(lp647
Vhttp://dbpedia.org/resource/Receptor_antagonist
p648
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p649
aasg18
(lp650
Vat high concentrations of agonist, a maximal physiological responds is not possible even in the presence of the antagonist
p651
aVwith competitive inhibition, the dose effect curve is shifted to the right
p652
aVis irreversible
p653
aVis produced by antagonists that have the ability to activate receptors
p654
asg24
(lp655
Vhttp://dbpedia.org/resource/Concentration
p656
aVhttp://dbpedia.org/resource/Agonist
p657
aVhttp://dbpedia.org/resource/Physiology
p658
aVhttp://dbpedia.org/resource/Receptor_antagonist
p659
asg29
S'http://www.pharmacology2000.com/General/Pharmacodynamics/questions1/questionset1.htm'
p660
sg31
S'Competitive inhibition:'
p661
sg33
I46
sg34
S'Q9#10'
p662
sg36
I2
sg37
S'10'
p663
sg38
I1
sg39
S'9'
sa(dp664
g3
(lp665
(lp666
Vhttp://dbpedia.org/resource/Aspartic_acid
p667
aa(lp668
Vhttp://dbpedia.org/resource/Acetylcholine
p669
aa(lp670
Vhttp://dbpedia.org/resource/Glutamic_acid
p671
aasg18
(lp672
Vaspartate
p673
aVGABA
p674
aVacetylcholine
p675
aVglutamate
p676
aV serotonin
p677
asg24
(lp678
Vhttp://dbpedia.org/resource/Diazepam
p679
aVhttp://dbpedia.org/resource/Diazepam
p680
aVhttp://dbpedia.org/resource/Air_Corps_Tactical_School
p681
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p682
asg29
S'http://www.pharmacology2000.com/General/Pharmacodynamics/questions2/questionset2.htm'
p683
sg31
S'Valium (diazepam) acts through this receptor system:'
p684
sg33
I5
sg34
S'Q10#0'
p685
sg36
I9
sg37
S'0'
sg38
I1
sg39
S'10'
p686
sa(dp687
g3
(lp688
(lp689
Vhttp://dbpedia.org/resource/Median_lethal_dose
p690
aasg18
(lp691
VLD50
p692
aVKd
p693
aVEC50
p694
aVTI
p695
asg24
(lp696
Vhttp://dbpedia.org/resource/Drug
p697
aVhttp://dbpedia.org/resource/Concentration
p698
aVhttp://dbpedia.org/resource/Drug
p699
aVhttp://dbpedia.org/resource/Maximal_%28Transformers%29
p700
asg29
S'http://www.pharmacology2000.com/General/Pharmacodynamics/questions2/questionset2.htm'
p701
sg31
S"Refers to drug concentration producing 50% of that drug's maximal effect:"
p702
sg33
I4
sg34
S'Q10#8'
p703
sg36
I13
sg37
S'8'
sg38
I2
sg39
S'10'
p704
sa(dp705
g3
(lp706
(lp707
Vhttp://dbpedia.org/resource/Somatic
p708
aVhttp://dbpedia.org/resource/Peripheral_nerve
p709
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p710
aVhttp://dbpedia.org/resource/Peripheral_nerve
p711
aVhttp://dbpedia.org/resource/Ganglion
p712
aa(lp713
Vhttp://dbpedia.org/resource/Fiber
p714
aVhttp://dbpedia.org/resource/Vagus_nerve
p715
aVhttp://dbpedia.org/resource/Sensory_neuron
p716
aa(lp717
Vhttp://dbpedia.org/resource/Motor_neuron
p718
aVhttp://dbpedia.org/resource/Myelin
p719
aasg18
(lp720
Vsomatic nerves, like autonomic nerves contain ganglia.
p721
aVMost of the fibers in the vagus nerve ar sensory
p722
aVdenervated smooth muscle show spontaneous activity
p723
aVmotor nerves are typically unmyelinated.
p724
asg24
(lp725
Vhttp://dbpedia.org/resource/Autonomic_nervous_system
p726
aVhttp://dbpedia.org/resource/Somatic
p727
aVhttp://dbpedia.org/resource/Peripheral_nerve
p728
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p729
sg31
S'Comparing autonomic and somatic nerves:'
p730
sg33
I30
sg34
S'Q11#1'
p731
sg36
I5
sg37
S'1'
sg38
I1
sg39
S'11'
p732
sa(dp733
g3
(lp734
(lp735
Vhttp://dbpedia.org/resource/Cerebellum
p736
aa(lp737
Vhttp://dbpedia.org/resource/Hypothalamus
p738
aa(lp739
Vhttp://dbpedia.org/resource/Spinal_cord
p740
aasg18
(lp741
Vcerebellum
p742
aVsensory cortex
p743
aVhypothalamus
p744
aVspinal cord--dorsal horn
p745
asg24
(lp746
Vhttp://dbpedia.org/resource/Anatomy
p747
aVhttp://dbpedia.org/resource/Integral
p748
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p749
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p750
sg31
S'Major anatomical site for integration of autonomic information:'
p751
sg33
I9
sg34
S'Q11#2'
p752
sg36
I8
sg37
S'2'
sg38
I2
sg39
S'11'
p753
sa(dp754
g3
(lp755
(lp756
Vhttp://dbpedia.org/resource/Vasoconstriction
p757
aVhttp://dbpedia.org/resource/Vasoconstriction
p758
aa(lp759
Vhttp://dbpedia.org/resource/Vasodilation
p760
aVhttp://dbpedia.org/resource/Vasodilation
p761
aa(lp762
Vhttp://dbpedia.org/resource/Vasodilation
p763
aVhttp://dbpedia.org/resource/Vasoconstriction
p764
aa(lp765
Vhttp://dbpedia.org/resource/Vasoconstriction
p766
aVhttp://dbpedia.org/resource/Vasodilation
p767
aasg18
(lp768
Vvasoconstriction, vasoconstriction
p769
aVvasodilatation, vasodilatation
p770
aVvasodilatation, vasoconstriction
p771
aVvasoconstriction, vasodilation
p772
asg24
(lp773
Vhttp://dbpedia.org/resource/Activation_energy
p774
aVhttp://dbpedia.org/resource/Sympathetic_nervous_system
p775
aVhttp://dbpedia.org/resource/Menopause
p776
aVhttp://dbpedia.org/resource/Skin
p777
aVhttp://dbpedia.org/resource/Vascular
p778
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p779
sg31
S'Activation of the sympathetic nervous system will caus which change in the skeletal muscle versus cutaneous vascular beds.'
p780
sg33
I12
sg34
S'Q11#4'
p781
sg36
I19
sg37
S'4'
sg38
I2
sg39
S'11'
p782
sa(dp783
g3
(lp784
(lp785
Vhttp://dbpedia.org/resource/Beta_cell
p786
aa(lp787
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p788
aa(lp789
Vhttp://dbpedia.org/resource/Serotonergic
p790
aasg18
(lp791
Vbeta-2
p792
aValpha-1
p793
aVmuscarinic
p794
aVserotonergic
p795
asg24
(lp796
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p797
aVhttp://dbpedia.org/resource/Type_theory
p798
aVhttp://dbpedia.org/resource/Mediation
p799
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p800
sg31
S'Adrenergic receptor type(s) mediating pupillary dilation'
p801
sg33
I4
sg34
S'Q11#5'
p802
sg36
I9
sg37
S'5'
sg38
I1
sg39
S'11'
p803
sa(dp804
g3
(lp805
(lp806
Vhttp://dbpedia.org/resource/Nicotinic_acetylcholine_receptor
p807
aa(lp808
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p809
aa(lp810
Vhttp://dbpedia.org/resource/Nitric_oxide
p811
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p812
aa(lp813
Vhttp://dbpedia.org/resource/Substance_P
p814
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p815
aasg18
(lp816
Vnicotinic
p817
aVmuscarinic
p818
aVnitric oxide receptor
p819
aVsubstance P receptor
p820
asg24
(lp821
Vhttp://dbpedia.org/resource/Mediation
p822
aVhttp://dbpedia.org/resource/Vasodilation
p823
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p824
aVhttp://dbpedia.org/resource/Acetylcholine
p825
aVhttp://dbpedia.org/resource/Administration_%28government%29
p826
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p827
sg31
S'Cholinergic receptor type that mediates vasodilation following low-dose i.v. acetylcholine administration:'
p828
sg33
I8
sg34
S'Q11#6'
p829
sg36
I11
sg37
S'6'
sg38
I1
sg39
S'11'
p830
sa(dp831
g3
(lp832
(lp833
Vhttp://dbpedia.org/resource/Liver
p834
aa(lp835
Vhttp://dbpedia.org/resource/Red_blood_cell
p836
aa(lp837
Vhttp://dbpedia.org/resource/Blood_plasma
p838
aasg18
(lp839
Vglia
p840
aVliver
p841
aVerythrocytes
p842
aVplasma
p843
asg24
(lp844
Vhttp://dbpedia.org/resource/True_%28Spandau_Ballet_song%29
p845
aVhttp://dbpedia.org/resource/Acetylcholinesterase
p846
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p847
sg31
S'"True" acetylcholinesterase is found in:'
p848
sg33
I4
sg34
S'Q11#7'
p849
sg36
I7
sg37
S'7'
sg38
I2
sg39
S'11'
p850
sa(dp851
g3
(lp852
(lp853
Vhttp://dbpedia.org/resource/Methyl_group
p854
aVhttp://dbpedia.org/resource/Transferase
p855
aasg18
(lp856
VDOPA decarboxylase
p857
aVphenylethanolamine N-methyl transferase
p858
aVtyrosine hydroxylase
p859
aVdopamine-beta-hydroxylase
p860
asg24
(lp861
Vhttp://dbpedia.org/resource/Catalysis
p862
aVhttp://dbpedia.org/resource/Catecholamine
p863
aVhttp://dbpedia.org/resource/Biosynthesis
p864
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p865
sg31
S'Catalyzes rate-limiting step in catecholamine biosynthesis:'
p866
sg33
I8
sg34
S'Q11#8'
p867
sg36
I6
sg37
S'8'
sg38
I2
sg39
S'11'
p868
sa(dp869
g3
(lp870
(lp871
Vhttp://dbpedia.org/resource/Monoamine_oxidase
p872
aVhttp://dbpedia.org/resource/Monoamine_oxidase
p873
aa(lp874
Vhttp://dbpedia.org/resource/Reuptake
p875
aasg18
(lp876
VCOMT (catechol-O-methyl transferase)
p877
aVMAO (monoamine oxidase)
p878
aVcholine acetyltransferase
p879
aVreuptake-I inhibitor
p880
asg24
(lp881
Vhttp://dbpedia.org/resource/Drug
p882
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p883
sg31
S'Inhibited by drugs such as phenelzine or tranylcypromine;'
p884
sg33
I14
sg34
S'Q11#9'
p885
sg36
I9
sg37
S'9'
sg38
I1
sg39
S'11'
p886
sa(dp887
g3
(lp888
(lp889
Vhttp://dbpedia.org/resource/Epinephrine
p890
aa(lp891
Vhttp://dbpedia.org/resource/Phenylephrine
p892
aasg18
(lp893
Vepinephrine
p894
aVterbutaline (Brethine)
p895
aVphenylephrine
p896
aVphentolamine (Regitine)
p897
asg24
(lp898
Vhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p899
aVhttp://dbpedia.org/resource/Sensitivity_and_specificity
p900
aVhttp://dbpedia.org/resource/Catecholamine
p901
aVhttp://dbpedia.org/resource/Produce
p902
aVhttp://dbpedia.org/resource/Relaxation_technique
p903
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p904
sg31
S'Due to receptor specificity, catecholamine LEAST likely to produce bronchiolar smooth muscle relaxation:'
p905
sg33
I10
sg34
S'Q11#11'
p906
sg36
I14
sg37
S'11'
p907
sg38
I2
sg39
S'11'
p908
sa(dp909
g3
(lp910
sg18
(lp911
Vedrophonium (Tensilon)
p912
aVdiisopropylphosphate (DFP)
p913
aVatropine
p914
aVmuscarine
p915
asg24
(lp916
Vhttp://dbpedia.org/resource/Atropine
p917
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p918
sg31
S'Covalent inhibitor of acetylcholinesterse:'
p919
sg33
I10
sg34
S'Q11#13'
p920
sg36
I4
sg37
S'13'
p921
sg38
I1
sg39
S'11'
p922
sa(dp923
g3
(lp924
(lp925
Vhttp://dbpedia.org/resource/Atropine
p926
aasg18
(lp927
Vterbutaline (Brethine)
p928
aVatropine
p929
aVmethoxamine (Vasoxyl)
p930
aVisoproterenol (Isuprel)
p931
asg24
(lp932
Vhttp://dbpedia.org/resource/Alpha_helix
p933
aVhttp://dbpedia.org/resource/Agonist
p934
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p935
sg31
S'Alpha-adenergic receptor agonist:'
p936
sg33
I13
sg34
S'Q11#14'
p937
sg36
I3
sg37
S'14'
p938
sg38
I2
sg39
S'11'
p939
sa(dp940
g3
(lp941
(lp942
Vhttp://dbpedia.org/resource/Heart_rate
p943
aa(lp944
Vhttp://dbpedia.org/resource/Heart_rate
p945
aa(lp946
Vhttp://dbpedia.org/resource/Heart_rate
p947
aasg18
(lp948
Vdecrease heart rate; increase contractility
p949
aVincrease heart rate; decrease contractility
p950
aVdecrease heart rate; decrease contractility
p951
aVincrease AV nodal conduction velocity
p952
asg24
(lp953
Vhttp://dbpedia.org/resource/Parasympathetic_nervous_system
p954
aVhttp://dbpedia.org/resource/Direct_current
p955
aVhttp://dbpedia.org/resource/Heart
p956
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p957
sg31
S'Parasympathetic direct cardiac effects:'
p958
sg33
I23
sg34
S'Q11#15'
p959
sg36
I4
sg37
S'15'
p960
sg38
I2
sg39
S'11'
p961
sa(dp962
g3
(lp963
(lp964
Vhttp://dbpedia.org/resource/Physostigmine
p965
aasg18
(lp966
VDFP
p967
aVpilocarpine (Pilocar)
p968
aVphysostigmine (Antilirium)
p969
aVipratropium (Atrovent)
p970
asg24
(lp971
Vhttp://dbpedia.org/resource/Alkaloid
p972
aVhttp://dbpedia.org/resource/Agonist
p973
aVhttp://dbpedia.org/resource/Acting_%28law%29
p974
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p975
aVhttp://dbpedia.org/resource/Cholinergic
p976
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p977
sg31
S'Alkaloid agonist acting at muscarinic, cholinergic receptors:'
p978
sg33
I13
sg34
S'Q11#17'
p979
sg36
I8
sg37
S'17'
p980
sg38
I1
sg39
S'11'
p981
sa(dp982
g3
(lp983
(lp984
Vhttp://dbpedia.org/resource/Nicotine
p985
aa(lp986
Vhttp://dbpedia.org/resource/Atropine
p987
aasg18
(lp988
Vnicotine
p989
aVechothiophate (Phospholine)
p990
aVatropine
p991
aVpilocarpine (Pilocar)
p992
asg24
(lp993
Vhttp://dbpedia.org/resource/Effectiveness
p994
aVhttp://dbpedia.org/resource/Organophosphate
p995
aVhttp://dbpedia.org/resource/Toxicity
p996
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p997
sg31
S'Effective in treating both organophosphate and muscarine intoxication:'
p998
sg33
I10
sg34
S'Q11#18'
p999
sg36
I8
sg37
S'18'
p1000
sg38
I2
sg39
S'11'
p1001
sa(dp1002
g3
(lp1003
sg18
(lp1004
Vincreased
p1005
aVdecreased
p1006
aVno changed
p1007
aVone of the others is right
p1008
asg24
(lp1009
Vhttp://dbpedia.org/resource/Cholinergic
p1010
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p1011
aVhttp://dbpedia.org/resource/Gastric_acid
p1012
aVhttp://dbpedia.org/resource/Secretion
p1013
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions3/intro1.htm'
p1014
sg31
S'Cholinergic activity on stomach acid secretion'
p1015
sg33
I10
sg34
S'Q11#19'
p1016
sg36
I6
sg37
S'19'
p1017
sg38
I0
sg39
S'11'
p1018
sa(dp1019
g3
(lp1020
(lp1021
Vhttp://dbpedia.org/resource/Propranolol
p1022
aVhttp://dbpedia.org/resource/Propranolol
p1023
aa(lp1024
Vhttp://dbpedia.org/resource/Sodium
p1025
aa(lp1026
Vhttp://dbpedia.org/resource/Phenylephrine
p1027
aVhttp://dbpedia.org/resource/Phenylephrine
p1028
aasg18
(lp1029
Vphentolamine (Regitine)
p1030
aVpropranolol (Inderal)
p1031
aVnitroprusside sodium (Nipride)
p1032
aVphenylephrine (Neo-Synephrine)
p1033
asg24
(lp1034
Vhttp://dbpedia.org/resource/Redox
p1035
aVhttp://dbpedia.org/resource/Blood_pressure
p1036
aVhttp://dbpedia.org/resource/Heart_rate
p1037
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1038
sg31
S'Most likely to reduce blood pressure by directly decreasing heart rate:'
p1039
sg33
I17
sg34
S'Q12#0'
p1040
sg36
I11
sg37
S'0'
sg38
I1
sg39
S'12'
p1041
sa(dp1042
g3
(lp1043
(lp1044
Vhttp://dbpedia.org/resource/Sodium
p1045
aa(lp1046
Vhttp://dbpedia.org/resource/Propranolol
p1047
aVhttp://dbpedia.org/resource/Propranolol
p1048
aasg18
(lp1049
Vmethoxamine (Vasoxyl)
p1050
aVnitroprusside sodium (Nipride)
p1051
aVpropranolol (Inderal)
p1052
aVmetoprolol (Lopressor)
p1053
asg24
(lp1054
Vhttp://dbpedia.org/resource/Perspective_%28cognitive%29
p1055
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1056
sg31
S"From the point of view of Starling's law which antihypertensive would be most likely to reduce contractility."
p1057
sg33
I17
sg34
S'Q12#1'
p1058
sg36
I19
sg37
S'1'
sg38
I1
sg39
S'12'
p1059
sa(dp1060
g3
(lp1061
(lp1062
Vhttp://dbpedia.org/resource/Norepinephrine
p1063
aasg18
(lp1064
Visoproterenol (Isuprel)
p1065
aVepinephrine
p1066
aVdiltiazem (Cardiazem)
p1067
aVnorepinephrine
p1068
asg24
(lp1069
Vhttp://dbpedia.org/resource/Epinephrine
p1070
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1071
sg31
S'Negative inotropism'
p1072
sg33
I10
sg34
S'Q12#2'
p1073
sg36
I2
sg37
S'2'
sg38
I2
sg39
S'12'
p1074
sa(dp1075
g3
(lp1076
(lp1077
Vhttp://dbpedia.org/resource/Dopamine
p1078
aVhttp://dbpedia.org/resource/Dopamine
p1079
aa(lp1080
Vhttp://dbpedia.org/resource/Sodium
p1081
aa(lp1082
Vhttp://dbpedia.org/resource/Digoxin
p1083
aVhttp://dbpedia.org/resource/Digoxin
p1084
aasg18
(lp1085
Vdopamine (Intropin)
p1086
aVmetoprolol (Lopressor)
p1087
aVnitroprusside sodium (Nipride)
p1088
aVdigoxin (Lanoxin, Lanoxicaps)
p1089
asg24
(lp1090
Vhttp://dbpedia.org/resource/Pulmonary_edema
p1091
aVhttp://dbpedia.org/resource/Heart_failure
p1092
aVhttp://dbpedia.org/resource/Swiss_franc
p1093
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1094
sg31
S'Increases pulmonary congestion in congestive heart failure (CHF)'
p1095
sg33
I19
sg34
S'Q12#3'
p1096
sg36
I10
sg37
S'3'
sg38
I1
sg39
S'12'
p1097
sa(dp1098
g3
(lp1099
(lp1100
Vhttp://dbpedia.org/resource/Dopamine
p1101
aVhttp://dbpedia.org/resource/Dopamine
p1102
aa(lp1103
Vhttp://dbpedia.org/resource/Epinephrine
p1104
aa(lp1105
Vhttp://dbpedia.org/resource/Norepinephrine
p1106
aa(lp1107
Vhttp://dbpedia.org/resource/Acetylcholine
p1108
aasg18
(lp1109
Vdopamine (Intropin)
p1110
aVepinephrine
p1111
aVnorepinephrine
p1112
aVacetylcholine
p1113
asg24
(lp1114
Vhttp://dbpedia.org/resource/Major_%28United_States%29
p1115
aVhttp://dbpedia.org/resource/Neurotransmitter
p1116
aVhttp://dbpedia.org/resource/Organ_%28anatomy%29
p1117
aVhttp://dbpedia.org/resource/Division_%28business%29
p1118
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p1119
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1120
sg31
S'Major neurotransmitter released at end organ effectors of the thoracolumbar division of the autonomic nervous system:'
p1121
sg33
I7
sg34
S'Q12#4'
p1122
sg36
I16
sg37
S'4'
sg38
I2
sg39
S'12'
p1123
sa(dp1124
g3
(lp1125
(lp1126
Vhttp://dbpedia.org/resource/Norepinephrine
p1127
aa(lp1128
Vhttp://dbpedia.org/resource/Substance_P
p1129
aa(lp1130
Vhttp://dbpedia.org/resource/Epinephrine
p1131
aa(lp1132
Vhttp://dbpedia.org/resource/Acetylcholine
p1133
aasg18
(lp1134
Vnorepinephrine
p1135
aVsubstance P
p1136
aVepinephrine
p1137
aVacetylcholine
p1138
asg24
(lp1139
Vhttp://dbpedia.org/resource/Neurotransmitter
p1140
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1141
sg31
S'Neurotransmitter of preganglionic fibers:'
p1142
sg33
I5
sg34
S'Q12#5'
p1143
sg36
I4
sg37
S'5'
sg38
I3
sg39
S'12'
p1144
sa(dp1145
g3
(lp1146
(lp1147
Vhttp://dbpedia.org/resource/Pupil
p1148
aVhttp://dbpedia.org/resource/Constriction
p1149
aa(lp1150
Vhttp://dbpedia.org/resource/Blood_flow
p1151
aVhttp://dbpedia.org/resource/Skin
p1152
aa(lp1153
Vhttp://dbpedia.org/resource/Blood_sugar
p1154
aVhttp://dbpedia.org/resource/Falls_Festival
p1155
aa(lp1156
Vhttp://dbpedia.org/resource/Constriction
p1157
aasg18
(lp1158
Vpupillary constriction
p1159
aVblood flow shifted from cutaneous beds to skeletal muscle
p1160
aVblood glucose falls
p1161
aVbronchiolar constriction
p1162
asg24
(lp1163
Vhttp://dbpedia.org/resource/Fight-or-flight_response
p1164
aVhttp://dbpedia.org/resource/Activation_energy
p1165
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p1166
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1167
sg31
S'"Fight or flight" activation of the ANS:'
p1168
sg33
I16
sg34
S'Q12#6'
p1169
sg36
I9
sg37
S'6'
sg38
I1
sg39
S'12'
p1170
sa(dp1171
g3
(lp1172
(lp1173
Vhttp://dbpedia.org/resource/Tyrosine
p1174
aa(lp1175
Vhttp://dbpedia.org/resource/Dopamine
p1176
aa(lp1177
Vhttp://dbpedia.org/resource/Dopamine
p1178
aVhttp://dbpedia.org/resource/Norepinephrine
p1179
aa(lp1180
Vhttp://dbpedia.org/resource/Norepinephrine
p1181
aVhttp://dbpedia.org/resource/Epinephrine
p1182
aasg18
(lp1183
Vtyrosine to DOPA
p1184
aVDOPA to dopamine
p1185
aVdopamine to norepinephrine
p1186
aVnorepinephrine to epinephrine
p1187
asg24
(lp1188
Vhttp://dbpedia.org/resource/Catalysis
p1189
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1190
sg31
S'Dopamine beta hydroxylase catalyzes:'
p1191
sg33
I12
sg34
S'Q12#8'
p1192
sg36
I4
sg37
S'8'
sg38
I2
sg39
S'12'
p1193
sa(dp1194
g3
(lp1195
(lp1196
Vhttp://dbpedia.org/resource/Metabolism
p1197
aVhttp://dbpedia.org/resource/Transformation_%28genetics%29
p1198
aVhttp://dbpedia.org/resource/Catalysis
p1199
aVhttp://dbpedia.org/resource/Monoamine_oxidase
p1200
aa(lp1201
Vhttp://dbpedia.org/resource/Metabolism
p1202
aVhttp://dbpedia.org/resource/Transformation_%28genetics%29
p1203
aVhttp://dbpedia.org/resource/Catalysis
p1204
aa(lp1205
Vhttp://dbpedia.org/resource/Diffusion
p1206
aVhttp://dbpedia.org/resource/Chemical_synapse
p1207
aa(lp1208
Vhttp://dbpedia.org/resource/Reuptake
p1209
aVhttp://dbpedia.org/resource/Nervous_system
p1210
aasg18
(lp1211
Vmetabolic transformation catalyzed by MAO
p1212
aVmetabolic transformation catalyzed by COMT
p1213
aVdiffusion away from the synaptic cleft and uptake at extraneuronal sites
p1214
aVreuptake into nerve terminals
p1215
asg24
(lp1216
Vhttp://dbpedia.org/resource/Norepinephrine
p1217
aVhttp://dbpedia.org/resource/Epinephrine
p1218
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1219
sg31
S'Primary mechaism for termination of norepinephrine and epinephrine action:'
p1220
sg33
I25
sg34
S'Q12#9'
p1221
sg36
I9
sg37
S'9'
sg38
I3
sg39
S'12'
p1222
sa(dp1223
g3
(lp1224
(lp1225
Vhttp://dbpedia.org/resource/Epinephrine
p1226
aa(lp1227
Vhttp://dbpedia.org/resource/Norepinephrine
p1228
aa(lp1229
Vhttp://dbpedia.org/resource/Dopamine
p1230
aasg18
(lp1231
Vepinephrine
p1232
aVisoproterenol (Isuprel)
p1233
aVnorepinephrine
p1234
aVdopamine
p1235
asg24
(lp1236
Vhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p1237
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1238
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1239
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1240
sg31
S'Most potent at beta adrenergic receptors'
p1241
sg33
I7
sg34
S'Q12#10'
p1242
sg36
I6
sg37
S'10'
p1243
sg38
I1
sg39
S'12'
p1244
sa(dp1245
g3
(lp1246
(lp1247
Vhttp://dbpedia.org/resource/Chemical_synthesis
p1248
aVhttp://dbpedia.org/resource/Protein
p1249
aVhttp://dbpedia.org/resource/Chemical_synapse
p1250
aVhttp://dbpedia.org/resource/Biological_membrane
p1251
aa(lp1252
Vhttp://dbpedia.org/resource/Stimulation
p1253
aa(lp1254
Vhttp://dbpedia.org/resource/Reserpine
p1255
aasg18
(lp1256
Valpha-methyltyrosine by preventing synthesis of a protein that promotes fusion of the vesicle and the presynaptic membrane
p1257
aVbretylium (Bretylol) following a transient stimulation of release by displacement
p1258
aVreserpine
p1259
asg24
(lp1260
Vhttp://dbpedia.org/resource/Norepinephrine
p1261
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1262
sg31
S'Interferes with norepinephrine release:'
p1263
sg33
I30
sg34
S'Q12#11'
p1264
sg36
I4
sg37
S'11'
p1265
sg38
I1
sg39
S'12'
p1266
sa(dp1267
g3
(lp1268
(lp1269
Vhttp://dbpedia.org/resource/Clonidine
p1270
aVhttp://dbpedia.org/resource/Clonidine
p1271
aa(lp1272
Vhttp://dbpedia.org/resource/Phenylephrine
p1273
aasg18
(lp1274
Vyohimbine (Yocon)
p1275
aVdobutamine (Dobutrex)
p1276
aVclonidine (Catapres)
p1277
aVphenylephrine
p1278
asg24
(lp1279
Vhttp://dbpedia.org/resource/Alpha-2_adrenergic_receptor
p1280
aVhttp://dbpedia.org/resource/Agonist
p1281
aVhttp://dbpedia.org/resource/Peripheral
p1282
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1283
sg31
S'alpha-2 receptor agonist; peripheral sympathomimetic'
p1284
sg33
I13
sg34
S'Q12#12'
p1285
sg36
I6
sg37
S'12'
p1286
sg38
I2
sg39
S'12'
p1287
sa(dp1288
g3
(lp1289
(lp1290
Vhttp://dbpedia.org/resource/Atropine
p1291
aa(lp1292
Vhttp://dbpedia.org/resource/Sodium
p1293
aasg18
(lp1294
Vatropine
p1295
aVnitroprusside sodium (Nipride)
p1296
aVmecamylamine (Inversine)
p1297
aVcaptopril (Capoten)
p1298
asg24
(lp1299
Vhttp://dbpedia.org/resource/Nitric_oxide
p1300
aVhttp://dbpedia.org/resource/Relaxation_technique
p1301
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1302
sg31
S'Primary antihypertensive effect due to nitric oxide mediation of smooth muscle relaxation.'
p1303
sg33
I14
sg34
S'Q12#13'
p1304
sg36
I13
sg37
S'13'
p1305
sg38
I1
sg39
S'12'
p1306
sa(dp1307
g3
(lp1308
(lp1309
Vhttp://dbpedia.org/resource/Physostigmine
p1310
aasg18
(lp1311
Vtubocurarine
p1312
aVphenoxybenzamine (Dibenzyline)
p1313
aVphysostigmine (Antilirium)
p1314
aVbretylium (Bretylol)
p1315
asg24
(lp1316
Vhttp://dbpedia.org/resource/Neurotransmitter
p1317
aVhttp://dbpedia.org/resource/Enzyme
p1318
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1319
sg31
S'Inhibits neurotransmitter enzymic degradation:'
p1320
sg33
I13
sg34
S'Q12#14'
p1321
sg36
I4
sg37
S'14'
p1322
sg38
I2
sg39
S'12'
p1323
sa(dp1324
g3
(lp1325
(lp1326
Vhttp://dbpedia.org/resource/Acetylcholine
p1327
aa(lp1328
Vhttp://dbpedia.org/resource/Vagus_nerve
p1329
aVhttp://dbpedia.org/resource/Stimulation
p1330
aasg18
(lp1331
Vacetylcholine
p1332
aVmethacholine (Provocholine)
p1333
aVvagal stimulation
p1334
aVcarbamylcholine (carbachol)
p1335
asg24
(lp1336
Vhttp://dbpedia.org/resource/Heart
p1337
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1338
sg31
S'Cardiac effects not like to be directly affected by the presence of an anticholinesterase:'
p1339
sg33
I11
sg34
S'Q12#15'
p1340
sg36
I14
sg37
S'15'
p1341
sg38
I3
sg39
S'12'
p1342
sa(dp1343
g3
(lp1344
(lp1345
Vhttp://dbpedia.org/resource/Relaxation_technique
p1346
aasg18
(lp1347
Vdry mouth
p1348
aVpupillary dilation
p1349
aVincreased gastrointestinal tone
p1350
aVbronchiolar relaxation
p1351
asg24
(lp1352
Vhttp://dbpedia.org/resource/Xerostomia
p1353
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions2/matching1.htm'
p1354
sg31
S'Pilocarpine (Pilocar):'
p1355
sg33
I9
sg34
S'Q12#16'
p1356
sg36
I5
sg37
S'16'
p1357
sg38
I2
sg39
S'12'
p1358
sa(dp1359
g3
(lp1360
(lp1361
Vhttp://dbpedia.org/resource/Atropine
p1362
aa(lp1363
Vhttp://dbpedia.org/resource/Scopolamine
p1364
aasg18
(lp1365
Vatropine
p1366
aVscopolamine
p1367
aVipratropium (Atrovent)
p1368
aVDFP
p1369
asg24
(lp1370
Vhttp://dbpedia.org/resource/Cholinergic
p1371
aVhttp://dbpedia.org/resource/Sports_agent
p1372
aVhttp://dbpedia.org/resource/Brain
p1373
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1374
sg31
S'Cholinergic agent least likely to enter the brain:'
p1375
sg33
I7
sg34
S'Q13#1'
p1376
sg36
I8
sg37
S'1'
sg38
I2
sg39
S'13'
p1377
sa(dp1378
g3
(lp1379
(lp1380
Vhttp://dbpedia.org/resource/Physostigmine
p1381
aa(lp1382
Vhttp://dbpedia.org/resource/Milind_Soman
p1383
aasg18
(lp1384
Vphysostigmine (Antilirium)
p1385
aVDFP
p1386
aVedrophonium (Tensilon)
p1387
aVsoman
p1388
asg24
(lp1389
Vhttp://dbpedia.org/resource/Acetylcholinesterase
p1390
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1391
sg31
S'Reversible, noncovalent inhibitor of acetylcholinesterase'
p1392
sg33
I10
sg34
S'Q13#2'
p1393
sg36
I6
sg37
S'2'
sg38
I2
sg39
S'13'
p1394
sa(dp1395
g3
(lp1396
(lp1397
Vhttp://dbpedia.org/resource/Dopamine
p1398
aVhttp://dbpedia.org/resource/Dopamine
p1399
aasg18
(lp1400
Vscopolamine
p1401
aVdopamine (Intropin)
p1402
aVmecamylamine (Inversine)
p1403
asg24
(lp1404
Vhttp://dbpedia.org/resource/Scopolamine
p1405
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1406
sg31
S'Ganglionic blocker:'
p1407
sg33
I9
sg34
S'Q13#3'
p1408
sg36
I2
sg37
S'3'
sg38
I2
sg39
S'13'
p1409
sa(dp1410
g3
(lp1411
(lp1412
Vhttp://dbpedia.org/resource/Vein
p1413
aVhttp://dbpedia.org/resource/Parasympathetic_nervous_system
p1414
aa(lp1415
Vhttp://dbpedia.org/resource/Heart
p1416
aVhttp://dbpedia.org/resource/Sympathetic_nervous_system
p1417
aa(lp1418
Vhttp://dbpedia.org/resource/Ciliary_muscle
p1419
aVhttp://dbpedia.org/resource/Sympathetic_nervous_system
p1420
aa(lp1421
Vhttp://dbpedia.org/resource/Salivary_gland
p1422
aVhttp://dbpedia.org/resource/Parasympathetic_nervous_system
p1423
aasg18
(lp1424
Vveins:parasympathetic
p1425
aVheart:sympathetic
p1426
aVciliary muscle: sympathetic
p1427
aVsalivary glands: parasympathetic
p1428
asg24
(lp1429
Vhttp://dbpedia.org/resource/Autonomic_nervous_system
p1430
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1431
sg31
S'Predominant autonomic tone:'
p1432
sg33
I14
sg34
S'Q13#4'
p1433
sg36
I3
sg37
S'4'
sg38
I3
sg39
S'13'
p1434
sa(dp1435
g3
(lp1436
(lp1437
Vhttp://dbpedia.org/resource/Dopamine
p1438
aVhttp://dbpedia.org/resource/Dopamine
p1439
aa(lp1440
Vhttp://dbpedia.org/resource/Clonidine
p1441
aVhttp://dbpedia.org/resource/Clonidine
p1442
aa(lp1443
Vhttp://dbpedia.org/resource/Epinephrine
p1444
aasg18
(lp1445
Visoproterenol (Isuprel)
p1446
aVdopamine (Intropin)
p1447
aVclonidine (Catapres)
p1448
aVepinephrine
p1449
asg24
(lp1450
Vhttp://dbpedia.org/resource/Agonist
p1451
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1452
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1453
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1454
sg31
S'Powerful agonist at both alpha and beta adrenergic receptors'
p1455
sg33
I13
sg34
S'Q13#5'
p1456
sg36
I9
sg37
S'5'
sg38
I3
sg39
S'13'
p1457
sa(dp1458
g3
(lp1459
sg18
(lp1460
Vdobutamine (Dobutrex)
p1461
aVdopamine (Intropin)
p1462
aVterbutaline (Brethine)
p1463
aVlodoxamine (Alomide)
p1464
asg24
(lp1465
Vhttp://dbpedia.org/resource/Dopamine
p1466
aVhttp://dbpedia.org/resource/Dopamine
p1467
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1468
sg31
S'Positive inotropic drug that at low doses specifically promotes an increase in renal blood flow:'
p1469
sg33
I16
sg34
S'Q13#6'
p1470
sg36
I15
sg37
S'6'
sg38
I1
sg39
S'13'
p1471
sa(dp1472
g3
(lp1473
sg18
(lp1474
Vguanfacine (Tenex)
p1475
aVcaptopril (Capoten)
p1476
aVesmolol (Brevibloc)
p1477
aVphenoxybenzamine (Dibenzyline)
p1478
asg24
(lp1479
Vhttp://dbpedia.org/resource/Activation_energy
p1480
aVhttp://dbpedia.org/resource/Central_nervous_system
p1481
aVhttp://dbpedia.org/resource/Alpha
p1482
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1483
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1484
sg31
S'Antihypertensive effect due to activation of CNS alpha-2 receptors'
p1485
sg33
I16
sg34
S'Q13#8'
p1486
sg36
I9
sg37
S'8'
sg38
I0
sg39
S'13'
p1487
sa(dp1488
g3
(lp1489
(lp1490
Vhttp://dbpedia.org/resource/Scopolamine
p1491
aa(lp1492
Vhttp://dbpedia.org/resource/Methylphenidate
p1493
aVhttp://dbpedia.org/resource/Methylphenidate
p1494
aa(lp1495
Vhttp://dbpedia.org/resource/Clonidine
p1496
aVhttp://dbpedia.org/resource/Clonidine
p1497
aasg18
(lp1498
Vscopolamine
p1499
aVmethylphenidate (Ritalin)
p1500
aVmecamylamine (Inversine)
p1501
aVclonidine (Catapres)
p1502
asg24
(lp1503
Vhttp://dbpedia.org/resource/Stimulant
p1504
aVhttp://dbpedia.org/resource/Narcolepsy
p1505
aVhttp://dbpedia.org/resource/Attention_deficit_hyperactivity_disorder
p1506
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1507
sg31
S'CNS stimulant used in management of narcolepsy or attention-deficit disorder'
p1508
sg33
I13
sg34
S'Q13#9'
p1509
sg36
I10
sg37
S'9'
sg38
I1
sg39
S'13'
p1510
sa(dp1511
g3
(lp1512
sg18
(lp1513
Vlabetalol (Trandate, Normodyne)
p1514
aVhydralazine (Apresoline)
p1515
aVmethoxamine (Vasoxyl)
p1516
aVreserpine
p1517
asg24
(lp1518
Vhttp://dbpedia.org/resource/Reserpine
p1519
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1520
sg31
S'Antihypertensive agent that acts by direct arteriolar dilation:'
p1521
sg33
I15
sg34
S'Q13#10'
p1522
sg36
I8
sg37
S'10'
p1523
sg38
I1
sg39
S'13'
p1524
sa(dp1525
g3
(lp1526
(lp1527
Vhttp://dbpedia.org/resource/Sodium
p1528
aasg18
(lp1529
Vcaptopril (Capoten)
p1530
aVnitroprusside sodium (Nipride)
p1531
aVphenoxybenzamine (Dibenzyline)
p1532
aVminoxidil (Loniten)
p1533
asg24
(lp1534
Vhttp://dbpedia.org/resource/Vasodilation
p1535
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1536
sg31
S'Vasodilator used to manage hypertensive emergencies:'
p1537
sg33
I17
sg34
S'Q13#12'
p1538
sg36
I6
sg37
S'12'
p1539
sg38
I1
sg39
S'13'
p1540
sa(dp1541
g3
(lp1542
(lp1543
Vhttp://dbpedia.org/resource/Tremor
p1544
aa(lp1545
Vhttp://dbpedia.org/resource/Vasodilation
p1546
aa(lp1547
Vhttp://dbpedia.org/resource/Tachycardia
p1548
aasg18
(lp1549
Vbrochodilation
p1550
aVtremor
p1551
aVvasodilation
p1552
aVtachycardia
p1553
asg24
(lp1554
Vhttp://dbpedia.org/resource/Side_effect
p1555
aVhttp://dbpedia.org/resource/Agonist
p1556
asg29
S'http://www.pharmacology2000.com/Autonomics/Introduction/questions4/intro3.htm'
p1557
sg31
S'Most common side effect of oral beta-2 receptor agonists'
p1558
sg33
I4
sg34
S'Q13#14'
p1559
sg36
I9
sg37
S'14'
p1560
sg38
I1
sg39
S'13'
p1561
sa(dp1562
g3
(lp1563
(lp1564
Vhttp://dbpedia.org/resource/Adrenergic
p1565
aa(lp1566
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p1567
aVhttp://dbpedia.org/resource/Cholinergic
p1568
aa(lp1569
Vhttp://dbpedia.org/resource/Adrenergic
p1570
aa(lp1571
Vhttp://dbpedia.org/resource/Nicotinic_acetylcholine_receptor
p1572
aVhttp://dbpedia.org/resource/Cholinergic
p1573
aasg18
(lp1574
Vbeta1 adrenergic
p1575
aVmuscarinic cholinergic
p1576
aVbeta2 adrenergic
p1577
aVnicotinic cholinergic
p1578
asg24
(lp1579
Vhttp://dbpedia.org/resource/Drug
p1580
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p1581
aVhttp://dbpedia.org/resource/Asthma
p1582
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1583
sg31
S'Drugs activating this receptor are used in treating asthma:'
p1584
sg33
I8
sg34
S'Q14#0'
p1585
sg36
I9
sg37
S'0'
sg38
I2
sg39
S'14'
p1586
sa(dp1587
g3
(lp1588
(lp1589
Vhttp://dbpedia.org/resource/Dopamine_receptor
p1590
aa(lp1591
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p1592
aVhttp://dbpedia.org/resource/Cholinergic
p1593
aasg18
(lp1594
Valpha1
p1595
aVbeta1
p1596
aVdopamine D1
p1597
aVmuscarinic cholinergic
p1598
asg24
(lp1599
Vhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p1600
aVhttp://dbpedia.org/resource/Activation_energy
p1601
aVhttp://dbpedia.org/resource/Positive_law
p1602
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1603
sg31
S'Receptor activation mainly responsible for positive inotropism:'
p1604
sg33
I6
sg34
S'Q14#2'
p1605
sg36
I7
sg37
S'2'
sg38
I1
sg39
S'14'
p1606
sa(dp1607
g3
(lp1608
(lp1609
Vhttp://dbpedia.org/resource/Propranolol
p1610
aVhttp://dbpedia.org/resource/Propranolol
p1611
aa(lp1612
Vhttp://dbpedia.org/resource/Phenylephrine
p1613
aVhttp://dbpedia.org/resource/Phenylephrine
p1614
aasg18
(lp1615
Visoproterenol (Isuprel)
p1616
aVpropranolol (Inderal)
p1617
aVphenylephrine (Neo-Synephrine)
p1618
aVterbutaline (Brethine)
p1619
asg24
(lp1620
Vhttp://dbpedia.org/resource/Alpha
p1621
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1622
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1623
sg31
S'Activates alpha receptors'
p1624
sg33
I16
sg34
S'Q14#4'
p1625
sg36
I3
sg37
S'4'
sg38
I2
sg39
S'14'
p1626
sa(dp1627
g3
(lp1628
(lp1629
Vhttp://dbpedia.org/resource/Atropine
p1630
aasg18
(lp1631
Vterbutaline (Brethine)
p1632
aVesmolol (Brevibloc)
p1633
aVatropine
p1634
aVmecamylamine (Inversine)
p1635
asg24
(lp1636
Vhttp://dbpedia.org/resource/Blocking_%28American_football%29
p1637
aVhttp://dbpedia.org/resource/Heart
p1638
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1639
sg31
S'Blocks cardiac isoproterenol effects'
p1640
sg33
I13
sg34
S'Q14#5'
p1641
sg36
I4
sg37
S'5'
sg38
I1
sg39
S'14'
p1642
sa(dp1643
g3
(lp1644
sg18
(lp1645
Vmetoprolol (Lopressor)
p1646
aVmethoxamine (Vasoxyl)
p1647
aVterbutaline (Brethine)
p1648
aVipratropium (Atrovent)
p1649
asg24
(lp1650
Vhttp://dbpedia.org/resource/Alpha
p1651
aVhttp://dbpedia.org/resource/Agonist
p1652
aVhttp://dbpedia.org/resource/Vasoconstriction
p1653
aVhttp://dbpedia.org/resource/Blood_pressure
p1654
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1655
sg31
S'Alpha agonist: vasoconstriction and elevates blood pressure:'
p1656
sg33
I16
sg34
S'Q14#6'
p1657
sg36
I8
sg37
S'6'
sg38
I1
sg39
S'14'
p1658
sa(dp1659
g3
(lp1660
(lp1661
Vhttp://dbpedia.org/resource/Cocaine
p1662
aa(lp1663
Vhttp://dbpedia.org/resource/Reserpine
p1664
aasg18
(lp1665
Vmethoxamine (Vasoxyl)
p1666
aVcocaine
p1667
aVreserpine
p1668
aVtimolol (Blocadren)
p1669
asg24
(lp1670
Vhttp://dbpedia.org/resource/Peripheral_nerve
p1671
aVhttp://dbpedia.org/resource/Reuptake_inhibitor
p1672
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1673
sg31
S'Nerve terminal reuptake inhibitor'
p1674
sg33
I10
sg34
S'Q14#7'
p1675
sg36
I4
sg37
S'7'
sg38
I1
sg39
S'14'
p1676
sa(dp1677
g3
(lp1678
(lp1679
Vhttp://dbpedia.org/resource/Propranolol
p1680
aVhttp://dbpedia.org/resource/Propranolol
p1681
aasg18
(lp1682
Vpropranolol (Inderal)
p1683
aVphenoxybenzamine (Dibenzyline)
p1684
aVphentolamine (Regitine)
p1685
aVpilocarpine (Pilocar)
p1686
asg24
(lp1687
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p1688
aVhttp://dbpedia.org/resource/Dan_Blocker
p1689
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1690
sg31
S'Alpha adrenoceptor COVALENT blocker:'
p1691
sg33
I16
sg34
S'Q14#8'
p1692
sg36
I4
sg37
S'8'
sg38
I1
sg39
S'14'
p1693
sa(dp1694
g3
(lp1695
(lp1696
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p1697
aVhttp://dbpedia.org/resource/Activation_energy
p1698
aa(lp1699
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p1700
aVhttp://dbpedia.org/resource/Activation_energy
p1701
aa(lp1702
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p1703
aVhttp://dbpedia.org/resource/Dan_Blocker
p1704
aa(lp1705
Vhttp://dbpedia.org/resource/Dopamine_receptor
p1706
aVhttp://dbpedia.org/resource/Blockade
p1707
aasg18
(lp1708
Vbeta receptor activation
p1709
aValpha receptor activation
p1710
aValpha receptor blocker
p1711
aVdopamine receptor blockade
p1712
asg24
(lp1713
Vhttp://dbpedia.org/resource/Hypotension
p1714
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1715
sg31
S'Orthostatic (postural) hypotension'
p1716
sg33
I12
sg34
S'Q14#9'
p1717
sg36
I5
sg37
S'9'
sg38
I2
sg39
S'14'
p1718
sa(dp1719
g3
(lp1720
(lp1721
Vhttp://dbpedia.org/resource/Atropine
p1722
aa(lp1723
Vhttp://dbpedia.org/resource/Propranolol
p1724
aVhttp://dbpedia.org/resource/Propranolol
p1725
aasg18
(lp1726
Vmecamylamine (Inversine)
p1727
aVprazosin (Minipress)
p1728
aVatropine
p1729
aVpropranolol (Inderal)
p1730
asg24
(lp1731
Vhttp://dbpedia.org/resource/Norepinephrine
p1732
aVhttp://dbpedia.org/resource/Vasoconstriction
p1733
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1734
sg31
S'Norepinephrine pressor response blocked by:'
p1735
sg33
I13
sg34
S'Q14#10'
p1736
sg36
I5
sg37
S'10'
p1737
sg38
I1
sg39
S'14'
p1738
sa(dp1739
g3
(lp1740
(lp1741
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p1742
aa(lp1743
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p1744
aa(lp1745
Vhttp://dbpedia.org/resource/Clinical_trial
p1746
aasg18
(lp1747
Vphase 0
p1748
aVphase 4
p1749
aVphase 2
p1750
aVphase 3
p1751
asg24
(lp1752
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p1753
aVhttp://dbpedia.org/resource/Heart_rate
p1754
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1755
sg31
S'Phase of the cardiac action potential that principally determine heart rate'
p1756
sg33
I8
sg34
S'Q14#14'
p1757
sg36
I11
sg37
S'14'
p1758
sg38
I1
sg39
S'14'
p1759
sa(dp1760
g3
(lp1761
(lp1762
Vhttp://dbpedia.org/resource/ACE_inhibitor
p1763
aVhttp://dbpedia.org/resource/Angiotensin
p1764
aVhttp://dbpedia.org/resource/Concentration
p1765
aa(lp1766
Vhttp://dbpedia.org/resource/Propranolol
p1767
aVhttp://dbpedia.org/resource/Propranolol
p1768
aa(lp1769
Vhttp://dbpedia.org/resource/Phenylephrine
p1770
aVhttp://dbpedia.org/resource/Phenylephrine
p1771
aa(lp1772
Vhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p1773
aVhttp://dbpedia.org/resource/Epinephrine
p1774
aasg18
(lp1775
Vangiotensin converting enzyme inhibitor (decreases angiotensin II concentration)
p1776
aVpropranolol (Inderal)
p1777
aVphenylephrine (Neo-Synephrine)
p1778
aVlow-dose epinephrine
p1779
asg24
(lp1780
Vhttp://dbpedia.org/resource/Cardiac_muscle
p1781
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1782
sg31
S'Most likely to increase myocardial afterload'
p1783
sg33
I20
sg34
S'Q14#15'
p1784
sg36
I6
sg37
S'15'
p1785
sg38
I2
sg39
S'14'
p1786
sa(dp1787
g3
(lp1788
(lp1789
Vhttp://dbpedia.org/resource/Propranolol
p1790
aVhttp://dbpedia.org/resource/Propranolol
p1791
aa(lp1792
Vhttp://dbpedia.org/resource/Phenylephrine
p1793
aVhttp://dbpedia.org/resource/Phenylephrine
p1794
aasg18
(lp1795
Vpropranolol (Inderal)
p1796
aVphentolamine (Regitine)
p1797
aVphenylephrine (Neo-Synephrine)
p1798
aVmetoprolol (Lopressor)
p1799
asg24
(lp1800
Vhttp://dbpedia.org/resource/Vasoconstriction
p1801
aVhttp://dbpedia.org/resource/Epinephrine
p1802
aVhttp://dbpedia.org/resource/Drug
p1803
aVhttp://dbpedia.org/resource/Epinephrine
p1804
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1805
sg31
S'Pressor effects of epinephrine are blocked by this drug ("epinephrine reversal")'
p1806
sg33
I16
sg34
S'Q14#16'
p1807
sg36
I15
sg37
S'16'
p1808
sg38
I1
sg39
S'14'
p1809
sa(dp1810
g3
(lp1811
(lp1812
Vhttp://dbpedia.org/resource/Propranolol
p1813
aVhttp://dbpedia.org/resource/Propranolol
p1814
aasg18
(lp1815
Vphenoxybenzamine (Dibenzyline)
p1816
aVpropranolol (Inderal)
p1817
aVguanfacine (Tenex)
p1818
aVmethoxamine (Vasoxyl)
p1819
asg24
(lp1820
Vhttp://dbpedia.org/resource/Specific_name_%28zoology%29
p1821
aVhttp://dbpedia.org/resource/Agonist
p1822
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1823
sg31
S'Specific alpha2 receptor agonist'
p1824
sg33
I16
sg34
S'Q14#18'
p1825
sg36
I4
sg37
S'18'
p1826
sg38
I2
sg39
S'14'
p1827
sa(dp1828
g3
(lp1829
(lp1830
Vhttp://dbpedia.org/resource/Sodium
p1831
aa(lp1832
Vhttp://dbpedia.org/resource/Clonidine
p1833
aVhttp://dbpedia.org/resource/Clonidine
p1834
aasg18
(lp1835
Vnitroprusside sodium (Nipride)
p1836
aVclonidine (Catapres)
p1837
aVmethoxamine (Vasoxyl)
p1838
aVcaptopril (Capoten)
p1839
asg24
(lp1840
Vhttp://dbpedia.org/resource/Acting_%28law%29
p1841
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/question5/auto1.htm'
p1842
sg31
S'Centrally-acting antihypertensive drug'
p1843
sg33
I17
sg34
S'Q14#19'
p1844
sg36
I3
sg37
S'19'
p1845
sg38
I1
sg39
S'14'
p1846
sa(dp1847
g3
(lp1848
(lp1849
Vhttp://dbpedia.org/resource/Limited_company
p1850
aa(lp1851
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p1852
aVhttp://dbpedia.org/resource/Activation_energy
p1853
aVhttp://dbpedia.org/resource/Renin
p1854
aVhttp://dbpedia.org/resource/Stop_consonant
p1855
aa(lp1856
Vhttp://dbpedia.org/resource/Statistical_significance
p1857
aa(lp1858
Vhttp://dbpedia.org/resource/Mechanism_of_action
p1859
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p1860
aVhttp://dbpedia.org/resource/Dopamine
p1861
aasg18
(lp1862
Vlimited effect
p1863
aVbeta1 adrenergic receptor  activation decreases renin release
p1864
aVsignificant reduction in renal blood flow
p1865
aVsignificant increase in renal blood flow; mechanism similar to that exhibited by low-dose dopamine
p1866
asg24
(lp1867
Vhttp://dbpedia.org/resource/Kidney
p1868
aVhttp://dbpedia.org/resource/Epinephrine
p1869
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p1870
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p1871
sg31
S'Renal effects relatively low epinephrine dose.'
p1872
sg33
I30
sg34
S'Q16#4'
p1873
sg36
I7
sg37
S'4'
sg38
I2
sg39
S'16'
p1874
sa(dp1875
g3
(lp1876
(lp1877
Vhttp://dbpedia.org/resource/Administration_%28government%29
p1878
aVhttp://dbpedia.org/resource/Alpha
p1879
aVhttp://dbpedia.org/resource/Receptor_antagonist
p1880
aVhttp://dbpedia.org/resource/David_Williamson
p1881
aVhttp://dbpedia.org/resource/Blood_pressure
p1882
aVhttp://dbpedia.org/resource/Epinephrine
p1883
aa(lp1884
Vhttp://dbpedia.org/resource/Blood_pressure
p1885
aVhttp://dbpedia.org/resource/Epinephrine
p1886
aa(lp1887
Vhttp://dbpedia.org/resource/Blood_pressure
p1888
aVhttp://dbpedia.org/resource/Epinephrine
p1889
aasg18
(lp1890
Vprevious administration of the alpha-receptor antagonist will not influence the blood-pressure response to epinephrine
p1891
aVincreased blood-pressure response to epinephrine
p1892
aVdecreased blood-pressure response to epinephrine
p1893
asg24
(lp1894
Vhttp://dbpedia.org/resource/Probability
p1895
aVhttp://dbpedia.org/resource/Epinephrine
p1896
aVhttp://dbpedia.org/resource/Epinephrine
p1897
aVhttp://dbpedia.org/resource/Alpha
p1898
aVhttp://dbpedia.org/resource/Receptor_antagonist
p1899
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p1900
sg31
S'Most probable BP effect of epinephrine, if epinephrine is administered after an alpha-receptor antagonist:'
p1901
sg33
I24
sg34
S'Q16#5'
p1902
sg36
I15
sg37
S'5'
sg38
I2
sg39
S'16'
p1903
sa(dp1904
g3
(lp1905
(lp1906
Vhttp://dbpedia.org/resource/Beta_cell
p1907
aa(lp1908
Vhttp://dbpedia.org/resource/Beta_cell
p1909
aa(lp1910
Vhttp://dbpedia.org/resource/Beta_cell
p1911
aasg18
(lp1912
Vbeta-1
p1913
aVbeta-2
p1914
aVbeta-3
p1915
asg24
(lp1916
Vhttp://dbpedia.org/resource/Heart
p1917
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1918
aVhttp://dbpedia.org/resource/Type_theory
p1919
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p1920
sg31
S'Prominent cardiac beta-adrenergic receptor type:'
p1921
sg33
I3
sg34
S'Q16#6'
p1922
sg36
I5
sg37
S'6'
sg38
I0
sg39
S'16'
p1923
sa(dp1924
g3
(lp1925
(lp1926
Vhttp://dbpedia.org/resource/Bronchodilator
p1927
aa(lp1928
Vhttp://dbpedia.org/resource/Bronchodilator
p1929
aa(lp1930
Vhttp://dbpedia.org/resource/Bronchodilator
p1931
aasg18
(lp1932
Vbeta-2 receptor mediated bronchoconstriction
p1933
aValpha-1 receptor-mediated bronchodilation
p1934
aVbeta-1 receptor-mediated bronchodilation
p1935
aVbeta-2 receptor-mediated bronchodilation
p1936
asg24
(lp1937
Vhttp://dbpedia.org/resource/Respiratory_tract
p1938
aVhttp://dbpedia.org/resource/Epinephrine
p1939
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p1940
sg31
S'Significant respiratory tract effects of epinephrine:'
p1941
sg33
I13
sg34
S'Q16#8'
p1942
sg36
I6
sg37
S'8'
sg38
I3
sg39
S'16'
p1943
sa(dp1944
g3
(lp1945
(lp1946
Vhttp://dbpedia.org/resource/Insulin
p1947
aVhttp://dbpedia.org/resource/Secretion
p1948
aVhttp://dbpedia.org/resource/Redox
p1949
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1950
aVhttp://dbpedia.org/resource/Activation_energy
p1951
aa(lp1952
Vhttp://dbpedia.org/resource/Glucagon
p1953
aVhttp://dbpedia.org/resource/Secretion
p1954
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p1955
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p1956
aVhttp://dbpedia.org/resource/Activation_energy
p1957
aa(lp1958
Vhttp://dbpedia.org/resource/Fatty_acid
p1959
aa(lp1960
Vhttp://dbpedia.org/resource/Glycolysis
p1961
aasg18
(lp1962
Vinsulin secretion reduced by beta2 adrenergic receptor activation
p1963
aVglucagon secretion: diminished by beta adrenergic receptor activation
p1964
aVfree fatty acids: increased
p1965
aVminimal calorigenic effect
p1966
aVglycolysis inhibition
p1967
asg24
(lp1968
Vhttp://dbpedia.org/resource/Epinephrine
p1969
aVhttp://dbpedia.org/resource/Metabolism
p1970
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p1971
sg31
S'Examples of epinephrine metabolic effects'
p1972
sg33
I27
sg34
S'Q16#9'
p1973
sg36
I5
sg37
S'9'
sg38
I2
sg39
S'16'
p1974
sa(dp1975
g3
(lp1976
(lp1977
Vhttp://dbpedia.org/resource/Dopamine
p1978
aVhttp://dbpedia.org/resource/Dopamine
p1979
aa(lp1980
Vhttp://dbpedia.org/resource/Atropine
p1981
aasg18
(lp1982
Vphentolamine (Regitine)
p1983
aVterbutaline (Brethine)
p1984
aVdopamine (Intropin)
p1985
aVdobutamine (Dobutrex)
p1986
aVatropine
p1987
asg24
(lp1988
Vhttp://dbpedia.org/resource/Drug
p1989
aVhttp://dbpedia.org/resource/Epinephrine
p1990
aVhttp://dbpedia.org/resource/Vasoconstriction
p1991
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p1992
sg31
S'Drugs antagonize epinephrine pressor effects:'
p1993
sg33
I17
sg34
S'Q16#11'
p1994
sg36
I5
sg37
S'11'
p1995
sg38
I0
sg39
S'16'
p1996
sa(dp1997
g3
(lp1998
sg18
(lp1999
Vincreased conduction velocity
p2000
aVdecreased conduction velocity
p2001
aVpromotes AV block
p2002
asg24
(lp2003
Vhttp://dbpedia.org/resource/Epinephrine
p2004
aVhttp://dbpedia.org/resource/Electrical_conduction_system_of_the_heart
p2005
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions6/questionset6.htm'
p2006
sg31
S'Epinephrine effects on AV nodall conduction:'
p2007
sg33
I9
sg34
S'Q16#12'
p2008
sg36
I6
sg37
S'12'
p2009
sg38
I0
sg39
S'16'
p2010
sa(dp2011
g3
(lp2012
(lp2013
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p2014
aa(lp2015
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p2016
aa(lp2017
Vhttp://dbpedia.org/resource/Cholinergic
p2018
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2019
aasg18
(lp2020
Vbeta-1 adrenergic receptor effect
p2021
aValpha adrenergic receptor effect
p2022
aVcholinergic muscarinic receptor effect
p2023
asg24
(lp2024
Vhttp://dbpedia.org/resource/Vasopressin
p2025
aVhttp://dbpedia.org/resource/Secretion
p2026
aVhttp://dbpedia.org/resource/Secretion
p2027
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions7/questionset7.htm'
p2028
sg31
S'Enhanced antidiuretic hormone secretion (ADH secretion):'
p2029
sg33
I12
sg34
S'Q17#8'
p2030
sg36
I9
sg37
S'8'
sg38
I0
sg39
S'17'
p2031
sa(dp2032
g3
(lp2033
(lp2034
Vhttp://dbpedia.org/resource/Alpha-1_adrenergic_receptor
p2035
aa(lp2036
Vhttp://dbpedia.org/resource/Beta_cell
p2037
aVhttp://dbpedia.org/resource/Adrenergic
p2038
aa(lp2039
Vhttp://dbpedia.org/resource/Cholinergic
p2040
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2041
aasg18
(lp2042
Valpha-1 adrenergic
p2043
aVbeta-2 adrenergic
p2044
aVcholinergic muscarinic
p2045
asg24
(lp2046
Vhttp://dbpedia.org/resource/Gland
p2047
aVhttp://dbpedia.org/resource/Secretion
p2048
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions7/questionset7.htm'
p2049
sg31
S'Decreases bronchial gland secretion'
p2050
sg33
I6
sg34
S'Q17#9'
p2051
sg36
I4
sg37
S'9'
sg38
I0
sg39
S'17'
p2052
sa(dp2053
g3
(lp2054
(lp2055
Vhttp://dbpedia.org/resource/Epinephrine
p2056
aa(lp2057
Vhttp://dbpedia.org/resource/Dopamine
p2058
aa(lp2059
Vhttp://dbpedia.org/resource/Norepinephrine
p2060
aa(lp2061
Vhttp://dbpedia.org/resource/Phenylephrine
p2062
aasg18
(lp2063
Vepinephrine
p2064
aVdopamine
p2065
aVdobutamine
p2066
aVnorepinephrine
p2067
aVphenylephrine
p2068
asg24
(lp2069
Vhttp://dbpedia.org/resource/Primary_school
p2070
aVhttp://dbpedia.org/resource/Neurotransmitter
p2071
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p2072
aVhttp://dbpedia.org/resource/Sympathetic_nervous_system
p2073
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2074
sg31
S'Primary neurotransmitter released by postganglionic neurons of the autonomic sympathetic system:'
p2075
sg33
I5
sg34
S'Q18#0'
p2076
sg36
I11
sg37
S'0'
sg38
I3
sg39
S'18'
p2077
sa(dp2078
g3
(lp2079
(lp2080
Vhttp://dbpedia.org/resource/Filtration
p2081
aa(lp2082
Vhttp://dbpedia.org/resource/Effectiveness
p2083
aVhttp://dbpedia.org/resource/Polymorphism_%28biology%29
p2084
aa(lp2085
Vhttp://dbpedia.org/resource/Norepinephrine
p2086
aVhttp://dbpedia.org/resource/Vasoconstriction
p2087
aa(lp2088
Vhttp://dbpedia.org/resource/Blood_flow
p2089
aVhttp://dbpedia.org/resource/Liver
p2090
aVhttp://dbpedia.org/resource/Kidney
p2091
aasg18
(lp2092
Vsignificantly decreases  glomerularl filtration rates
p2093
aVeffective in treating variant (Prinzmetal\u005c
p2094
aVnorepinephrine pressor effects blocked by prazosin (Minipress)
p2095
aVincreased blood flow to liver, kidney, and skeletal muscle
p2096
asg24
(lp2097
Vhttp://dbpedia.org/resource/Vascular
p2098
aVhttp://dbpedia.org/resource/Norepinephrine
p2099
aVhttp://dbpedia.org/resource/Norepinephrine
p2100
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2101
sg31
S'Vascular effects of norepinephrine (Levophed):'
p2102
sg33
I31
sg34
S'Q18#2'
p2103
sg36
I8
sg37
S'2'
sg38
I2
sg39
S'18'
p2104
sa(dp2105
g3
(lp2106
(lp2107
Vhttp://dbpedia.org/resource/Epinephrine
p2108
aa(lp2109
Vhttp://dbpedia.org/resource/Tyrosine
p2110
aa(lp2111
Vhttp://dbpedia.org/resource/Dopamine
p2112
aasg18
(lp2113
Vepinephrine
p2114
aVtyrosine
p2115
aVtyrosine hydroxylase
p2116
aVdopamine
p2117
aVdopa
p2118
asg24
(lp2119
Vhttp://dbpedia.org/resource/Synthetic_rubber
p2120
aVhttp://dbpedia.org/resource/Precursor_%28chemistry%29
p2121
aVhttp://dbpedia.org/resource/Norepinephrine
p2122
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2123
sg31
S'Immediate synthetic precursor of norepinephrine:'
p2124
sg33
I6
sg34
S'Q18#3'
p2125
sg36
I5
sg37
S'3'
sg38
I3
sg39
S'18'
p2126
sa(dp2127
g3
(lp2128
(lp2129
Vhttp://dbpedia.org/resource/Epinephrine
p2130
aa(lp2131
Vhttp://dbpedia.org/resource/Dopamine
p2132
aVhttp://dbpedia.org/resource/Dopamine
p2133
aa(lp2134
Vhttp://dbpedia.org/resource/Sodium
p2135
aasg18
(lp2136
Vepinephrine
p2137
aVdopa
p2138
aVdopamine (Intropin)
p2139
aVdobutamine (Dobutrex)
p2140
aVnitroprusside sodium (Nipride)
p2141
asg24
(lp2142
Vhttp://dbpedia.org/resource/Precursor_%28chemistry%29
p2143
aVhttp://dbpedia.org/resource/Norepinephrine
p2144
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2145
sg31
S'Low doses, this precursor of norepinephrine causes renovascular dilation:'
p2146
sg33
I15
sg34
S'Q18#5'
p2147
sg36
I10
sg37
S'5'
sg38
I2
sg39
S'18'
p2148
sa(dp2149
g3
(lp2150
(lp2151
Vhttp://dbpedia.org/resource/Management
p2152
aVhttp://dbpedia.org/resource/Sleep
p2153
aa(lp2154
Vhttp://dbpedia.org/resource/Raynaud%27s_phenomenon
p2155
aa(lp2156
Vhttp://dbpedia.org/resource/Heart
p2157
aVhttp://dbpedia.org/resource/Hypovolemia
p2158
aa(lp2159
Vhttp://dbpedia.org/resource/Management
p2160
aasg18
(lp2161
Vmanagement of sleep cycles
p2162
aVtreatment of Raynaud\u005c
p2163
aVtreatment of cardiogenic/hypovolemic shock
p2164
aVmanagement of tachyarrhythmias
p2165
asg24
(lp2166
Vhttp://dbpedia.org/resource/Therapy
p2167
aVhttp://dbpedia.org/resource/Dopamine
p2168
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2169
sg31
S'Significant therapeutic use for dopamine:'
p2170
sg33
I14
sg34
S'Q18#7'
p2171
sg36
I5
sg37
S'7'
sg38
I2
sg39
S'18'
p2172
sa(dp2173
g3
(lp2174
(lp2175
Vhttp://dbpedia.org/resource/Phenylephrine
p2176
aVhttp://dbpedia.org/resource/Phenylephrine
p2177
aa(lp2178
Vhttp://dbpedia.org/resource/Norepinephrine
p2179
aVhttp://dbpedia.org/resource/Norepinephrine
p2180
aasg18
(lp2181
Vphenylephrine (Neo-Synephrine)
p2182
aVmethoxamine (Vasoxyl)
p2183
aVnorepinephrine (Levophed)
p2184
aVisoproterenol (Isuprel)
p2185
aVprazosin (Minipress)
p2186
asg24
(lp2187
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p2188
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p2189
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2190
sg31
S'Has limited action at alpha-adrenergic receptors'
p2191
sg33
I20
sg34
S'Q18#8'
p2192
sg36
I6
sg37
S'8'
sg38
I3
sg39
S'18'
p2193
sa(dp2194
g3
(lp2195
(lp2196
Vhttp://dbpedia.org/resource/Vasoconstriction
p2197
aa(lp2198
Vhttp://dbpedia.org/resource/Hypotension
p2199
aa(lp2200
Vhttp://dbpedia.org/resource/Slighting
p2201
aVhttp://dbpedia.org/resource/Pressure
p2202
aVhttp://dbpedia.org/resource/Blood_pressure
p2203
aa(lp2204
Vhttp://dbpedia.org/resource/Blood_pressure
p2205
aVhttp://dbpedia.org/resource/Minimalism
p2206
aVhttp://dbpedia.org/resource/Blood_pressure
p2207
aasg18
(lp2208
Vsignificant vasopressor effect
p2209
aVsignificant hypotensive effect
p2210
aVslight decrease in mean pressure with a significant decrease in diastolic pressure
p2211
aVsignificant increase in systolic pressure with minimal effect on diastolic pressure
p2212
asg24
(lp2213
Vhttp://dbpedia.org/resource/Blood_pressure
p2214
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions8/questionset8.htm'
p2215
sg31
S'Effect of IV isoproterenol (Isuprel) infusions on blood pressure:'
p2216
sg33
I29
sg34
S'Q18#9'
p2217
sg36
I11
sg37
S'9'
sg38
I2
sg39
S'18'
p2218
sa(dp2219
g3
(lp2220
(lp2221
Vhttp://dbpedia.org/resource/Systemic_circulation
p2222
aVhttp://dbpedia.org/resource/Blood_pressure
p2223
aa(lp2224
Vhttp://dbpedia.org/resource/Atrium_%28heart%29
p2225
aVhttp://dbpedia.org/resource/Pressure
p2226
aa(lp2227
Vhttp://dbpedia.org/resource/Urinary_system
p2228
aVhttp://dbpedia.org/resource/Output
p2229
aasg18
(lp2230
Vlow systemic blood pressure
p2231
aVdecreased atrial filling pressures
p2232
aVhigh urinary output
p2233
asg24
(lp2234
Vhttp://dbpedia.org/resource/Circulatory_system
p2235
aVhttp://dbpedia.org/resource/Patient
p2236
aVhttp://dbpedia.org/resource/Employee_benefit
p2237
aVhttp://dbpedia.org/resource/Dopamine
p2238
aVhttp://dbpedia.org/resource/Dopamine
p2239
aVhttp://dbpedia.org/resource/Administration_%28government%29
p2240
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions9/questionset9.htm'
p2241
sg31
S'Cardiovascular characteristics of patients who might benefit from IV dopamine (Intropin) administration:'
p2242
sg33
I11
sg34
S'Q19#0'
p2243
sg36
I14
sg37
S'0'
sg38
I2
sg39
S'19'
p2244
sa(dp2245
g3
(lp2246
(lp2247
Vhttp://dbpedia.org/resource/Epinephrine
p2248
aa(lp2249
Vhttp://dbpedia.org/resource/Phenylephrine
p2250
aVhttp://dbpedia.org/resource/Phenylephrine
p2251
aa(lp2252
Vhttp://dbpedia.org/resource/Dopamine
p2253
aVhttp://dbpedia.org/resource/Dopamine
p2254
aa(lp2255
Vhttp://dbpedia.org/resource/Norepinephrine
p2256
aVhttp://dbpedia.org/resource/Norepinephrine
p2257
aasg18
(lp2258
Vepinephrine
p2259
aVisoproterenol (Isuprel)
p2260
aVphenylephrine (Neo-Synephrine)
p2261
aVdopamine (Intropin)
p2262
aVnorepinephrine (Levophed)
p2263
asg24
(lp2264
Vhttp://dbpedia.org/resource/Cardiac_muscle
p2265
aVhttp://dbpedia.org/resource/Renal_function
p2266
aVhttp://dbpedia.org/resource/Sodium
p2267
aVhttp://dbpedia.org/resource/Excretion
p2268
aVhttp://dbpedia.org/resource/Urine
p2269
aVhttp://dbpedia.org/resource/Output
p2270
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions9/questionset9.htm'
p2271
sg31
S'Simultaneous increases in myocardial contractility, glomerular filtration rate, sodium excretion, urine output, and renal blood flow are associated most likely with:'
p2272
sg33
I17
sg34
S'Q19#1'
p2273
sg36
I25
sg37
S'1'
sg38
I3
sg39
S'19'
p2274
sa(dp2275
g3
(lp2276
(lp2277
Vhttp://dbpedia.org/resource/Kidney
p2278
aVhttp://dbpedia.org/resource/Solid
p2279
aa(lp2280
Vhttp://dbpedia.org/resource/Sodium
p2281
aVhttp://dbpedia.org/resource/Excretion
p2282
aa(lp2283
Vhttp://dbpedia.org/resource/Redox
p2284
aVhttp://dbpedia.org/resource/Artery
p2285
aa(lp2286
Vhttp://dbpedia.org/resource/Cardiac_muscle
p2287
aa(lp2288
Vhttp://dbpedia.org/resource/Atrium_%28heart%29
p2289
aVhttp://dbpedia.org/resource/Pressure
p2290
aasg18
(lp2291
Vpromotes renal tubule or solid reabsorption
p2292
aVreduces sodium excretion
p2293
aVcauses reduced ventilatory response to arterial hypoxemia
p2294
aVdecreases myocardial contractility
p2295
aVincreases atrial filling pressures
p2296
asg24
(lp2297
Vhttp://dbpedia.org/resource/Dopamine
p2298
aVhttp://dbpedia.org/resource/Dopamine
p2299
aVhttp://dbpedia.org/resource/Property
p2300
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions9/questionset9.htm'
p2301
sg31
S'IV dopamine (Intropin) properties:'
p2302
sg33
I23
sg34
S'Q19#2'
p2303
sg36
I6
sg37
S'2'
sg38
I2
sg39
S'19'
p2304
sa(dp2305
g3
(lp2306
(lp2307
Vhttp://dbpedia.org/resource/Positive_law
p2308
aVhttp://dbpedia.org/resource/Tachycardia
p2309
aa(lp2310
Vhttp://dbpedia.org/resource/Catecholamine
p2311
aVhttp://dbpedia.org/resource/Release_%28music%29
p2312
aa(lp2313
Vhttp://dbpedia.org/resource/Acts_of_the_Apostles
p2314
aVhttp://dbpedia.org/resource/Dopamine_receptor
p2315
aa(lp2316
Vhttp://dbpedia.org/resource/Positive_law
p2317
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p2318
aVhttp://dbpedia.org/resource/Activation_energy
p2319
aa(lp2320
Vhttp://dbpedia.org/resource/Long-Term_Capital_Management
p2321
aVhttp://dbpedia.org/resource/Management
p2322
aVhttp://dbpedia.org/resource/Cardiac_muscle
p2323
aVhttp://dbpedia.org/resource/Pump
p2324
aVhttp://dbpedia.org/resource/Failure
p2325
aVhttp://dbpedia.org/resource/Surgery
p2326
aasg18
(lp2327
Vpositive inotropic agent; causes significant increase in heart rate
p2328
aVpromotes catecholamine release
p2329
aVmainly acts through dopamine receptors
p2330
aVpositive inotropic effect is mediated through beta-adrenergic receptor activation
p2331
aVappropriate for long-term management of myocardial pump-failure following surgery
p2332
asg24
(lp2333
Vhttp://dbpedia.org/resource/Property
p2334
asg29
S'http://www.pharmacology2000.com/Autonomics/Adrenergics1/questions9/questionset9.htm'
p2335
sg31
S'Properties of dobutamine (Dobutrex):'
p2336
sg33
I36
sg34
S'Q19#4'
p2337
sg36
I7
sg37
S'4'
sg38
I3
sg39
S'19'
p2338
sa(dp2339
g3
(lp2340
(lp2341
Vhttp://dbpedia.org/resource/Ganglion
p2342
aVhttp://dbpedia.org/resource/Neurotransmitter
p2343
aVhttp://dbpedia.org/resource/Acetylcholine
p2344
aa(lp2345
Vhttp://dbpedia.org/resource/Sympathetic_nervous_system
p2346
aVhttp://dbpedia.org/resource/Activation_energy
p2347
aa(lp2348
Vhttp://dbpedia.org/resource/Lumbar
p2349
aVhttp://dbpedia.org/resource/Origin_of_replication
p2350
aVhttp://dbpedia.org/resource/Ganglion
p2351
aVhttp://dbpedia.org/resource/Bodie_Broadus
p2352
aasg18
(lp2353
VGanglionic neurotransmitter: acetylcholine
p2354
aVgeneralized response upon sympathetic activation
p2355
aVthoraco-lumbar origin for preganglionic cell bodies
p2356
aVA, B and C
p2357
asg24
(lp2358
Vhttp://dbpedia.org/resource/Sympathetic_nervous_system
p2359
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2360
sg31
S'Sympathetic Nervous System'
p2361
sg33
I20
sg34
S'Q20#0'
p2362
sg36
I3
sg37
S'0'
sg38
I3
sg39
S'20'
p2363
sa(dp2364
g3
(lp2365
(lp2366
Vhttp://dbpedia.org/resource/Acetylcholine
p2367
aasg18
(lp2368
Vcarbachol
p2369
aVacetylcholine
p2370
aVmethacholine (Provocholine)
p2371
aVpilocarpine (Pilocar)
p2372
asg24
(lp2373
Vhttp://dbpedia.org/resource/Choline
p2374
aVhttp://dbpedia.org/resource/Ester
p2375
aVhttp://dbpedia.org/resource/Hydrolysis
p2376
aVhttp://dbpedia.org/resource/Acetylcholinesterase
p2377
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2378
sg31
S'Choline ester most susceptible to hydrolysis by acetylcholinesterase:'
p2379
sg33
I10
sg34
S'Q20#1'
p2380
sg36
I8
sg37
S'1'
sg38
I1
sg39
S'20'
p2381
sa(dp2382
g3
(lp2383
(lp2384
Vhttp://dbpedia.org/resource/Acetylcholine
p2385
aa(lp2386
Vhttp://dbpedia.org/resource/Atropine
p2387
aasg18
(lp2388
Vacetylcholine
p2389
aVatropine
p2390
aVmethacholine (Provocholine)
p2391
aVcarbachol
p2392
asg24
(lp2393
Vhttp://dbpedia.org/resource/Nicotinic_acetylcholine_receptor
p2394
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p2395
aVhttp://dbpedia.org/resource/Choline
p2396
aVhttp://dbpedia.org/resource/Ester
p2397
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2398
sg31
S'Highest nicotinic receptor activity among choline esters:'
p2399
sg33
I7
sg34
S'Q20#3'
p2400
sg36
I7
sg37
S'3'
sg38
I3
sg39
S'20'
p2401
sa(dp2402
g3
(lp2403
(lp2404
Vhttp://dbpedia.org/resource/Heart_rate
p2405
aa(lp2406
Vhttp://dbpedia.org/resource/Motility
p2407
aa(lp2408
Vhttp://dbpedia.org/resource/Urinary_retention
p2409
aasg18
(lp2410
Vincrease heart rate
p2411
aVdecreased GI motility
p2412
aVdecrease cardiac contractility
p2413
aVurinary retention
p2414
asg24
(lp2415
Vhttp://dbpedia.org/resource/Parasympathetic_nervous_system
p2416
aVhttp://dbpedia.org/resource/Activation_energy
p2417
aVhttp://dbpedia.org/resource/Direct_current
p2418
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2419
sg31
S'Associated with parasympathetic activation (direct effects):'
p2420
sg33
I11
sg34
S'Q20#4'
p2421
sg36
I9
sg37
S'4'
sg38
I2
sg39
S'20'
p2422
sa(dp2423
g3
(lp2424
(lp2425
Vhttp://dbpedia.org/resource/Atropine
p2426
aa(lp2427
Vhttp://dbpedia.org/resource/Salbutamol
p2428
aVhttp://dbpedia.org/resource/Salbutamol
p2429
aVhttp://dbpedia.org/resource/Salbutamol
p2430
aasg18
(lp2431
Vmetoprolol (Lopressor)
p2432
aVatropine
p2433
aValbuterol (Ventolin,Proventil)
p2434
aV ipratropium (Atrovent)
p2435
asg24
(lp2436
Vhttp://dbpedia.org/resource/Asthma
p2437
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2438
sg31
S'Bronchoconstriction in an asthmatic:'
p2439
sg33
I15
sg34
S'Q20#5'
p2440
sg36
I4
sg37
S'5'
sg38
I0
sg39
S'20'
p2441
sa(dp2442
g3
(lp2443
(lp2444
Vhttp://dbpedia.org/resource/Atropine
p2445
aa(lp2446
Vhttp://dbpedia.org/resource/Scopolamine
p2447
aasg18
(lp2448
Vatropine
p2449
aVscopolamine
p2450
aVhomatropine
p2451
aVmuscarine
p2452
asg24
(lp2453
Vhttp://dbpedia.org/resource/Drug
p2454
aVhttp://dbpedia.org/resource/Central_nervous_system
p2455
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p2456
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2457
sg31
S'Antimuscarinic drug with highest CNS activity'
p2458
sg33
I4
sg34
S'Q20#7'
p2459
sg36
I6
sg37
S'7'
sg38
I1
sg39
S'20'
p2460
sa(dp2461
g3
(lp2462
(lp2463
Vhttp://dbpedia.org/resource/Atropine
p2464
aa(lp2465
Vhttp://dbpedia.org/resource/Propranolol
p2466
aVhttp://dbpedia.org/resource/Propranolol
p2467
aasg18
(lp2468
Visoproterenol (Isuprel)
p2469
aVatropine
p2470
aVpropranolol (Inderal)
p2471
aVmethacholine (Provocholine)
p2472
asg24
(lp2473
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2474
aVhttp://dbpedia.org/resource/Foreign_Agents_Registration_Act
p2475
aVhttp://dbpedia.org/resource/Transmission_%28song%29
p2476
aVhttp://dbpedia.org/resource/Node_%28networking%29
p2477
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2478
sg31
S'Muscarinic agent: enhances transmission through the A-V node:'
p2479
sg33
I13
sg34
S'Q20#8'
p2480
sg36
I9
sg37
S'8'
sg38
I1
sg39
S'20'
p2481
sa(dp2482
g3
(lp2483
(lp2484
Vhttp://dbpedia.org/resource/Atropine
p2485
aasg18
(lp2486
Vhomatropine (Isopto Homatropine)
p2487
aVatropine
p2488
aVcyclopentolate (Cyclogyl)
p2489
aVbenztropine (Cogentin)
p2490
asg24
(lp2491
Vhttp://dbpedia.org/resource/Mydriasis
p2492
aVhttp://dbpedia.org/resource/Long_%28finance%29
p2493
aVhttp://dbpedia.org/resource/Duration_%28music%29
p2494
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2495
sg31
S'Least likely to be used as a mydriatic because of long-duration of action:'
p2496
sg33
I14
sg34
S'Q20#9'
p2497
sg36
I13
sg37
S'9'
sg38
I1
sg39
S'20'
p2498
sa(dp2499
g3
(lp2500
(lp2501
Vhttp://dbpedia.org/resource/Atropine
p2502
aasg18
(lp2503
Vhomatropine (Isopto Homatropine)
p2504
aVatropine
p2505
aVbenztropine (Cogentin)
p2506
aVtropicamide (Mydriacyl)
p2507
asg24
(lp2508
Vhttp://dbpedia.org/resource/Secondary_school
p2509
aVhttp://dbpedia.org/resource/Myocardial_infarction
p2510
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions2/cho1.htm'
p2511
sg31
S'Clinically-used to treat sinus bradycardia secondary to acute myocardial infarction:'
p2512
sg33
I14
sg34
S'Q20#10'
p2513
sg36
I10
sg37
S'10'
p2514
sg38
I1
sg39
S'20'
p2515
sa(dp2516
g3
(lp2517
sg18
(lp2518
VM1
p2519
aVM2
p2520
aVM3
p2521
aVM4
p2522
asg24
(lp2523
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2524
aVhttp://dbpedia.org/resource/Heart
p2525
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions3/questionset3.htm'
p2526
sg31
S'Muscarinic receptor subtype primarily associated with the heart:'
p2527
sg33
I4
sg34
S'Q21#5'
p2528
sg36
I8
sg37
S'5'
sg38
I1
sg39
S'21'
p2529
sa(dp2530
g3
(lp2531
(lp2532
Vhttp://dbpedia.org/resource/Atropine
p2533
aa(lp2534
Vhttp://dbpedia.org/resource/Acetylcholine
p2535
aa(lp2536
Vhttp://dbpedia.org/resource/Ephedrine
p2537
aasg18
(lp2538
Vatropine
p2539
aVedrophonium (Tensilon)
p2540
aVcarbachol
p2541
aVacetylcholine
p2542
aVephedrine
p2543
asg24
(lp2544
Vhttp://dbpedia.org/resource/Acting
p2545
aVhttp://dbpedia.org/resource/Acetylcholine
p2546
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions3/questionset3.htm'
p2547
sg31
S'Indirect-acting cholinomimetic:'
p2548
sg33
I8
sg34
S'Q21#12'
p2549
sg36
I2
sg37
S'12'
p2550
sg38
I1
sg39
S'21'
p2551
sa(dp2552
g3
(lp2553
(lp2554
Vhttp://dbpedia.org/resource/Sodium
p2555
aa(lp2556
Vhttp://dbpedia.org/resource/Potassium
p2557
aa(lp2558
Vhttp://dbpedia.org/resource/Chloride
p2559
aa(lp2560
Vhttp://dbpedia.org/resource/Calcium
p2561
aa(lp2562
Vhttp://dbpedia.org/resource/Magnesium
p2563
aasg18
(lp2564
Vsodium
p2565
aVpotassium
p2566
aVchloride
p2567
aVcalcium
p2568
aVmagnesium
p2569
asg24
(lp2570
Vhttp://dbpedia.org/resource/Cholinergic
p2571
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p2572
aVhttp://dbpedia.org/resource/Vasodilation
p2573
aVhttp://dbpedia.org/resource/Intracellular
p2574
aVhttp://dbpedia.org/resource/Concentration
p2575
aVhttp://dbpedia.org/resource/Ion
p2576
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions4/questionset4.htm'
p2577
sg31
S'Cholinergic-receptor-mediated vasodilation -- changes in intracellular concentration of this ion is principally responsible:'
p2578
sg33
I5
sg34
S'Q22#0'
p2579
sg36
I13
sg37
S'0'
sg38
I3
sg39
S'22'
p2580
sa(dp2581
g3
(lp2582
(lp2583
Vhttp://dbpedia.org/resource/Prostaglandin
p2584
aa(lp2585
Vhttp://dbpedia.org/resource/Leukotriene
p2586
aa(lp2587
Vhttp://dbpedia.org/resource/Nitric_oxide
p2588
aa(lp2589
Vhttp://dbpedia.org/resource/Calcium
p2590
aasg18
(lp2591
Vprostaglandins
p2592
aVleukotrienes
p2593
aVnitric oxide
p2594
aVcalcium
p2595
asg24
(lp2596
Vhttp://dbpedia.org/resource/Cholinergic
p2597
aVhttp://dbpedia.org/resource/Vasodilation
p2598
aVhttp://dbpedia.org/resource/Gas
p2599
aVhttp://dbpedia.org/resource/Endothelium
p2600
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions4/questionset4.htm'
p2601
sg31
S'Cholinergic-mediated vasodilation involves liberation of this substance, a gas, from endothelial cells:'
p2602
sg33
I5
sg34
S'Q22#1'
p2603
sg36
I14
sg37
S'1'
sg38
I2
sg39
S'22'
p2604
sa(dp2605
g3
(lp2606
(lp2607
Vhttp://dbpedia.org/resource/Physostigmine
p2608
aa(lp2609
Vhttp://dbpedia.org/resource/Atropine
p2610
aasg18
(lp2611
Vphysostigmine (Antilirium)
p2612
aVneostigmine (Prostigmin)
p2613
aVedrophonium (Tensilon)
p2614
aVtacrine (Cognex)
p2615
aVatropine
p2616
asg24
(lp2617
Vhttp://dbpedia.org/resource/Quaternary_ammonium_cation
p2618
aVhttp://dbpedia.org/resource/Duration_%28music%29
p2619
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions5/questionset5.htm'
p2620
sg31
S'anticholinesterase agent; quaternary ammonium compound; intermediate-duration, carbamylating agent:'
p2621
sg33
I17
sg34
S'Q23#1'
p2622
sg36
I11
sg37
S'1'
sg38
I1
sg39
S'23'
p2623
sa(dp2624
g3
(lp2625
(lp2626
Vhttp://dbpedia.org/resource/Primary_school
p2627
aa(lp2628
Vhttp://dbpedia.org/resource/Congenital_disorder
p2629
aasg18
(lp2630
Vprimary
p2631
aVsecondary
p2632
aVcongenital
p2633
asg24
(lp2634
Vhttp://dbpedia.org/resource/Data_type
p2635
aVhttp://dbpedia.org/resource/Glaucoma
p2636
aVhttp://dbpedia.org/resource/Antiphon
p2637
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions5/questionset5.htm'
p2638
sg31
S'Which type of glaucoma response to anticholinesterase treatment?'
p2639
sg33
I3
sg34
S'Q23#7'
p2640
sg36
I9
sg37
S'7'
sg38
I0
sg39
S'23'
p2641
sa(dp2642
g3
(lp2643
(lp2644
Vhttp://dbpedia.org/resource/Chemical_synthesis
p2645
aVhttp://dbpedia.org/resource/Cholinergic
p2646
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p2647
aa(lp2648
Vhttp://dbpedia.org/resource/Chemical_synthesis
p2649
aVhttp://dbpedia.org/resource/Acetylcholine
p2650
aa(lp2651
Vhttp://dbpedia.org/resource/Failure
p2652
aVhttp://dbpedia.org/resource/Acetylcholine
p2653
aVhttp://dbpedia.org/resource/Reuptake
p2654
aa(lp2655
Vhttp://dbpedia.org/resource/Binding_energy
p2656
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2657
aVhttp://dbpedia.org/resource/Antibody
p2658
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2659
aa(lp2660
Vhttp://dbpedia.org/resource/Binding_energy
p2661
aVhttp://dbpedia.org/resource/Nicotinic_acetylcholine_receptor
p2662
aVhttp://dbpedia.org/resource/Antibody
p2663
aVhttp://dbpedia.org/resource/Nicotinic_acetylcholine_receptor
p2664
aasg18
(lp2665
Vexcessive synthesis of cholinergic receptors
p2666
aVinadequate synthesis of acetylcholine
p2667
aVfailure of acetylcholine reuptake system
p2668
aVbinding of anti--muscarinic receptor antibodies to the muscarinic cholinergic receptor
p2669
aVbinding of anti-nicotinic receptor antibodies to the nicotinic cholinergic receptor
p2670
asg24
(lp2671
Vhttp://dbpedia.org/resource/Probable_cause
p2672
aVhttp://dbpedia.org/resource/Myasthenia_gravis
p2673
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions5/questionset5.htm'
p2674
sg31
S'Probable cause of myasthenia gravis:'
p2675
sg33
I36
sg34
S'Q23#9'
p2676
sg36
I5
sg37
S'9'
sg38
I4
sg39
S'23'
p2677
sa(dp2678
g3
(lp2679
(lp2680
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p2681
aVhttp://dbpedia.org/resource/Blocking_%28American_football%29
p2682
aVhttp://dbpedia.org/resource/Drug
p2683
aa(lp2684
Vhttp://dbpedia.org/resource/Activity_%28chemistry%29
p2685
aVhttp://dbpedia.org/resource/Pharmacology
p2686
aVhttp://dbpedia.org/resource/Receptor_antagonist
p2687
aVhttp://dbpedia.org/resource/Drug
p2688
aa(lp2689
Vhttp://dbpedia.org/resource/Summation
p2690
aa(lp2691
Vhttp://dbpedia.org/resource/Subtraction
p2692
aasg18
(lp2693
Vspontaneous recovery rate from the blocking drug
p2694
aVactivity of the pharmacologic antagonist (anticholinesterase drug)
p2695
aVboth (sum of A plus B)
p2696
aVdifference (A- B)
p2697
asg24
(lp2698
Vhttp://dbpedia.org/resource/Recovery_model
p2699
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p2700
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2701
aVhttp://dbpedia.org/resource/Blockade
p2702
aVhttp://dbpedia.org/resource/Receptor_antagonist
p2703
aVhttp://dbpedia.org/resource/Reversal_film
p2704
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions6/questionset6.htm'
p2705
sg31
S'Determination of the recovery rates from neuromuscular-blockade when antagonist-assisted reversal is used:'
p2706
sg33
I29
sg34
S'Q24#2'
p2707
sg36
I12
sg37
S'2'
sg38
I2
sg39
S'24'
p2708
sa(dp2709
g3
(lp2710
(lp2711
Vhttp://dbpedia.org/resource/Spontaneous_generation
p2712
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2713
aVhttp://dbpedia.org/resource/Blockade
p2714
aVhttp://dbpedia.org/resource/Recovery_model
p2715
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2716
aVhttp://dbpedia.org/resource/Blocking_%28American_football%29
p2717
aVhttp://dbpedia.org/resource/Administration_%28government%29
p2718
aasg18
(lp2719
Vbefore the neuromuscular-blocking drug is given
p2720
aVwhile the neuromuscular-blocking drug is being infused
p2721
aVduring the spontaneous neuromuscular-blockade recovery, following cessation of neuromuscular-blocking administration
p2722
asg24
(lp2723
Vhttp://dbpedia.org/resource/Infusion
p2724
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions6/questionset6.htm'
p2725
sg31
S'When our anticholinesterase agents usually administered to enhance neuromuscular blockade reversal?'
p2726
sg33
I24
sg34
S'Q24#3'
p2727
sg36
I12
sg37
S'3'
sg38
I2
sg39
S'24'
p2728
sa(dp2729
g3
(lp2730
(lp2731
Vhttp://dbpedia.org/resource/Short_film
p2732
aVhttp://dbpedia.org/resource/Acting
p2733
aa(lp2734
Vhttp://dbpedia.org/resource/Long_%28finance%29
p2735
aVhttp://dbpedia.org/resource/Acting
p2736
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2737
aVhttp://dbpedia.org/resource/Blockade
p2738
aa(lp2739
Vhttp://dbpedia.org/resource/Effectiveness
p2740
aasg18
(lp2741
Vshort-or intermediate-acting neuromuscular-blocking drugs
p2742
aVlong-acting nondepolarizing neuromuscular-blockade
p2743
aVequally effective
p2744
asg24
(lp2745
Vhttp://dbpedia.org/resource/Pharmacology
p2746
aVhttp://dbpedia.org/resource/Drug
p2747
aVhttp://dbpedia.org/resource/Effectiveness
p2748
aVhttp://dbpedia.org/resource/Movable_type
p2749
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions6/questionset6.htm'
p2750
sg31
S'Pharmacologic antagonism (anticholinesterase drugs) would likely be more effective for which type of neuromuscular blocking drug?'
p2751
sg33
I9
sg34
S'Q24#4'
p2752
sg36
I19
sg37
S'4'
sg38
I0
sg39
S'24'
p2753
sa(dp2754
g3
(lp2755
(lp2756
Vhttp://dbpedia.org/resource/Acetylcholine
p2757
aVhttp://dbpedia.org/resource/Concentration
p2758
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2759
aa(lp2760
Vhttp://dbpedia.org/resource/Acetylcholinesterase
p2761
aa(lp2762
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p2763
aVhttp://dbpedia.org/resource/Drug
p2764
aasg18
(lp2765
Vincreases acetylcholine concentration that neuromuscular junctions
p2766
aVinhibits acetylcholinesterase
p2767
aVminimizes muscarinic receptor-mediated effects of anticholinesterase drugs
p2768
asg24
(lp2769
Vhttp://dbpedia.org/resource/Pharmacology
p2770
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2771
aVhttp://dbpedia.org/resource/Blockade
p2772
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions6/questionset6.htm'
p2773
sg31
S'Rationale for using muscarinic antagonists in pharmacologic (anticholinesterase-mediated) reversal of neuromuscular-blockade:'
p2774
sg33
I15
sg34
S'Q24#5'
p2775
sg36
I13
sg37
S'5'
sg38
I2
sg39
S'24'
p2776
sa(dp2777
g3
(lp2778
(lp2779
Vhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p2780
aVhttp://dbpedia.org/resource/Atropine
p2781
aasg18
(lp2782
Vedrophonium (Tensilon)
p2783
aVhigh-dose atropine (10-15 ug/kg)
p2784
aVneostigmine (Prostigmin)
p2785
asg24
(lp2786
Vhttp://dbpedia.org/resource/Sports_agent
p2787
aVhttp://dbpedia.org/resource/Combination
p2788
aVhttp://dbpedia.org/resource/Reversal_film
p2789
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2790
aVhttp://dbpedia.org/resource/Blockade
p2791
aVhttp://dbpedia.org/resource/Opioid
p2792
aVhttp://dbpedia.org/resource/Anesthesia
p2793
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions6/questionset6.htm'
p2794
sg31
S'which antimuscarinic agent might be used in combination with an anticholinesterase when desiring reversal of neuromuscular-blockade and opioid-based maintenance anesthesia has been used:'
p2795
sg33
I14
sg34
S'Q24#6'
p2796
sg36
I23
sg37
S'6'
sg38
I1
sg39
S'24'
p2797
sa(dp2798
g3
(lp2799
(lp2800
Vhttp://dbpedia.org/resource/Effectiveness
p2801
aasg18
(lp2802
Vedrophonium (Tensilon)
p2803
aVneostigmine (Prostigmin)
p2804
aVboth are equally effective
p2805
asg24
(lp2806
Vhttp://dbpedia.org/resource/Effectiveness
p2807
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p2808
aVhttp://dbpedia.org/resource/Blockade
p2809
aVhttp://dbpedia.org/resource/Continuous_function
p2810
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions6/questionset6.htm'
p2811
sg31
S'More effective in reversing deep neuromuscular-blockade produced by continuous atracurium (Tracrium), vecuronium (Norcuron), or pancuronium (Pavulon) infusions'
p2812
sg33
I12
sg34
S'Q24#7'
p2813
sg36
I25
sg37
S'7'
sg38
I1
sg39
S'24'
p2814
sa(dp2815
g3
(lp2816
(lp2817
Vhttp://dbpedia.org/resource/Scopolamine
p2818
aa(lp2819
Vhttp://dbpedia.org/resource/Atropine
p2820
aasg18
(lp2821
Vscopolamine
p2822
aVatropine
p2823
aVglycopyrrolate (Robinul)
p2824
asg24
(lp2825
Vhttp://dbpedia.org/resource/Anticholinergic
p2826
aVhttp://dbpedia.org/resource/Drug
p2827
aVhttp://dbpedia.org/resource/Pharmaceutical_drug
p2828
aVhttp://dbpedia.org/resource/Patient
p2829
aVhttp://dbpedia.org/resource/Glaucoma
p2830
aVhttp://dbpedia.org/resource/Drug
p2831
aVhttp://dbpedia.org/resource/Pupil
p2832
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions7/questionset7.htm'
p2833
sg31
S'In using anticholinergic drugs as preoperative medication in a patient with glaucoma: drug least likely to have an effect on pupil size'
p2834
sg33
I6
sg34
S'Q25#2'
p2835
sg36
I23
sg37
S'2'
sg38
I2
sg39
S'25'
p2836
sa(dp2837
g3
(lp2838
(lp2839
Vhttp://dbpedia.org/resource/Atropine
p2840
aa(lp2841
Vhttp://dbpedia.org/resource/Scopolamine
p2842
aasg18
(lp2843
Vatropine
p2844
aVglycopyrrolate (Robinul)
p2845
aVscopolamine
p2846
asg24
(lp2847
Vhttp://dbpedia.org/resource/Preference
p2848
aVhttp://dbpedia.org/resource/Anticholinergic
p2849
aVhttp://dbpedia.org/resource/Sedation
p2850
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions7/questionset7.htm'
p2851
sg31
S'Preferred anticholinergic drug when sedation is the principal objective, preoperatively:'
p2852
sg33
I6
sg34
S'Q25#3'
p2853
sg36
I11
sg37
S'3'
sg38
I2
sg39
S'25'
p2854
sa(dp2855
g3
(lp2856
(lp2857
Vhttp://dbpedia.org/resource/Young_adult_%28psychology%29
p2858
aa(lp2859
Vhttp://dbpedia.org/resource/Infant
p2860
aa(lp2861
Vhttp://dbpedia.org/resource/Old_age
p2862
aasg18
(lp2863
Vyoung adult
p2864
aVinfants
p2865
aVelderly
p2866
asg24
(lp2867
Vhttp://dbpedia.org/resource/Atropine
p2868
aVhttp://dbpedia.org/resource/Heart_rate
p2869
aVhttp://dbpedia.org/resource/Patient
p2870
aVhttp://dbpedia.org/resource/Population
p2871
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions7/questionset7.htm'
p2872
sg31
S'Atropine: most likely to increase heart rate in this patient population:'
p2873
sg33
I4
sg34
S'Q25#4'
p2874
sg36
I12
sg37
S'4'
sg38
I0
sg39
S'25'
p2875
sa(dp2876
g3
(lp2877
(lp2878
Vhttp://dbpedia.org/resource/Salbutamol
p2879
aVhttp://dbpedia.org/resource/Salbutamol
p2880
aVhttp://dbpedia.org/resource/Salbutamol
p2881
aa(lp2882
Vhttp://dbpedia.org/resource/Effectiveness
p2883
aasg18
(lp2884
Valbuterol (Ventolin,Proventil) (beta-adrenergic agonist)
p2885
aVipratropium (Atrovent) (antimuscarinic agent)
p2886
aVequally effective
p2887
asg24
(lp2888
Vhttp://dbpedia.org/resource/Effectiveness
p2889
aVhttp://dbpedia.org/resource/Bronchodilator
p2890
aVhttp://dbpedia.org/resource/Patient
p2891
aVhttp://dbpedia.org/resource/Chronic_bronchitis
p2892
aVhttp://dbpedia.org/resource/Emphysema
p2893
asg29
S'http://www.pharmacology2000.com/Autonomics/Cholinergics/questions7/questionset7.htm'
p2894
sg31
S'More effective in producing bronchodilation in patients with chronic bronchitis or emphysema:'
p2895
sg33
I20
sg34
S'Q25#6'
p2896
sg36
I12
sg37
S'6'
sg38
I1
sg39
S'25'
p2897
sa(dp2898
g3
(lp2899
(lp2900
Vhttp://dbpedia.org/resource/Norepinephrine
p2901
aVhttp://dbpedia.org/resource/Norepinephrine
p2902
aasg18
(lp2903
Vminoxidil (Loniten): TPR increases
p2904
aVfosinopril (Monopril): TPR increases
p2905
aVnorepinephrine (Levophed): TPR increases
p2906
aVphenoxybenzamine (Dibenzyline): TPR increases
p2907
asg24
(lp2908
Vhttp://dbpedia.org/resource/Factors_of_production
p2909
aVhttp://dbpedia.org/resource/Map
p2910
aVhttp://dbpedia.org/resource/Cardiac_output
p2911
aVhttp://dbpedia.org/resource/Norepinephrine
p2912
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p2913
sg31
S'Total peripheral resistance (TPR) is a determining factor for mean arterial pressure, i.e. Mean arterial pressure (MAP) = cardiac output x total peripheral resistance (TPR). What are correct relationships between norepinephrine, minoxidil, and lisinopril and TPR?'
p2914
sg33
I28
sg34
S'Q26#0'
p2915
sg36
I47
sg37
S'0'
sg38
I2
sg39
S'26'
p2916
sa(dp2917
g3
(lp2918
(lp2919
Vhttp://dbpedia.org/resource/Nifedipine
p2920
aVhttp://dbpedia.org/resource/Nifedipine
p2921
aasg18
(lp2922
Vnifedipine (Procardia, Adalat)
p2923
aVcaptopril (Capoten)
p2924
aVtimolol (Blocadren)
p2925
aVmethyldopa (Aldomet)
p2926
asg24
(lp2927
Vhttp://dbpedia.org/resource/ACE_inhibitor
p2928
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p2929
sg31
S'ACE inhibitor'
p2930
sg33
I18
sg34
S'Q26#4'
p2931
sg36
I2
sg37
S'4'
sg38
I1
sg39
S'26'
p2932
sa(dp2933
g3
(lp2934
(lp2935
Vhttp://dbpedia.org/resource/Propranolol
p2936
aVhttp://dbpedia.org/resource/Propranolol
p2937
aasg18
(lp2938
Vtimolol (Blocadren)
p2939
aVlabetalol (Trandate, Normodyne)
p2940
aVpropranolol (Inderal)
p2941
aVdiazoxide (Hyperstat)
p2942
asg24
(lp2943
Vhttp://dbpedia.org/resource/Block_matrix
p2944
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p2945
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p2946
sg31
S'Blocks both alpha and beta receptors:'
p2947
sg33
I18
sg34
S'Q26#5'
p2948
sg36
I6
sg37
S'5'
sg38
I1
sg39
S'26'
p2949
sa(dp2950
g3
(lp2951
(lp2952
Vhttp://dbpedia.org/resource/Reserpine
p2953
aa(lp2954
Vhttp://dbpedia.org/resource/Phenylephrine
p2955
aVhttp://dbpedia.org/resource/Phenylephrine
p2956
aasg18
(lp2957
Vdiltiazem (Cardiazem)
p2958
aVnitroprusside sodium (Nipride)
p2959
aVreserpine
p2960
aVphenylephrine (Neo-Synephrine)
p2961
asg24
(lp2962
Vhttp://dbpedia.org/resource/Sodium
p2963
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p2964
sg31
S'Hypertensive emergencies:'
p2965
sg33
I14
sg34
S'Q26#6'
p2966
sg36
I2
sg37
S'6'
sg38
I1
sg39
S'26'
p2967
sa(dp2968
g3
(lp2969
(lp2970
Vhttp://dbpedia.org/resource/Propranolol
p2971
aVhttp://dbpedia.org/resource/Propranolol
p2972
aasg18
(lp2973
Vpropranolol (Inderal)
p2974
aVmecamylamine (Inversine)
p2975
aVhydralazine (Apresoline)
p2976
aVdiazoxide (Hyperstat)
p2977
asg24
(lp2978
Vhttp://dbpedia.org/resource/Side_effect
p2979
aVhttp://dbpedia.org/resource/Tachycardia
p2980
aVhttp://dbpedia.org/resource/Angina_pectoris
p2981
aVhttp://dbpedia.org/resource/Lupus_erythematosus
p2982
aVhttp://dbpedia.org/resource/Syndrome
p2983
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p2984
sg31
S'Side effects of this antihypertensive agent includes tachycardia, angina, reversible lupus-like syndrome'
p2985
sg33
I16
sg34
S'Q26#7'
p2986
sg36
I14
sg37
S'7'
sg38
I2
sg39
S'26'
p2987
sa(dp2988
g3
(lp2989
(lp2990
Vhttp://dbpedia.org/resource/Blockade
p2991
aVhttp://dbpedia.org/resource/Calcium_channel
p2992
aa(lp2993
Vhttp://dbpedia.org/resource/Alpha-1_adrenergic_receptor
p2994
aVhttp://dbpedia.org/resource/Receptor_antagonist
p2995
aa(lp2996
Vhttp://dbpedia.org/resource/Receptor_antagonist
p2997
aasg18
(lp2998
Vphosphodiesterase inhibitor
p2999
aVblockade of calcium channels
p3000
aValpha-1 receptor antagonists
p3001
aVbeta-1 receptor antagonist
p3002
asg24
(lp3003
Vhttp://dbpedia.org/resource/Mechanism_of_action
p3004
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3005
sg31
S'Mechanism of action:diltiazem (Cardiazem)'
p3006
sg33
I12
sg34
S'Q26#8'
p3007
sg36
I8
sg37
S'8'
sg38
I1
sg39
S'26'
p3008
sa(dp3009
g3
(lp3010
(lp3011
Vhttp://dbpedia.org/resource/Alpha-1_adrenergic_receptor
p3012
aVhttp://dbpedia.org/resource/Dan_Blocker
p3013
aa(lp3014
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3015
aVhttp://dbpedia.org/resource/Dan_Blocker
p3016
aa(lp3017
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p3018
aasg18
(lp3019
Valpha-1 receptor blocker
p3020
aVbeta receptor blocker
p3021
aVphosphodiesterase inhibitor
p3022
aVcalcium channel blocker
p3023
asg24
(lp3024
Vhttp://dbpedia.org/resource/Mechanism_of_action
p3025
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3026
sg31
S'Mechanism of action: prazosin (Minipress)'
p3027
sg33
I11
sg34
S'Q26#9'
p3028
sg36
I8
sg37
S'9'
sg38
I0
sg39
S'26'
p3029
sa(dp3030
g3
(lp3031
(lp3032
Vhttp://dbpedia.org/resource/Propranolol
p3033
aVhttp://dbpedia.org/resource/Propranolol
p3034
aasg18
(lp3035
Vpropranolol (Inderal)
p3036
aVmetoprolol (Lopressor)
p3037
aVchlorothiazide (Diuril)
p3038
aVdiltiazem (Cardiazem)
p3039
asg24
(lp3040
Vhttp://dbpedia.org/resource/Blood_serum
p3041
aVhttp://dbpedia.org/resource/Lipid
p3042
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3043
sg31
S'Antihypertensive drug LEAST likely to elevate serum lipids:'
p3044
sg33
I16
sg34
S'Q26#10'
p3045
sg36
I8
sg37
S'10'
p3046
sg38
I3
sg39
S'26'
p3047
sa(dp3048
g3
(lp3049
(lp3050
Vhttp://dbpedia.org/resource/Propranolol
p3051
aVhttp://dbpedia.org/resource/Propranolol
p3052
aasg18
(lp3053
Vchlorothiazide (Diuril)
p3054
aVcaptopril (Capoten)
p3055
aVpropranolol (Inderal)
p3056
aVmetoprolol (Lopressor)
p3057
asg24
(lp3058
Vhttp://dbpedia.org/resource/Old_age
p3059
aVhttp://dbpedia.org/resource/Male
p3060
aVhttp://dbpedia.org/resource/Patient
p3061
aVhttp://dbpedia.org/resource/Heart_failure
p3062
aVhttp://dbpedia.org/resource/Insulin
p3063
aVhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p3064
aVhttp://dbpedia.org/resource/Failure
p3065
aVhttp://dbpedia.org/resource/Developed_country
p3066
aVhttp://dbpedia.org/resource/Hyperlipidemia
p3067
aVhttp://dbpedia.org/resource/Patient
p3068
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3069
sg31
S'An elderly male patient has essential hypertension, congestive heart failure, and type I insulin-dependent diabetes. His congestive failure developed secondary to coronary vascular disease associated with hyperlipidemia. What antihypertensive drug(s) may be most appropriate for this patient?'
p3070
sg33
I16
sg34
S'Q26#11'
p3071
sg36
I43
sg37
S'11'
p3072
sg38
I1
sg39
S'26'
p3073
sa(dp3074
g3
(lp3075
(lp3076
Vhttp://dbpedia.org/resource/Nifedipine
p3077
aVhttp://dbpedia.org/resource/Nifedipine
p3078
aa(lp3079
Vhttp://dbpedia.org/resource/Sodium
p3080
aasg18
(lp3081
Vnifedipine (Procardia, Adalat)
p3082
aVnitroprusside sodium (Nipride)
p3083
aVnicardipine (Cardene)
p3084
asg24
(lp3085
Vhttp://dbpedia.org/resource/Route_of_administration
p3086
aVhttp://dbpedia.org/resource/Side_effect
p3087
aVhttp://dbpedia.org/resource/Effectiveness
p3088
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3089
sg31
S'i.v. route of administration; few side effects; effective in treating hypertensive crisis:'
p3090
sg33
I15
sg34
S'Q26#12'
p3091
sg36
I14
sg37
S'12'
p3092
sg38
I1
sg39
S'26'
p3093
sa(dp3094
g3
(lp3095
(lp3096
Vhttp://dbpedia.org/resource/Propranolol
p3097
aVhttp://dbpedia.org/resource/Propranolol
p3098
aVhttp://dbpedia.org/resource/Redox
p3099
aVhttp://dbpedia.org/resource/Heart_rate
p3100
aVhttp://dbpedia.org/resource/Cardiac_output
p3101
aVhttp://dbpedia.org/resource/Negative_feedback
p3102
aVhttp://dbpedia.org/resource/Redox
p3103
aVhttp://dbpedia.org/resource/Incidence_%28epidemiology%29
p3104
aVhttp://dbpedia.org/resource/Angina_pectoris
p3105
aVhttp://dbpedia.org/resource/Effectiveness
p3106
aa(lp3107
Vhttp://dbpedia.org/resource/Propranolol
p3108
aVhttp://dbpedia.org/resource/Propranolol
p3109
aVhttp://dbpedia.org/resource/Hypertension
p3110
aVhttp://dbpedia.org/resource/Drug
p3111
aVhttp://dbpedia.org/resource/Effectiveness
p3112
aVhttp://dbpedia.org/resource/Blood_pressure
p3113
aa(lp3114
Vhttp://dbpedia.org/resource/Propranolol
p3115
aVhttp://dbpedia.org/resource/Propranolol
p3116
aVhttp://dbpedia.org/resource/Effectiveness
p3117
aVhttp://dbpedia.org/resource/Augmented_reality
p3118
aa(lp3119
Vhttp://dbpedia.org/resource/Propranolol
p3120
aVhttp://dbpedia.org/resource/Propranolol
p3121
aVhttp://dbpedia.org/resource/Contraindication
p3122
aVhttp://dbpedia.org/resource/Patient
p3123
aVhttp://dbpedia.org/resource/Asthma
p3124
aasg18
(lp3125
VPropranolol (Inderal) is appropriate because it will reduce heart rate and cardiac output. Negative inotropism will help reduce the incidence of angina. It is an effective antihypertensive agent
p3126
aVPropranolol (Inderal) is inappropriate because it is only useful in mild hypertension; a better drug would be minoxidil or hydralazine because they are more effective in lowering blood pressure
p3127
aVPropranolol (Inderal) is appropriate because it is an effective, low-cost antihypertensive. It will augment the effects of terbutaline, an additional benefit
p3128
aVPropranolol (Inderal) is inappropriate because its use is contraindicated in a patient with asthma.
p3129
asg24
(lp3130
Vhttp://dbpedia.org/resource/Patient
p3131
aVhttp://dbpedia.org/resource/Blood_pressure
p3132
aVhttp://dbpedia.org/resource/Patient
p3133
aVhttp://dbpedia.org/resource/Medical_history
p3134
aVhttp://dbpedia.org/resource/Angina_pectoris
p3135
aVhttp://dbpedia.org/resource/Evidence-based_medicine
p3136
aVhttp://dbpedia.org/resource/Heart_failure
p3137
aVhttp://dbpedia.org/resource/Patient
p3138
aVhttp://dbpedia.org/resource/Asthma
p3139
aVhttp://dbpedia.org/resource/Aerosol
p3140
aVhttp://dbpedia.org/resource/Inhalation
p3141
aVhttp://dbpedia.org/resource/Propranolol
p3142
aVhttp://dbpedia.org/resource/Propranolol
p3143
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3144
sg31
S'A patient presents with a blood pressure of 160/110 mm Hg. The patient has a history of coronary vascular disease, resulting in angina, but has no evidence of congestive heart failure. The patient also has asthma and has been treated mainly using terbutaline (Brethine), by aerosol inhalation Propranolol (Inderal) was prescribed to manage essential hypertension. Was this action appropriate?'
p3145
sg33
I104
sg34
S'Q26#13'
p3146
sg36
I67
sg37
S'13'
p3147
sg38
I3
sg39
S'26'
p3148
sa(dp3149
g3
(lp3150
(lp3151
Vhttp://dbpedia.org/resource/Block_%28data_storage%29
p3152
aa(lp3153
Vhttp://dbpedia.org/resource/Block_%28data_storage%29
p3154
aVhttp://dbpedia.org/resource/Vasoconstriction
p3155
aa(lp3156
Vhttp://dbpedia.org/resource/Block_%28data_storage%29
p3157
aVhttp://dbpedia.org/resource/Vasoconstriction
p3158
aasg18
(lp3159
Vblocks all three
p3160
aVblocks only vasoconstriction
p3161
aVblocks all except vasoconstriction
p3162
aVno effect
p3163
asg24
(lp3164
Vhttp://dbpedia.org/resource/Vasoconstriction
p3165
aVhttp://dbpedia.org/resource/Aldosterone
p3166
aVhttp://dbpedia.org/resource/Secretion
p3167
aVhttp://dbpedia.org/resource/Renin
p3168
aVhttp://dbpedia.org/resource/Stop_consonant
p3169
aVhttp://dbpedia.org/resource/Suppression_of_the_Society_of_Jesus
p3170
aVhttp://dbpedia.org/resource/Activation_energy
p3171
aVhttp://dbpedia.org/resource/Renin-angiotensin_system
p3172
aVhttp://dbpedia.org/resource/Affection
p3173
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3174
sg31
S'Vasoconstriction, aldosterone secretion, and renin release suppression occur upon activation of the renin-angiotensin-aldosterone system. How would captopril (Capoten) affect these responses?'
p3175
sg33
I12
sg34
S'Q26#14'
p3176
sg36
I26
sg37
S'14'
p3177
sg38
I0
sg39
S'26'
p3178
sa(dp3179
g3
(lp3180
(lp3181
Vhttp://dbpedia.org/resource/Propranolol
p3182
aVhttp://dbpedia.org/resource/Propranolol
p3183
aasg18
(lp3184
Vpropranolol (Inderal)
p3185
aVguanadrel (Hylorel)
p3186
aVmecamylamine (Inversine)
p3187
aVphentolamine (Regitine)
p3188
asg24
(lp3189
Vhttp://dbpedia.org/resource/Norepinephrine
p3190
aVhttp://dbpedia.org/resource/Adrenergic
p3191
aVhttp://dbpedia.org/resource/Peripheral_nerve
p3192
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3193
sg31
S'Antihypertensive: action based on inhibition of norepinephrine release from adrenergic nerve endings:'
p3194
sg33
I16
sg34
S'Q26#16'
p3195
sg36
I13
sg37
S'16'
p3196
sg38
I1
sg39
S'26'
p3197
sa(dp3198
g3
(lp3199
(lp3200
Vhttp://dbpedia.org/resource/Clonidine
p3201
aVhttp://dbpedia.org/resource/Clonidine
p3202
aasg18
(lp3203
Vdoxazosin (Cardura), prazosin (Minipress), metoprolol (Lopressor)
p3204
aVnifedipine (Procardia, Adalat), verapamil (Isoptin, Calan), diltiazem (Cardiazem)
p3205
aVclonidine (Catapres), guanabenz (Wytensin),terazosin (Hytrin)
p3206
aVlisinopril (Prinvivil, Zestril), fosinopril (Monopril), guanadrel (Hylorel)
p3207
asg24
(lp3208
Vhttp://dbpedia.org/resource/Nifedipine
p3209
aVhttp://dbpedia.org/resource/Nifedipine
p3210
aVhttp://dbpedia.org/resource/Verapamil
p3211
aVhttp://dbpedia.org/resource/Verapamil
p3212
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions2/ah1.htm'
p3213
sg31
S'Antihypertensive drugs belonging to the same class:'
p3214
sg33
I62
sg34
S'Q26#18'
p3215
sg36
I7
sg37
S'18'
p3216
sg38
I1
sg39
S'26'
p3217
sa(dp3218
g3
(lp3219
(lp3220
Vhttp://dbpedia.org/resource/Pheochromocytoma
p3221
aa(lp3222
Vhttp://dbpedia.org/resource/Chronic_%28medicine%29
p3223
aVhttp://dbpedia.org/resource/Pyelonephritis
p3224
aasg18
(lp3225
Vpheochromocytoma
p3226
aVaortic coarctation
p3227
aVfamilial dysautonomia
p3228
aVchronic pyelonephritis
p3229
asg24
(lp3230
Vhttp://dbpedia.org/resource/Nervous_system
p3231
aVhttp://dbpedia.org/resource/Hypertension
p3232
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions3/questionset3.htm'
p3233
sg31
S'Neurogenic hypertension:'
p3234
sg33
I7
sg34
S'Q27#2'
p3235
sg36
I2
sg37
S'2'
sg38
I2
sg39
S'27'
p3236
sa(dp3237
g3
(lp3238
(lp3239
Vhttp://dbpedia.org/resource/Bolted_joint
p3240
aa(lp3241
Vhttp://dbpedia.org/resource/Heart_rate
p3242
aasg18
(lp3243
Vincreased preload
p3244
aVincreased afterload
p3245
aVdecreased heart rate
p3246
aVincrease contractility
p3247
aV increased peripheral resistance
p3248
asg24
(lp3249
Vhttp://dbpedia.org/resource/Menopause
p3250
aVhttp://dbpedia.org/resource/Redox
p3251
aVhttp://dbpedia.org/resource/Artery
p3252
aVhttp://dbpedia.org/resource/Blood_pressure
p3253
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions3/questionset3.htm'
p3254
sg31
S'Hemodynamic change(s) that may reduce arterial blood-pressure:'
p3255
sg33
I12
sg34
S'Q27#5'
p3256
sg36
I10
sg37
S'5'
sg38
I2
sg39
S'27'
p3257
sa(dp3258
g3
(lp3259
(lp3260
Vhttp://dbpedia.org/resource/Sodium_channel
p3261
aVhttp://dbpedia.org/resource/Blockade
p3262
aVhttp://dbpedia.org/resource/Distal_convoluted_tubule
p3263
aa(lp3264
Vhttp://dbpedia.org/resource/Mineralocorticoid
p3265
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p3266
aa(lp3267
Vhttp://dbpedia.org/resource/Sodium
p3268
aVhttp://dbpedia.org/resource/Chloride
p3269
aVhttp://dbpedia.org/resource/Distal_convoluted_tubule
p3270
aasg18
(lp3271
Vsodium channel blockade in late distal  tubule and collecting duct
p3272
aVmineralocorticoid receptors
p3273
aVsodium, chloride synport transporter at the distal convoluted tubule
p3274
aVloop of Henle
p3275
asg24
(lp3276
Vhttp://dbpedia.org/resource/Ribosome
p3277
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3278
sg31
S'Site of action of thiazide diuretics:'
p3279
sg33
I25
sg34
S'Q28#6'
p3280
sg36
I6
sg37
S'6'
sg38
I2
sg39
S'28'
p3281
sa(dp3282
g3
(lp3283
(lp3284
Vhttp://dbpedia.org/resource/Acetazolamide
p3285
aVhttp://dbpedia.org/resource/Acetazolamide
p3286
aasg18
(lp3287
Vbumetanide (Bumex)
p3288
aVchlorothiazide (Diuril)
p3289
aVamiloride (Midamor)
p3290
aVmannitol (Osmitrol)
p3291
aVacetazolamide (Diamox)
p3292
asg24
(lp3293
Vhttp://dbpedia.org/resource/Mannitol
p3294
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3295
sg31
S'Potassium sparing diuretic:'
p3296
sg33
I20
sg34
S'Q28#7'
p3297
sg36
I3
sg37
S'7'
sg38
I2
sg39
S'28'
p3298
sa(dp3299
g3
(lp3300
(lp3301
Vhttp://dbpedia.org/resource/Sodium
p3302
aasg18
(lp3303
Vhydralazine (Apresoline)
p3304
aVdiltiazem (Cardiazem)
p3305
aVguanabenz (Wytensin)
p3306
aVnitroprusside sodium (Nipride)
p3307
aVmecamylamine (Inversine)
p3308
asg24
(lp3309
Vhttp://dbpedia.org/resource/Acting_%28law%29
p3310
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3311
sg31
S'Example(s) of centrally-acting sympatholytics:'
p3312
sg33
I21
sg34
S'Q28#8'
p3313
sg36
I7
sg37
S'8'
sg38
I2
sg39
S'28'
p3314
sa(dp3315
g3
(lp3316
(lp3317
Vhttp://dbpedia.org/resource/Management
p3318
aVhttp://dbpedia.org/resource/Moderate
p3319
aVhttp://dbpedia.org/resource/Hypertension
p3320
aa(lp3321
Vhttp://dbpedia.org/resource/Ileus
p3322
aa(lp3323
Vhttp://dbpedia.org/resource/Redox
p3324
aVhttp://dbpedia.org/resource/Heart_rate
p3325
aa(lp3326
Vhttp://dbpedia.org/resource/Hypertension
p3327
aVhttp://dbpedia.org/resource/Aortic_dissection
p3328
aa(lp3329
Vhttp://dbpedia.org/resource/Stenosis
p3330
aasg18
(lp3331
Vmanagement of moderate hypertension
p3332
aVtreatment of paralytic ileus
p3333
aVto reduce heart rate
p3334
aVhypertension associated with dissecting aortic aneurysm
p3335
aVrenovascular stenosis
p3336
asg24
(lp3337
Vhttp://dbpedia.org/resource/Common_land
p3338
aVhttp://dbpedia.org/resource/Ganglion
p3339
aVhttp://dbpedia.org/resource/Blocking_%28American_football%29
p3340
aVhttp://dbpedia.org/resource/Drug
p3341
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3342
sg31
S'Relatively common use for ganglionic blocking drugs'
p3343
sg33
I20
sg34
S'Q28#10'
p3344
sg36
I7
sg37
S'10'
p3345
sg38
I3
sg39
S'28'
p3346
sa(dp3347
g3
(lp3348
(lp3349
Vhttp://dbpedia.org/resource/Propranolol
p3350
aVhttp://dbpedia.org/resource/Propranolol
p3351
aa(lp3352
Vhttp://dbpedia.org/resource/Atenolol
p3353
aVhttp://dbpedia.org/resource/Atenolol
p3354
aasg18
(lp3355
Vpropranolol (Inderal)
p3356
aVtimolol (Blocadren)
p3357
aVatenolol (Tenormin)
p3358
aVpindolol (Visken)
p3359
asg24
(lp3360
Vhttp://dbpedia.org/resource/Beta_blocker
p3361
aVhttp://dbpedia.org/resource/Patient
p3362
aVhttp://dbpedia.org/resource/Insulin
p3363
aVhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p3364
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3365
sg31
S'Beta-blocker that might be preferable in a patient with insulin-dependent diabetes:'
p3366
sg33
I16
sg34
S'Q28#16'
p3367
sg36
I11
sg37
S'16'
p3368
sg38
I2
sg39
S'28'
p3369
sa(dp3370
g3
(lp3371
(lp3372
Vhttp://dbpedia.org/resource/Vasodilation
p3373
aa(lp3374
Vhttp://dbpedia.org/resource/Vasodilation
p3375
aa(lp3376
Vhttp://dbpedia.org/resource/Redox
p3377
aVhttp://dbpedia.org/resource/Heart_rate
p3378
aVhttp://dbpedia.org/resource/Redox
p3379
aVhttp://dbpedia.org/resource/Cardiac_muscle
p3380
aa(lp3381
Vhttp://dbpedia.org/resource/Blockade
p3382
aVhttp://dbpedia.org/resource/Angiotensin
p3383
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p3384
aa(lp3385
Vhttp://dbpedia.org/resource/Sympathetic_nervous_system
p3386
aVhttp://dbpedia.org/resource/Outflow_%28meteorology%29
p3387
aasg18
(lp3388
Vvasodilation-- arteriolar
p3389
aVvasodilation -- venular
p3390
aVreduced heart rate and reduced myocardial contractility
p3391
aVblockade of angiotensin  II receptors
p3392
aVdecreased central sympathetic outflow
p3393
asg24
(lp3394
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3395
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p3396
aVhttp://dbpedia.org/resource/Blockade
p3397
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3398
sg31
S'Principal mechanisms by which beta adrenergic receptor blockade decreases BP:'
p3399
sg33
I22
sg34
S'Q28#18'
p3400
sg36
I10
sg37
S'18'
p3401
sg38
I2
sg39
S'28'
p3402
sa(dp3403
g3
(lp3404
sg18
(lp3405
Vincrease
p3406
aVdecrease
p3407
aVno effect
p3408
asg24
(lp3409
Vhttp://dbpedia.org/resource/Renin
p3410
aVhttp://dbpedia.org/resource/GCE_Advanced_Level
p3411
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3412
sg31
S'Effect of beta adrenergic blockers on renin levels:'
p3413
sg33
I4
sg34
S'Q28#19'
p3414
sg36
I8
sg37
S'19'
p3415
sg38
I1
sg39
S'28'
p3416
sa(dp3417
g3
(lp3418
sg18
(lp3419
Vincrease
p3420
aVdecrease
p3421
aVno effect
p3422
asg24
(lp3423
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3424
aVhttp://dbpedia.org/resource/Angiotensin
p3425
aVhttp://dbpedia.org/resource/GCE_Advanced_Level
p3426
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions4/questionset4.htm'
p3427
sg31
S'Effect of beta adrenergic blockers on angiotensin II levels:'
p3428
sg33
I4
sg34
S'Q28#20'
p3429
sg36
I9
sg37
S'20'
p3430
sg38
I1
sg39
S'28'
p3431
sa(dp3432
g3
(lp3433
(lp3434
Vhttp://dbpedia.org/resource/Degree_%28angle%29
p3435
aa(lp3436
Vhttp://dbpedia.org/resource/Degree_%28angle%29
p3437
aVhttp://dbpedia.org/resource/Movable_type
p3438
aa(lp3439
Vhttp://dbpedia.org/resource/Secondary_school
p3440
aVhttp://dbpedia.org/resource/Movable_type
p3441
aa(lp3442
Vhttp://dbpedia.org/resource/Degree_%28angle%29
p3443
aasg18
(lp3444
Vfirst-degree heart block
p3445
aVsecond-degree heart block, Mobitz Type I
p3446
aVsecondary heart block, Mobitz Type II
p3447
aVthird-degree heart block
p3448
asg24
(lp3449
Vhttp://dbpedia.org/resource/Queensr%C3%BFche
p3450
aVhttp://dbpedia.org/resource/Regular_expression
p3451
aVhttp://dbpedia.org/resource/Methodology
p3452
aVhttp://dbpedia.org/resource/Time
p3453
aVhttp://dbpedia.org/resource/Second
p3454
aVhttp://dbpedia.org/resource/Queensr%C3%BFche
p3455
aVhttp://dbpedia.org/resource/Time
p3456
aVhttp://dbpedia.org/resource/Second
p3457
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions5/questionset5.htm'
p3458
sg31
S'Heart block in which the P wave appears before each QRS in a regular manner; P-R interval > 0.2 seconds; QRS interval < 0.12 seconds'
p3459
sg33
I20
sg34
S'Q29#0'
p3460
sg36
I27
sg37
S'0'
sg38
I0
sg39
S'29'
p3461
sa(dp3462
g3
(lp3463
(lp3464
Vhttp://dbpedia.org/resource/Sodium
p3465
aasg18
(lp3466
Vhydralazine (Apresoline)
p3467
aVisoproterenol (Isuprel)
p3468
aVmetoprolol (Lopressor)
p3469
aVpindolol (Visken)
p3470
aVnitroprusside sodium (Nipride)
p3471
asg24
(lp3472
Vhttp://dbpedia.org/resource/Reflex
p3473
aVhttp://dbpedia.org/resource/Heart
p3474
aVhttp://dbpedia.org/resource/Stimulation
p3475
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions5/questionset5.htm'
p3476
sg31
S'Agent which would attenuate reflex-mediated cardiac stimulation following minoxidil (Loniten) administration:'
p3477
sg33
I21
sg34
S'Q29#4'
p3478
sg36
I13
sg37
S'4'
sg38
I2
sg39
S'29'
p3479
sa(dp3480
g3
(lp3481
sg18
(lp3482
Vmore arteriolar dilation compared to venular dilation
p3483
aVmore venular dilation compared to arteriolar dilation
p3484
aVarteriolar and venular dilation similar with hydralazine (Apresoline)
p3485
asg24
(lp3486
Vhttp://dbpedia.org/resource/Vascular
p3487
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions5/questionset5.htm'
p3488
sg31
S'Hydralazine (Apresoline)--vascular effects:'
p3489
sg33
I24
sg34
S'Q29#5'
p3490
sg36
I7
sg37
S'5'
sg38
I0
sg39
S'29'
p3491
sa(dp3492
g3
(lp3493
(lp3494
Vhttp://dbpedia.org/resource/Propranolol
p3495
aVhttp://dbpedia.org/resource/Propranolol
p3496
aa(lp3497
Vhttp://dbpedia.org/resource/Phenylephrine
p3498
aVhttp://dbpedia.org/resource/Phenylephrine
p3499
aasg18
(lp3500
Vpropranolol (Inderal)
p3501
aVprazosin (Minipress)
p3502
aVminoxidil (Loniten)
p3503
aVphenylephrine (Neo-Synephrine)
p3504
aVisoproterenol (Isuprel)
p3505
asg24
(lp3506
Vhttp://dbpedia.org/resource/Relaxation_technique
p3507
aVhttp://dbpedia.org/resource/Diuretic
p3508
aVhttp://dbpedia.org/resource/Effectiveness
p3509
aVhttp://dbpedia.org/resource/Hypertension
p3510
aVhttp://dbpedia.org/resource/Disease
p3511
aVhttp://dbpedia.org/resource/Transplant_rejection
p3512
aVhttp://dbpedia.org/resource/Renal_failure
p3513
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions5/questionset5.htm'
p3514
sg31
S'Direct relaxation of arteriolar smooth muscle; when combined with the diuretic and sympatholytic, can be very effective for management of severe hypertension associated with renovascular disease, transplant rejection, renal failure:'
p3515
sg33
I20
sg34
S'Q29#8'
p3516
sg36
I34
sg37
S'8'
sg38
I2
sg39
S'29'
p3517
sa(dp3518
g3
(lp3519
(lp3520
Vhttp://dbpedia.org/resource/Sodium
p3521
aasg18
(lp3522
Vlabetalol (Trandate, Normodyne)
p3523
aVhydralazine (Apresoline)
p3524
aVminoxidil (Loniten)
p3525
aVnitroprusside sodium (Nipride)
p3526
asg24
(lp3527
Vhttp://dbpedia.org/resource/Acting_%28law%29
p3528
aVhttp://dbpedia.org/resource/Peripheral
p3529
aVhttp://dbpedia.org/resource/Vasodilation
p3530
aVhttp://dbpedia.org/resource/Vein
p3531
aVhttp://dbpedia.org/resource/Cyanide
p3532
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions5/questionset5.htm'
p3533
sg31
S'Antihypertensive: direct acting, nonselective peripheral vasodilator -- acts on arteriole and venous vascular smooth muscle: 44% cyanide by weight --'
p3534
sg33
I19
sg34
S'Q29#10'
p3535
sg36
I24
sg37
S'10'
p3536
sg38
I3
sg39
S'29'
p3537
sa(dp3538
g3
(lp3539
sg18
(lp3540
Vnitroprusside sodium (Nipride)
p3541
aVhydralazine (Apresoline)
p3542
aVminoxidil (Loniten)
p3543
aVmethyldopa (Aldomet)
p3544
aVguanfacine (Tenex)
p3545
asg24
(lp3546
Vhttp://dbpedia.org/resource/Sodium
p3547
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions6/questionset6.htm'
p3548
sg31
S'Antihypertensive drug associated with hypertrichosis (particularly around phase, arms)'
p3549
sg33
I21
sg34
S'Q30#4'
p3550
sg36
I12
sg37
S'4'
sg38
I2
sg39
S'30'
p3551
sa(dp3552
g3
(lp3553
(lp3554
Vhttp://dbpedia.org/resource/Sodium
p3555
aasg18
(lp3556
Vminoxidil (Loniten)
p3557
aVnitroprusside sodium (Nipride)
p3558
aVhydralazine (Apresoline)
p3559
aVcaptopril (Capoten)
p3560
aVdiltiazem (Cardiazem)
p3561
asg24
(lp3562
Vhttp://dbpedia.org/resource/Systemic_lupus_erythematosus
p3563
aVhttp://dbpedia.org/resource/Syndrome
p3564
aVhttp://dbpedia.org/resource/Frequency
p3565
aVhttp://dbpedia.org/resource/Drug
p3566
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions6/questionset6.htm'
p3567
sg31
S'Antihypertensive drug associated with a lupus-like syndrome: frequency 10%-20%; reversible upon drug discontinuation:'
p3568
sg33
I21
sg34
S'Q30#5'
p3569
sg36
I18
sg37
S'5'
sg38
I2
sg39
S'30'
p3570
sa(dp3571
g3
(lp3572
(lp3573
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p3574
aa(lp3575
Vhttp://dbpedia.org/resource/Beta_blocker
p3576
aa(lp3577
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3578
aa(lp3579
Vhttp://dbpedia.org/resource/ACE_inhibitor
p3580
aa(lp3581
Vhttp://dbpedia.org/resource/Vasodilation
p3582
aasg18
(lp3583
Vcalcium channel blockers
p3584
aVbeta-blockers
p3585
aValpha-adrenergic blockers
p3586
aVACE inhibitors
p3587
aVvasodilators
p3588
asg24
(lp3589
Vhttp://dbpedia.org/resource/Group_dynamics
p3590
aVhttp://dbpedia.org/resource/Management
p3591
aVhttp://dbpedia.org/resource/Diabetes_mellitus
p3592
aVhttp://dbpedia.org/resource/Patient
p3593
aVhttp://dbpedia.org/resource/Drug
p3594
aVhttp://dbpedia.org/resource/Redox
p3595
aVhttp://dbpedia.org/resource/Developmental_biology
p3596
aVhttp://dbpedia.org/resource/Diabetic_neuropathy
p3597
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions6/questionset6.htm'
p3598
sg31
S'Antihypertensive drug group considered advantageous and management of diabetic patients because these drugs reduce/delay development of diabetic neuropathy and glomerulosclerosis--'
p3599
sg33
I9
sg34
S'Q30#9'
p3600
sg36
I21
sg37
S'9'
sg38
I3
sg39
S'30'
p3601
sa(dp3602
g3
(lp3603
(lp3604
Vhttp://dbpedia.org/resource/Mannitol
p3605
aa(lp3606
Vhttp://dbpedia.org/resource/Furosemide
p3607
aVhttp://dbpedia.org/resource/Furosemide
p3608
aa(lp3609
Vhttp://dbpedia.org/resource/Acetazolamide
p3610
aVhttp://dbpedia.org/resource/Acetazolamide
p3611
aasg18
(lp3612
Vmannitol (Osmitrol)
p3613
aVfurosemide (Lasix)
p3614
aVchlorothiazide (Diuril)
p3615
aVtriamterene (Dyrenium)
p3616
aVacetazolamide (Diamox)
p3617
asg24
(lp3618
Vhttp://dbpedia.org/resource/Distal_convoluted_tubule
p3619
aVhttp://dbpedia.org/resource/Sodium
p3620
aVhttp://dbpedia.org/resource/Calcium
p3621
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions7/questionset7.htm'
p3622
sg31
S'Promotes hyperosmolar diuresis; acts in the distal tubule to decrease sodium absorption; promotes calcium reabsorption'
p3623
sg33
I20
sg34
S'Q31#0'
p3624
sg36
I17
sg37
S'0'
sg38
I2
sg39
S'31'
p3625
sa(dp3626
g3
(lp3627
(lp3628
Vhttp://dbpedia.org/resource/Spironolactone
p3629
aVhttp://dbpedia.org/resource/Spironolactone
p3630
aasg18
(lp3631
Vtriamterene (Dyrenium)
p3632
aVspironolactone (Aldactone)
p3633
aVbumetanide (Bumex)
p3634
aVamiloride (Midamor)
p3635
aVchlorothiazide (Diuril)
p3636
asg24
(lp3637
Vhttp://dbpedia.org/resource/Ceiling
p3638
aVhttp://dbpedia.org/resource/Diuretic
p3639
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions7/questionset7.htm'
p3640
sg31
S'Example(s) of "high-ceiling" diuretic(s):'
p3641
sg33
I20
sg34
S'Q31#2'
p3642
sg36
I13
sg37
S'2'
sg38
I2
sg39
S'31'
p3643
sa(dp3644
g3
(lp3645
(lp3646
Vhttp://dbpedia.org/resource/Propranolol
p3647
aVhttp://dbpedia.org/resource/Propranolol
p3648
aa(lp3649
Vhttp://dbpedia.org/resource/Verapamil
p3650
aVhttp://dbpedia.org/resource/Verapamil
p3651
aasg18
(lp3652
Vmetoprolol (Lopressor)
p3653
aVpropranolol (Inderal)
p3654
aVguanethidine (Ismelin)
p3655
aVverapamil (Isoptin, Calan)
p3656
aVtriamterene (Dyrenium)
p3657
asg24
(lp3658
Vhttp://dbpedia.org/resource/Imipramine
p3659
aVhttp://dbpedia.org/resource/Imipramine
p3660
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions7/questionset7.htm'
p3661
sg31
S'Antihypertensive drug effect inhibited by imipramine (Tofranil) or cocaine:'
p3662
sg33
I22
sg34
S'Q31#8'
p3663
sg36
I11
sg37
S'8'
sg38
I2
sg39
S'31'
p3664
sa(dp3665
g3
(lp3666
(lp3667
Vhttp://dbpedia.org/resource/Physostigmine
p3668
aasg18
(lp3669
Vmetoprolol (Lopressor)
p3670
aVesmolol (Brevibloc)
p3671
aVtimolol (Blocadren)
p3672
aVlabetalol (Trandate, Normodyne)
p3673
aVphysostigmine (Antilirium)
p3674
asg24
(lp3675
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3676
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions7/questionset7.htm'
p3677
sg31
S'Adrenergic antagonist but with intrinsic sympathomimetic effect at beta2 adrenergic receptors:'
p3678
sg33
I22
sg34
S'Q31#9'
p3679
sg36
I11
sg37
S'9'
sg38
I3
sg39
S'31'
p3680
sa(dp3681
g3
(lp3682
(lp3683
Vhttp://dbpedia.org/resource/Reflex
p3684
aVhttp://dbpedia.org/resource/Tachycardia
p3685
aa(lp3686
Vhttp://dbpedia.org/resource/Blood_plasma
p3687
aVhttp://dbpedia.org/resource/Renin
p3688
aa(lp3689
Vhttp://dbpedia.org/resource/Chemical_affinity
p3690
aVhttp://dbpedia.org/resource/Alpha_helix
p3691
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p3692
aVhttp://dbpedia.org/resource/Alpha_helix
p3693
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p3694
aa(lp3695
Vhttp://dbpedia.org/resource/Blood_plasma
p3696
aVhttp://dbpedia.org/resource/Lipid
p3697
aasg18
(lp3698
Vcauses reflex mediated tachycardia
p3699
aVcauses an increase in plasma renin
p3700
aVhigher affinity for venular alpha receptors compared to arteriolar alpha receptors
p3701
aVimpairs renal blood flow
p3702
aVno effect on plasma lipids
p3703
asg24
(lp3704
Vhttp://dbpedia.org/resource/Circulatory_system
p3705
aVhttp://dbpedia.org/resource/Chronic_%28medicine%29
p3706
aVhttp://dbpedia.org/resource/Administration_%28government%29
p3707
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions7/questionset7.htm'
p3708
sg31
S'Cardiovascular effects of chronic prazosin administration:'
p3709
sg33
I30
sg34
S'Q31#11'
p3710
sg36
I6
sg37
S'11'
p3711
sg38
I2
sg39
S'31'
p3712
sa(dp3713
g3
(lp3714
(lp3715
Vhttp://dbpedia.org/resource/Cushing%27s_syndrome
p3716
aa(lp3717
Vhttp://dbpedia.org/resource/Pheochromocytoma
p3718
aa(lp3719
Vhttp://dbpedia.org/resource/Legal_case
p3720
aasg18
(lp3721
Vcaused by Cushing\u005c
p3722
aVmay be due to pheochromocytoma
p3723
aVcaused by hyperaldosteronism
p3724
aV> 90% of cases
p3725
asg24
(lp3726
Vhttp://dbpedia.org/resource/Primary_school
p3727
aVhttp://dbpedia.org/resource/Idiopathic
p3728
aVhttp://dbpedia.org/resource/Hypertension
p3729
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3730
sg31
S'Primary or idiopathic hypertension:'
p3731
sg33
I16
sg34
S'Q32#0'
p3732
sg36
I4
sg37
S'0'
sg38
I3
sg39
S'32'
p3733
sa(dp3734
g3
(lp3735
(lp3736
Vhttp://dbpedia.org/resource/Vasodilation
p3737
aa(lp3738
Vhttp://dbpedia.org/resource/Tachycardia
p3739
aasg18
(lp3740
Vhypothyroidism
p3741
aVperipheral vasodilators
p3742
aVaortic regurgitation
p3743
aVtachycardia
p3744
asg24
(lp3745
Vhttp://dbpedia.org/resource/Hypothyroidism
p3746
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3747
sg31
S'Increases stroke volume:'
p3748
sg33
I6
sg34
S'Q32#1'
p3749
sg36
I3
sg37
S'1'
sg38
I2
sg39
S'32'
p3750
sa(dp3751
g3
(lp3752
(lp3753
Vhttp://dbpedia.org/resource/Acromegaly
p3754
aa(lp3755
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3756
aVhttp://dbpedia.org/resource/Receptor_antagonist
p3757
aa(lp3758
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3759
aVhttp://dbpedia.org/resource/Activation_energy
p3760
aasg18
(lp3761
Vacromegaly
p3762
aVhypocalcemia
p3763
aValpha1 adrenergic receptor antagonists
p3764
aVbeta2 adrenergic receptor activation
p3765
asg24
(lp3766
Vhttp://dbpedia.org/resource/Diastole
p3767
aVhttp://dbpedia.org/resource/Hypertension
p3768
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3769
sg31
S'Systolic/diastolic hypertension:'
p3770
sg33
I10
sg34
S'Q32#2'
p3771
sg36
I2
sg37
S'2'
sg38
I0
sg39
S'32'
p3772
sa(dp3773
g3
(lp3774
(lp3775
Vhttp://dbpedia.org/resource/Heart_rate
p3776
aa(lp3777
Vhttp://dbpedia.org/resource/Heart_rate
p3778
aVhttp://dbpedia.org/resource/Blood_pressure
p3779
aa(lp3780
Vhttp://dbpedia.org/resource/Heart_rate
p3781
aasg18
(lp3782
Vheart rate x peripheral resistance
p3783
aVstroke volume x  peripheral resistance
p3784
aVheart rate x arterial pressure
p3785
aVstroke volume x heart rate
p3786
asg24
(lp3787
Vhttp://dbpedia.org/resource/Cardiac_output
p3788
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3789
sg31
S'Cardiac output:'
p3790
sg33
I20
sg34
S'Q32#4'
p3791
sg36
I2
sg37
S'4'
sg38
I3
sg39
S'32'
p3792
sa(dp3793
g3
(lp3794
(lp3795
Vhttp://dbpedia.org/resource/Calcium
p3796
aVhttp://dbpedia.org/resource/Ruminant
p3797
aa(lp3798
Vhttp://dbpedia.org/resource/Redox
p3799
aVhttp://dbpedia.org/resource/Electrocardiography
p3800
aVhttp://dbpedia.org/resource/Blood_pressure
p3801
aa(lp3802
Vhttp://dbpedia.org/resource/Administration_%28government%29
p3803
aVhttp://dbpedia.org/resource/Tendril
p3804
aasg18
(lp3805
Vincreased ventricular stretch may reduce ventricular function (reduced output)
p3806
aVmost antihypertensive drugs promote calcium release from sarcoplasmic reticulum stores
p3807
aVreduced preload coupled with increased contractility will lead to increased stroke volume and usually an increase in arterial pressure
p3808
aVmetoprolol (Lopressor) administration would tend to increase contractility
p3809
asg24
(lp3810
Vhttp://dbpedia.org/resource/Stretching
p3811
aVhttp://dbpedia.org/resource/Redox
p3812
aVhttp://dbpedia.org/resource/Ventricle_%28heart%29
p3813
aVhttp://dbpedia.org/resource/Redox
p3814
aVhttp://dbpedia.org/resource/Output
p3815
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3816
sg31
S'Preload and contractility:'
p3817
sg33
I50
sg34
S'Q32#5'
p3818
sg36
I3
sg37
S'5'
sg38
I0
sg39
S'32'
p3819
sa(dp3820
g3
(lp3821
sg18
(lp3822
Vtypically increase afterload
p3823
aVmay increase heart rate
p3824
aVusually increase contractility
p3825
aVusually increased peripheral resistance
p3826
asg24
(lp3827
Vhttp://dbpedia.org/resource/Heart_rate
p3828
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3829
sg31
S'Antihypertensive agents, directly or indirectly:'
p3830
sg33
I14
sg34
S'Q32#6'
p3831
sg36
I6
sg37
S'6'
sg38
I1
sg39
S'32'
p3832
sa(dp3833
g3
(lp3834
(lp3835
Vhttp://dbpedia.org/resource/Redox
p3836
aVhttp://dbpedia.org/resource/Likelihood_function
p3837
aVhttp://dbpedia.org/resource/Orthostatic_hypotension
p3838
aa(lp3839
Vhttp://dbpedia.org/resource/Hypotension
p3840
aVhttp://dbpedia.org/resource/Acute_%28medicine%29
p3841
aVhttp://dbpedia.org/resource/Bleeding
p3842
aa(lp3843
Vhttp://dbpedia.org/resource/Sensitivity_and_specificity
p3844
aVhttp://dbpedia.org/resource/Acting
p3845
aVhttp://dbpedia.org/resource/Drug
p3846
aa(lp3847
Vhttp://dbpedia.org/resource/Hyperactivity
p3848
aVhttp://dbpedia.org/resource/Expected_value
p3849
aasg18
(lp3850
Vreduced likelihood of orthostatic hypotension
p3851
aVincreased hypotensive response to acute blood loss
p3852
aVsupersensitivity (significantly increase sensitivity) to actions of indirect-acting sympathomimetic drugs
p3853
aVhyperactivity would be expected
p3854
asg24
(lp3855
Vhttp://dbpedia.org/resource/Patient
p3856
aVhttp://dbpedia.org/resource/Pharmaceutical_drug
p3857
aVhttp://dbpedia.org/resource/Prior_probability
p3858
aVhttp://dbpedia.org/resource/Anesthesia
p3859
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3860
sg31
S'Patients receiving antihypertensive medications prior to undergoing anesthesia:'
p3861
sg33
I28
sg34
S'Q32#7'
p3862
sg36
I8
sg37
S'7'
sg38
I1
sg39
S'32'
p3863
sa(dp3864
g3
(lp3865
(lp3866
Vhttp://dbpedia.org/resource/Systemic_circulation
p3867
aVhttp://dbpedia.org/resource/Blood_pressure
p3868
aVhttp://dbpedia.org/resource/Heart_rate
p3869
aVhttp://dbpedia.org/resource/Anesthesia
p3870
aa(lp3871
Vhttp://dbpedia.org/resource/Likelihood_function
p3872
aa(lp3873
Vhttp://dbpedia.org/resource/Effectiveness
p3874
aVhttp://dbpedia.org/resource/Therapy
p3875
aVhttp://dbpedia.org/resource/Time
p3876
aVhttp://dbpedia.org/resource/Pharmacology
p3877
aVhttp://dbpedia.org/resource/Developmental_biology
p3878
aVhttp://dbpedia.org/resource/Anesthesia
p3879
aVhttp://dbpedia.org/resource/401%28k%29
p3880
aa(lp3881
Vhttp://dbpedia.org/resource/Patient
p3882
aVhttp://dbpedia.org/resource/Diuretic
p3883
aVhttp://dbpedia.org/resource/Drug
p3884
aVhttp://dbpedia.org/resource/Redox
p3885
aVhttp://dbpedia.org/resource/Blood_pressure
p3886
aasg18
(lp3887
Vassociated with increased systemic blood-pressure and heart rate fluctuations during anesthesia
p3888
aVdecrease likelihood of arrhythmias
p3889
aVsince previously effective antihypertensive drug therapy typically should be continued during the perioperative time frame, the pharmacology of the particular antihypertensive agent need not be considered in the development of the anesthesia plan.
p3890
aVusually, is appropriate to maintaina patient on preoperative diuretics when those drugs are used to reduce blood pressure
p3891
asg24
(lp3892
Vhttp://dbpedia.org/resource/Time
p3893
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3894
sg31
S'Maintenance of antihypertensive drug treatment during perioperative time frame:'
p3895
sg33
I68
sg34
S'Q32#8'
p3896
sg36
I9
sg37
S'8'
sg38
I1
sg39
S'32'
p3897
sa(dp3898
g3
(lp3899
(lp3900
Vhttp://dbpedia.org/resource/Endothelium
p3901
aVhttp://dbpedia.org/resource/Vascular
p3902
aVhttp://dbpedia.org/resource/Relaxation_technique
p3903
aa(lp3904
Vhttp://dbpedia.org/resource/Vasoconstriction
p3905
aVhttp://dbpedia.org/resource/Timbre
p3906
aVhttp://dbpedia.org/resource/Chronic_%28medicine%29
p3907
aVhttp://dbpedia.org/resource/Vasoconstriction
p3908
aa(lp3909
Vhttp://dbpedia.org/resource/Redox
p3910
aVhttp://dbpedia.org/resource/Sympathetic_nervous_system
p3911
aVhttp://dbpedia.org/resource/Activation_energy
p3912
aasg18
(lp3913
Vbeta adrenergic receptor up regulation
p3914
aVincreased endothelium-mediated vascular relaxation
p3915
aVincreased vasoconstrictive tone (chronic vasoconstriction)
p3916
aVreduced sympathetic activation
p3917
asg24
(lp3918
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p3919
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p3920
asg29
S'http://www.pharmacology2000.com/Cardio/antihyper/questions8/questionset8.htm'
p3921
sg31
S'Essential hypertension:'
p3922
sg33
I19
sg34
S'Q32#10'
p3923
sg36
I2
sg37
S'10'
p3924
sg38
I2
sg39
S'32'
p3925
sa(dp3926
g3
(lp3927
(lp3928
Vhttp://dbpedia.org/resource/Quinidine
p3929
aVhttp://dbpedia.org/resource/Quinidine
p3930
aVhttp://dbpedia.org/resource/Quinidine
p3931
aa(lp3932
Vhttp://dbpedia.org/resource/Lidocaine
p3933
aVhttp://dbpedia.org/resource/Lidocaine
p3934
aa(lp3935
Vhttp://dbpedia.org/resource/Verapamil
p3936
aVhttp://dbpedia.org/resource/Verapamil
p3937
aasg18
(lp3938
Vquinidine gluconate (Quinaglute, Quinalan)
p3939
aVlidocaine (Xylocaine)
p3940
aVencainide (Enkaid)
p3941
aVverapamil (Isoptin, Calan)
p3942
asg24
(lp3943
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p3944
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p3945
sg31
S'Not a class I antiarrhythmic Drug:'
p3946
sg33
I21
sg34
S'Q34#0'
p3947
sg36
I6
sg37
S'0'
sg38
I3
sg39
S'34'
p3948
sa(dp3949
g3
(lp3950
(lp3951
Vhttp://dbpedia.org/resource/Lidocaine
p3952
aVhttp://dbpedia.org/resource/Lidocaine
p3953
aa(lp3954
Vhttp://dbpedia.org/resource/Quinidine
p3955
aVhttp://dbpedia.org/resource/Quinidine
p3956
aVhttp://dbpedia.org/resource/Quinidine
p3957
aa(lp3958
Vhttp://dbpedia.org/resource/Adenosine
p3959
aVhttp://dbpedia.org/resource/Adenosine
p3960
aasg18
(lp3961
Vlidocaine (Xylocaine)
p3962
aVquinidine gluconate (Quinaglute, Quinalan)
p3963
aVadenosine (Adenocard)
p3964
aVencainide (Enkaid)
p3965
asg24
(lp3966
Vhttp://dbpedia.org/resource/Data_type
p3967
aVhttp://dbpedia.org/resource/Antiarrhythmic_agent
p3968
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p3969
sg31
S'Not classified as a Type I antiarrhythmic'
p3970
sg33
I19
sg34
S'Q34#1'
p3971
sg36
I7
sg37
S'1'
sg38
I2
sg39
S'34'
p3972
sa(dp3973
g3
(lp3974
(lp3975
Vhttp://dbpedia.org/resource/Adenosine
p3976
aVhttp://dbpedia.org/resource/Adenosine
p3977
aa(lp3978
Vhttp://dbpedia.org/resource/Amiodarone
p3979
aVhttp://dbpedia.org/resource/Amiodarone
p3980
aasg18
(lp3981
Vadenosine (Adenocard)
p3982
aVencainide (Enkaid)
p3983
aVamiodarone (Cordarone)
p3984
aVdiltiazem (Cardiazem)
p3985
asg24
(lp3986
Vhttp://dbpedia.org/resource/Cornea
p3987
aVhttp://dbpedia.org/resource/Photophobia
p3988
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p3989
sg31
S'Corneal microdeposits, blurred vision, and photophobia:'
p3990
sg33
I16
sg34
S'Q34#3'
p3991
sg36
I8
sg37
S'3'
sg38
I2
sg39
S'34'
p3992
sa(dp3993
g3
(lp3994
(lp3995
Vhttp://dbpedia.org/resource/Quinidine
p3996
aVhttp://dbpedia.org/resource/Quinidine
p3997
aVhttp://dbpedia.org/resource/Quinidine
p3998
aasg18
(lp3999
Vquinidine gluconate (Quinaglute, Quinalan)
p4000
aVsotalol (Betapace)
p4001
aVbretylium (Bretylol)
p4002
aVpropafenone (Rythmol)
p4003
asg24
(lp4004
Vhttp://dbpedia.org/resource/Class_III_railroad
p4005
aVhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4006
aVhttp://dbpedia.org/resource/Potassium_channel
p4007
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4008
sg31
S'Class III anti-arrhythmic drug which also blocks potassium channels:'
p4009
sg33
I19
sg34
S'Q34#4'
p4010
sg36
I9
sg37
S'4'
sg38
I1
sg39
S'34'
p4011
sa(dp4012
g3
(lp4013
(lp4014
Vhttp://dbpedia.org/resource/Quinidine
p4015
aVhttp://dbpedia.org/resource/Beta_cell
p4016
aVhttp://dbpedia.org/resource/Heart
p4017
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p4018
aVhttp://dbpedia.org/resource/Tachycardia
p4019
aa(lp4020
Vhttp://dbpedia.org/resource/Quinidine
p4021
aVhttp://dbpedia.org/resource/Religious_conversion
p4022
aVhttp://dbpedia.org/resource/Atrial_fibrillation
p4023
aVhttp://dbpedia.org/resource/Atrial_flutter
p4024
aVhttp://dbpedia.org/resource/Tachycardia
p4025
aa(lp4026
Vhttp://dbpedia.org/resource/Quinidine
p4027
aVhttp://dbpedia.org/resource/Vagus_nerve
p4028
aVhttp://dbpedia.org/resource/Religious_conversion
p4029
aVhttp://dbpedia.org/resource/Atrial_fibrillation
p4030
aVhttp://dbpedia.org/resource/Atrial_flutter
p4031
aVhttp://dbpedia.org/resource/Heart_rate
p4032
aa(lp4033
Vhttp://dbpedia.org/resource/Quinidine
p4034
aVhttp://dbpedia.org/resource/Vagus_nerve
p4035
aVhttp://dbpedia.org/resource/Transmission_%28telecommunications%29
p4036
aVhttp://dbpedia.org/resource/Plant_stem
p4037
aasg18
(lp4038
VQuinidine activated beta-1 cardiac receptors which cause the increase in heart rate.
p4039
aVQuinidine converted the atrial fibrillation to atrial flutter which resulted in an increase in heart rate.
p4040
aVQuinidine produced an anti-vagal effect and converted atrial fibrillation to atrial flutter. Both effects caused the heart rate to increase.
p4041
aVQuinidine has an anti-vagal effect which facilitated transmission through the A-V  node.
p4042
asg24
(lp4043
Vhttp://dbpedia.org/resource/Patient
p4044
aVhttp://dbpedia.org/resource/Diagnosis
p4045
aVhttp://dbpedia.org/resource/Atrial_fibrillation
p4046
aVhttp://dbpedia.org/resource/Exhibition
p4047
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p4048
aVhttp://dbpedia.org/resource/Minute
p4049
aVhttp://dbpedia.org/resource/Quinidine
p4050
aVhttp://dbpedia.org/resource/Quinidine
p4051
aVhttp://dbpedia.org/resource/Quinidine
p4052
aVhttp://dbpedia.org/resource/Atrial_fibrillation
p4053
aVhttp://dbpedia.org/resource/Religious_conversion
p4054
aVhttp://dbpedia.org/resource/Atrial_flutter
p4055
aVhttp://dbpedia.org/resource/Heart_rate
p4056
aVhttp://dbpedia.org/resource/Minute
p4057
aVhttp://dbpedia.org/resource/Heart_rate
p4058
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4059
sg31
S'A patient is diagnosed with atrial fibrillation and exhibits a ventricular following rate of 150 beats / min. Quinidine gluconate (Quinaglute, Quinalan) was administered and although atrial fibrillation was converted to atrial flutter, the ventricular rate increased to 190 beats / min. What is the most likely explanation for the effect on heart rate?'
p4060
sg33
I61
sg34
S'Q34#5'
p4061
sg36
I59
sg37
S'5'
sg38
I2
sg39
S'34'
p4062
sa(dp4063
g3
(lp4064
(lp4065
Vhttp://dbpedia.org/resource/Lidocaine
p4066
aVhttp://dbpedia.org/resource/Lidocaine
p4067
aa(lp4068
Vhttp://dbpedia.org/resource/Quinidine
p4069
aVhttp://dbpedia.org/resource/Quinidine
p4070
aVhttp://dbpedia.org/resource/Quinidine
p4071
aa(lp4072
Vhttp://dbpedia.org/resource/Digoxin
p4073
aVhttp://dbpedia.org/resource/Digoxin
p4074
aa(lp4075
Vhttp://dbpedia.org/resource/Propranolol
p4076
aVhttp://dbpedia.org/resource/Propranolol
p4077
aasg18
(lp4078
Vlidocaine (Xylocaine)
p4079
aVquinidine gluconate (Quinaglute, Quinalan)
p4080
aVdigoxin (Lanoxin, Lanoxicaps)
p4081
aVpropranolol (Inderal)
p4082
asg24
(lp4083
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4084
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4085
sg31
S'Torsades de Pointes, a polymorphic ventricular arrhythmia, is associated with prolongation of Q-T intervals. Which antiarrhythmic agent is most likely to cause this arrhythmia?'
p4086
sg33
I21
sg34
S'Q34#9'
p4087
sg36
I27
sg37
S'9'
sg38
I1
sg39
S'34'
p4088
sa(dp4089
g3
(lp4090
(lp4091
Vhttp://dbpedia.org/resource/Time
p4092
aa(lp4093
Vhttp://dbpedia.org/resource/Heart_rate
p4094
aa(lp4095
Vhttp://dbpedia.org/resource/Weight_loss
p4096
aa(lp4097
Vhttp://dbpedia.org/resource/Acceleration
p4098
aVhttp://dbpedia.org/resource/Depolarization
p4099
aasg18
(lp4100
Vshortened P-R interval
p4101
aVdecreased ventricular rate
p4102
aVweight loss
p4103
aVaccelerated ventricular repolarization
p4104
asg24
(lp4105
Vhttp://dbpedia.org/resource/Indicator_function
p4106
aVhttp://dbpedia.org/resource/Digoxin
p4107
aVhttp://dbpedia.org/resource/Digoxin
p4108
aVhttp://dbpedia.org/resource/Efficacy
p4109
aVhttp://dbpedia.org/resource/Atrial_fibrillation
p4110
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4111
sg31
S'Best indicator of digoxin (Lanoxin, Lanoxicaps) efficacy in treating atrial fibrillation:'
p4112
sg33
I11
sg34
S'Q34#10'
p4113
sg36
I14
sg37
S'10'
p4114
sg38
I1
sg39
S'34'
p4115
sa(dp4116
g3
(lp4117
(lp4118
Vhttp://dbpedia.org/resource/Digoxin
p4119
aVhttp://dbpedia.org/resource/Digoxin
p4120
aa(lp4121
Vhttp://dbpedia.org/resource/Lidocaine
p4122
aVhttp://dbpedia.org/resource/Lidocaine
p4123
aa(lp4124
Vhttp://dbpedia.org/resource/Adenosine
p4125
aVhttp://dbpedia.org/resource/Adenosine
p4126
aasg18
(lp4127
Vdigoxin (Lanoxin, Lanoxicaps)
p4128
aVprocainamide (Procan SR, Pronestyl-SR)
p4129
aVlidocaine (Xylocaine)
p4130
aVadenosine (Adenocard)
p4131
asg24
(lp4132
Vhttp://dbpedia.org/resource/Heart
p4133
aVhttp://dbpedia.org/resource/Quinidine
p4134
aVhttp://dbpedia.org/resource/Quinidine
p4135
aVhttp://dbpedia.org/resource/Quinidine
p4136
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4137
sg31
S'cardiac effects resemble those of quinidine gluconate (Quinaglute, Quinalan):'
p4138
sg33
I21
sg34
S'Q34#11'
p4139
sg36
I13
sg37
S'11'
p4140
sg38
I1
sg39
S'34'
p4141
sa(dp4142
g3
(lp4143
(lp4144
Vhttp://dbpedia.org/resource/Supraventricular_tachycardia
p4145
aa(lp4146
Vhttp://dbpedia.org/resource/Angina_pectoris
p4147
aa(lp4148
Vhttp://dbpedia.org/resource/Heart_failure
p4149
aasg18
(lp4150
Vsupraventricular tachycardia
p4151
aVangina
p4152
aVcongestive heart failure
p4153
aVventricular arrhythmias
p4154
asg24
(lp4155
Vhttp://dbpedia.org/resource/Intravenous_therapy
p4156
aVhttp://dbpedia.org/resource/Lidocaine
p4157
aVhttp://dbpedia.org/resource/Lidocaine
p4158
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4159
sg31
S'Intravenous lidocaine (Xylocaine):'
p4160
sg33
I8
sg34
S'Q34#12'
p4161
sg36
I6
sg37
S'12'
p4162
sg38
I3
sg39
S'34'
p4163
sa(dp4164
g3
(lp4165
(lp4166
Vhttp://dbpedia.org/resource/Nausea
p4167
aVhttp://dbpedia.org/resource/Vomiting
p4168
aa(lp4169
Vhttp://dbpedia.org/resource/Ventricular_tachycardia
p4170
aa(lp4171
Vhttp://dbpedia.org/resource/Atrial_fibrillation
p4172
aasg18
(lp4173
Vnausea and vomiting 
p4174
aVirregular P waves
p4175
aVventricular tachycardia with alterations in the QRS complex
p4176
aVatrial fibrillation
p4177
asg24
(lp4178
Vhttp://dbpedia.org/resource/Medical_sign
p4179
aVhttp://dbpedia.org/resource/Digoxin
p4180
aVhttp://dbpedia.org/resource/Digoxin
p4181
aVhttp://dbpedia.org/resource/Toxicity
p4182
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4183
sg31
S'Most ominous sign of digoxin (Lanoxin, Lanoxicaps) intoxication: '
p4184
sg33
I16
sg34
S'Q34#13'
p4185
sg36
I12
sg37
S'13'
p4186
sg38
I2
sg39
S'34'
p4187
sa(dp4188
g3
(lp4189
(lp4190
Vhttp://dbpedia.org/resource/Quinidine
p4191
aVhttp://dbpedia.org/resource/Quinidine
p4192
aVhttp://dbpedia.org/resource/Quinidine
p4193
aa(lp4194
Vhttp://dbpedia.org/resource/Lidocaine
p4195
aVhttp://dbpedia.org/resource/Lidocaine
p4196
aasg18
(lp4197
Vsotalol (Betapace)
p4198
aVprocainamide (Procan SR, Pronestyl-SR)
p4199
aVquinidine gluconate (Quinaglute, Quinalan) than
p4200
aVlidocaine (Xylocaine)
p4201
asg24
(lp4202
Vhttp://dbpedia.org/resource/Patient
p4203
aVhttp://dbpedia.org/resource/Myocardial_infarction
p4204
aVhttp://dbpedia.org/resource/Recovery_model
p4205
aVhttp://dbpedia.org/resource/Menstrual_cycle
p4206
aVhttp://dbpedia.org/resource/Patient
p4207
aVhttp://dbpedia.org/resource/Experience
p4208
aVhttp://dbpedia.org/resource/Episode
p4209
aVhttp://dbpedia.org/resource/Tachycardia
p4210
aVhttp://dbpedia.org/resource/Military_discharge
p4211
aVhttp://dbpedia.org/resource/Hospital
p4212
aVhttp://dbpedia.org/resource/Patient
p4213
aVhttp://dbpedia.org/resource/Drug
p4214
aVhttp://dbpedia.org/resource/Ventricular_tachycardia
p4215
aVhttp://dbpedia.org/resource/Patient
p4216
aVhttp://dbpedia.org/resource/Dizziness
p4217
aVhttp://dbpedia.org/resource/Lost_%28TV_series%29
p4218
aVhttp://dbpedia.org/resource/Consciousness
p4219
aVhttp://dbpedia.org/resource/Hospital
p4220
aVhttp://dbpedia.org/resource/Patient
p4221
aVhttp://dbpedia.org/resource/Hypokalemia
p4222
aVhttp://dbpedia.org/resource/Diagnosis
p4223
aVhttp://dbpedia.org/resource/Test_cricket
p4224
aVhttp://dbpedia.org/resource/Blood_pressure
p4225
aVhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4226
aVhttp://dbpedia.org/resource/Drug
p4227
aVhttp://dbpedia.org/resource/Drug
p4228
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4229
sg31
S'A patient is admitted for treatment of myocardial infarction. During a prolonged recovery period, the patient experienced episodes of vetnricular tachycardia. Following discharge from hospital, the patient was instructed to take a drug to prevent recurrence of ventricular tachycardia. After a few days, the patient complained of dizziness and then lost consciousness. Upon admission to the hospital, the patient was found to be somewhat hypokalemic. A diagnosis of Torsades de Pointes was made. A test to determine the blood level of the antiarrhythmic reveal the drug was present in a slightly subtherapeutic level. What was the drug?'
p4230
sg33
I23
sg34
S'Q34#15'
p4231
sg36
I102
sg37
S'15'
p4232
sg38
I2
sg39
S'34'
p4233
sa(dp4234
g3
(lp4235
(lp4236
Vhttp://dbpedia.org/resource/Amiodarone
p4237
aVhttp://dbpedia.org/resource/Amiodarone
p4238
aa(lp4239
Vhttp://dbpedia.org/resource/Lidocaine
p4240
aVhttp://dbpedia.org/resource/Lidocaine
p4241
aa(lp4242
Vhttp://dbpedia.org/resource/Adenosine
p4243
aVhttp://dbpedia.org/resource/Adenosine
p4244
aa(lp4245
Vhttp://dbpedia.org/resource/Propranolol
p4246
aVhttp://dbpedia.org/resource/Propranolol
p4247
aasg18
(lp4248
Vamiodarone (Cordarone)
p4249
aVlidocaine (Xylocaine)
p4250
aVadenosine (Adenocard)
p4251
aVpropranolol (Inderal)
p4252
asg24
(lp4253
Vhttp://dbpedia.org/resource/Patient
p4254
aVhttp://dbpedia.org/resource/Digoxin
p4255
aVhttp://dbpedia.org/resource/Heart_failure
p4256
aVhttp://dbpedia.org/resource/Patient
p4257
aVhttp://dbpedia.org/resource/Dizziness
p4258
aVhttp://dbpedia.org/resource/Fatigue_%28medical%29
p4259
aVhttp://dbpedia.org/resource/Visual_perception
p4260
aVhttp://dbpedia.org/resource/Electrocardiography
p4261
aVhttp://dbpedia.org/resource/Electrocardiography
p4262
aVhttp://dbpedia.org/resource/Digitalis
p4263
aVhttp://dbpedia.org/resource/Toxicity
p4264
aVhttp://dbpedia.org/resource/Patient
p4265
aVhttp://dbpedia.org/resource/Digoxin
p4266
aVhttp://dbpedia.org/resource/Heart_failure
p4267
aVhttp://dbpedia.org/resource/Patient
p4268
aVhttp://dbpedia.org/resource/Dizziness
p4269
aVhttp://dbpedia.org/resource/Fatigue_%28medical%29
p4270
aVhttp://dbpedia.org/resource/Visual_perception
p4271
aVhttp://dbpedia.org/resource/Electrocardiography
p4272
aVhttp://dbpedia.org/resource/Exhibition
p4273
aVhttp://dbpedia.org/resource/Toxicity
p4274
aVhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4275
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4276
sg31
S'A patient is being treated with digoxin for congestive heart failure. To enhance inotropic effects, the dosage was increased. Soon afterwards, the patient complained of dizziness, fatigue, and disturbances in color vision. An ECG was taken. What ECG finding(s) would be consistent with digitalis intoxication?A patient is being treated with digoxin for congestive heart failure. To enhance inotropic effects, the dosage was increased. Soon afterwards, the patient complained of dizziness, fatigue, and disturbances in color vision. An ECG was taken and exhibit arrhythmias consistent with digitialis intoxication. What antiarrhythmic drugs might be used to treat worsening ventricular arrhythmias with hemodynamic compromise?'
p4277
sg33
I16
sg34
S'Q34#18'
p4278
sg36
I115
sg37
S'18'
p4279
sg38
I1
sg39
S'34'
p4280
sa(dp4281
g3
(lp4282
(lp4283
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4284
aa(lp4285
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4286
aa(lp4287
Vhttp://dbpedia.org/resource/Clinical_trial
p4288
aasg18
(lp4289
VPhase 0
p4290
aVPhase 1
p4291
aVPhase 2
p4292
aVPhase 3
p4293
asg24
(lp4294
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4295
aVhttp://dbpedia.org/resource/Muscle
p4296
aVhttp://dbpedia.org/resource/Action_potential
p4297
aVhttp://dbpedia.org/resource/Depolarization
p4298
aVhttp://dbpedia.org/resource/Calcium_in_biology
p4299
aVhttp://dbpedia.org/resource/Electric_current
p4300
aVhttp://dbpedia.org/resource/Electric_current
p4301
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions2/arrset1.htm'
p4302
sg31
S'Phase of ventricular muscle action potential is associated with an inward,depolarizing Ca2+ current and an outward, repolarizing K+ current.'
p4303
sg33
I8
sg34
S'Q34#19'
p4304
sg36
I23
sg37
S'19'
p4305
sg38
I2
sg39
S'34'
p4306
sa(dp4307
g3
(lp4308
(lp4309
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p4310
aa(lp4311
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p4312
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p4313
aVhttp://dbpedia.org/resource/Dan_Blocker
p4314
aasg18
(lp4315
Vsodium channel blocker
p4316
aVcalcium channel blocker
p4317
aVbeta adrenergic receptor blocker
p4318
aVpotassium channel blocker
p4319
asg24
(lp4320
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4321
aVhttp://dbpedia.org/resource/Biological_classification
p4322
aVhttp://dbpedia.org/resource/Class_II_railroad
p4323
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions3/questionset3.htm'
p4324
sg31
S'Antiarrhythmic drug classification: class II'
p4325
sg33
I13
sg34
S'Q35#1'
p4326
sg36
I6
sg37
S'1'
sg38
I2
sg39
S'35'
p4327
sa(dp4328
g3
(lp4329
(lp4330
Vhttp://dbpedia.org/resource/Chloride
p4331
aVhttp://dbpedia.org/resource/Sodium
p4332
aVhttp://dbpedia.org/resource/Potassium
p4333
aa(lp4334
Vhttp://dbpedia.org/resource/Potassium
p4335
aVhttp://dbpedia.org/resource/Calcium
p4336
aVhttp://dbpedia.org/resource/Chloride
p4337
aa(lp4338
Vhttp://dbpedia.org/resource/Sodium
p4339
aVhttp://dbpedia.org/resource/Calcium
p4340
aVhttp://dbpedia.org/resource/Large_intestine
p4341
aVhttp://dbpedia.org/resource/Organic_compound
p4342
aVhttp://dbpedia.org/resource/Ion
p4343
aa(lp4344
Vhttp://dbpedia.org/resource/Sodium
p4345
aVhttp://dbpedia.org/resource/Calcium
p4346
aVhttp://dbpedia.org/resource/Potassium
p4347
aa(lp4348
Vhttp://dbpedia.org/resource/Sodium
p4349
aVhttp://dbpedia.org/resource/Potassium
p4350
aVhttp://dbpedia.org/resource/Large_intestine
p4351
aVhttp://dbpedia.org/resource/Organic_compound
p4352
aVhttp://dbpedia.org/resource/Ion
p4353
aasg18
(lp4354
Vchloride, sodium, potassium
p4355
aVpotassium, calcium, chloride
p4356
aVsodium, calcium, large organic anions
p4357
aVsodium, calcium, potassium
p4358
aVsodium, potassium, large organic anions
p4359
asg24
(lp4360
Vhttp://dbpedia.org/resource/Principal_dancer
p4361
aVhttp://dbpedia.org/resource/Ion
p4362
aVhttp://dbpedia.org/resource/Heart
p4363
aVhttp://dbpedia.org/resource/Membrane_potential
p4364
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions3/questionset3.htm'
p4365
sg31
S'Principal ions involved in determining the cardiac transmembrane potential:'
p4366
sg33
I29
sg34
S'Q35#6'
p4367
sg36
I9
sg37
S'6'
sg38
I3
sg39
S'35'
p4368
sa(dp4369
g3
(lp4370
(lp4371
Vhttp://dbpedia.org/resource/Rapid
p4372
aVhttp://dbpedia.org/resource/Calcium
p4373
aVhttp://dbpedia.org/resource/Permeability_%28electromagnetism%29
p4374
aa(lp4375
Vhttp://dbpedia.org/resource/Rapid
p4376
aVhttp://dbpedia.org/resource/Potassium
p4377
aa(lp4378
Vhttp://dbpedia.org/resource/Rapid
p4379
aVhttp://dbpedia.org/resource/Sodium
p4380
aa(lp4381
Vhttp://dbpedia.org/resource/Chloride
p4382
aasg18
(lp4383
Vdue to rapid increase in calcium permeability
p4384
aVdue to rapid decrease in potassium conductance
p4385
aVdue to rapid increase in sodium conductance
p4386
aVdue to significant outward chloride currents
p4387
asg24
(lp4388
Vhttp://dbpedia.org/resource/Rapid
p4389
aVhttp://dbpedia.org/resource/Light_characteristic
p4390
aVhttp://dbpedia.org/resource/Phase_transition
p4391
aVhttp://dbpedia.org/resource/Depolarization
p4392
aVhttp://dbpedia.org/resource/Purkinje_cell
p4393
aVhttp://dbpedia.org/resource/Myocyte
p4394
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions3/questionset3.htm'
p4395
sg31
S'Rapid upstroke characteristic of phase 0 depolarization in Purkinje and ventricular muscle cells:'
p4396
sg33
I27
sg34
S'Q35#13'
p4397
sg36
I13
sg37
S'13'
p4398
sg38
I2
sg39
S'35'
p4399
sa(dp4400
g3
(lp4401
(lp4402
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4403
aa(lp4404
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4405
aa(lp4406
Vhttp://dbpedia.org/resource/Clinical_trial
p4407
aa(lp4408
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4409
aasg18
(lp4410
Vphase 0
p4411
aVphase 1
p4412
aVphase 2
p4413
aVphase 3
p4414
aVphase 4
p4415
asg24
(lp4416
Vhttp://dbpedia.org/resource/Phase_%28waves%29
p4417
aVhttp://dbpedia.org/resource/Cell_%28biology%29
p4418
aVhttp://dbpedia.org/resource/Diastole
p4419
aVhttp://dbpedia.org/resource/Depolarization
p4420
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions3/questionset3.htm'
p4421
sg31
S'Phase of the cardiac action potential (in SA nodal cells, for example) that is associated with "diastolic depolarization":'
p4422
sg33
I10
sg34
S'Q35#14'
p4423
sg36
I24
sg37
S'14'
p4424
sg38
I4
sg39
S'35'
p4425
sa(dp4426
g3
(lp4427
(lp4428
Vhttp://dbpedia.org/resource/Calcium_in_biology
p4429
aVhttp://dbpedia.org/resource/Potassium
p4430
aVhttp://dbpedia.org/resource/Sodium
p4431
aa(lp4432
Vhttp://dbpedia.org/resource/Potassium
p4433
aVhttp://dbpedia.org/resource/Calcium_in_biology
p4434
aVhttp://dbpedia.org/resource/Sodium
p4435
aa(lp4436
Vhttp://dbpedia.org/resource/Sodium
p4437
aVhttp://dbpedia.org/resource/Calcium_in_biology
p4438
aVhttp://dbpedia.org/resource/Potassium
p4439
aasg18
(lp4440
Vcalcium, potassium, sodium
p4441
aVpotassium, calcium, sodium
p4442
aVsodium, calcium, potassium
p4443
asg24
(lp4444
Vhttp://dbpedia.org/resource/Sequence_%28biology%29
p4445
aVhttp://dbpedia.org/resource/Heart
p4446
aVhttp://dbpedia.org/resource/Ion_channel
p4447
aVhttp://dbpedia.org/resource/Activation_energy
p4448
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions3/questionset3.htm'
p4449
sg31
S'Sequence of cardiac Purkinje fiber ion channel activation:'
p4450
sg33
I15
sg34
S'Q35#16'
p4451
sg36
I8
sg37
S'16'
p4452
sg38
I2
sg39
S'35'
p4453
sa(dp4454
g3
(lp4455
(lp4456
Vhttp://dbpedia.org/resource/Calcium_in_biology
p4457
aa(lp4458
Vhttp://dbpedia.org/resource/Potassium
p4459
aa(lp4460
Vhttp://dbpedia.org/resource/Sodium
p4461
aasg18
(lp4462
Vcalcium
p4463
aVpotassium
p4464
aVsodium
p4465
asg24
(lp4466
Vhttp://dbpedia.org/resource/Activation_energy
p4467
aVhttp://dbpedia.org/resource/Ion_channel
p4468
aVhttp://dbpedia.org/resource/Cardiac_muscle
p4469
aVhttp://dbpedia.org/resource/Depolarization
p4470
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions3/questionset3.htm'
p4471
sg31
S'Activation of this ion channel mainly associated with cardiac cell repolarization:'
p4472
sg33
I3
sg34
S'Q35#17'
p4473
sg36
I11
sg37
S'17'
p4474
sg38
I1
sg39
S'35'
p4475
sa(dp4476
g3
(lp4477
(lp4478
Vhttp://dbpedia.org/resource/Sodium
p4479
aa(lp4480
Vhttp://dbpedia.org/resource/Calcium
p4481
aa(lp4482
Vhttp://dbpedia.org/resource/Potassium
p4483
aasg18
(lp4484
Vsodium
p4485
aVcalcium
p4486
aVpotassium
p4487
asg24
(lp4488
Vhttp://dbpedia.org/resource/Ion
p4489
aVhttp://dbpedia.org/resource/Action_potential
p4490
aVhttp://dbpedia.org/resource/Conducting
p4491
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions4/questionset4.htm'
p4492
sg31
S'Principal ion responsible for action potentials in specialized conducting SA nodal and AV nodal tissues:'
p4493
sg33
I3
sg34
S'Q36#2'
p4494
sg36
I15
sg37
S'2'
sg38
I1
sg39
S'36'
p4495
sa(dp4496
g3
(lp4497
(lp4498
Vhttp://dbpedia.org/resource/Early_modern_Europe
p4499
aa(lp4500
Vhttp://dbpedia.org/resource/Mechanism_of_action
p4501
aasg18
(lp4502
Vdelayed afterdepolarization
p4503
aVearly afterdepolarization
p4504
aVreentry
p4505
aVeach mechanism equally likely
p4506
asg24
(lp4507
Vhttp://dbpedia.org/resource/Common_good
p4508
aVhttp://dbpedia.org/resource/Heart
p4509
aVhttp://dbpedia.org/resource/Electrical_conduction_system_of_the_heart
p4510
aVhttp://dbpedia.org/resource/Leadership
p4511
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions4/questionset4.htm'
p4512
sg31
S'Most common cardiac conduction abnormality leading to arrhythmias:'
p4513
sg33
I9
sg34
S'Q36#8'
p4514
sg36
I8
sg37
S'8'
sg38
I2
sg39
S'36'
p4515
sa(dp4516
g3
(lp4517
(lp4518
Vhttp://dbpedia.org/resource/Atropine
p4519
aasg18
(lp4520
Vedrophonium (Tensilon)
p4521
aVatropine
p4522
aVisoproterenol (Isuprel)
p4523
asg24
(lp4524
Vhttp://dbpedia.org/resource/Slope
p4525
aVhttp://dbpedia.org/resource/Phase_%28waves%29
p4526
aVhttp://dbpedia.org/resource/Depolarization
p4527
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions4/questionset4.htm'
p4528
sg31
S'More likely to decrease the slope of phase 4 depolarization:'
p4529
sg33
I9
sg34
S'Q36#11'
p4530
sg36
I10
sg37
S'11'
p4531
sg38
I0
sg39
S'36'
p4532
sa(dp4533
g3
(lp4534
(lp4535
Vhttp://dbpedia.org/resource/Quinidine
p4536
aVhttp://dbpedia.org/resource/Quinidine
p4537
aVhttp://dbpedia.org/resource/Quinidine
p4538
aa(lp4539
Vhttp://dbpedia.org/resource/Lidocaine
p4540
aVhttp://dbpedia.org/resource/Lidocaine
p4541
aasg18
(lp4542
Vtocainide (Tonocard)
p4543
aVprocainamide (Procan SR, Pronestyl-SR)
p4544
aVmetoprolol (Lopressor)
p4545
aVquinidine gluconate (Quinaglute, Quinalan)
p4546
aVlidocaine (Xylocaine)
p4547
asg24
(lp4548
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4549
aVhttp://dbpedia.org/resource/Antipyretic
p4550
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions5/questionset5.htm'
p4551
sg31
S'Antiarrhythmic drug with antimalarial and antipyretic effects:'
p4552
sg33
I26
sg34
S'Q37#2'
p4553
sg36
I7
sg37
S'2'
sg38
I3
sg39
S'37'
p4554
sa(dp4555
g3
(lp4556
(lp4557
Vhttp://dbpedia.org/resource/Digitalis
p4558
aVhttp://dbpedia.org/resource/Heart
p4559
aa(lp4560
Vhttp://dbpedia.org/resource/Digitalis
p4561
aVhttp://dbpedia.org/resource/Insurance
p4562
aVhttp://dbpedia.org/resource/Quinidine
p4563
aa(lp4564
Vhttp://dbpedia.org/resource/Digitalis
p4565
aVhttp://dbpedia.org/resource/Vagus_nerve
p4566
aVhttp://dbpedia.org/resource/Transmission_%28telecommunications%29
p4567
aa(lp4568
Vhttp://dbpedia.org/resource/Digitalis
p4569
aVhttp://dbpedia.org/resource/Block_%28data_storage%29
p4570
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p4571
aasg18
(lp4572
Vdigitalis improves the inotropic state of the heart
p4573
aVdigitalis insures adequate renal excretion of quinidine
p4574
aVdigitalis enhances vagal tone and reduces AV nodal transmission
p4575
aVdigitalis blocks muscarinic receptors
p4576
asg24
(lp4577
Vhttp://dbpedia.org/resource/Management
p4578
aVhttp://dbpedia.org/resource/Atrial_fibrillation
p4579
aVhttp://dbpedia.org/resource/Purpose
p4580
aVhttp://dbpedia.org/resource/Digitalis
p4581
aVhttp://dbpedia.org/resource/Quinidine
p4582
aVhttp://dbpedia.org/resource/Quinidine
p4583
aVhttp://dbpedia.org/resource/Quinidine
p4584
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions5/questionset5.htm'
p4585
sg31
S'In management of atrial fibrillation: the purpose of administering digitalis before quinidine gluconate (Quinaglute, Quinalan) --'
p4586
sg33
I28
sg34
S'Q37#8'
p4587
sg36
I20
sg37
S'8'
sg38
I2
sg39
S'37'
p4588
sa(dp4589
g3
(lp4590
(lp4591
Vhttp://dbpedia.org/resource/Quinidine
p4592
aVhttp://dbpedia.org/resource/Quinidine
p4593
aVhttp://dbpedia.org/resource/Quinidine
p4594
aa(lp4595
Vhttp://dbpedia.org/resource/Verapamil
p4596
aVhttp://dbpedia.org/resource/Verapamil
p4597
aasg18
(lp4598
Vquinidine gluconate (Quinaglute, Quinalan)
p4599
aVhydralazine (Apresoline)
p4600
aVprocainamide (Procan SR, Pronestyl-SR)
p4601
aVverapamil (Isoptin, Calan)
p4602
asg24
(lp4603
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4604
aVhttp://dbpedia.org/resource/Systemic_lupus_erythematosus
p4605
aVhttp://dbpedia.org/resource/Side_effect
p4606
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions5/questionset5.htm'
p4607
sg31
S'Antiarrhythmic drug: long-term use associated with a lupus-related side effect:'
p4608
sg33
I24
sg34
S'Q37#14'
p4609
sg36
I11
sg37
S'14'
p4610
sg38
I2
sg39
S'37'
p4611
sa(dp4612
g3
(lp4613
(lp4614
Vhttp://dbpedia.org/resource/Quinidine
p4615
aVhttp://dbpedia.org/resource/Quinidine
p4616
aVhttp://dbpedia.org/resource/Quinidine
p4617
aasg18
(lp4618
Vquinidine gluconate (Quinaglute, Quinalan)
p4619
aVprocainamide (Procan SR, Pronestyl-SR)
p4620
aVabout equal
p4621
asg24
(lp4622
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4623
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p4624
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions5/questionset5.htm'
p4625
sg31
S'Antiarrhythmic drug with more antimuscarinic activity:'
p4626
sg33
I16
sg34
S'Q37#15'
p4627
sg36
I6
sg37
S'15'
p4628
sg38
I0
sg39
S'37'
p4629
sa(dp4630
g3
(lp4631
(lp4632
Vhttp://dbpedia.org/resource/Arthralgia
p4633
aVhttp://dbpedia.org/resource/Arthritis
p4634
aa(lp4635
Vhttp://dbpedia.org/resource/Pericarditis
p4636
aVhttp://dbpedia.org/resource/Parenchyma
p4637
aa(lp4638
Vhttp://dbpedia.org/resource/Vasculitis
p4639
aasg18
(lp4640
Vserositis, arthralgia, arthritis
p4641
aVpluritis, pericarditis, parenchymal pulmonary disease
p4642
aVvasculitis
p4643
aVpositive antinuclear antibody test
p4644
aVmore frequent occurrence in slow acetylators
p4645
asg24
(lp4646
Vhttp://dbpedia.org/resource/Lupus_erythematosus
p4647
aVhttp://dbpedia.org/resource/Syndrome
p4648
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions5/questionset5.htm'
p4649
sg31
S'NOT a characteristics of procainamide (Procan SR, Pronestyl-SR)-mediated lupus erythematosus-like syndrome:'
p4650
sg33
I23
sg34
S'Q37#17'
p4651
sg36
I15
sg37
S'17'
p4652
sg38
I2
sg39
S'37'
p4653
sa(dp4654
g3
(lp4655
(lp4656
Vhttp://dbpedia.org/resource/Quinidine
p4657
aVhttp://dbpedia.org/resource/Quinidine
p4658
aVhttp://dbpedia.org/resource/Quinidine
p4659
aa(lp4660
Vhttp://dbpedia.org/resource/Lidocaine
p4661
aVhttp://dbpedia.org/resource/Lidocaine
p4662
aasg18
(lp4663
Vprocainamide (Procan SR, Pronestyl-SR)
p4664
aVdisopyramide (Norpace)
p4665
aVquinidine gluconate (Quinaglute, Quinalan)
p4666
aVlidocaine (Xylocaine)
p4667
aVesmolol (Brevibloc)
p4668
asg24
(lp4669
Vhttp://dbpedia.org/resource/Antiarrhythmic_agent
p4670
asg29
S'http://www.pharmacology2000.com/Cardio/antiarr/questions5/questionset5.htm'
p4671
sg31
S'Not a first-line antiarrhythmic age and because of its negative inotropic effects:'
p4672
sg33
I26
sg34
S'Q37#18'
p4673
sg36
I12
sg37
S'18'
p4674
sg38
I1
sg39
S'37'
p4675
sa(dp4676
g3
(lp4677
(lp4678
Vhttp://dbpedia.org/resource/Amyl_nitrite
p4679
aa(lp4680
Vhttp://dbpedia.org/resource/Nitrate
p4681
aasg18
(lp4682
Visosorbide dinitrate (Isordil, Sorbitrate)
p4683
aVamyl nitrite
p4684
aVglyeryl trinitrate
p4685
asg24
(lp4686
Vhttp://dbpedia.org/resource/Drug
p4687
aVhttp://dbpedia.org/resource/Inhalation
p4688
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions2/cv1.htm'
p4689
sg31
S'Antianginal drug administered by inhalation:'
p4690
sg33
I11
sg34
S'Q39#0'
p4691
sg36
I5
sg37
S'0'
sg38
I1
sg39
S'39'
p4692
sa(dp4693
g3
(lp4694
(lp4695
Vhttp://dbpedia.org/resource/Pain
p4696
aVhttp://dbpedia.org/resource/Cardiac_muscle
p4697
aVhttp://dbpedia.org/resource/Oxygen
p4698
aVhttp://dbpedia.org/resource/Cause_of_action
p4699
aVhttp://dbpedia.org/resource/Nitroglycerin
p4700
aVhttp://dbpedia.org/resource/Heart
p4701
aa(lp4702
Vhttp://dbpedia.org/resource/Pain
p4703
aVhttp://dbpedia.org/resource/Heart
p4704
aa(lp4705
Vhttp://dbpedia.org/resource/Test_cricket
p4706
aVhttp://dbpedia.org/resource/Nitrate
p4707
aVhttp://dbpedia.org/resource/Relax_%28song%29
p4708
aVhttp://dbpedia.org/resource/Angina_pectoris
p4709
aVhttp://dbpedia.org/resource/Symptom
p4710
aVhttp://dbpedia.org/resource/Symptom
p4711
aasg18
(lp4712
Vthat the pain was due to myocardial oxygen insufficiency, relieved by the action of nitroglycerin on cardiac preload
p4713
aVthat the pain is more likely due to esophageal spasm, because if it were due to the heart, relief would have taken longer.
p4714
aVthe test is inconclusive, since nitrates relax almost all smooth muscle--terminating anginal symptoms or symptoms of esophageal spasm
p4715
asg24
(lp4716
Vhttp://dbpedia.org/resource/Patient
p4717
aVhttp://dbpedia.org/resource/Medical_history
p4718
aVhttp://dbpedia.org/resource/Angina_pectoris
p4719
aVhttp://dbpedia.org/resource/Esophageal_cancer
p4720
aVhttp://dbpedia.org/resource/Spasm
p4721
aVhttp://dbpedia.org/resource/Physician
p4722
aVhttp://dbpedia.org/resource/Recurrence_relation
p4723
aVhttp://dbpedia.org/resource/Pain
p4724
aVhttp://dbpedia.org/resource/Pain
p4725
aVhttp://dbpedia.org/resource/Patient
p4726
aVhttp://dbpedia.org/resource/Nitroglycerin
p4727
aVhttp://dbpedia.org/resource/Pain
p4728
aVhttp://dbpedia.org/resource/Minute
p4729
aVhttp://dbpedia.org/resource/Reason
p4730
aVhttp://dbpedia.org/resource/Analysis
p4731
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions2/cv1.htm'
p4732
sg31
S'A patient with a history of both angina and esophageal spasms is told by his physician that upon recurrence of pain, take a nitroglycerin tablet, sublingually and note what happens. When pain recurs, the patient takes the "nitro" and the pain goes away in about a minute. Reasonable analysis would suggest:'
p4733
sg33
I65
sg34
S'Q39#1'
p4734
sg36
I56
sg37
S'1'
sg38
I2
sg39
S'39'
p4735
sa(dp4736
g3
(lp4737
(lp4738
Vhttp://dbpedia.org/resource/Nifedipine
p4739
aVhttp://dbpedia.org/resource/Nifedipine
p4740
aasg18
(lp4741
Vnifedipine (Procardia, Adalat)
p4742
aVnicardipine (Cardene)
p4743
aVdiltiazem (Cardiazem)
p4744
asg24
(lp4745
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p4746
aVhttp://dbpedia.org/resource/Cardiac_muscle
p4747
aVhttp://dbpedia.org/resource/Electrical_conduction_system_of_the_heart
p4748
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions2/cv1.htm'
p4749
sg31
S'Calcium channel blocker(s) most likely to affect myocardial contractility and AV conduction:'
p4750
sg33
I14
sg34
S'Q39#4'
p4751
sg36
I15
sg37
S'4'
sg38
I2
sg39
S'39'
p4752
sa(dp4753
g3
(lp4754
(lp4755
Vhttp://dbpedia.org/resource/Nifedipine
p4756
aVhttp://dbpedia.org/resource/Nifedipine
p4757
aVhttp://dbpedia.org/resource/Angina_pectoris
p4758
aa(lp4759
Vhttp://dbpedia.org/resource/Nifedipine
p4760
aVhttp://dbpedia.org/resource/Nifedipine
p4761
aVhttp://dbpedia.org/resource/Calcium_channel_blocker
p4762
aVhttp://dbpedia.org/resource/Vasodilation
p4763
aVhttp://dbpedia.org/resource/Hypotension
p4764
aVhttp://dbpedia.org/resource/Reflex
p4765
aVhttp://dbpedia.org/resource/Heart
p4766
aVhttp://dbpedia.org/resource/Stimulation
p4767
aVhttp://dbpedia.org/resource/Angina_pectoris
p4768
aVhttp://dbpedia.org/resource/Episode
p4769
aa(lp4770
Vhttp://dbpedia.org/resource/Nifedipine
p4771
aVhttp://dbpedia.org/resource/Nifedipine
p4772
aVhttp://dbpedia.org/resource/Portmanteau
p4773
aVhttp://dbpedia.org/resource/Propranolol
p4774
aVhttp://dbpedia.org/resource/Propranolol
p4775
aVhttp://dbpedia.org/resource/Tachycardia
p4776
aVhttp://dbpedia.org/resource/Nifedipine
p4777
aasg18
(lp4778
VNifedipine (Procardia, Adalat) should not be used for angina.
p4779
aVNifedipine (Procardia, Adalat), a calcium channel blocker, causes significant vasodilation. Hypotension and reflex cardiac stimulation result in increased anginal episodes
p4780
aVNifedipine (Procardia, Adalat) in combination with propranolol, since propranolol would block reflex tachycardia due to nifedipine\u005c
p4781
asg24
(lp4782
Vhttp://dbpedia.org/resource/Male
p4783
aVhttp://dbpedia.org/resource/Confirmation
p4784
aVhttp://dbpedia.org/resource/Vessels
p4785
aVhttp://dbpedia.org/resource/Chronic_obstructive_pulmonary_disease
p4786
aVhttp://dbpedia.org/resource/Chronic_obstructive_pulmonary_disease
p4787
aVhttp://dbpedia.org/resource/Angina_pectoris
p4788
aVhttp://dbpedia.org/resource/Nifedipine
p4789
aVhttp://dbpedia.org/resource/Angina_pectoris
p4790
aVhttp://dbpedia.org/resource/Pharmaceutical_drug
p4791
aVhttp://dbpedia.org/resource/Angina_pectoris
p4792
aVhttp://dbpedia.org/resource/Incidence_%28epidemiology%29
p4793
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions2/cv1.htm'
p4794
sg31
S'70 year old male with confirmed multi-vessel coronary vascular disease also suffers from COAD [chronic obstructive airway disease] and exertional angina. He is prescribed nifedipine for his angina, but shortly after beginning the medication complains of increased angina incidence. Choose an explanation:'
p4795
sg33
I57
sg34
S'Q39#5'
p4796
sg36
I45
sg37
S'5'
sg38
I1
sg39
S'39'
p4797
sa(dp4798
g3
(lp4799
(lp4800
Vhttp://dbpedia.org/resource/Effectiveness
p4801
aVhttp://dbpedia.org/resource/Drug
p4802
aVhttp://dbpedia.org/resource/Case_study
p4803
aa(lp4804
Vhttp://dbpedia.org/resource/Effectiveness
p4805
aa(lp4806
Vhttp://dbpedia.org/resource/Negative_feedback
p4807
aVhttp://dbpedia.org/resource/Property
p4808
aVhttp://dbpedia.org/resource/Cardiac_muscle
p4809
aVhttp://dbpedia.org/resource/Heart_failure
p4810
aa(lp4811
Vhttp://dbpedia.org/resource/Portmanteau
p4812
aVhttp://dbpedia.org/resource/Propranolol
p4813
aVhttp://dbpedia.org/resource/Propranolol
p4814
aVhttp://dbpedia.org/resource/Tachycardia
p4815
aasg18
(lp4816
VDiltiazem (Cardiazem) is an effective antianginal drug which would be appropriate in this case.
p4817
aVDiltiazem (Cardiazem) is only effective in Prinzmetal\u005c
p4818
aVDiltiazem (Cardiazem) is not appropriate because of its negative inotropic properties (decrease myocardial contractility) which would worsen left ventricular failure
p4819
aV Diltiazem (Cardiazem) in combination with propranolol (Inderal) would work since reflex tachycardia would be blocked
p4820
asg24
(lp4821
Vhttp://dbpedia.org/resource/Patient
p4822
aVhttp://dbpedia.org/resource/Suffering
p4823
aVhttp://dbpedia.org/resource/Myocardial_infarction
p4824
aVhttp://dbpedia.org/resource/Patient
p4825
aVhttp://dbpedia.org/resource/Moderate
p4826
aVhttp://dbpedia.org/resource/Heart_failure
p4827
aVhttp://dbpedia.org/resource/Diuretic
p4828
aVhttp://dbpedia.org/resource/Angina_pectoris
p4829
aVhttp://dbpedia.org/resource/Episode
p4830
aVhttp://dbpedia.org/resource/Calcium_channel_blocker
p4831
aVhttp://dbpedia.org/resource/Management
p4832
aVhttp://dbpedia.org/resource/Patient
p4833
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions2/cv1.htm'
p4834
sg31
S'A 60 year old patient with multivessel coronary vascular disease has suffered several myocardial infarctions. The patient is in moderate heart failure precariously controlled with diuretics and cardiac glycosides and has exertional anginal episodes about twice a day. Consider a calcium channel blocker in management of this patient:'
p4835
sg33
I68
sg34
S'Q39#6'
p4836
sg36
I48
sg37
S'6'
sg38
I2
sg39
S'39'
p4837
sa(dp4838
g3
(lp4839
(lp4840
Vhttp://dbpedia.org/resource/Nifedipine
p4841
aVhttp://dbpedia.org/resource/Nifedipine
p4842
aasg18
(lp4843
Vdiltiazem (Cardiazem)
p4844
aVbepridil (Vascor)
p4845
aVnifedipine (Procardia, Adalat)
p4846
aVlisinopril (Prinvivil, Zestril)
p4847
asg24
(lp4848
Vhttp://dbpedia.org/resource/Chronic_%28medicine%29
p4849
aVhttp://dbpedia.org/resource/Angina_pectoris
p4850
aVhttp://dbpedia.org/resource/Drug
p4851
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions2/cv1.htm'
p4852
sg31
S'Calcium and sodium channel blocker useful in treating chronic, stable angina not responsive to typical antianginal drugs:'
p4853
sg33
I20
sg34
S'Q39#7'
p4854
sg36
I18
sg37
S'7'
sg38
I1
sg39
S'39'
p4855
sa(dp4856
g3
(lp4857
(lp4858
Vhttp://dbpedia.org/resource/Tyrosine
p4859
aa(lp4860
Vhttp://dbpedia.org/resource/Tryptophan
p4861
aa(lp4862
Vhttp://dbpedia.org/resource/Arginine
p4863
aa(lp4864
Vhttp://dbpedia.org/resource/Proline
p4865
aa(lp4866
Vhttp://dbpedia.org/resource/Phenylalanine
p4867
aasg18
(lp4868
Vtyrosine
p4869
aVtryptophan
p4870
aVarginine
p4871
aVproline
p4872
aVphenylalanine
p4873
asg24
(lp4874
Vhttp://dbpedia.org/resource/Nitric_oxide
p4875
aVhttp://dbpedia.org/resource/Precursor_%28chemistry%29
p4876
aVhttp://dbpedia.org/resource/Amino_acid
p4877
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p4878
sg31
S'\n\tNitric oxide: precursor amino acid'
p4879
sg33
I5
sg34
S'Q40#2'
p4880
sg36
I6
sg37
S'2'
sg38
I2
sg39
S'40'
p4881
sa(dp4882
g3
(lp4883
(lp4884
Vhttp://dbpedia.org/resource/Second
p4885
aa(lp4886
Vhttp://dbpedia.org/resource/Second
p4887
aa(lp4888
Vhttp://dbpedia.org/resource/Minute
p4889
aa(lp4890
Vhttp://dbpedia.org/resource/120_Minutes
p4891
aa(lp4892
Vhttp://dbpedia.org/resource/Hour
p4893
aasg18
(lp4894
V< 5 seconds
p4895
aVthirty seconds
p4896
aVone-minute
p4897
aVthirty minutes
p4898
aV> one-hour
p4899
asg24
(lp4900
Vhttp://dbpedia.org/resource/Nitric_oxide
p4901
aVhttp://dbpedia.org/resource/Half-life
p4902
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p4903
sg31
S'Nitric oxide half-life:'
p4904
sg33
I10
sg34
S'Q40#3'
p4905
sg36
I3
sg37
S'3'
sg38
I0
sg39
S'40'
p4906
sa(dp4907
g3
(lp4908
(lp4909
Vhttp://dbpedia.org/resource/Nitric_oxide_synthase
p4910
aa(lp4911
Vhttp://dbpedia.org/resource/Reuptake
p4912
aa(lp4913
Vhttp://dbpedia.org/resource/Interaction
p4914
aVhttp://dbpedia.org/resource/Hemoglobin
p4915
aa(lp4916
Vhttp://dbpedia.org/resource/Monoamine_oxidase
p4917
aasg18
(lp4918
VNO synthase
p4919
aVreuptake
p4920
aVinteraction with hemoglobin
p4921
aVmonoamine oxidase
p4922
aVcatechol-O-methyltransferase
p4923
asg24
(lp4924
Vhttp://dbpedia.org/resource/Nitric_oxide
p4925
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p4926
sg31
S'Nitric oxide mainly inactivated by:'
p4927
sg33
I9
sg34
S'Q40#4'
p4928
sg36
I5
sg37
S'4'
sg38
I2
sg39
S'40'
p4929
sa(dp4930
g3
(lp4931
(lp4932
Vhttp://dbpedia.org/resource/Production_line
p4933
aa(lp4934
Vhttp://dbpedia.org/resource/Production_line
p4935
aa(lp4936
Vhttp://dbpedia.org/resource/Production_line
p4937
aasg18
(lp4938
Vincreased NO production
p4939
aVdecreased NO production
p4940
aVno effect on NO production
p4941
asg24
(lp4942
Vhttp://dbpedia.org/resource/Nitric_oxide
p4943
aVhttp://dbpedia.org/resource/Antiphon
p4944
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p4945
sg31
S'Decreased oxygenation \n\tand nitric oxide response:'
p4946
sg33
I11
sg34
S'Q40#6'
p4947
sg36
I6
sg37
S'6'
sg38
I0
sg39
S'40'
p4948
sa(dp4949
g3
(lp4950
(lp4951
Vhttp://dbpedia.org/resource/Vein
p4952
aVhttp://dbpedia.org/resource/Produce
p4953
aa(lp4954
Vhttp://dbpedia.org/resource/Artery
p4955
aVhttp://dbpedia.org/resource/Produce
p4956
aa(lp4957
Vhttp://dbpedia.org/resource/Equality_%28mathematics%29
p4958
aasg18
(lp4959
Vveins produce more
p4960
aVarteries produce more
p4961
aVequal
p4962
asg24
(lp4963
Vhttp://dbpedia.org/resource/Artery
p4964
aVhttp://dbpedia.org/resource/Vein
p4965
aVhttp://dbpedia.org/resource/Nitric_oxide
p4966
aVhttp://dbpedia.org/resource/Production_line
p4967
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p4968
sg31
S'Comparing arteries \n\tand veins: nitric oxide production'
p4969
sg33
I7
sg34
S'Q40#7'
p4970
sg36
I8
sg37
S'7'
sg38
I1
sg39
S'40'
p4971
sa(dp4972
g3
(lp4973
(lp4974
Vhttp://dbpedia.org/resource/Nitric_oxide
p4975
aVhttp://dbpedia.org/resource/Platelet
p4976
aVhttp://dbpedia.org/resource/Adhesion
p4977
aa(lp4978
Vhttp://dbpedia.org/resource/Nitric_oxide
p4979
aVhttp://dbpedia.org/resource/Platelet
p4980
aVhttp://dbpedia.org/resource/Adhesion
p4981
aasg18
(lp4982
Vnitric oxide inhibits  platelet aggregation and adhesion
p4983
aVnitric oxide promotes platelet aggregation and adhesion
p4984
aVno effect
p4985
asg24
(lp4986
Vhttp://dbpedia.org/resource/Nitric_oxide
p4987
aVhttp://dbpedia.org/resource/Platelet
p4988
aVhttp://dbpedia.org/resource/Adhesion
p4989
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p4990
sg31
S'Nitric oxide \n\tand platelet aggregation and adhesion:'
p4991
sg33
I16
sg34
S'Q40#8'
p4992
sg36
I7
sg37
S'8'
sg38
I0
sg39
S'40'
p4993
sa(dp4994
g3
(lp4995
(lp4996
Vhttp://dbpedia.org/resource/Neuromuscular_junction
p4997
aa(lp4998
Vhttp://dbpedia.org/resource/Peripheral_nerve
p4999
aa(lp5000
Vhttp://dbpedia.org/resource/Basal_ganglia
p5001
aasg18
(lp5002
Vneuromuscular junction
p5003
aVinnervation of the corpora cavernosa
p5004
aVbasal ganglia
p5005
aVRenshaw cell
p5006
asg24
(lp5007
Vhttp://dbpedia.org/resource/Probability
p5008
aVhttp://dbpedia.org/resource/Ribosome
p5009
aVhttp://dbpedia.org/resource/Neurotransmitter
p5010
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions3/questionset3.htm'
p5011
sg31
S'Probable site \n\twhere NO acts as a neurotransmitter:'
p5012
sg33
I11
sg34
S'Q40#9'
p5013
sg36
I8
sg37
S'9'
sg38
I1
sg39
S'40'
p5014
sa(dp5015
g3
(lp5016
(lp5017
Vhttp://dbpedia.org/resource/Sodium
p5018
aa(lp5019
Vhttp://dbpedia.org/resource/Nitroglycerin
p5020
aa(lp5021
Vhttp://dbpedia.org/resource/Propranolol
p5022
aVhttp://dbpedia.org/resource/Propranolol
p5023
aasg18
(lp5024
Vnitroprusside sodium (Nipride)
p5025
aVhydralazine (Apresoline)
p5026
aVsublingual nitroglycerin
p5027
aVpropranolol (Inderal)
p5028
aVminoxidil (Loniten)
p5029
asg24
(lp5030
Vhttp://dbpedia.org/resource/Angina_pectoris
p5031
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions4/questionset4.htm'
p5032
sg31
S'Preferred for acute management of angina:'
p5033
sg33
I19
sg34
S'Q41#8'
p5034
sg36
I6
sg37
S'8'
sg38
I2
sg39
S'41'
p5035
sa(dp5036
g3
(lp5037
(lp5038
Vhttp://dbpedia.org/resource/Vasodilation
p5039
aa(lp5040
Vhttp://dbpedia.org/resource/Heart_rate
p5041
aasg18
(lp5042
Vcoronary vasodilation
p5043
aVdecreased afterload
p5044
aVdecreased preload
p5045
aVdecreased heart rate
p5046
aVdecreased contractility
p5047
asg24
(lp5048
Vhttp://dbpedia.org/resource/Mechanism_of_action
p5049
aVhttp://dbpedia.org/resource/Nitroglycerin
p5050
aVhttp://dbpedia.org/resource/Angina_pectoris
p5051
aVhttp://dbpedia.org/resource/Episode
p5052
aVhttp://dbpedia.org/resource/Patient
p5053
aVhttp://dbpedia.org/resource/Atherosclerosis
p5054
aVhttp://dbpedia.org/resource/Disease
p5055
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions4/questionset4.htm'
p5056
sg31
S'Principal mechanism by which sublingual nitroglycerin terminates anginal episodes in patients with advanced atherosclerotic coronary vessel disease:'
p5057
sg33
I11
sg34
S'Q41#9'
p5058
sg36
I17
sg37
S'9'
sg38
I2
sg39
S'41'
p5059
sa(dp5060
g3
(lp5061
(lp5062
Vhttp://dbpedia.org/resource/Phenylalanine
p5063
aa(lp5064
Vhttp://dbpedia.org/resource/Arginine
p5065
aa(lp5066
Vhttp://dbpedia.org/resource/Proline
p5067
aa(lp5068
Vhttp://dbpedia.org/resource/Tryptophan
p5069
aasg18
(lp5070
Vphenylalanine
p5071
aVarginine
p5072
aVproline
p5073
aVtranylcypromine (Parnate)
p5074
aVtryptophan
p5075
asg24
(lp5076
Vhttp://dbpedia.org/resource/Substrate_%28chemistry%29
p5077
aVhttp://dbpedia.org/resource/Nitric_oxide_synthase
p5078
aVhttp://dbpedia.org/resource/Nitrate
p5079
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions4/questionset4.htm'
p5080
sg31
S'Substrate for nitric oxide synthase for production of endogenous nitrates:'
p5081
sg33
I8
sg34
S'Q41#12'
p5082
sg36
I10
sg37
S'12'
p5083
sg38
I1
sg39
S'41'
p5084
sa(dp5085
g3
(lp5086
(lp5087
Vhttp://dbpedia.org/resource/Sodium
p5088
aa(lp5089
Vhttp://dbpedia.org/resource/Calcium
p5090
aa(lp5091
Vhttp://dbpedia.org/resource/Magnesium
p5092
aasg18
(lp5093
Vsodium
p5094
aVcalcium
p5095
aVmagnesium
p5096
asg24
(lp5097
Vhttp://dbpedia.org/resource/Depolarization
p5098
aVhttp://dbpedia.org/resource/Electric_current
p5099
aVhttp://dbpedia.org/resource/Ion
p5100
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5101
sg31
S'Major depolarizing current is carried by this ion in vascular smooth muscle:'
p5102
sg33
I3
sg34
S'Q42#6'
p5103
sg36
I12
sg37
S'6'
sg38
I1
sg39
S'42'
p5104
sa(dp5105
g3
(lp5106
(lp5107
Vhttp://dbpedia.org/resource/Sodium
p5108
aa(lp5109
Vhttp://dbpedia.org/resource/Calcium
p5110
aa(lp5111
Vhttp://dbpedia.org/resource/Magnesium
p5112
aa(lp5113
Vhttp://dbpedia.org/resource/Potassium
p5114
aa(lp5115
Vhttp://dbpedia.org/resource/Chloride
p5116
aasg18
(lp5117
Vsodium
p5118
aVcalcium
p5119
aVmagnesium
p5120
aVpotassium
p5121
aVchloride
p5122
asg24
(lp5123
Vhttp://dbpedia.org/resource/Heart
p5124
aVhttp://dbpedia.org/resource/Fasting
p5125
aVhttp://dbpedia.org/resource/Antiphon
p5126
aVhttp://dbpedia.org/resource/Ion
p5127
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5128
sg31
S'In the heart, the"fast" response is mediated by this ion:'
p5129
sg33
I5
sg34
S'Q42#7'
p5130
sg36
I14
sg37
S'7'
sg38
I0
sg39
S'42'
p5131
sa(dp5132
g3
(lp5133
(lp5134
Vhttp://dbpedia.org/resource/Sodium
p5135
aa(lp5136
Vhttp://dbpedia.org/resource/Calcium
p5137
aa(lp5138
Vhttp://dbpedia.org/resource/Magnesium
p5139
aa(lp5140
Vhttp://dbpedia.org/resource/Potassium
p5141
aa(lp5142
Vhttp://dbpedia.org/resource/Chloride
p5143
aasg18
(lp5144
Vsodium
p5145
aVcalcium
p5146
aVmagnesium
p5147
aVpotassium
p5148
aVchloride
p5149
asg24
(lp5150
Vhttp://dbpedia.org/resource/Heart
p5151
aVhttp://dbpedia.org/resource/Slow_%28song%29
p5152
aVhttp://dbpedia.org/resource/Ion
p5153
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5154
sg31
S'In the heart, the "slow" responses mediated by this ion:'
p5155
sg33
I5
sg34
S'Q42#8'
p5156
sg36
I13
sg37
S'8'
sg38
I1
sg39
S'42'
p5157
sa(dp5158
g3
(lp5159
(lp5160
Vhttp://dbpedia.org/resource/Sodium
p5161
aa(lp5162
Vhttp://dbpedia.org/resource/Calcium
p5163
aa(lp5164
Vhttp://dbpedia.org/resource/Potassium
p5165
aa(lp5166
Vhttp://dbpedia.org/resource/Chloride
p5167
aa(lp5168
Vhttp://dbpedia.org/resource/Magnesium
p5169
aasg18
(lp5170
Vsodium
p5171
aVcalcium
p5172
aVpotassium
p5173
aVchloride
p5174
aVmagnesium
p5175
asg24
(lp5176
Vhttp://dbpedia.org/resource/Depolarization
p5177
aVhttp://dbpedia.org/resource/Electrical_conduction_system_of_the_heart
p5178
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p5179
aVhttp://dbpedia.org/resource/Ion
p5180
aVhttp://dbpedia.org/resource/Movement_%28music%29
p5181
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5182
sg31
S'Depolarization in the specialized conduction system, the SA. and AV nodal tissue, is mediated by this ion movement:'
p5183
sg33
I5
sg34
S'Q42#9'
p5184
sg36
I20
sg37
S'9'
sg38
I1
sg39
S'42'
p5185
sa(dp5186
g3
(lp5187
(lp5188
Vhttp://dbpedia.org/resource/Nifedipine
p5189
aVhttp://dbpedia.org/resource/Nifedipine
p5190
aasg18
(lp5191
Vnicardipine (Cardene)
p5192
aVdiltiazem (Cardiazem)
p5193
aVamlodipine (Norvasc)
p5194
aVnifedipine (Procardia, Adalat)
p5195
aVall equal
p5196
asg24
(lp5197
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p5198
aVhttp://dbpedia.org/resource/Heart_failure
p5199
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5200
sg31
S'Calcium channel blocker most likely to worsen congestive heart failure:'
p5201
sg33
I20
sg34
S'Q42#11'
p5202
sg36
I10
sg37
S'11'
p5203
sg38
I1
sg39
S'42'
p5204
sa(dp5205
g3
(lp5206
(lp5207
Vhttp://dbpedia.org/resource/Verapamil
p5208
aVhttp://dbpedia.org/resource/Verapamil
p5209
aa(lp5210
Vhttp://dbpedia.org/resource/Nifedipine
p5211
aVhttp://dbpedia.org/resource/Nifedipine
p5212
aasg18
(lp5213
Vamlodipine (Norvasc)
p5214
aVverapamil (Isoptin, Calan)
p5215
aVnifedipine (Procardia, Adalat)
p5216
aVnimodipine (Nimotop)
p5217
aVdiltiazem (Cardiazem)
p5218
asg24
(lp5219
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p5220
aVhttp://dbpedia.org/resource/Patient
p5221
aVhttp://dbpedia.org/resource/Central_nervous_system
p5222
aVhttp://dbpedia.org/resource/Cerebral_aneurysm
p5223
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5224
sg31
S'Calcium channel blocker approved for use in patients with CNS deficits following rupture of congenital intracranial aneurysm:'
p5225
sg33
I24
sg34
S'Q42#17'
p5226
sg36
I17
sg37
S'17'
p5227
sg38
I3
sg39
S'42'
p5228
sa(dp5229
g3
(lp5230
(lp5231
Vhttp://dbpedia.org/resource/Beta_blocker
p5232
aa(lp5233
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p5234
aasg18
(lp5235
Vbeta-blockers
p5236
aVcalcium channel blockers
p5237
aVequally appropriate
p5238
asg24
(lp5239
Vhttp://dbpedia.org/resource/Drug
p5240
aVhttp://dbpedia.org/resource/Social_class
p5241
aVhttp://dbpedia.org/resource/Talent_manager
p5242
asg29
S'http://www.pharmacology2000.com/Cardio/coronary/questions5/questionset5.htm'
p5243
sg31
S'Better drug class for management of variant angina:'
p5244
sg33
I6
sg34
S'Q42#19'
p5245
sg36
I8
sg37
S'19'
p5246
sg38
I1
sg39
S'42'
p5247
sa(dp5248
g3
(lp5249
(lp5250
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p5251
aa(lp5252
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p5253
aa(lp5254
Vhttp://dbpedia.org/resource/Dopamine_receptor
p5255
aVhttp://dbpedia.org/resource/Chemical_synapse
p5256
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p5257
aa(lp5258
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p5259
aa(lp5260
Vhttp://dbpedia.org/resource/Leukotriene
p5261
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p5262
aasg18
(lp5263
Vbeta2 adrenergic receptors
p5264
aVbeta1 adrenergic receptors
p5265
aVdopamine D1 and D2 postsynaptic receptors
p5266
aVmuscarinic receptors
p5267
aVleukotriene receptors
p5268
asg24
(lp5269
Vhttp://dbpedia.org/resource/Dopamine_receptor
p5270
aVhttp://dbpedia.org/resource/Dopamine
p5271
aVhttp://dbpedia.org/resource/Kidney
p5272
aVhttp://dbpedia.org/resource/Vasodilation
p5273
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p5274
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions3/questionset3.htm'
p5275
sg31
S'Dopamine (Intropin) -mediated renal vasodilation is caused by which receptor(s) system(s):'
p5276
sg33
I16
sg34
S'Q44#6'
p5277
sg36
I20
sg37
S'6'
sg38
I2
sg39
S'44'
p5278
sa(dp5279
g3
(lp5280
(lp5281
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p5282
aa(lp5283
Vhttp://dbpedia.org/resource/Electrical_conduction_system_of_the_heart
p5284
aa(lp5285
Vhttp://dbpedia.org/resource/Peripheral
p5286
aVhttp://dbpedia.org/resource/Vasodilation
p5287
aa(lp5288
Vhttp://dbpedia.org/resource/Force
p5289
aVhttp://dbpedia.org/resource/Velocity
p5290
aVhttp://dbpedia.org/resource/Curveball
p5291
aVhttp://dbpedia.org/resource/Upward_Bound
p5292
aasg18
(lp5293
Vincreased rate
p5294
aVdecreased AV conduction
p5295
aVperipheral vasodilation
p5296
aVshifted the force-velocity curve upward
p5297
aVincreased diuresis
p5298
asg24
(lp5299
Vhttp://dbpedia.org/resource/Heart
p5300
aVhttp://dbpedia.org/resource/Digoxin
p5301
aVhttp://dbpedia.org/resource/Management
p5302
aVhttp://dbpedia.org/resource/Heart_failure
p5303
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions3/questionset3.htm'
p5304
sg31
S'Most important cardiac effect produced by digoxin relative to management of congestive heart failure:'
p5305
sg33
I14
sg34
S'Q44#8'
p5306
sg36
I14
sg37
S'8'
sg38
I3
sg39
S'44'
p5307
sa(dp5308
g3
(lp5309
(lp5310
Vhttp://dbpedia.org/resource/Amiodarone
p5311
aVhttp://dbpedia.org/resource/Amiodarone
p5312
aa(lp5313
Vhttp://dbpedia.org/resource/Theophylline
p5314
aasg18
(lp5315
Vamrinone (Inocor)
p5316
aVamiodarone (Cordarone)
p5317
aVmilrinone (Primacor)
p5318
aVlosartin (Cozaar)
p5319
aVtheophylline
p5320
asg24
(lp5321
Vhttp://dbpedia.org/resource/Choice
p5322
aVhttp://dbpedia.org/resource/Short_film
p5323
aVhttp://dbpedia.org/resource/Parenteral
p5324
aVhttp://dbpedia.org/resource/Support_group
p5325
aVhttp://dbpedia.org/resource/Heart_failure
p5326
aVhttp://dbpedia.org/resource/Patient
p5327
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions3/questionset3.htm'
p5328
sg31
S'Agent of choice among the phosphodiesterase inhibitors for short term parenteral support in severe heart failure patients:'
p5329
sg33
I17
sg34
S'Q44#9'
p5330
sg36
I17
sg37
S'9'
sg38
I2
sg39
S'44'
p5331
sa(dp5332
g3
(lp5333
(lp5334
Vhttp://dbpedia.org/resource/Redox
p5335
aVhttp://dbpedia.org/resource/Parasympathetic_nervous_system
p5336
aa(lp5337
Vhttp://dbpedia.org/resource/Catecholamine
p5338
aa(lp5339
Vhttp://dbpedia.org/resource/Adrenergic
p5340
aVhttp://dbpedia.org/resource/Nervous_system
p5341
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p5342
aasg18
(lp5343
Vreduction in parasympathetic  tone
p5344
aVcirculating catecholamine levels
p5345
aVadrenergic nerve activity
p5346
asg24
(lp5347
Vhttp://dbpedia.org/resource/Acute_%28medicine%29
p5348
aVhttp://dbpedia.org/resource/Factors_of_production
p5349
aVhttp://dbpedia.org/resource/Force
p5350
aVhttp://dbpedia.org/resource/Velocity
p5351
aVhttp://dbpedia.org/resource/Ventricle_%28heart%29
p5352
aVhttp://dbpedia.org/resource/Curve
p5353
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5354
sg31
S'Most important acute factor in changing the position of the force-velocity in ventricular function curves:'
p5355
sg33
I10
sg34
S'Q45#0'
p5356
sg36
I15
sg37
S'0'
sg38
I2
sg39
S'45'
p5357
sa(dp5358
g3
(lp5359
(lp5360
Vhttp://dbpedia.org/resource/Calcium
p5361
aa(lp5362
Vhttp://dbpedia.org/resource/Caffeine
p5363
aa(lp5364
Vhttp://dbpedia.org/resource/Theophylline
p5365
aasg18
(lp5366
Vcalcium
p5367
aVcaffeine
p5368
aVcardiac glycosides
p5369
aVdisopyramide (Norpace)
p5370
aVtheophylline
p5371
asg24
(lp5372
Vhttp://dbpedia.org/resource/Performance_management
p5373
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5374
sg31
S'Agents which decreased ventricular performance:'
p5375
sg33
I9
sg34
S'Q45#6'
p5376
sg36
I5
sg37
S'6'
sg38
I3
sg39
S'45'
p5377
sa(dp5378
g3
(lp5379
(lp5380
Vhttp://dbpedia.org/resource/Steroid
p5381
aVhttp://dbpedia.org/resource/GCE_Advanced_Level
p5382
aasg18
(lp5383
Vafterload
p5384
aVcirculating steroid levels
p5385
aVextent of ventricular dilatation
p5386
asg24
(lp5387
Vhttp://dbpedia.org/resource/Performance
p5388
aVhttp://dbpedia.org/resource/Heart
p5389
aVhttp://dbpedia.org/resource/Bolted_joint
p5390
aVhttp://dbpedia.org/resource/Reserve_team
p5391
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5392
sg31
S'Ventricular performance in the failing heart (with no preload reserve) is determined by:'
p5393
sg33
I8
sg34
S'Q45#8'
p5394
sg36
I15
sg37
S'8'
sg38
I0
sg39
S'45'
p5395
sa(dp5396
g3
(lp5397
(lp5398
Vhttp://dbpedia.org/resource/Cardiac_output
p5399
aVhttp://dbpedia.org/resource/Oxygen
p5400
aVhttp://dbpedia.org/resource/Demand_curve
p5401
aa(lp5402
Vhttp://dbpedia.org/resource/Cardiac_output
p5403
aVhttp://dbpedia.org/resource/Oxygen
p5404
aVhttp://dbpedia.org/resource/Demand_curve
p5405
aa(lp5406
Vhttp://dbpedia.org/resource/Cardiac_output
p5407
aVhttp://dbpedia.org/resource/Oxygen
p5408
aVhttp://dbpedia.org/resource/Demand_curve
p5409
aa(lp5410
Vhttp://dbpedia.org/resource/Cardiac_output
p5411
aVhttp://dbpedia.org/resource/Oxygen
p5412
aVhttp://dbpedia.org/resource/Demand_curve
p5413
aasg18
(lp5414
Vcardiac output increased; oxygen demand increased
p5415
aVcardiac output decreased; oxygen demand decreased
p5416
aVcardiac output decreased; oxygen demand increased
p5417
aVcardiac output increased; oxygen demand decreased
p5418
asg24
(lp5419
Vhttp://dbpedia.org/resource/Hard_water
p5420
aVhttp://dbpedia.org/resource/Cardiac_output
p5421
aVhttp://dbpedia.org/resource/Oxygen
p5422
aVhttp://dbpedia.org/resource/Demand_curve
p5423
aVhttp://dbpedia.org/resource/Vasoconstriction
p5424
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5425
sg31
S'In the failing hard, the effect on cardiac output and oxygen demand when afterload increases (increased vasoconstriction):'
p5426
sg33
I28
sg34
S'Q45#9'
p5427
sg36
I21
sg37
S'9'
sg38
I2
sg39
S'45'
p5428
sa(dp5429
g3
(lp5430
(lp5431
Vhttp://dbpedia.org/resource/Redox
p5432
aVhttp://dbpedia.org/resource/Vein
p5433
aVhttp://dbpedia.org/resource/Rate_of_return
p5434
aVhttp://dbpedia.org/resource/Peripheral
p5435
aa(lp5436
Vhttp://dbpedia.org/resource/Vein
p5437
aVhttp://dbpedia.org/resource/Rate_of_return
p5438
aa(lp5439
Vhttp://dbpedia.org/resource/The_Normal_Heart
p5440
aasg18
(lp5441
Vdecreased due to reduced venous return (peripheral pooling)
p5442
aVincreased with due to enhanced venous return and ventricular filling
p5443
aVno effect in the normal heart
p5444
asg24
(lp5445
Vhttp://dbpedia.org/resource/Physical_exercise
p5446
aVhttp://dbpedia.org/resource/Bolted_joint
p5447
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5448
sg31
S'Effect of exercise on preload and ventricular filling:'
p5449
sg33
I26
sg34
S'Q45#10'
p5450
sg36
I8
sg37
S'10'
p5451
sg38
I1
sg39
S'45'
p5452
sa(dp5453
g3
(lp5454
(lp5455
Vhttp://dbpedia.org/resource/Asia_Minor
p5456
aa(lp5457
Vhttp://dbpedia.org/resource/Menopause
p5458
aasg18
(lp5459
Vnotable increase
p5460
aVdecrease
p5461
aVminor increase
p5462
aVno change
p5463
asg24
(lp5464
Vhttp://dbpedia.org/resource/Physical_exercise
p5465
aVhttp://dbpedia.org/resource/Blood_pressure
p5466
aVhttp://dbpedia.org/resource/The_Normal_Heart
p5467
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5468
sg31
S'With exercise, what happens to arterial pressure (normal heart)?'
p5469
sg33
I7
sg34
S'Q45#11'
p5470
sg36
I13
sg37
S'11'
p5471
sg38
I2
sg39
S'45'
p5472
sa(dp5473
g3
(lp5474
(lp5475
Vhttp://dbpedia.org/resource/Rapid_transit
p5476
aa(lp5477
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p5478
aa(lp5479
Vhttp://dbpedia.org/resource/Menopause
p5480
aasg18
(lp5481
Vtypically elevated
p5482
aVtypically depressed
p5483
aVno change from normal
p5484
asg24
(lp5485
Vhttp://dbpedia.org/resource/Norepinephrine
p5486
aVhttp://dbpedia.org/resource/GCE_Advanced_Level
p5487
aVhttp://dbpedia.org/resource/Patient
p5488
aVhttp://dbpedia.org/resource/Heart_failure
p5489
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions4/questionset4.htm'
p5490
sg31
S'Circulating norepinephrine levels in patients with heart failure:'
p5491
sg33
I8
sg34
S'Q45#14'
p5492
sg36
I8
sg37
S'14'
p5493
sg38
I0
sg39
S'45'
p5494
sa(dp5495
g3
(lp5496
(lp5497
Vhttp://dbpedia.org/resource/Dopamine
p5498
aVhttp://dbpedia.org/resource/Dopamine
p5499
aasg18
(lp5500
Vdobutamine (Dobutrex)
p5501
aVdigoxin (Lanoxin, Lanoxicaps)
p5502
aVamrinone (Inocor)
p5503
aVdopamine (Intropin)
p5504
asg24
(lp5505
Vhttp://dbpedia.org/resource/Digoxin
p5506
aVhttp://dbpedia.org/resource/Digoxin
p5507
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions5/questionset5.htm'
p5508
sg31
S'Positive inotropic agent -- phosphodiesterase inhibitor'
p5509
sg33
I18
sg34
S'Q46#3'
p5510
sg36
I6
sg37
S'3'
sg38
I2
sg39
S'46'
p5511
sa(dp5512
g3
(lp5513
(lp5514
Vhttp://dbpedia.org/resource/Cardiac_output
p5515
aa(lp5516
Vhttp://dbpedia.org/resource/Heart_rate
p5517
aasg18
(lp5518
Vcardiac output directly dependent on contractility and peripheral resistance
p5519
aVfactors affecting stroke volume include preload, afterload, and contractility
p5520
aVheart rate mainly depend on idioventricular rhythm
p5521
asg24
(lp5522
Vhttp://dbpedia.org/resource/Cardiac_output
p5523
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p5524
aVhttp://dbpedia.org/resource/Perfusion
p5525
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions5/questionset5.htm'
p5526
sg31
S'Cardiac output and tissue perfusion:'
p5527
sg33
I27
sg34
S'Q46#6'
p5528
sg36
I5
sg37
S'6'
sg38
I1
sg39
S'46'
p5529
sa(dp5530
g3
(lp5531
(lp5532
Vhttp://dbpedia.org/resource/Vessels
p5533
aVhttp://dbpedia.org/resource/Radius
p5534
aa(lp5535
Vhttp://dbpedia.org/resource/Vessels
p5536
aVhttp://dbpedia.org/resource/Length
p5537
aa(lp5538
Vhttp://dbpedia.org/resource/Blood_plasma
p5539
aasg18
(lp5540
Vblood viscosity
p5541
aVvessel radius
p5542
aVvessel length
p5543
aVintravascular volume
p5544
aVpulmonary artery pressure
p5545
asg24
(lp5546
Vhttp://dbpedia.org/resource/Factor_%28agent%29
p5547
aVhttp://dbpedia.org/resource/Blood_flow
p5548
aVhttp://dbpedia.org/resource/Drug_resistance
p5549
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions5/questionset5.htm'
p5550
sg31
S'Most significant factor in blood flow resistance:'
p5551
sg33
I11
sg34
S'Q46#8'
p5552
sg36
I7
sg37
S'8'
sg38
I1
sg39
S'46'
p5553
sa(dp5554
g3
(lp5555
(lp5556
Vhttp://dbpedia.org/resource/Sympathetic_nervous_system
p5557
aa(lp5558
Vhttp://dbpedia.org/resource/Parasympathetic_nervous_system
p5559
aa(lp5560
Vhttp://dbpedia.org/resource/Equality_%28mathematics%29
p5561
aVhttp://dbpedia.org/resource/Dominant_%28music%29
p5562
aasg18
(lp5563
Vsympathetic
p5564
aVparasympathetic
p5565
aVequal; neither dominant
p5566
asg24
(lp5567
Vhttp://dbpedia.org/resource/Dominant_%28music%29
p5568
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p5569
aVhttp://dbpedia.org/resource/Tone_%28linguistics%29
p5570
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions5/questionset5.htm'
p5571
sg31
S'Dominant autonomic tone in vascular smooth muscle:'
p5572
sg33
I6
sg34
S'Q46#9'
p5573
sg36
I7
sg37
S'9'
sg38
I0
sg39
S'46'
p5574
sa(dp5575
g3
(lp5576
(lp5577
Vhttp://dbpedia.org/resource/Redox
p5578
aVhttp://dbpedia.org/resource/Cardiac_output
p5579
aa(lp5580
Vhttp://dbpedia.org/resource/Renal_failure
p5581
aasg18
(lp5582
Vreduced cardiac output
p5583
aVrenal failure
p5584
aVinadequate oxygenation
p5585
aVmicrocirculatory failure
p5586
asg24
(lp5587
Vhttp://dbpedia.org/resource/Shock_%28circulatory%29
p5588
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions5/questionset5.htm'
p5589
sg31
S'Most critical failure in shock:'
p5590
sg33
I9
sg34
S'Q46#13'
p5591
sg36
I5
sg37
S'13'
p5592
sg38
I3
sg39
S'46'
p5593
sa(dp5594
g3
(lp5595
(lp5596
Vhttp://dbpedia.org/resource/Angina_pectoris
p5597
aa(lp5598
Vhttp://dbpedia.org/resource/Pulmonary_hypertension
p5599
aa(lp5600
Vhttp://dbpedia.org/resource/Dyspnea
p5601
aasg18
(lp5602
Vperipheral edema
p5603
aVangina
p5604
aVpulmonary hypertension
p5605
aVdyspnea
p5606
asg24
(lp5607
Vhttp://dbpedia.org/resource/Symptom
p5608
aVhttp://dbpedia.org/resource/Heart_failure
p5609
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5610
sg31
S'Most common symptom of heart failure:'
p5611
sg33
I6
sg34
S'Q47#0'
p5612
sg36
I6
sg37
S'0'
sg38
I3
sg39
S'47'
p5613
sa(dp5614
g3
(lp5615
(lp5616
Vhttp://dbpedia.org/resource/Nocturnality
p5617
aVhttp://dbpedia.org/resource/Dyspnea
p5618
aasg18
(lp5619
Vorthopnea
p5620
aVparoxysmal (nocturnal) dyspnea
p5621
aVcardiac dyspnea
p5622
asg24
(lp5623
Vhttp://dbpedia.org/resource/Dyspnea
p5624
aVhttp://dbpedia.org/resource/Cough
p5625
aVhttp://dbpedia.org/resource/Bodhi
p5626
aVhttp://dbpedia.org/resource/Patient
p5627
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5628
sg31
S'Sudden onset of severe shortness of breath and coughing, awakening the patient:'
p5629
sg33
I8
sg34
S'Q47#2'
p5630
sg36
I13
sg37
S'2'
sg38
I1
sg39
S'47'
p5631
sa(dp5632
g3
(lp5633
(lp5634
Vhttp://dbpedia.org/resource/ATPase
p5635
aVhttp://dbpedia.org/resource/Binding_energy
p5636
aa(lp5637
Vhttp://dbpedia.org/resource/Pharmacokinetics
p5638
aVhttp://dbpedia.org/resource/Behavior
p5639
aasg18
(lp5640
Vprimarily affects Na/K ATPase binding
p5641
aVprimarily affects pharmacokinetic behavior
p5642
aVaffects both
p5643
aVaffects neither
p5644
asg24
(lp5645
Vhttp://dbpedia.org/resource/Digitalis
p5646
aVhttp://dbpedia.org/resource/Glycoside
p5647
aVhttp://dbpedia.org/resource/Functional_group
p5648
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5649
sg31
S'Concerning digitalis glycosides:removal of glycoside moiety --'
p5650
sg33
I13
sg34
S'Q47#5'
p5651
sg36
I9
sg37
S'5'
sg38
I1
sg39
S'47'
p5652
sa(dp5653
g3
(lp5654
(lp5655
Vhttp://dbpedia.org/resource/City_block
p5656
aVhttp://dbpedia.org/resource/Adrenergic
p5657
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p5658
aa(lp5659
Vhttp://dbpedia.org/resource/Cardiac_muscle
p5660
aVhttp://dbpedia.org/resource/Leukotriene
p5661
aa(lp5662
Vhttp://dbpedia.org/resource/ATPase
p5663
aa(lp5664
Vhttp://dbpedia.org/resource/Calcium_in_biology
p5665
aVhttp://dbpedia.org/resource/Transport
p5666
aasg18
(lp5667
Vblocks beta-adrenergic receptors
p5668
aVactivates myocardial leukotrienes
p5669
aVinhibits Na/K ATPase
p5670
aVinhibits calcium transport
p5671
aVincreases circulating endothelin I
p5672
asg24
(lp5673
Vhttp://dbpedia.org/resource/Mechanism_of_action
p5674
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5675
sg31
S'Cardiac glycosides: principal mechanism of action --'
p5676
sg33
I16
sg34
S'Q47#7'
p5677
sg36
I8
sg37
S'7'
sg38
I2
sg39
S'47'
p5678
sa(dp5679
g3
(lp5680
(lp5681
Vhttp://dbpedia.org/resource/Benefit_concert
p5682
aVhttp://dbpedia.org/resource/Redox
p5683
aVhttp://dbpedia.org/resource/Angiotensin
p5684
aVhttp://dbpedia.org/resource/GCE_Advanced_Level
p5685
aa(lp5686
Vhttp://dbpedia.org/resource/Contraindication
p5687
aVhttp://dbpedia.org/resource/Diabetes_mellitus
p5688
aVhttp://dbpedia.org/resource/Patient
p5689
aa(lp5690
Vhttp://dbpedia.org/resource/Contraindication
p5691
aVhttp://dbpedia.org/resource/Hypertension
p5692
aVhttp://dbpedia.org/resource/Patient
p5693
aVhttp://dbpedia.org/resource/Hypertrophy
p5694
aVhttp://dbpedia.org/resource/Left-wing_politics
p5695
aVhttp://dbpedia.org/resource/Ventricular_system
p5696
aa(lp5697
Vhttp://dbpedia.org/resource/Efficacy
p5698
aVhttp://dbpedia.org/resource/Diuretic
p5699
aVhttp://dbpedia.org/resource/Higher_%28Scottish%29
p5700
aVhttp://dbpedia.org/resource/Diuretic
p5701
aasg18
(lp5702
Vbenefits due to reduction in circulating angiotensin II levels
p5703
aVcontraindicated in diabetic patients
p5704
aVcontraindicated in hypertensive patients with hypertrophic left ventricles
p5705
aVreduces efficacy of diuretic treatment requiring higher diuretic dosages
p5706
asg24
(lp5707
Vhttp://dbpedia.org/resource/ACE_inhibitor
p5708
aVhttp://dbpedia.org/resource/Heart_disease
p5709
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5710
sg31
S'Concerning the use of ACE inhibitors in heart disease:'
p5711
sg33
I30
sg34
S'Q47#14'
p5712
sg36
I9
sg37
S'14'
p5713
sg38
I0
sg39
S'47'
p5714
sa(dp5715
g3
(lp5716
(lp5717
Vhttp://dbpedia.org/resource/Distal_convoluted_tubule
p5718
aasg18
(lp5719
Vproximal tubule
p5720
aVdistal  tubule
p5721
aVdescending limb -- loop of Henle
p5722
aVthick ascending limb -- loop of Henle
p5723
asg24
(lp5724
Vhttp://dbpedia.org/resource/Ribosome
p5725
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5726
sg31
S'Site of action torsemide:'
p5727
sg33
I17
sg34
S'Q47#16'
p5728
sg36
I4
sg37
S'16'
p5729
sg38
I3
sg39
S'47'
p5730
sa(dp5731
g3
(lp5732
(lp5733
Vhttp://dbpedia.org/resource/Percentage
p5734
aa(lp5735
Vhttp://dbpedia.org/resource/Percentage
p5736
aa(lp5737
Vhttp://dbpedia.org/resource/Percentage
p5738
aasg18
(lp5739
Vfive percent
p5740
aVten percent
p5741
aV25 percent
p5742
aVfifty percent
p5743
aV90 percent
p5744
asg24
(lp5745
Vhttp://dbpedia.org/resource/Fraction_%28mathematics%29
p5746
aVhttp://dbpedia.org/resource/Filtration
p5747
aVhttp://dbpedia.org/resource/Load_Records
p5748
asg29
S'http://www.pharmacology2000.com/Cardio/CHF/questions6/questionset6.htm'
p5749
sg31
S'Fraction of filtered solute load reabsorbed by thick ascending limb of loop of Henle:'
p5750
sg33
I10
sg34
S'Q47#17'
p5751
sg36
I14
sg37
S'17'
p5752
sg38
I2
sg39
S'47'
p5753
sa(dp5754
g3
(lp5755
(lp5756
Vhttp://dbpedia.org/resource/Hyperlipidemia
p5757
aa(lp5758
Vhttp://dbpedia.org/resource/Ligand
p5759
aa(lp5760
Vhttp://dbpedia.org/resource/Cofactor_%28biochemistry%29
p5761
aasg18
(lp5762
Vfamilial combined hyperlipoproteinemia
p5763
aVfamilial ligand-defective ApoB
p5764
aVfamilial lipoprotein lipase or cofactor deficiency
p5765
aVfamilial dysbetalipoproteinemia
p5766
asg24
(lp5767
Vhttp://dbpedia.org/resource/Acute_pancreatitis
p5768
aVhttp://dbpedia.org/resource/Symptom
p5769
aVhttp://dbpedia.org/resource/Lipoprotein
p5770
aVhttp://dbpedia.org/resource/Disease
p5771
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question1/questionset1.htm'
p5772
sg31
S'An attack of acute pancreatitis is likely to be the first presenting symptom of this lipoprotein disorder:'
p5773
sg33
I14
sg34
S'Q48#0'
p5774
sg36
I17
sg37
S'0'
sg38
I2
sg39
S'48'
p5775
sa(dp5776
g3
(lp5777
(lp5778
Vhttp://dbpedia.org/resource/Diabetes_mellitus
p5779
aa(lp5780
Vhttp://dbpedia.org/resource/Alcohol
p5781
aVhttp://dbpedia.org/resource/Ingestion
p5782
aa(lp5783
Vhttp://dbpedia.org/resource/Estrogen
p5784
aasg18
(lp5785
Vdiabetes mellitus
p5786
aValcohol ingestion
p5787
aVcholestasis
p5788
aVlipodystrophy
p5789
aVthe estrogens
p5790
asg24
(lp5791
Vhttp://dbpedia.org/resource/Secondary_school
p5792
aVhttp://dbpedia.org/resource/Hypercholesterolemia
p5793
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question1/questionset1.htm'
p5794
sg31
S'Secondary cause of hypercholesterolemia:'
p5795
sg33
I8
sg34
S'Q48#1'
p5796
sg36
I4
sg37
S'1'
sg38
I2
sg39
S'48'
p5797
sa(dp5798
g3
(lp5799
(lp5800
Vhttp://dbpedia.org/resource/Diet_%28nutrition%29
p5801
aa(lp5802
Vhttp://dbpedia.org/resource/Bile_acid
p5803
aVhttp://dbpedia.org/resource/Presence_information
p5804
aVhttp://dbpedia.org/resource/Niacin
p5805
aasg18
(lp5806
Vdiet
p5807
aVgemfibrozil (Lopid)
p5808
aVbile acid-binding presence with niacin
p5809
asg24
(lp5810
Vhttp://dbpedia.org/resource/Hyperlipidemia
p5811
aVhttp://dbpedia.org/resource/Chronic_%28medicine%29
p5812
aVhttp://dbpedia.org/resource/Nephrotic_syndrome
p5813
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question1/questionset1.htm'
p5814
sg31
S'Treatment of choice for hyperlipidemia associated with chronic nephrotic syndrome:'
p5815
sg33
I10
sg34
S'Q48#6'
p5816
sg36
I10
sg37
S'6'
sg38
I2
sg39
S'48'
p5817
sa(dp5818
g3
(lp5819
(lp5820
Vhttp://dbpedia.org/resource/Niacin
p5821
aVhttp://dbpedia.org/resource/Niacin
p5822
aasg18
(lp5823
Vgemfibrozil (Lopid)
p5824
aVniacin (vitamin B3)
p5825
aVcholestyramine (Questran, Questran Light)
p5826
aVclofibrate (Abitrate, Atromid-S)
p5827
aVlovastatin (Mevacor)
p5828
asg24
(lp5829
Vhttp://dbpedia.org/resource/Lipid
p5830
aVhttp://dbpedia.org/resource/Drug
p5831
aVhttp://dbpedia.org/resource/Skin
p5832
aVhttp://dbpedia.org/resource/Vasodilation
p5833
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p5834
aVhttp://dbpedia.org/resource/Drug
p5835
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question1/questionset1.htm'
p5836
sg31
S'Anti-lipid drug that usually causes cutaneous vasodilation after each dose when the drug is started'
p5837
sg33
I26
sg34
S'Q48#7'
p5838
sg36
I15
sg37
S'7'
sg38
I1
sg39
S'48'
p5839
sa(dp5840
g3
(lp5841
(lp5842
Vhttp://dbpedia.org/resource/Niacin
p5843
aVhttp://dbpedia.org/resource/Niacin
p5844
aasg18
(lp5845
Vpravastatin (Pravachol)
p5846
aVniacin (vitamin B3)
p5847
aVgemfibrozil (Lopid)
p5848
aVcholestyramine (Questran, Questran Light)
p5849
asg24
(lp5850
Vhttp://dbpedia.org/resource/Constipation
p5851
aVhttp://dbpedia.org/resource/Bloating
p5852
aVhttp://dbpedia.org/resource/Sensationalism
p5853
aVhttp://dbpedia.org/resource/Drug
p5854
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question2/questionset2.htm'
p5855
sg31
S'Constipation and a bloating sensation -- most common complaints of this antilipidemic drug:'
p5856
sg33
I20
sg34
S'Q49#0'
p5857
sg36
I13
sg37
S'0'
sg38
I3
sg39
S'49'
p5858
sa(dp5859
g3
(lp5860
(lp5861
Vhttp://dbpedia.org/resource/Light
p5862
aa(lp5863
Vhttp://dbpedia.org/resource/Niacin
p5864
aVhttp://dbpedia.org/resource/Niacin
p5865
aasg18
(lp5866
Vcholestyramine (Questran, Questran Light)
p5867
aVgemfibrozil (Lopid)
p5868
aVpravastatin (Pravachol)
p5869
aVniacin (vitamin B3)
p5870
asg24
(lp5871
Vhttp://dbpedia.org/resource/Pharmaceutical_drug
p5872
aVhttp://dbpedia.org/resource/Structural_analog
p5873
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question2/questionset2.htm'
p5874
sg31
S'Antilipid medication -- structural analog of HMG-CoA intermediate'
p5875
sg33
I20
sg34
S'Q49#1'
p5876
sg36
I8
sg37
S'1'
sg38
I2
sg39
S'49'
p5877
sa(dp5878
g3
(lp5879
(lp5880
Vhttp://dbpedia.org/resource/Bile_acid
p5881
aVhttp://dbpedia.org/resource/Binding_energy
p5882
aVhttp://dbpedia.org/resource/Resin
p5883
aa(lp5884
Vhttp://dbpedia.org/resource/Niacin
p5885
aasg18
(lp5886
Vbile acid-binding resins
p5887
aVreductase inhibitors
p5888
aVnicotinic acid
p5889
asg24
(lp5890
Vhttp://dbpedia.org/resource/Drug
p5891
aVhttp://dbpedia.org/resource/Patient
p5892
aVhttp://dbpedia.org/resource/Rhabdomyolysis
p5893
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question2/questionset2.htm'
p5894
sg31
S'Drugs of this antilipidemic class may cause in a few patients rhabdomyolysis and myoglobinuria:'
p5895
sg33
I7
sg34
S'Q49#2'
p5896
sg36
I14
sg37
S'2'
sg38
I1
sg39
S'49'
p5897
sa(dp5898
g3
(lp5899
(lp5900
Vhttp://dbpedia.org/resource/Niacin
p5901
aVhttp://dbpedia.org/resource/Niacin
p5902
aasg18
(lp5903
Vniacin (vitamin B3)
p5904
aVcolestipol (Colestid)
p5905
aVpravastatin (Pravachol)
p5906
aVclofibrate (Abitrate, Atromid-S)
p5907
asg24
(lp5908
Vhttp://dbpedia.org/resource/Polymer
p5909
aVhttp://dbpedia.org/resource/Resin
p5910
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question2/questionset2.htm'
p5911
sg31
S'Very large polymeric cationic exchange resins:'
p5912
sg33
I19
sg34
S'Q49#3'
p5913
sg36
I6
sg37
S'3'
sg38
I1
sg39
S'49'
p5914
sa(dp5915
g3
(lp5916
sg18
(lp5917
Vclofibrate (Abitrate, Atromid-S)
p5918
aVgemfibrozil (Lopid)
p5919
aVcholestyramine (Questran, Questran Light)
p5920
aVpravastatin (Pravachol)
p5921
asg24
(lp5922
Vhttp://dbpedia.org/resource/Blood_serum
p5923
aVhttp://dbpedia.org/resource/Digoxin
p5924
aVhttp://dbpedia.org/resource/Digoxin
p5925
aVhttp://dbpedia.org/resource/Blood_serum
p5926
aVhttp://dbpedia.org/resource/Vancomycin
p5927
aVhttp://dbpedia.org/resource/Vancomycin
p5928
asg29
S'http://www.pharmacology2000.com/Cardio/hypo/question2/questionset2.htm'
p5929
sg31
S'Antilipidemic drug most likely to reduce serum digoxin (Lanoxin, Lanoxicaps) levels, serum vancomycin (Vancocin) levels, and thiazide levels:'
p5930
sg33
I21
sg34
S'Q49#4'
p5931
sg36
I25
sg37
S'4'
sg38
I2
sg39
S'49'
p5932
sa(dp5933
g3
(lp5934
(lp5935
Vhttp://dbpedia.org/resource/Norepinephrine
p5936
aa(lp5937
Vhttp://dbpedia.org/resource/Cholinergic
p5938
aa(lp5939
Vhttp://dbpedia.org/resource/Glycine
p5940
aVhttp://dbpedia.org/resource/System
p5941
aasg18
(lp5942
Vnoradrenergic
p5943
aVGABA system
p5944
aVcholinergic
p5945
aVglycine system
p5946
asg24
(lp5947
Vhttp://dbpedia.org/resource/Benzodiazepine
p5948
aVhttp://dbpedia.org/resource/Pharmacology
p5949
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p5950
sg31
S'Benzodiazepine pharmacology is most closely linked to which neurotransmitter system?'
p5951
sg33
I6
sg34
S'Q50#0'
p5952
sg36
I11
sg37
S'0'
sg38
I1
sg39
S'50'
p5953
sa(dp5954
g3
(lp5955
(lp5956
Vhttp://dbpedia.org/resource/Diazepam
p5957
aVhttp://dbpedia.org/resource/Diazepam
p5958
aa(lp5959
Vhttp://dbpedia.org/resource/Triazolam
p5960
aVhttp://dbpedia.org/resource/Triazolam
p5961
aa(lp5962
Vhttp://dbpedia.org/resource/Phenobarbital
p5963
aasg18
(lp5964
Vdiazepam (Valium)
p5965
aVbuspirone (BuSpar)
p5966
aVtriazolam (Halcion)
p5967
aVphenobarbital
p5968
asg24
(lp5969
Vhttp://dbpedia.org/resource/Anxiolytic
p5970
aVhttp://dbpedia.org/resource/Drug
p5971
aVhttp://dbpedia.org/resource/Acting_%28law%29
p5972
aVhttp://dbpedia.org/resource/5-HT_receptor
p5973
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p5974
sg31
S'Anxiolytic drug acting through serotonin receptors:'
p5975
sg33
I13
sg34
S'Q50#1'
p5976
sg36
I6
sg37
S'1'
sg38
I1
sg39
S'50'
p5977
sa(dp5978
g3
(lp5979
(lp5980
Vhttp://dbpedia.org/resource/Sedative
p5981
aVhttp://dbpedia.org/resource/Benzodiazepine
p5982
aa(lp5983
Vhttp://dbpedia.org/resource/Management
p5984
aVhttp://dbpedia.org/resource/Benzodiazepine_withdrawal_syndrome
p5985
aVhttp://dbpedia.org/resource/Drug
p5986
aVhttp://dbpedia.org/resource/Haloperidol
p5987
aa(lp5988
Vhttp://dbpedia.org/resource/Management
p5989
aVhttp://dbpedia.org/resource/Withdrawal
p5990
aasg18
(lp5991
VBuspirone (BuSpar) dosage too low.
p5992
aVBuspirone (BuSpar) does not exhibit cross-tolerance with sedative-hypnotic/benzodiazepines.
p5993
aVManagement of alcohol or benzodiazepine withdrawal must be managed with a stronger drug, such as haloperidol.
p5994
aVBuspirone (BuSpar) is too rapidly inactivated (first-pass effect) to be useful in managing withdrawal.
p5995
asg24
(lp5996
Vhttp://dbpedia.org/resource/Chronic_%28medicine%29
p5997
aVhttp://dbpedia.org/resource/Diazepam
p5998
aVhttp://dbpedia.org/resource/Abuse
p5999
aVhttp://dbpedia.org/resource/Management
p6000
aVhttp://dbpedia.org/resource/Withdrawal
p6001
aVhttp://dbpedia.org/resource/Anxiolytic
p6002
aVhttp://dbpedia.org/resource/Withdrawal
p6003
aVhttp://dbpedia.org/resource/Symptom
p6004
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6005
sg31
S'A chronic alcohol and diazepam abuser is hospitalized for management of withdrawal symptoms. Buspirone, an anxiolytic, is administered to alleviate withdrawal, but the symptoms continue and worsen. Why?'
p6006
sg33
I53
sg34
S'Q50#3'
p6007
sg36
I32
sg37
S'3'
sg38
I1
sg39
S'50'
p6008
sa(dp6009
g3
(lp6010
(lp6011
Vhttp://dbpedia.org/resource/Diazepam
p6012
aVhttp://dbpedia.org/resource/Diazepam
p6013
aa(lp6014
Vhttp://dbpedia.org/resource/Triazolam
p6015
aVhttp://dbpedia.org/resource/Triazolam
p6016
aasg18
(lp6017
Vdiazepam (Valium)
p6018
aVflurazepam (Dalmane)
p6019
aVtriazolam (Halcion)
p6020
aVbuspirone (BuSpar)
p6021
asg24
(lp6022
Vhttp://dbpedia.org/resource/Acting_%28law%29
p6023
aVhttp://dbpedia.org/resource/Benzodiazepine
p6024
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6025
sg31
S'Short-acting benzodiazepine'
p6026
sg33
I16
sg34
S'Q50#4'
p6027
sg36
I2
sg37
S'4'
sg38
I2
sg39
S'50'
p6028
sa(dp6029
g3
(lp6030
(lp6031
Vhttp://dbpedia.org/resource/Lorazepam
p6032
aVhttp://dbpedia.org/resource/Lorazepam
p6033
aVhttp://dbpedia.org/resource/Long_%28finance%29
p6034
aVhttp://dbpedia.org/resource/Acting
p6035
aVhttp://dbpedia.org/resource/Metabolite
p6036
aa(lp6037
Vhttp://dbpedia.org/resource/Long_%28finance%29
p6038
aVhttp://dbpedia.org/resource/Acting
p6039
aVhttp://dbpedia.org/resource/Metabolite
p6040
aa(lp6041
Vhttp://dbpedia.org/resource/Limited_company
p6042
aVhttp://dbpedia.org/resource/Substance_abuse
p6043
aasg18
(lp6044
VLorazepam (Ativan) because of first-pass effects and because it lacks long-acting metabolites.
p6045
aVOxazepam (Serax) since it has no long-acting metabolites and is conjugated to an inactive glucuronide directly.
p6046
aVBuspirone (BuSpar) since it has limited abuse potential
p6047
asg24
(lp6048
Vhttp://dbpedia.org/resource/Benzodiazepine
p6049
aVhttp://dbpedia.org/resource/Patient
p6050
aVhttp://dbpedia.org/resource/Disability
p6051
aVhttp://dbpedia.org/resource/Liver
p6052
aVhttp://dbpedia.org/resource/Function_%28mathematics%29
p6053
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6054
sg31
S'Benzodiazepine most appropriate in patients with impaired hepatic function:'
p6055
sg33
I42
sg34
S'Q50#5'
p6056
sg36
I9
sg37
S'5'
sg38
I1
sg39
S'50'
p6057
sa(dp6058
g3
(lp6059
(lp6060
Vhttp://dbpedia.org/resource/Sodium
p6061
aa(lp6062
Vhttp://dbpedia.org/resource/Calcium
p6063
aa(lp6064
Vhttp://dbpedia.org/resource/Chloride
p6065
aa(lp6066
Vhttp://dbpedia.org/resource/Potassium
p6067
aasg18
(lp6068
Vsodium
p6069
aVcalcium
p6070
aVchloride
p6071
aVpotassium
p6072
asg24
(lp6073
Vhttp://dbpedia.org/resource/Ion_channel
p6074
aVhttp://dbpedia.org/resource/GABAA_receptor
p6075
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6076
sg31
S'Ion channel that contains the GABA receptor:'
p6077
sg33
I4
sg34
S'Q50#8'
p6078
sg36
I7
sg37
S'8'
sg38
I2
sg39
S'50'
p6079
sa(dp6080
g3
(lp6081
(lp6082
Vhttp://dbpedia.org/resource/Muscle_relaxant
p6083
aa(lp6084
Vhttp://dbpedia.org/resource/Minimalism
p6085
aVhttp://dbpedia.org/resource/Hypnotic
p6086
aVhttp://dbpedia.org/resource/Property
p6087
aa(lp6088
Vhttp://dbpedia.org/resource/Long_%28finance%29
p6089
aVhttp://dbpedia.org/resource/Duration_%28music%29
p6090
aVhttp://dbpedia.org/resource/Action_%28physics%29
p6091
aasg18
(lp6092
Vantagonized by flumazenil (Romazicon)
p6093
aVmuscle relaxation
p6094
aVminimal hypnotic properties
p6095
aVLong duration of action
p6096
asg24
(lp6097
Vhttp://dbpedia.org/resource/Zolpidem
p6098
aVhttp://dbpedia.org/resource/Zolpidem
p6099
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6100
sg31
S'Zolpidem (Ambien):'
p6101
sg33
I15
sg34
S'Q50#9'
p6102
sg36
I5
sg37
S'9'
sg38
I0
sg39
S'50'
p6103
sa(dp6104
g3
(lp6105
(lp6106
Vhttp://dbpedia.org/resource/Propranolol
p6107
aVhttp://dbpedia.org/resource/Propranolol
p6108
aa(lp6109
Vhttp://dbpedia.org/resource/Phenobarbital
p6110
aVhttp://dbpedia.org/resource/Phenobarbital
p6111
aasg18
(lp6112
Vpropranolol (Inderal)
p6113
aVbuspirone (BuSpar)
p6114
aVphenobarbital (Luminal)
p6115
aVall  of the above
p6116
asg24
(lp6117
Vhttp://dbpedia.org/resource/Anxiolytic
p6118
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6119
sg31
S'Antianxiety drug(s)'
p6120
sg33
I16
sg34
S'Q50#12'
p6121
sg36
I5
sg37
S'12'
p6122
sg38
I3
sg39
S'50'
p6123
sa(dp6124
g3
(lp6125
(lp6126
Vhttp://dbpedia.org/resource/Amphetamine
p6127
aa(lp6128
Vhttp://dbpedia.org/resource/Naltrexone
p6129
aVhttp://dbpedia.org/resource/Naltrexone
p6130
aasg18
(lp6131
Vamphetamine
p6132
aVbuspirone (BuSpar)
p6133
aVflumazenil (Romazicon)
p6134
aVnaltrexone (ReVia)
p6135
asg24
(lp6136
Vhttp://dbpedia.org/resource/Symptom
p6137
aVhttp://dbpedia.org/resource/Benzodiazepine
p6138
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6139
sg31
S'Most useful in reversing symptoms of benzodiazepine overdosage:'
p6140
sg33
I13
sg34
S'Q50#14'
p6141
sg36
I8
sg37
S'14'
p6142
sg38
I2
sg39
S'50'
p6143
sa(dp6144
g3
(lp6145
(lp6146
Vhttp://dbpedia.org/resource/Diazepam
p6147
aVhttp://dbpedia.org/resource/Diazepam
p6148
aa(lp6149
Vhttp://dbpedia.org/resource/Phenobarbital
p6150
aVhttp://dbpedia.org/resource/Phenobarbital
p6151
aa(lp6152
Vhttp://dbpedia.org/resource/Clonazepam
p6153
aVhttp://dbpedia.org/resource/Clonazepam
p6154
aasg18
(lp6155
Vdiazepam (Valium)
p6156
aVphenobarbital (Luminal)
p6157
aVclonazepam (Klonopin)
p6158
aVbuspirone (BuSpar)
p6159
asg24
(lp6160
Vhttp://dbpedia.org/resource/Contraindication
p6161
aVhttp://dbpedia.org/resource/Patient
p6162
aVhttp://dbpedia.org/resource/Medical_history
p6163
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6164
sg31
S'Contraindicated in patients with a history of acute intermittent porphyria:'
p6165
sg33
I16
sg34
S'Q50#16'
p6166
sg36
I10
sg37
S'16'
p6167
sg38
I1
sg39
S'50'
p6168
sa(dp6169
g3
(lp6170
(lp6171
Vhttp://dbpedia.org/resource/Diazepam
p6172
aVhttp://dbpedia.org/resource/Diazepam
p6173
aa(lp6174
Vhttp://dbpedia.org/resource/Triazolam
p6175
aVhttp://dbpedia.org/resource/Triazolam
p6176
aasg18
(lp6177
Vdiazepam (Valium)
p6178
aVbuspirone (BuSpar)
p6179
aVtriazolam (Halcion)
p6180
aVflumazenil (Romazicon)
p6181
asg24
(lp6182
Vhttp://dbpedia.org/resource/Pupil
p6183
aVhttp://dbpedia.org/resource/Constriction
p6184
asg29
S'http://www.pharmacology2000.com/Central/sedhyp/questions2/sedhyp1.htm'
p6185
sg31
S'Pupillary constriction:'
p6186
sg33
I16
sg34
S'Q50#17'
p6187
sg36
I2
sg37
S'17'
p6188
sg38
I1
sg39
S'50'
p6189
sa(dp6190
g3
(lp6191
(lp6192
Vhttp://dbpedia.org/resource/Morphine
p6193
aa(lp6194
Vhttp://dbpedia.org/resource/Pethidine
p6195
aVhttp://dbpedia.org/resource/Pethidine
p6196
aa(lp6197
Vhttp://dbpedia.org/resource/Pentazocine
p6198
aa(lp6199
Vhttp://dbpedia.org/resource/Oxycodone
p6200
aVhttp://dbpedia.org/resource/Oxycodone
p6201
aasg18
(lp6202
Vmorphine
p6203
aVmeperidine (Demerol)
p6204
aVpentazocine (Talwain)
p6205
aVoxycodone (Roxicodone)
p6206
asg24
(lp6207
Vhttp://dbpedia.org/resource/Opioid
p6208
aVhttp://dbpedia.org/resource/Agonist
p6209
aVhttp://dbpedia.org/resource/Receptor_antagonist
p6210
asg29
S'http://www.pharmacology2000.com/Central/Opioid/questions2/opi1.htm'
p6211
sg31
S'An opioid with both agonist and antagonist properties:'
p6212
sg33
I13
sg34
S'Q54#0'
p6213
sg36
I8
sg37
S'0'
sg38
I2
sg39
S'54'
p6214
sa(dp6215
g3
(lp6216
(lp6217
Vhttp://dbpedia.org/resource/Convulsion
p6218
aa(lp6219
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p6220
aasg18
(lp6221
Vcardiac arrhythmias
p6222
aVrespiratory depression
p6223
aVconvulsions
p6224
aVendogenous depression
p6225
asg24
(lp6226
Vhttp://dbpedia.org/resource/Narcotic
p6227
aVhttp://dbpedia.org/resource/Agonist
p6228
aVhttp://dbpedia.org/resource/Adverse_effect
p6229
asg29
S'http://www.pharmacology2000.com/Central/Opioid/questions2/opi1.htm'
p6230
sg31
S'Narcotic agonists: most serious adverse effect:'
p6231
sg33
I7
sg34
S'Q54#4'
p6232
sg36
I7
sg37
S'4'
sg38
I1
sg39
S'54'
p6233
sa(dp6234
g3
(lp6235
(lp6236
Vhttp://dbpedia.org/resource/Morphine
p6237
aa(lp6238
Vhttp://dbpedia.org/resource/Fentanyl
p6239
aVhttp://dbpedia.org/resource/Fentanyl
p6240
aa(lp6241
Vhttp://dbpedia.org/resource/Codeine
p6242
aa(lp6243
Vhttp://dbpedia.org/resource/Naloxone
p6244
aVhttp://dbpedia.org/resource/Naloxone
p6245
aa(lp6246
Vhttp://dbpedia.org/resource/Pethidine
p6247
aVhttp://dbpedia.org/resource/Pethidine
p6248
aasg18
(lp6249
Vmorphine
p6250
aVfentanyl (Sublimaze)
p6251
aVcodeine
p6252
aVnaloxone (Narcan)
p6253
aVmeperidine (Demerol) 
p6254
asg24
(lp6255
Vhttp://dbpedia.org/resource/Principal_%28academia%29
p6256
aVhttp://dbpedia.org/resource/Alkaloid
p6257
aVhttp://dbpedia.org/resource/Opium_poppy
p6258
aVhttp://dbpedia.org/resource/Opium_poppy
p6259
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6260
sg31
S'Principal alkaloid in opium (derived from opium poppy)'
p6261
sg33
I14
sg34
S'Q55#1'
p6262
sg36
I10
sg37
S'1'
sg38
I0
sg39
S'55'
p6263
sa(dp6264
g3
(lp6265
(lp6266
Vhttp://dbpedia.org/resource/Agonist
p6267
aa(lp6268
Vhttp://dbpedia.org/resource/Receptor_antagonist
p6269
aa(lp6270
Vhttp://dbpedia.org/resource/Mixed_media
p6271
aVhttp://dbpedia.org/resource/Agonist
p6272
aVhttp://dbpedia.org/resource/Receptor_antagonist
p6273
aa(lp6274
Vhttp://dbpedia.org/resource/Endorphin
p6275
aasg18
(lp6276
Vfull agonist
p6277
aVpure antagonist
p6278
aVmixed agonist-antagonist
p6279
aVendorphin
p6280
aVdynorphins
p6281
asg24
(lp6282
Vhttp://dbpedia.org/resource/Descriptive_statistics
p6283
aVhttp://dbpedia.org/resource/Drug
p6284
aVhttp://dbpedia.org/resource/Agonist
p6285
aVhttp://dbpedia.org/resource/Opioid_receptor
p6286
aVhttp://dbpedia.org/resource/Ribosome
p6287
aVhttp://dbpedia.org/resource/Receptor_antagonist
p6288
aVhttp://dbpedia.org/resource/Opioid_receptor
p6289
aVhttp://dbpedia.org/resource/Ribosome
p6290
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6291
sg31
S'Descriptive of the drug that may have an agonist effect at one opioid receptor site and an antagonist effect at another opioid receptor site.'
p6292
sg33
I8
sg34
S'Q55#2'
p6293
sg36
I25
sg37
S'2'
sg38
I2
sg39
S'55'
p6294
sa(dp6295
g3
(lp6296
sg18
(lp6297
Vpreproenkephalin (proenkephalin A)
p6298
aVprepro-opiomelanocortin (POMC)
p6299
aVpreprodynorphin (proenkephalin B)
p6300
asg24
(lp6301
Vhttp://dbpedia.org/resource/Opioid
p6302
aVhttp://dbpedia.org/resource/Precursor_%28chemistry%29
p6303
aVhttp://dbpedia.org/resource/Sequence_%28biology%29
p6304
aVhttp://dbpedia.org/resource/Endorphin
p6305
aVhttp://dbpedia.org/resource/Peptide
p6306
aVhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p6307
aVhttp://dbpedia.org/resource/Beta_cell
p6308
aVhttp://dbpedia.org/resource/Melanocyte-stimulating_hormone
p6309
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6310
sg31
S'Endogenous opioid precursor that contains the met-enkephalin sequence, beta-endorphins, and several nonopioid peptides including ACTH, beta-lipotropin, and melanocyte-stimulating hormone.'
p6311
sg33
I14
sg34
S'Q55#3'
p6312
sg36
I24
sg37
S'3'
sg38
I1
sg39
S'55'
p6313
sa(dp6314
g3
(lp6315
(lp6316
Vhttp://dbpedia.org/resource/Fat
p6317
aa(lp6318
Vhttp://dbpedia.org/resource/Spleen
p6319
aa(lp6320
Vhttp://dbpedia.org/resource/Liver
p6321
aa(lp6322
Vhttp://dbpedia.org/resource/Lung
p6323
aasg18
(lp6324
Vfat
p6325
aVskeletal muscle
p6326
aVspleen
p6327
aVliver
p6328
aVlungs
p6329
asg24
(lp6330
Vhttp://dbpedia.org/resource/Main_%28river%29
p6331
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p6332
aVhttp://dbpedia.org/resource/Reservoir,_Victoria
p6333
aVhttp://dbpedia.org/resource/Opioid
p6334
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6335
sg31
S'Main tissue reservoir for opioids:'
p6336
sg33
I6
sg34
S'Q55#4'
p6337
sg36
I5
sg37
S'4'
sg38
I1
sg39
S'55'
p6338
sa(dp6339
g3
(lp6340
(lp6341
Vhttp://dbpedia.org/resource/Delta_%28letter%29
p6342
aasg18
(lp6343
VKappa
p6344
aVDelta
p6345
aVMu
p6346
asg24
(lp6347
Vhttp://dbpedia.org/resource/Analgesic
p6348
aVhttp://dbpedia.org/resource/Euphoria
p6349
aVhttp://dbpedia.org/resource/Morphine
p6350
aVhttp://dbpedia.org/resource/Opioid_receptor
p6351
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6352
sg31
S'Analgesia, euphoria, respiratory depression associated with morphine are probably mediated mainly through this opioid receptor type:'
p6353
sg33
I3
sg34
S'Q55#9'
p6354
sg36
I18
sg37
S'9'
sg38
I2
sg39
S'55'
p6355
sa(dp6356
g3
(lp6357
(lp6358
Vhttp://dbpedia.org/resource/Redox
p6359
aVhttp://dbpedia.org/resource/Patient
p6360
aa(lp6361
Vhttp://dbpedia.org/resource/Carbon_dioxide
p6362
aa(lp6363
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p6364
aVhttp://dbpedia.org/resource/Patient
p6365
aVhttp://dbpedia.org/resource/Carbon_dioxide
p6366
aa(lp6367
Vhttp://dbpedia.org/resource/Alkaline_phosphatase
p6368
aa(lp6369
Vhttp://dbpedia.org/resource/Creatinine
p6370
aasg18
(lp6371
Vreduced patient responsiveness
p6372
aValveolar PCO2 increased
p6373
aVdepressed patient response to a carbon dioxide challenge
p6374
aVincreased levels of alkaline phosphatase
p6375
aVincreased levels of creatinine
p6376
asg24
(lp6377
Vhttp://dbpedia.org/resource/Indicator_function
p6378
aVhttp://dbpedia.org/resource/Opioid
p6379
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6380
sg31
S'Most reliable indicator of opioid-mediated respiratory depression:'
p6381
sg33
I23
sg34
S'Q55#12'
p6382
sg36
I7
sg37
S'12'
p6383
sg38
I2
sg39
S'55'
p6384
sa(dp6385
g3
(lp6386
(lp6387
Vhttp://dbpedia.org/resource/Pentazocine
p6388
aa(lp6389
Vhttp://dbpedia.org/resource/Intravenous_therapy
p6390
aVhttp://dbpedia.org/resource/Infusion
p6391
aa(lp6392
Vhttp://dbpedia.org/resource/Intravenous_therapy
p6393
aVhttp://dbpedia.org/resource/Naloxone
p6394
aVhttp://dbpedia.org/resource/Naloxone
p6395
aa(lp6396
Vhttp://dbpedia.org/resource/Intravenous_therapy
p6397
aVhttp://dbpedia.org/resource/Naltrexone
p6398
aVhttp://dbpedia.org/resource/Naltrexone
p6399
aasg18
(lp6400
Voral pentazocine (Talwain)
p6401
aVoral propoxyphene (Darvon)
p6402
aVintravenous, rapidly infused, alfentanil
p6403
aVintravenous naloxone (Narcan)
p6404
aVintravenous  naltrexone (ReVia)
p6405
asg24
(lp6406
Vhttp://dbpedia.org/resource/Opioid
p6407
aVhttp://dbpedia.org/resource/Route_of_administration
p6408
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6409
sg31
S'Opioid + Route of Administration most likely associated with truncal rigidity:'
p6410
sg33
I26
sg34
S'Q55#13'
p6411
sg36
I11
sg37
S'13'
p6412
sg38
I2
sg39
S'55'
p6413
sa(dp6414
g3
(lp6415
(lp6416
Vhttp://dbpedia.org/resource/Analgesic
p6417
aa(lp6418
Vhttp://dbpedia.org/resource/Bradycardia
p6419
aa(lp6420
Vhttp://dbpedia.org/resource/Miosis
p6421
aa(lp6422
Vhttp://dbpedia.org/resource/Euphoria
p6423
aasg18
(lp6424
Vanalgesia
p6425
aVbradycardia
p6426
aVrespiratory depression
p6427
aVmiosis
p6428
aVeuphoria
p6429
asg24
(lp6430
Vhttp://dbpedia.org/resource/Opioid
p6431
aVhttp://dbpedia.org/resource/Exhibition
p6432
aVhttp://dbpedia.org/resource/Opioid
p6433
aVhttp://dbpedia.org/resource/Administration_%28government%29
p6434
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question1/questionset1.htm'
p6435
sg31
S'Opioid effect least likely to exhibit tolerance following prolonged opioid administration:'
p6436
sg33
I6
sg34
S'Q55#14'
p6437
sg36
I11
sg37
S'14'
p6438
sg38
I3
sg39
S'55'
p6439
sa(dp6440
g3
(lp6441
(lp6442
Vhttp://dbpedia.org/resource/Constipation
p6443
aa(lp6444
Vhttp://dbpedia.org/resource/Constriction
p6445
aVhttp://dbpedia.org/resource/Bile_duct
p6446
aa(lp6447
Vhttp://dbpedia.org/resource/Renal_function
p6448
aa(lp6449
Vhttp://dbpedia.org/resource/Limited_company
p6450
aVhttp://dbpedia.org/resource/Direct_current
p6451
aVhttp://dbpedia.org/resource/Circulatory_system
p6452
aa(lp6453
Vhttp://dbpedia.org/resource/Childbirth
p6454
aasg18
(lp6455
Vconstipation
p6456
aVconstriction of biliary smooth muscle
p6457
aVenhanced renal function
p6458
aVlimited direct cardiovascular effects
p6459
aVmay prolong labor
p6460
asg24
(lp6461
Vhttp://dbpedia.org/resource/Physiology
p6462
aVhttp://dbpedia.org/resource/Opioid
p6463
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question3/questionset3.htm'
p6464
sg31
S'Physiological effect NOT typically associated with opioids:'
p6465
sg33
I16
sg34
S'Q56#0'
p6466
sg36
I7
sg37
S'0'
sg38
I2
sg39
S'56'
p6467
sa(dp6468
g3
(lp6469
(lp6470
Vhttp://dbpedia.org/resource/Naloxone
p6471
aVhttp://dbpedia.org/resource/Naloxone
p6472
aa(lp6473
Vhttp://dbpedia.org/resource/Naltrexone
p6474
aVhttp://dbpedia.org/resource/Naltrexone
p6475
aa(lp6476
Vhttp://dbpedia.org/resource/Hydromorphone
p6477
aVhttp://dbpedia.org/resource/Hydromorphone
p6478
aasg18
(lp6479
Vnaloxone (Narcan)
p6480
aVnaltrexone (ReVia)
p6481
aVhydromorphone (Dilaudid)
p6482
aVnalbuphine (Nubain)
p6483
aVdiphenoxylate (Lomotil)
p6484
asg24
(lp6485
Vhttp://dbpedia.org/resource/Agonist
p6486
aVhttp://dbpedia.org/resource/Receptor_antagonist
p6487
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question3/questionset3.htm'
p6488
sg31
S'Mixed agonist-antagonist:'
p6489
sg33
I20
sg34
S'Q56#1'
p6490
sg36
I2
sg37
S'1'
sg38
I3
sg39
S'56'
p6491
sa(dp6492
g3
(lp6493
(lp6494
Vhttp://dbpedia.org/resource/Naloxone
p6495
aVhttp://dbpedia.org/resource/Naloxone
p6496
aa(lp6497
Vhttp://dbpedia.org/resource/Naltrexone
p6498
aVhttp://dbpedia.org/resource/Naltrexone
p6499
aa(lp6500
Vhttp://dbpedia.org/resource/Duration_%28music%29
p6501
aVhttp://dbpedia.org/resource/Action_game
p6502
aa(lp6503
Vhttp://dbpedia.org/resource/Agent_%28economics%29
p6504
aVhttp://dbpedia.org/resource/Opioid
p6505
aVhttp://dbpedia.org/resource/Receptor_antagonist
p6506
aasg18
(lp6507
Vnaloxone (Narcan)
p6508
aVnalmefene (Revex)
p6509
aVnaltrexone (ReVia)
p6510
aVall about equal duration of action
p6511
aVthese agents are not opioid antagonists
p6512
asg24
(lp6513
Vhttp://dbpedia.org/resource/Duration_%28music%29
p6514
aVhttp://dbpedia.org/resource/Action_game
p6515
asg29
S'http://www.pharmacology2000.com/Central/Opioid/question3/questionset3.htm'
p6516
sg31
S'Opioid antagonist with shortest duration of action:'
p6517
sg33
I24
sg34
S'Q56#6'
p6518
sg36
I7
sg37
S'6'
sg38
I0
sg39
S'56'
p6519
sa(dp6520
g3
(lp6521
(lp6522
Vhttp://dbpedia.org/resource/Solubility
p6523
aa(lp6524
Vhttp://dbpedia.org/resource/Anesthetic
p6525
aVhttp://dbpedia.org/resource/Tension_%28physics%29
p6526
aVhttp://dbpedia.org/resource/Rise_Records
p6527
aVhttp://dbpedia.org/resource/Solubility
p6528
aVhttp://dbpedia.org/resource/Drug
p6529
aa(lp6530
Vhttp://dbpedia.org/resource/Brain
p6531
aVhttp://dbpedia.org/resource/Concentration
p6532
aVhttp://dbpedia.org/resource/Nitrous_oxide
p6533
aVhttp://dbpedia.org/resource/Rise_Records
p6534
aa(lp6535
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p6536
aVhttp://dbpedia.org/resource/Lung
p6537
aVhttp://dbpedia.org/resource/Blood_flow
p6538
aVhttp://dbpedia.org/resource/Time
p6539
aVhttp://dbpedia.org/resource/Anesthetic
p6540
aasg18
(lp6541
VMore soluble in blood leads to more rapid induction.
p6542
aVAnesthetic tension in the blood rises more rapidly for highly soluble drugs.
p6543
aVBrain concentration of nitrous oxide rises rapidly.
p6544
aVRate of pulmonary blood flow significantly affects time to anesthetic equilibrium.
p6545
asg24
(lp6546
Vhttp://dbpedia.org/resource/Property
p6547
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions2/GA1.htm'
p6548
sg31
S'Properties of inhalational anesthetics:'
p6549
sg33
I40
sg34
S'Q57#0'
p6550
sg36
I4
sg37
S'0'
sg38
I2
sg39
S'57'
p6551
sa(dp6552
g3
(lp6553
(lp6554
Vhttp://dbpedia.org/resource/Amphetamine
p6555
aVhttp://dbpedia.org/resource/Mathematical_induction
p6556
aa(lp6557
Vhttp://dbpedia.org/resource/Presence_information
p6558
aasg18
(lp6559
Vlipid solubility
p6560
aVspeed of induction.
p6561
aVpresence of a "second gas effect"
p6562
aVminimum alveolar concentration (MAC value)
p6563
asg24
(lp6564
Vhttp://dbpedia.org/resource/Measurement
p6565
aVhttp://dbpedia.org/resource/Anesthetic
p6566
aVhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p6567
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions2/GA1.htm'
p6568
sg31
S'Accepted measure of anesthetic potency.'
p6569
sg33
I20
sg34
S'Q57#1'
p6570
sg36
I6
sg37
S'1'
sg38
I3
sg39
S'57'
p6571
sa(dp6572
g3
(lp6573
(lp6574
Vhttp://dbpedia.org/resource/Halothane
p6575
aasg18
(lp6576
Visoflurane
p6577
aVenflurane
p6578
aVhalothane
p6579
aVdesflurane
p6580
asg24
(lp6581
Vhttp://dbpedia.org/resource/Hepatitis
p6582
aVhttp://dbpedia.org/resource/Max_Factor
p6583
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions2/GA1.htm'
p6584
sg31
S'Unpredictable hepatitis occurrence has been one factor that reduce the use of this inhalational anesthetic:'
p6585
sg33
I4
sg34
S'Q57#2'
p6586
sg36
I15
sg37
S'2'
sg38
I2
sg39
S'57'
p6587
sa(dp6588
g3
(lp6589
(lp6590
Vhttp://dbpedia.org/resource/Nitrous_oxide
p6591
aa(lp6592
Vhttp://dbpedia.org/resource/Halothane
p6593
aa(lp6594
Vhttp://dbpedia.org/resource/Sodium_thiopental
p6595
aa(lp6596
Vhttp://dbpedia.org/resource/Fentanyl
p6597
aasg18
(lp6598
Vnitrous oxide
p6599
aVhalothane
p6600
aVthiopental
p6601
aVfentanyl
p6602
asg24
(lp6603
Vhttp://dbpedia.org/resource/Anesthetic
p6604
aVhttp://dbpedia.org/resource/Barbiturate
p6605
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions2/GA1.htm'
p6606
sg31
S'Very brief anesthetic effects of this barbiturate is explained by "rapid redistribution":'
p6607
sg33
I5
sg34
S'Q57#3'
p6608
sg36
I15
sg37
S'3'
sg38
I2
sg39
S'57'
p6609
sa(dp6610
g3
(lp6611
(lp6612
Vhttp://dbpedia.org/resource/Propofol
p6613
aa(lp6614
Vhttp://dbpedia.org/resource/Fentanyl
p6615
aa(lp6616
Vhttp://dbpedia.org/resource/Ketamine
p6617
aasg18
(lp6618
Vpropofol
p6619
aVdroperidol + fentanyl citrate
p6620
aVketamine
p6621
aVenflurane + hydoxyzine
p6622
asg24
(lp6623
Vhttp://dbpedia.org/resource/Antipsychotic
p6624
aVhttp://dbpedia.org/resource/Analgesic
p6625
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions2/GA1.htm'
p6626
sg31
S'Neurolept analgesia:'
p6627
sg33
I9
sg34
S'Q57#4'
p6628
sg36
I2
sg37
S'4'
sg38
I1
sg39
S'57'
p6629
sa(dp6630
g3
(lp6631
(lp6632
Vhttp://dbpedia.org/resource/Patient
p6633
aVhttp://dbpedia.org/resource/Ageing
p6634
aa(lp6635
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p6636
aVhttp://dbpedia.org/resource/Liver
p6637
aVhttp://dbpedia.org/resource/Anesthetic
p6638
aVhttp://dbpedia.org/resource/Metabolism
p6639
aa(lp6640
Vhttp://dbpedia.org/resource/Anesthetic
p6641
aVhttp://dbpedia.org/resource/Partial_pressure
p6642
aVhttp://dbpedia.org/resource/Tension_%28physics%29
p6643
aVhttp://dbpedia.org/resource/Brain
p6644
aa(lp6645
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p6646
aVhttp://dbpedia.org/resource/Transfer_function
p6647
aVhttp://dbpedia.org/resource/Gas
p6648
aVhttp://dbpedia.org/resource/Pulmonary_alveolus
p6649
aa(lp6650
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p6651
aVhttp://dbpedia.org/resource/Anesthetic
p6652
aVhttp://dbpedia.org/resource/Brain
p6653
aasg18
(lp6654
Vpatient age
p6655
aVRate of hepatic anesthetic metabolism
p6656
aVanesthetic partial pressure (tension) in brain
p6657
aVrate of transfer of gas from the blood to alveoli
p6658
aVrate of redistribution of the anesthetic from the brain to other tissues
p6659
asg24
(lp6660
Vhttp://dbpedia.org/resource/Depth_perception
p6661
aVhttp://dbpedia.org/resource/Anesthesia
p6662
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions3/questionset3.htm'
p6663
sg31
S'Depth of anesthesia primarily depends on:'
p6664
sg33
I37
sg34
S'Q58#1'
p6665
sg36
I6
sg37
S'1'
sg38
I2
sg39
S'58'
p6666
sa(dp6667
g3
(lp6668
(lp6669
Vhttp://dbpedia.org/resource/Halothane
p6670
aVhttp://dbpedia.org/resource/Halothane
p6671
aa(lp6672
Vhttp://dbpedia.org/resource/Ether
p6673
aa(lp6674
Vhttp://dbpedia.org/resource/Nitrous_oxide
p6675
aasg18
(lp6676
Vhalothane (Fluothane)
p6677
aVether
p6678
aVnitrous oxide
p6679
aVisoflurane (Forane)
p6680
aVall are equal
p6681
asg24
(lp6682
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p6683
aVhttp://dbpedia.org/resource/Artery
p6684
aVhttp://dbpedia.org/resource/Gas
p6685
aVhttp://dbpedia.org/resource/Tension_%28physics%29
p6686
aVhttp://dbpedia.org/resource/Tension_%28physics%29
p6687
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions3/questionset3.htm'
p6688
sg31
S'Fastest rate of rise of arterial gas tension (as% of inspired tension):'
p6689
sg33
I14
sg34
S'Q58#2'
p6690
sg36
I16
sg37
S'2'
sg38
I2
sg39
S'58'
p6691
sa(dp6692
g3
(lp6693
(lp6694
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p6695
aVhttp://dbpedia.org/resource/Anesthetic
p6696
aVhttp://dbpedia.org/resource/Metabolism
p6697
aa(lp6698
Vhttp://dbpedia.org/resource/Differential_diagnosis
p6699
aVhttp://dbpedia.org/resource/Excretion
p6700
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p6701
aa(lp6702
Vhttp://dbpedia.org/resource/Anesthetic
p6703
aVhttp://dbpedia.org/resource/Physical_property
p6704
aVhttp://dbpedia.org/resource/Solubility
p6705
aasg18
(lp6706
Vdifferent rates of anesthetic metabolism
p6707
aVdifferential excretion rates
p6708
aVanesthetic physical properties, e.g. solubility
p6709
asg24
(lp6710
Vhttp://dbpedia.org/resource/Subtraction
p6711
aVhttp://dbpedia.org/resource/Anesthetic
p6712
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p6713
aVhttp://dbpedia.org/resource/Artery
p6714
aVhttp://dbpedia.org/resource/Gas
p6715
aVhttp://dbpedia.org/resource/Tension_%28physics%29
p6716
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions3/questionset3.htm'
p6717
sg31
S'Differences between anesthetics in terms of rate of rise of arterial gas tension are primarily due to:'
p6718
sg33
I14
sg34
S'Q58#3'
p6719
sg36
I17
sg37
S'3'
sg38
I2
sg39
S'58'
p6720
sa(dp6721
g3
(lp6722
(lp6723
Vhttp://dbpedia.org/resource/Solubility
p6724
aVhttp://dbpedia.org/resource/Blood_pressure
p6725
aVhttp://dbpedia.org/resource/Partial_pressure
p6726
aVhttp://dbpedia.org/resource/Tension_%28physics%29
p6727
aa(lp6728
Vhttp://dbpedia.org/resource/Inhalation
p6729
aVhttp://dbpedia.org/resource/Sports_agent
p6730
aVhttp://dbpedia.org/resource/Solubility
p6731
aVhttp://dbpedia.org/resource/Factor_%28agent%29
p6732
aVhttp://dbpedia.org/resource/Amphetamine
p6733
aVhttp://dbpedia.org/resource/Induction_heating
p6734
aVhttp://dbpedia.org/resource/Recovery_model
p6735
aa(lp6736
Vhttp://dbpedia.org/resource/Induction_heating
p6737
aVhttp://dbpedia.org/resource/The_Times
p6738
aVhttp://dbpedia.org/resource/Solubility
p6739
aasg18
(lp6740
VThe more soluble in age and is in the blood the less must be dissolved to raise its partial pressure (tension)
p6741
aV Inhalational agent solubility is a relatively unimportant factor in determining the speed of induction recovery
p6742
aVInduction times may be prolonged with methoxyflurane because of its high solubility
p6743
asg24
(lp6744
Vhttp://dbpedia.org/resource/Anesthetic
p6745
aVhttp://dbpedia.org/resource/Solubility
p6746
aVhttp://dbpedia.org/resource/Blood_pressure
p6747
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions3/questionset3.htm'
p6748
sg31
S'Anesthetic solubility in the blood:'
p6749
sg33
I50
sg34
S'Q58#6'
p6750
sg36
I5
sg37
S'6'
sg38
I2
sg39
S'58'
p6751
sa(dp6752
g3
(lp6753
sg18
(lp6754
V0.5-1
p6755
aV2-4
p6756
aV5-10
p6757
aV> 10
p6758
asg24
(lp6759
Vhttp://dbpedia.org/resource/Therapy
p6760
aVhttp://dbpedia.org/resource/Bruce_Hornsby
p6761
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6762
sg31
S'Therapeutics-index range -- general anesthetics:'
p6763
sg33
I5
sg34
S'Q59#0'
p6764
sg36
I5
sg37
S'0'
sg38
I1
sg39
S'59'
p6765
sa(dp6766
g3
(lp6767
(lp6768
Vhttp://dbpedia.org/resource/Gas_chamber
p6769
aVhttp://dbpedia.org/resource/Concentration
p6770
aVhttp://dbpedia.org/resource/Produce
p6771
aVhttp://dbpedia.org/resource/Retrograde_amnesia
p6772
aVhttp://dbpedia.org/resource/Patient
p6773
aa(lp6774
Vhttp://dbpedia.org/resource/Gas_chamber
p6775
aVhttp://dbpedia.org/resource/Concentration
p6776
aVhttp://dbpedia.org/resource/Produce
p6777
aVhttp://dbpedia.org/resource/Patient
p6778
aVhttp://dbpedia.org/resource/Led_Zeppelin
p6779
aa(lp6780
Vhttp://dbpedia.org/resource/Gas_chamber
p6781
aVhttp://dbpedia.org/resource/Concentration
p6782
aVhttp://dbpedia.org/resource/Produce
p6783
aVhttp://dbpedia.org/resource/Patient
p6784
aVhttp://dbpedia.org/resource/Pain
p6785
aasg18
(lp6786
VAlveolar gas concentration that will produce retrograde amnesia in at least 20% of patients:
p6787
aVAlveolar gas concentration that will produce immobility in 50% of patients exposed to Led Zeppelin
p6788
aVAlveolar gas concentration that will produce immobility in 50% of patients exposed to painful stimuli
p6789
asg24
(lp6790
Vhttp://dbpedia.org/resource/Fleetwood_Mac
p6791
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6792
sg31
S'MAC:'
p6793
sg33
I48
sg34
S'Q59#2'
p6794
sg36
I1
sg37
S'2'
sg38
I2
sg39
S'59'
p6795
sa(dp6796
g3
(lp6797
(lp6798
Vhttp://dbpedia.org/resource/Homeostasis
p6799
aVhttp://dbpedia.org/resource/Partial_pressure
p6800
aVhttp://dbpedia.org/resource/Anesthetic
p6801
aVhttp://dbpedia.org/resource/Gas
p6802
aVhttp://dbpedia.org/resource/Lung
p6803
aVhttp://dbpedia.org/resource/Partial_pressure
p6804
aVhttp://dbpedia.org/resource/Gas
p6805
aVhttp://dbpedia.org/resource/Brain
p6806
aa(lp6807
Vhttp://dbpedia.org/resource/Anesthetic
p6808
aVhttp://dbpedia.org/resource/Gas
p6809
aVhttp://dbpedia.org/resource/Homeostasis
p6810
aVhttp://dbpedia.org/resource/Blood_pressure
p6811
aVhttp://dbpedia.org/resource/Brain
p6812
aVhttp://dbpedia.org/resource/Partial_pressure
p6813
aa(lp6814
Vhttp://dbpedia.org/resource/Fleetwood_Mac
p6815
aVhttp://dbpedia.org/resource/Value_%28personal_and_cultural%29
p6816
aVhttp://dbpedia.org/resource/Nature
p6817
aVhttp://dbpedia.org/resource/Pain
p6818
aVhttp://dbpedia.org/resource/Stimulus_%28physiology%29
p6819
aa(lp6820
Vhttp://dbpedia.org/resource/Fleetwood_Mac
p6821
aVhttp://dbpedia.org/resource/Value_%28personal_and_cultural%29
p6822
aVhttp://dbpedia.org/resource/Psychic
p6823
aVhttp://dbpedia.org/resource/Patient
p6824
aVhttp://dbpedia.org/resource/Gender
p6825
aVhttp://dbpedia.org/resource/Height
p6826
aVhttp://dbpedia.org/resource/Weight
p6827
aVhttp://dbpedia.org/resource/Anesthesia
p6828
aVhttp://dbpedia.org/resource/Duration_%28music%29
p6829
aasg18
(lp6830
VAt equilibrium the partial pressure of the anesthetic gas in the lung is usually significantly higher than the partial pressure of the gas in the brain.
p6831
aVConcerning anesthetic gases -- there is a rapid equilibrium between blood and brain partial pressures
p6832
aVMAC values are highly dependent on the nature of the painful stimulus
p6833
aVMAC values are relatively sensitive to patient gender, height, weight, and anesthesia duration
p6834
asg24
(lp6835
Vhttp://dbpedia.org/resource/Anesthetic
p6836
aVhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p6837
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6838
sg31
S'Anesthetic potency --'
p6839
sg33
I69
sg34
S'Q59#3'
p6840
sg36
I3
sg37
S'3'
sg38
I1
sg39
S'59'
p6841
sa(dp6842
g3
(lp6843
(lp6844
Vhttp://dbpedia.org/resource/Amnesia
p6845
aVhttp://dbpedia.org/resource/Analgesic
p6846
aa(lp6847
Vhttp://dbpedia.org/resource/Delirium
p6848
aa(lp6849
Vhttp://dbpedia.org/resource/Surgery
p6850
aVhttp://dbpedia.org/resource/Anesthesia
p6851
aa(lp6852
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p6853
aasg18
(lp6854
Vamnesia/analgesia
p6855
aVdelirium
p6856
aVsurgical anesthesia
p6857
aVmedullary depression
p6858
asg24
(lp6859
Vhttp://dbpedia.org/resource/Apnea
p6860
aVhttp://dbpedia.org/resource/Mydriasis
p6861
aVhttp://dbpedia.org/resource/Circulatory_system
p6862
aVhttp://dbpedia.org/resource/Failure
p6863
aVhttp://dbpedia.org/resource/Hypertension
p6864
aVhttp://dbpedia.org/resource/General_anaesthesia
p6865
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6866
sg31
S'Apnea, non-reacted dilated pupils, circulatory failure, and hypertension are most likely associated with this stage of general anesthesia:'
p6867
sg33
I6
sg34
S'Q59#5'
p6868
sg36
I21
sg37
S'5'
sg38
I3
sg39
S'59'
p6869
sa(dp6870
g3
(lp6871
(lp6872
Vhttp://dbpedia.org/resource/Analgesic
p6873
aVhttp://dbpedia.org/resource/Amnesia
p6874
aa(lp6875
Vhttp://dbpedia.org/resource/Delirium
p6876
aa(lp6877
Vhttp://dbpedia.org/resource/Surgery
p6878
aVhttp://dbpedia.org/resource/Anesthesia
p6879
aa(lp6880
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p6881
aasg18
(lp6882
Vanalgesia/amnesia
p6883
aVdelirium
p6884
aVsurgical anesthesia
p6885
aVmedullary depression
p6886
asg24
(lp6887
Vhttp://dbpedia.org/resource/Andrew_Gaze
p6888
aVhttp://dbpedia.org/resource/Miosis
p6889
aVhttp://dbpedia.org/resource/Anesthetic
p6890
aVhttp://dbpedia.org/resource/Depth_perception
p6891
aVhttp://dbpedia.org/resource/Necessary_and_sufficient_condition
p6892
aVhttp://dbpedia.org/resource/Reflex
p6893
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p6894
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6895
sg31
S'Central gaze, constricted pupils, regular aspirations, and the anesthetic depth is sufficient that noxious stimuli does not cause reflexes or excessive autonomic effects'
p6896
sg33
I6
sg34
S'Q59#6'
p6897
sg36
I26
sg37
S'6'
sg38
I2
sg39
S'59'
p6898
sa(dp6899
g3
(lp6900
(lp6901
Vhttp://dbpedia.org/resource/Analgesic
p6902
aa(lp6903
Vhttp://dbpedia.org/resource/Muscle_relaxant
p6904
aa(lp6905
Vhttp://dbpedia.org/resource/Adult
p6906
aVhttp://dbpedia.org/resource/Child
p6907
aasg18
(lp6908
Vusually adequate analgesia
p6909
aVLikely to provide adequate muscle relaxation
p6910
aVcommonly used in adults; less likely to be used in children
p6911
aVreversible reduction of GFR
p6912
asg24
(lp6913
Vhttp://dbpedia.org/resource/Halothane
p6914
aVhttp://dbpedia.org/resource/Halothane
p6915
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6916
sg31
S'Halothane (Fluothane) --'
p6917
sg33
I25
sg34
S'Q59#7'
p6918
sg36
I5
sg37
S'7'
sg38
I3
sg39
S'59'
p6919
sa(dp6920
g3
(lp6921
(lp6922
Vhttp://dbpedia.org/resource/Concern_Worldwide
p6923
aVhttp://dbpedia.org/resource/Patient
p6924
aVhttp://dbpedia.org/resource/Epileptic_seizure
p6925
aVhttp://dbpedia.org/resource/Disease
p6926
aVhttp://dbpedia.org/resource/Medical_history
p6927
aa(lp6928
Vhttp://dbpedia.org/resource/Relaxation_technique
p6929
aVhttp://dbpedia.org/resource/Surgery
p6930
aa(lp6931
Vhttp://dbpedia.org/resource/Anesthesia
p6932
aVhttp://dbpedia.org/resource/Depth_perception
p6933
aVhttp://dbpedia.org/resource/Pulse
p6934
aVhttp://dbpedia.org/resource/Respiration_%28physiology%29
p6935
aasg18
(lp6936
VWidely used in pediatric cases
p6937
aVmay cause concern if patient has a seizure-disorder history
p6938
aVskeletal muscle relaxation:inadequate for surgery
p6939
aVDifficult adjustment of anesthesia depth due to significant effects on pulse and respiration
p6940
asg24
(lp6941
Vhttp://dbpedia.org/resource/Pediatrics
p6942
aVhttp://dbpedia.org/resource/Case_Western_Reserve_University
p6943
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6944
sg31
S'Enflurane (Ethrane)--'
p6945
sg33
I34
sg34
S'Q59#8'
p6946
sg36
I5
sg37
S'8'
sg38
I1
sg39
S'59'
p6947
sa(dp6948
g3
(lp6949
(lp6950
Vhttp://dbpedia.org/resource/Halothane
p6951
aVhttp://dbpedia.org/resource/Halothane
p6952
aasg18
(lp6953
Venflurane (Ethrane)
p6954
aVhalothane (Fluothane)
p6955
aVisoflurane (Forane)
p6956
asg24
(lp6957
Vhttp://dbpedia.org/resource/Halothane
p6958
aVhttp://dbpedia.org/resource/Halothane
p6959
aVhttp://dbpedia.org/resource/Cardiac_output
p6960
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6961
sg31
S'Considering enflurane (Ethrane), halothane (Fluothane), and isoflurane (Forane) -- cardiac output is well maintained --'
p6962
sg33
I12
sg34
S'Q59#9'
p6963
sg36
I23
sg37
S'9'
sg38
I2
sg39
S'59'
p6964
sa(dp6965
g3
(lp6966
(lp6967
Vhttp://dbpedia.org/resource/Muscle_contraction
p6968
aVhttp://dbpedia.org/resource/Requirement
p6969
aVhttp://dbpedia.org/resource/Bleeding
p6970
aa(lp6971
Vhttp://dbpedia.org/resource/Airway
p6972
aVhttp://dbpedia.org/resource/Reflex
p6973
aVhttp://dbpedia.org/resource/Secretion
p6974
aVhttp://dbpedia.org/resource/Cough
p6975
aa(lp6976
Vhttp://dbpedia.org/resource/Convulsion
p6977
aasg18
(lp6978
Vminimal muscle relaxation
p6979
aVpromotes uterine muscle contraction; desirable if uterine contraction is required  to limit blood loss
p6980
aVstimulates airway reflexes -- increasing secretions, coughing, and laryngospasm
p6981
aVconvulsive activity is associated with isoflurane (Forane), similar to enflurane (Ethrane)
p6982
asg24
(lp6983
Vhttp://dbpedia.org/resource/Minimalism
p6984
aVhttp://dbpedia.org/resource/Muscle_relaxant
p6985
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions4/questionset4.htm'
p6986
sg31
S'Isoflurane (Forane):'
p6987
sg33
I45
sg34
S'Q59#10'
p6988
sg36
I5
sg37
S'10'
p6989
sg38
I2
sg39
S'59'
p6990
sa(dp6991
g3
(lp6992
(lp6993
Vhttp://dbpedia.org/resource/Analgesic
p6994
aa(lp6995
Vhttp://dbpedia.org/resource/Rapid
p6996
aVhttp://dbpedia.org/resource/Rapid
p6997
aVhttp://dbpedia.org/resource/Liver
p6998
aVhttp://dbpedia.org/resource/Metabolism
p6999
aa(lp7000
Vhttp://dbpedia.org/resource/Placenta
p7001
aVhttp://dbpedia.org/resource/Fetus
p7002
aa(lp7003
Vhttp://dbpedia.org/resource/Circulatory_system
p7004
aVhttp://dbpedia.org/resource/Hypovolemia
p7005
aasg18
(lp7006
Vexcellent analgesic
p7007
aVrapid recovery (20-30 minutes) due to rapid hepatic metabolism
p7008
aVabsence of  respiratory depression
p7009
aVcrosses the placental barrier, depressing the fetus
p7010
aVsignificant cardiovascular effects, except in the presence of hypovolemia
p7011
asg24
(lp7012
Vhttp://dbpedia.org/resource/Sodium_thiopental
p7013
aVhttp://dbpedia.org/resource/Sodium_thiopental
p7014
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions5/questionset5.htm'
p7015
sg31
S'Thiopental (Pentothal):'
p7016
sg33
I35
sg34
S'Q60#3'
p7017
sg36
I5
sg37
S'3'
sg38
I3
sg39
S'60'
p7018
sa(dp7019
g3
(lp7020
(lp7021
Vhttp://dbpedia.org/resource/Combination
p7022
aVhttp://dbpedia.org/resource/Opioid
p7023
aVhttp://dbpedia.org/resource/Circulatory_system
p7024
aVhttp://dbpedia.org/resource/Depression_%28mood%29
p7025
aa(lp7026
Vhttp://dbpedia.org/resource/Naltrexone
p7027
aVhttp://dbpedia.org/resource/Naltrexone
p7028
aa(lp7029
Vhttp://dbpedia.org/resource/Effectiveness
p7030
aVhttp://dbpedia.org/resource/Analgesic
p7031
aa(lp7032
Vhttp://dbpedia.org/resource/Anterograde_amnesia
p7033
aasg18
(lp7034
Vadvantage: combination with opioids do not result in significant cardiovascular depression
p7035
aVCentral nervous system depression can be reversed with naltrexone (ReVia)
p7036
aVEffective analgesic
p7037
aVAssociated with anterograde amnesia
p7038
asg24
(lp7039
Vhttp://dbpedia.org/resource/Benzodiazepine
p7040
aVhttp://dbpedia.org/resource/Diazepam
p7041
aVhttp://dbpedia.org/resource/Diazepam
p7042
aVhttp://dbpedia.org/resource/Pharmacology
p7043
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions5/questionset5.htm'
p7044
sg31
S'Benzodiazepines: Diazepam (Valium) pharmacology --'
p7045
sg33
I30
sg34
S'Q60#6'
p7046
sg36
I8
sg37
S'6'
sg38
I3
sg39
S'60'
p7047
sa(dp7048
g3
(lp7049
(lp7050
Vhttp://dbpedia.org/resource/Chlorpromazine
p7051
aVhttp://dbpedia.org/resource/Chlorpromazine
p7052
aVhttp://dbpedia.org/resource/Midazolam
p7053
aa(lp7054
Vhttp://dbpedia.org/resource/Nitrous_oxide
p7055
aa(lp7056
Vhttp://dbpedia.org/resource/Fentanyl
p7057
aVhttp://dbpedia.org/resource/Fentanyl
p7058
aVhttp://dbpedia.org/resource/Pethidine
p7059
aVhttp://dbpedia.org/resource/Pethidine
p7060
aa(lp7061
Vhttp://dbpedia.org/resource/Fentanyl
p7062
aVhttp://dbpedia.org/resource/Fentanyl
p7063
aasg18
(lp7064
Vhaloperidol (Haldol) + nitrous oxide
p7065
aVchlorpromazine (Thorazine) +  midazolam (Versed)
p7066
aVdroperidol (Inapsine) + nitrous oxide
p7067
aVfentanyl (Sublimaze) + meperidine (Demerol)
p7068
aVfentanyl (Sublimaze) + droperidol (Inapsine)
p7069
asg24
(lp7070
Vhttp://dbpedia.org/resource/Haloperidol
p7071
aVhttp://dbpedia.org/resource/Haloperidol
p7072
aVhttp://dbpedia.org/resource/Nitrous_oxide
p7073
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions5/questionset5.htm'
p7074
sg31
S'Innovar --'
p7075
sg33
I41
sg34
S'Q60#16'
p7076
sg36
I2
sg37
S'16'
p7077
sg38
I4
sg39
S'60'
p7078
sa(dp7079
g3
(lp7080
(lp7081
Vhttp://dbpedia.org/resource/Sodium_thiopental
p7082
aVhttp://dbpedia.org/resource/Sodium_thiopental
p7083
aa(lp7084
Vhttp://dbpedia.org/resource/Ketamine
p7085
aVhttp://dbpedia.org/resource/Ketamine
p7086
aasg18
(lp7087
Vsimilar to sufentanil (Sufenta)
p7088
aVsimilar enflurane (Ethrane)
p7089
aVsimilar to thiopental (Pentothal)
p7090
aVsimilar to ketamine (Ketalar)
p7091
asg24
(lp7092
Vhttp://dbpedia.org/resource/Propofol
p7093
aVhttp://dbpedia.org/resource/Propofol
p7094
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions6/questionset6.htm'
p7095
sg31
S'Propofol (Diprivan):'
p7096
sg33
I23
sg34
S'Q61#1'
p7097
sg36
I5
sg37
S'1'
sg38
I2
sg39
S'61'
p7098
sa(dp7099
g3
(lp7100
(lp7101
Vhttp://dbpedia.org/resource/Redox
p7102
aVhttp://dbpedia.org/resource/Requirement
p7103
aVhttp://dbpedia.org/resource/Inhalation
p7104
aVhttp://dbpedia.org/resource/Agent_Orange
p7105
aa(lp7106
Vhttp://dbpedia.org/resource/Redox
p7107
aVhttp://dbpedia.org/resource/Acid
p7108
aVhttp://dbpedia.org/resource/Volume
p7109
aVhttp://dbpedia.org/resource/Stomach
p7110
aa(lp7111
Vhttp://dbpedia.org/resource/Relief_print
p7112
aVhttp://dbpedia.org/resource/Pain
p7113
aa(lp7114
Vhttp://dbpedia.org/resource/Redox
p7115
aVhttp://dbpedia.org/resource/Inhalation
p7116
aVhttp://dbpedia.org/resource/Agent_Orange
p7117
aasg18
(lp7118
Vreduction in the requirement for inhalational agents
p7119
aVreduction in the acidity and volume of gastric contents
p7120
aVrelief of preoperative pain
p7121
aVreduction inside effects associated with some inhalational agents
p7122
asg24
(lp7123
Vhttp://dbpedia.org/resource/Primary_school
p7124
aVhttp://dbpedia.org/resource/Goal
p7125
aVhttp://dbpedia.org/resource/Pharmaceutical_drug
p7126
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions6/questionset6.htm'
p7127
sg31
S'A primary goal in preanesthetic medication --'
p7128
sg33
I28
sg34
S'Q61#3'
p7129
sg36
I7
sg37
S'3'
sg38
I2
sg39
S'61'
p7130
sa(dp7131
g3
(lp7132
(lp7133
Vhttp://dbpedia.org/resource/Chlorpromazine
p7134
aVhttp://dbpedia.org/resource/Chlorpromazine
p7135
aa(lp7136
Vhttp://dbpedia.org/resource/Haloperidol
p7137
aVhttp://dbpedia.org/resource/Haloperidol
p7138
aasg18
(lp7139
V chlorpromazine (Thorazine)
p7140
aVhaloperidol (Haldol)
p7141
aVondansetron (Zofran)
p7142
asg24
(lp7143
Vhttp://dbpedia.org/resource/Antiemetic
p7144
aVhttp://dbpedia.org/resource/Drug
p7145
aVhttp://dbpedia.org/resource/Serotonin
p7146
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p7147
aVhttp://dbpedia.org/resource/Blockade
p7148
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions6/questionset6.htm'
p7149
sg31
S'Antiemetic drug that works through serotonin (subtype 3) receptor blockade'
p7150
sg33
I12
sg34
S'Q61#16'
p7151
sg36
I12
sg37
S'16'
p7152
sg38
I2
sg39
S'61'
p7153
sa(dp7154
g3
(lp7155
(lp7156
Vhttp://dbpedia.org/resource/Hydroxyzine
p7157
aVhttp://dbpedia.org/resource/Hydroxyzine
p7158
aVhttp://dbpedia.org/resource/Hydroxyzine
p7159
aa(lp7160
Vhttp://dbpedia.org/resource/Chlorpromazine
p7161
aVhttp://dbpedia.org/resource/Chlorpromazine
p7162
aasg18
(lp7163
Vhydroxyzine (Atarax,Vistaril)
p7164
aVchlorpromazine (Thorazine)
p7165
aVondansetron (Zofran)
p7166
asg24
(lp7167
Vhttp://dbpedia.org/resource/Hypotension
p7168
aVhttp://dbpedia.org/resource/Sedation
p7169
aVhttp://dbpedia.org/resource/Antiemetic
p7170
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions6/questionset6.htm'
p7171
sg31
S'Least likely to cause hypotension or sedation while providing antiemetic effect:'
p7172
sg33
I14
sg34
S'Q61#18'
p7173
sg36
I11
sg37
S'18'
p7174
sg38
I2
sg39
S'61'
p7175
sa(dp7176
g3
(lp7177
(lp7178
Vhttp://dbpedia.org/resource/Chlorpromazine
p7179
aVhttp://dbpedia.org/resource/Chlorpromazine
p7180
aa(lp7181
Vhttp://dbpedia.org/resource/Haloperidol
p7182
aVhttp://dbpedia.org/resource/Haloperidol
p7183
aa(lp7184
Vhttp://dbpedia.org/resource/Hydroxyzine
p7185
aVhttp://dbpedia.org/resource/Hydroxyzine
p7186
aVhttp://dbpedia.org/resource/Hydroxyzine
p7187
aasg18
(lp7188
Vchlorpromazine (Thorazine)
p7189
aVhaloperidol (Haldol)
p7190
aVhydroxyzine (Atarax,Vistaril)
p7191
aVtropisetron
p7192
asg24
(lp7193
Vhttp://dbpedia.org/resource/Antiemetic
p7194
aVhttp://dbpedia.org/resource/Drug
p7195
aVhttp://dbpedia.org/resource/Side_effect
p7196
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions6/questionset6.htm'
p7197
sg31
S'Antiemetic drug with least side effects'
p7198
sg33
I15
sg34
S'Q61#19'
p7199
sg36
I6
sg37
S'19'
p7200
sg38
I3
sg39
S'61'
p7201
sa(dp7202
g3
(lp7203
(lp7204
Vhttp://dbpedia.org/resource/Acetylcholine
p7205
aVhttp://dbpedia.org/resource/Property
p7206
aa(lp7207
Vhttp://dbpedia.org/resource/Anxiolytic
p7208
aasg18
(lp7209
Vcholinomimetic properties
p7210
aVanxiolytic
p7211
aVbronchoconstriction
p7212
asg24
(lp7213
Vhttp://dbpedia.org/resource/Hydroxyzine
p7214
aVhttp://dbpedia.org/resource/Hydroxyzine
p7215
aVhttp://dbpedia.org/resource/Hydroxyzine
p7216
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions7/questionset7.htm'
p7217
sg31
S' Hydroxyzine (Atarax,Vistaril) as a preanesthetic agent:'
p7218
sg33
I4
sg34
S'Q62#1'
p7219
sg36
I10
sg37
S'1'
sg38
I1
sg39
S'62'
p7220
sa(dp7221
g3
(lp7222
(lp7223
Vhttp://dbpedia.org/resource/Atropine
p7224
aa(lp7225
Vhttp://dbpedia.org/resource/Scopolamine
p7226
aasg18
(lp7227
Vatropine
p7228
aVscopolamine
p7229
aVglycopyrrolate (Robinul)
p7230
asg24
(lp7231
Vhttp://dbpedia.org/resource/Post_%28Bj%C3%B6rk_album%29
p7232
aVhttp://dbpedia.org/resource/Anesthesia
p7233
aVhttp://dbpedia.org/resource/Emergence
p7234
aVhttp://dbpedia.org/resource/Symptom
p7235
aVhttp://dbpedia.org/resource/Common_land
p7236
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions7/questionset7.htm'
p7237
sg31
S'Post-anesthesia emergence symptoms more common:'
p7238
sg33
I6
sg34
S'Q62#3'
p7239
sg36
I5
sg37
S'3'
sg38
I1
sg39
S'62'
p7240
sa(dp7241
g3
(lp7242
(lp7243
Vhttp://dbpedia.org/resource/Halothane
p7244
aVhttp://dbpedia.org/resource/Halothane
p7245
aasg18
(lp7246
Vhalothane (Fluothane)
p7247
aVenflurane (Ethrane)
p7248
aVisoflurane (Forane)
p7249
asg24
(lp7250
Vhttp://dbpedia.org/resource/Anesthetic
p7251
aVhttp://dbpedia.org/resource/Epileptic_seizure
p7252
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p7253
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7254
sg31
S'Anesthetic most likely to cause seizure activity'
p7255
sg33
I12
sg34
S'Q63#0'
p7256
sg36
I7
sg37
S'0'
sg38
I1
sg39
S'63'
p7257
sa(dp7258
g3
(lp7259
(lp7260
Vhttp://dbpedia.org/resource/Anticonvulsant
p7261
aVhttp://dbpedia.org/resource/Redox
p7262
aVhttp://dbpedia.org/resource/Surgery
p7263
aa(lp7264
Vhttp://dbpedia.org/resource/Phenobarbital
p7265
aVhttp://dbpedia.org/resource/Phenobarbital
p7266
aVhttp://dbpedia.org/resource/Anesthetic
p7267
aVhttp://dbpedia.org/resource/Agent_Orange
p7268
aVhttp://dbpedia.org/resource/Metabolism
p7269
aa(lp7270
Vhttp://dbpedia.org/resource/Metabolism
p7271
aVhttp://dbpedia.org/resource/Volatile_organic_compound
p7272
aVhttp://dbpedia.org/resource/Halogenation
p7273
aVhttp://dbpedia.org/resource/Anesthetic
p7274
aVhttp://dbpedia.org/resource/Organ_%28anatomy%29
p7275
aVhttp://dbpedia.org/resource/Toxicity
p7276
aVhttp://dbpedia.org/resource/Risk
p7277
aa(lp7278
Vhttp://dbpedia.org/resource/Surgery
p7279
aVhttp://dbpedia.org/resource/Anticonvulsant
p7280
aVhttp://dbpedia.org/resource/Patient
p7281
aVhttp://dbpedia.org/resource/Pharmaceutical_drug
p7282
aasg18
(lp7283
VAnticonvulsant medication should be slowly reduced in dosage and stopped  several days before surgery
p7284
aVPhenobarbital (Luminal) may increase anesthetic agent metabolism
p7285
aVIncreased metabolism of  volatile, halogenated anesthetics decrease organ toxicity risk
p7286
aVthe following surgery, anticonvulsant medication should be held until the patient is able to take the medication orally
p7287
asg24
(lp7288
Vhttp://dbpedia.org/resource/Anticonvulsant
p7289
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7290
sg31
S'Anticonvulsant medication and inhalational anesthetic use:'
p7291
sg33
I53
sg34
S'Q63#1'
p7292
sg36
I6
sg37
S'1'
sg38
I1
sg39
S'63'
p7293
sa(dp7294
g3
(lp7295
(lp7296
Vhttp://dbpedia.org/resource/Carbamazepine
p7297
aVhttp://dbpedia.org/resource/Carbamazepine
p7298
aa(lp7299
Vhttp://dbpedia.org/resource/Phenytoin
p7300
aVhttp://dbpedia.org/resource/Phenytoin
p7301
aasg18
(lp7302
Vcarbamazepine (Tegretol)
p7303
aVprimidone (Mysoline)
p7304
aVethosuximide (Zarontin)
p7305
aVphenytoin (Dilantin)
p7306
asg24
(lp7307
Vhttp://dbpedia.org/resource/Drug
p7308
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7309
sg31
S'A drug of choice in management of petit mal epilepsy:'
p7310
sg33
I16
sg34
S'Q63#2'
p7311
sg36
I10
sg37
S'2'
sg38
I2
sg39
S'63'
p7312
sa(dp7313
g3
(lp7314
sg18
(lp7315
Vsevoflurane (Sevorane, Ultane)
p7316
aVdesflurane (Suprane)
p7317
aVenflurane (Ethrane)
p7318
aVisoflurane (Forane)
p7319
asg24
(lp7320
Vhttp://dbpedia.org/resource/Electroencephalography
p7321
aVhttp://dbpedia.org/resource/Epileptic_seizure
p7322
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7323
sg31
S'Inhalational anesthetic most likely to cause EEG seizure activity'
p7324
sg33
I18
sg34
S'Q63#5'
p7325
sg36
I9
sg37
S'5'
sg38
I2
sg39
S'63'
p7326
sa(dp7327
g3
(lp7328
sg18
(lp7329
Vhalothane (Fluothane)
p7330
aVisoflurane (Forane)
p7331
aVenflurane (Ethrane)
p7332
asg24
(lp7333
Vhttp://dbpedia.org/resource/Halothane
p7334
aVhttp://dbpedia.org/resource/Halothane
p7335
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7336
sg31
S'Inhalational anesthetic agent with least effect on cerebral blood flow'
p7337
sg33
I12
sg34
S'Q63#11'
p7338
sg36
I10
sg37
S'11'
p7339
sg38
I1
sg39
S'63'
p7340
sa(dp7341
g3
(lp7342
(lp7343
Vhttp://dbpedia.org/resource/Sodium_thiopental
p7344
aVhttp://dbpedia.org/resource/Sodium_thiopental
p7345
aa(lp7346
Vhttp://dbpedia.org/resource/Halothane
p7347
aVhttp://dbpedia.org/resource/Halothane
p7348
aa(lp7349
Vhttp://dbpedia.org/resource/Midazolam
p7350
aa(lp7351
Vhttp://dbpedia.org/resource/Propofol
p7352
aVhttp://dbpedia.org/resource/Propofol
p7353
aasg18
(lp7354
Vthiopental (Pentothal)
p7355
aVetomidate (Amidate)
p7356
aVhalothane (Fluothane)
p7357
aVmidazolam (Versed)
p7358
aVpropofol (Diprivan)
p7359
asg24
(lp7360
Vhttp://dbpedia.org/resource/Vasodilation
p7361
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7362
sg31
S'direct cerebral vasodilation:'
p7363
sg33
I20
sg34
S'Q63#12'
p7364
sg36
I3
sg37
S'12'
p7365
sg38
I2
sg39
S'63'
p7366
sa(dp7367
g3
(lp7368
(lp7369
Vhttp://dbpedia.org/resource/Ketamine
p7370
aVhttp://dbpedia.org/resource/Ketamine
p7371
aa(lp7372
Vhttp://dbpedia.org/resource/Propofol
p7373
aVhttp://dbpedia.org/resource/Propofol
p7374
aa(lp7375
Vhttp://dbpedia.org/resource/Nitrous_oxide
p7376
aVhttp://dbpedia.org/resource/Intravenous_therapy
p7377
aVhttp://dbpedia.org/resource/Anesthetic
p7378
aa(lp7379
Vhttp://dbpedia.org/resource/Nitrous_oxide
p7380
aVhttp://dbpedia.org/resource/Carbonic_acid
p7381
aVhttp://dbpedia.org/resource/Anesthetic
p7382
aa(lp7383
Vhttp://dbpedia.org/resource/Nitrous_oxide
p7384
aasg18
(lp7385
Vketamine (Ketalar)
p7386
aVpropofol (Diprivan)
p7387
aVnitrous oxide + intravenous anesthetic
p7388
aVnitrous oxide  + volatile anesthetics
p7389
aVnitrous oxide alone
p7390
asg24
(lp7391
Vhttp://dbpedia.org/resource/Anesthetic
p7392
aVhttp://dbpedia.org/resource/Anesthetic
p7393
aVhttp://dbpedia.org/resource/Combination
p7394
aVhttp://dbpedia.org/resource/Menopause
p7395
aVhttp://dbpedia.org/resource/Direct_current
p7396
aVhttp://dbpedia.org/resource/Vasodilation
p7397
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions8/questionset8.htm'
p7398
sg31
S'Anesthetic or anesthetic combination least likely to change cerebral blood flow or cause direct cerebral vasodilation:'
p7399
sg33
I21
sg34
S'Q63#13'
p7400
sg36
I16
sg37
S'13'
p7401
sg38
I2
sg39
S'63'
p7402
sa(dp7403
g3
(lp7404
(lp7405
Vhttp://dbpedia.org/resource/Circulatory_system
p7406
aVhttp://dbpedia.org/resource/Depression_%28mood%29
p7407
aa(lp7408
Vhttp://dbpedia.org/resource/Redox
p7409
aVhttp://dbpedia.org/resource/Adrenal_cortex
p7410
aVhttp://dbpedia.org/resource/Stress_%28biology%29
p7411
aa(lp7412
Vhttp://dbpedia.org/resource/Cooperative_Baptist_Fellowship
p7413
aasg18
(lp7414
Vdirect acting  vasodilator
p7415
aVsignificant cardiovascular depression
p7416
aVreduced adrenocortical response to stress was prolonged use
p7417
aVincreased CBF
p7418
aVincreased CMR
p7419
asg24
(lp7420
Vhttp://dbpedia.org/resource/Direct_current
p7421
aVhttp://dbpedia.org/resource/Acting
p7422
aVhttp://dbpedia.org/resource/Vasodilation
p7423
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions9/questionset9.htm'
p7424
sg31
S'Etomidate: --'
p7425
sg33
I18
sg34
S'Q64#10'
p7426
sg36
I3
sg37
S'10'
p7427
sg38
I2
sg39
S'64'
p7428
sa(dp7429
g3
(lp7430
(lp7431
Vhttp://dbpedia.org/resource/Cooperative_Baptist_Fellowship
p7432
aa(lp7433
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p7434
aVhttp://dbpedia.org/resource/Barbiturate
p7435
aasg18
(lp7436
Vincreased ICP
p7437
aVincreased CBF
p7438
aVincreased CMR
p7439
aVlonger-lasting ventilatory depression compared to barbiturates
p7440
asg24
(lp7441
Vhttp://dbpedia.org/resource/Propofol
p7442
aVhttp://dbpedia.org/resource/Propofol
p7443
asg29
S'http://www.pharmacology2000.com/Central/General_Anesthesia/questions9/questionset9.htm'
p7444
sg31
S'Propofol (Diprivan) --'
p7445
sg33
I12
sg34
S'Q64#11'
p7446
sg36
I5
sg37
S'11'
p7447
sg38
I3
sg39
S'64'
p7448
sa(dp7449
g3
(lp7450
(lp7451
Vhttp://dbpedia.org/resource/Ester
p7452
aVhttp://dbpedia.org/resource/Type_theory
p7453
aVhttp://dbpedia.org/resource/Agent_Orange
p7454
aa(lp7455
Vhttp://dbpedia.org/resource/Amide
p7456
aVhttp://dbpedia.org/resource/Type_theory
p7457
aVhttp://dbpedia.org/resource/Agent_Orange
p7458
aa(lp7459
Vhttp://dbpedia.org/resource/Subtraction
p7460
aVhttp://dbpedia.org/resource/Duration_%28music%29
p7461
aVhttp://dbpedia.org/resource/Firearm_action
p7462
aasg18
(lp7463
VEster-type agents
p7464
aVAmide-type agents
p7465
aVno difference in duration of action
p7466
asg24
(lp7467
Vhttp://dbpedia.org/resource/Local_anesthetic
p7468
aVhttp://dbpedia.org/resource/Type_theory
p7469
aVhttp://dbpedia.org/resource/Wayne_Shorter
p7470
aVhttp://dbpedia.org/resource/Duration_%28music%29
p7471
aVhttp://dbpedia.org/resource/Firearm_action
p7472
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7473
sg31
S'Local anesthetics types: shorter duration of action'
p7474
sg33
I10
sg34
S'Q65#1'
p7475
sg36
I8
sg37
S'1'
sg38
I0
sg39
S'65'
p7476
sa(dp7477
g3
(lp7478
(lp7479
Vhttp://dbpedia.org/resource/Local_anesthetic
p7480
aVhttp://dbpedia.org/resource/Weak_acid
p7481
aa(lp7482
Vhttp://dbpedia.org/resource/Local_anesthetic
p7483
aVhttp://dbpedia.org/resource/Weak_acid
p7484
aVhttp://dbpedia.org/resource/Base_%28chemistry%29
p7485
aa(lp7486
Vhttp://dbpedia.org/resource/Local_anesthetic
p7487
aVhttp://dbpedia.org/resource/Ionization
p7488
aasg18
(lp7489
VLocal anesthetics are weak acids
p7490
aVLocal anesthetics are weak bases
p7491
aVLocal anesthetics have no ionizable groups
p7492
asg24
(lp7493
Vhttp://dbpedia.org/resource/Local_anesthetic
p7494
aVhttp://dbpedia.org/resource/Acid
p7495
aVhttp://dbpedia.org/resource/Base_%28chemistry%29
p7496
aVhttp://dbpedia.org/resource/Property
p7497
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7498
sg31
S'Local anesthetics: acid/base properties'
p7499
sg33
I16
sg34
S'Q65#2'
p7500
sg36
I5
sg37
S'2'
sg38
I1
sg39
S'65'
p7501
sa(dp7502
g3
(lp7503
sg18
(lp7504
V6.0-7.0
p7505
aV7.0-8.0
p7506
aV8.0-9.0
p7507
aV> 9.0
p7508
asg24
(lp7509
Vhttp://dbpedia.org/resource/Acid_dissociation_constant
p7510
aVhttp://dbpedia.org/resource/Local_anesthetic
p7511
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7512
sg31
S'pKa range for most local anesthetics'
p7513
sg33
I5
sg34
S'Q65#3'
p7514
sg36
I6
sg37
S'3'
sg38
I2
sg39
S'65'
p7515
sa(dp7516
g3
(lp7517
(lp7518
Vhttp://dbpedia.org/resource/Extracellular
p7519
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p7520
aVhttp://dbpedia.org/resource/Higher_%28Scottish%29
p7521
aa(lp7522
Vhttp://dbpedia.org/resource/Extracellular
p7523
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p7524
aasg18
(lp7525
VExtracellular pH in infected tissue is higher
p7526
aVExtracellular pH in infected tissue is  lower
p7527
aVabout the same
p7528
asg24
(lp7529
Vhttp://dbpedia.org/resource/Tissue_%28biology%29
p7530
aVhttp://dbpedia.org/resource/Infection
p7531
aVhttp://dbpedia.org/resource/Normal,_Illinois
p7532
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7533
sg31
S'Influence on tissue infection on pH, compared to normal physiological pH.'
p7534
sg33
I17
sg34
S'Q65#4'
p7535
sg36
I13
sg37
S'4'
sg38
I1
sg39
S'65'
p7536
sa(dp7537
g3
(lp7538
(lp7539
Vhttp://dbpedia.org/resource/Anesthesia
p7540
aa(lp7541
Vhttp://dbpedia.org/resource/Redox
p7542
aVhttp://dbpedia.org/resource/Redox
p7543
aVhttp://dbpedia.org/resource/Anesthesia
p7544
aa(lp7545
Vhttp://dbpedia.org/resource/Subtraction
p7546
aasg18
(lp7547
Vgreater effect (greater anesthesia)
p7548
aVreduced effect (reduced anesthesia)
p7549
aVno difference
p7550
asg24
(lp7551
Vhttp://dbpedia.org/resource/Effectiveness
p7552
aVhttp://dbpedia.org/resource/Local_anesthetic
p7553
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p7554
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7555
sg31
S'Effectiveness of local anesthetics when injected into infected tissue:'
p7556
sg33
I14
sg34
S'Q65#5'
p7557
sg36
I9
sg37
S'5'
sg38
I1
sg39
S'65'
p7558
sa(dp7559
g3
(lp7560
(lp7561
Vhttp://dbpedia.org/resource/Externality
p7562
aVhttp://dbpedia.org/resource/Cell_membrane
p7563
aVhttp://dbpedia.org/resource/Surface
p7564
aa(lp7565
Vhttp://dbpedia.org/resource/Biological_membrane
p7566
aVhttp://dbpedia.org/resource/Surface
p7567
aa(lp7568
Vhttp://dbpedia.org/resource/Nuclear_receptor
p7569
aVhttp://dbpedia.org/resource/Nucleolus
p7570
aasg18
(lp7571
Vthe receptor is localized on the external cell membrane surface
p7572
aVthe receptor is localized on the internal membrane surface
p7573
aVthe receptor is a nuclear receptor (located near the nucleolus)
p7574
asg24
(lp7575
Vhttp://dbpedia.org/resource/Localization_of_a_ring
p7576
aVhttp://dbpedia.org/resource/Local_anesthetic
p7577
aVhttp://dbpedia.org/resource/Cell_membrane
p7578
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7579
sg31
S'Localization of local anesthetic receptor relative to the cell membrane:'
p7580
sg33
I31
sg34
S'Q65#6'
p7581
sg36
I10
sg37
S'6'
sg38
I1
sg39
S'65'
p7582
sa(dp7583
g3
(lp7584
(lp7585
Vhttp://dbpedia.org/resource/Lidocaine
p7586
aVhttp://dbpedia.org/resource/Lidocaine
p7587
aa(lp7588
Vhttp://dbpedia.org/resource/Equality_%28mathematics%29
p7589
aasg18
(lp7590
Vlidocaine (Xylocaine)
p7591
aVmepivacaine (Carbocaine)
p7592
aVequal
p7593
asg24
(lp7594
Vhttp://dbpedia.org/resource/Vasodilation
p7595
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7596
sg31
S'Greatest vasodilation:'
p7597
sg33
I9
sg34
S'Q65#8'
p7598
sg36
I2
sg37
S'8'
sg38
I0
sg39
S'65'
p7599
sa(dp7600
g3
(lp7601
(lp7602
Vhttp://dbpedia.org/resource/Procaine
p7603
aVhttp://dbpedia.org/resource/Procaine
p7604
aa(lp7605
Vhttp://dbpedia.org/resource/Lidocaine
p7606
aVhttp://dbpedia.org/resource/Lidocaine
p7607
aasg18
(lp7608
Vprocaine (Novocain)
p7609
aVmepivacaine (Carbocaine)
p7610
aVlidocaine (Xylocaine)
p7611
aVbupivacaine (Marcaine)
p7612
asg24
(lp7613
Vhttp://dbpedia.org/resource/Inclusion_map
p7614
aVhttp://dbpedia.org/resource/Vasoconstriction
p7615
aVhttp://dbpedia.org/resource/Local_anesthetic
p7616
aVhttp://dbpedia.org/resource/Solution
p7617
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7618
sg31
S'Inclusion of a vasoconstrictor in the local anesthetic solution is least likely to prolong the action of:'
p7619
sg33
I16
sg34
S'Q65#12'
p7620
sg36
I17
sg37
S'12'
p7621
sg38
I3
sg39
S'65'
p7622
sa(dp7623
g3
(lp7624
(lp7625
Vhttp://dbpedia.org/resource/Local_anesthetic
p7626
aVhttp://dbpedia.org/resource/Effectiveness
p7627
aa(lp7628
Vhttp://dbpedia.org/resource/Redox
p7629
aVhttp://dbpedia.org/resource/Local_anesthetic
p7630
aVhttp://dbpedia.org/resource/Effectiveness
p7631
aa(lp7632
Vhttp://dbpedia.org/resource/Clonidine
p7633
aVhttp://dbpedia.org/resource/Clonidine
p7634
aVhttp://dbpedia.org/resource/David_Williamson
p7635
aVhttp://dbpedia.org/resource/Local_anesthetic
p7636
aVhttp://dbpedia.org/resource/Efficacy
p7637
aasg18
(lp7638
Venhanced local anesthetic effectiveness
p7639
aVreduced local anesthetic effectiveness
p7640
aVno clonidine (Catapres) influence on local anesthetic efficacy
p7641
asg24
(lp7642
Vhttp://dbpedia.org/resource/Clonidine
p7643
aVhttp://dbpedia.org/resource/Clonidine
p7644
aVhttp://dbpedia.org/resource/Local_anesthetic
p7645
aVhttp://dbpedia.org/resource/Solution
p7646
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7647
sg31
S'Effect of clonidine (Catapres) addition to local anesthetic solutions:'
p7648
sg33
I18
sg34
S'Q65#15'
p7649
sg36
I11
sg37
S'15'
p7650
sg38
I0
sg39
S'65'
p7651
sa(dp7652
g3
(lp7653
(lp7654
Vhttp://dbpedia.org/resource/Brachial_plexus
p7655
aa(lp7656
Vhttp://dbpedia.org/resource/Sciatic_nerve
p7657
aasg18
(lp7658
Vintercostal
p7659
aVbrachial plexus
p7660
aVsciatic nerve
p7661
asg24
(lp7662
Vhttp://dbpedia.org/resource/Comparative_genomics
p7663
aVhttp://dbpedia.org/resource/Maxima_and_minima
p7664
aVhttp://dbpedia.org/resource/Local_anesthetic
p7665
aVhttp://dbpedia.org/resource/Function_%28mathematics%29
p7666
aVhttp://dbpedia.org/resource/Injection_%28medicine%29
p7667
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7668
sg31
S'Based on comparative vascularity, maximum local anesthetic blood levels as a function of injection sites for regional anesthesia:'
p7669
sg33
I5
sg34
S'Q65#17'
p7670
sg36
I19
sg37
S'17'
p7671
sg38
I0
sg39
S'65'
p7672
sa(dp7673
g3
(lp7674
(lp7675
Vhttp://dbpedia.org/resource/Amide
p7676
aVhttp://dbpedia.org/resource/Agent_Orange
p7677
aa(lp7678
Vhttp://dbpedia.org/resource/Ester
p7679
aVhttp://dbpedia.org/resource/Agent_Orange
p7680
aa(lp7681
Vhttp://dbpedia.org/resource/Subtraction
p7682
aasg18
(lp7683
VAmide agents
p7684
aVEster agents
p7685
aVno difference
p7686
asg24
(lp7687
Vhttp://dbpedia.org/resource/Type_system
p7688
aVhttp://dbpedia.org/resource/Local_anesthetic
p7689
aVhttp://dbpedia.org/resource/Distribution_%28economics%29
p7690
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7691
sg31
S'Type of local anesthetic with wider distribution:'
p7692
sg33
I6
sg34
S'Q65#18'
p7693
sg36
I7
sg37
S'18'
p7694
sg38
I0
sg39
S'65'
p7695
sa(dp7696
g3
(lp7697
(lp7698
Vhttp://dbpedia.org/resource/Heart
p7699
aa(lp7700
Vhttp://dbpedia.org/resource/Brain
p7701
aa(lp7702
Vhttp://dbpedia.org/resource/Lung
p7703
aa(lp7704
Vhttp://dbpedia.org/resource/Kidney
p7705
aasg18
(lp7706
VHeart
p7707
aVBrain
p7708
aVLung
p7709
aVKidney
p7710
aVFat
p7711
asg24
(lp7712
Vhttp://dbpedia.org/resource/Route_of_administration
p7713
aVhttp://dbpedia.org/resource/Lidocaine
p7714
aVhttp://dbpedia.org/resource/Lidocaine
p7715
aVhttp://dbpedia.org/resource/Organ_%28anatomy%29
p7716
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions1/questionset1.htm'
p7717
sg31
S'Following IV infusion of lidocaine (Xylocaine): initial high uptake into this organ:'
p7718
sg33
I5
sg34
S'Q65#19'
p7719
sg36
I15
sg37
S'19'
p7720
sg38
I2
sg39
S'65'
p7721
sa(dp7722
g3
(lp7723
(lp7724
Vhttp://dbpedia.org/resource/Redox
p7725
aa(lp7726
Vhttp://dbpedia.org/resource/Local_anesthetic
p7727
aasg18
(lp7728
Venhanced accumulation
p7729
aVreduced accumulation
p7730
aVno effect on local anesthetic accumulation
p7731
asg24
(lp7732
Vhttp://dbpedia.org/resource/Fetus
p7733
aVhttp://dbpedia.org/resource/Acidosis
p7734
aVhttp://dbpedia.org/resource/Local_anesthetic
p7735
aVhttp://dbpedia.org/resource/Fetus
p7736
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7737
sg31
S'Effect of fetal acidosis on local anesthetic accumulation in the fetus'
p7738
sg33
I10
sg34
S'Q66#3'
p7739
sg36
I11
sg37
S'3'
sg38
I0
sg39
S'66'
p7740
sa(dp7741
g3
(lp7742
(lp7743
Vhttp://dbpedia.org/resource/Rapid
p7744
aVhttp://dbpedia.org/resource/Hydrolysis
p7745
aa(lp7746
Vhttp://dbpedia.org/resource/Liver
p7747
aVhttp://dbpedia.org/resource/Mediation
p7748
aasg18
(lp7749
Vrapid hydrolysis
p7750
aVhepatic mediation
p7751
aVsignificant renal excretion
p7752
asg24
(lp7753
Vhttp://dbpedia.org/resource/Highland_Clearances
p7754
aVhttp://dbpedia.org/resource/Amide
p7755
aVhttp://dbpedia.org/resource/Local_anesthetic
p7756
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7757
sg31
S'Clearance: amide local anesthetic'
p7758
sg33
I7
sg34
S'Q66#4'
p7759
sg36
I5
sg37
S'4'
sg38
I1
sg39
S'66'
p7760
sa(dp7761
g3
(lp7762
(lp7763
Vhttp://dbpedia.org/resource/Lidocaine
p7764
aVhttp://dbpedia.org/resource/Lidocaine
p7765
aasg18
(lp7766
Vprilocaine (Citanest)
p7767
aVropivacaine (Naropin)
p7768
aVlidocaine (Xylocaine)
p7769
aVmepivacaine (Carbocaine)
p7770
asg24
(lp7771
Vhttp://dbpedia.org/resource/Metabolism
p7772
aVhttp://dbpedia.org/resource/Amide
p7773
aVhttp://dbpedia.org/resource/Data_type
p7774
aVhttp://dbpedia.org/resource/Local_anesthetic
p7775
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7776
sg31
S'Slows metabolism among the amide-type local anesthetics'
p7777
sg33
I16
sg34
S'Q66#6'
p7778
sg36
I7
sg37
S'6'
sg38
I1
sg39
S'66'
p7779
sa(dp7780
g3
(lp7781
(lp7782
Vhttp://dbpedia.org/resource/Procaine
p7783
aVhttp://dbpedia.org/resource/Procaine
p7784
aasg18
(lp7785
Vtetracaine (pontocaine)
p7786
aVprocaine (Novocain)
p7787
aVchloroprocaine (Nesacaine)
p7788
asg24
(lp7789
Vhttp://dbpedia.org/resource/Local_anesthetic
p7790
aVhttp://dbpedia.org/resource/Metabolism
p7791
aVhttp://dbpedia.org/resource/Cholinesterase
p7792
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7793
sg31
S'Local anesthetic most rapidly metabolized by cholinesterase'
p7794
sg33
I12
sg34
S'Q66#8'
p7795
sg36
I7
sg37
S'8'
sg38
I2
sg39
S'66'
p7796
sa(dp7797
g3
(lp7798
(lp7799
Vhttp://dbpedia.org/resource/Proportionality_%28mathematics%29
p7800
aVhttp://dbpedia.org/resource/Hydrolysis
p7801
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p7802
aa(lp7803
Vhttp://dbpedia.org/resource/Proportionality_%28mathematics%29
p7804
aVhttp://dbpedia.org/resource/Hydrolysis
p7805
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p7806
aa(lp7807
Vhttp://dbpedia.org/resource/Independent_%28religion%29
p7808
aVhttp://dbpedia.org/resource/Hydrolysis
p7809
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p7810
aasg18
(lp7811
Vdirectly proportional to hydrolytic rate
p7812
aVinversely proportional to hydrolytic rate
p7813
aVindependent of hydrolytic rate
p7814
asg24
(lp7815
Vhttp://dbpedia.org/resource/Systemic_risk
p7816
aVhttp://dbpedia.org/resource/Toxicity
p7817
aVhttp://dbpedia.org/resource/Ester
p7818
aVhttp://dbpedia.org/resource/Type_theory
p7819
aVhttp://dbpedia.org/resource/Local_anesthetic
p7820
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7821
sg31
S'Systemic toxicity of ester-type local anesthetics:'
p7822
sg33
I14
sg34
S'Q66#9'
p7823
sg36
I6
sg37
S'9'
sg38
I1
sg39
S'66'
p7824
sa(dp7825
g3
(lp7826
(lp7827
Vhttp://dbpedia.org/resource/Redox
p7828
aVhttp://dbpedia.org/resource/Duration_%28music%29
p7829
aa(lp7830
Vhttp://dbpedia.org/resource/Duration_%28music%29
p7831
aa(lp7832
Vhttp://dbpedia.org/resource/Duration_%28music%29
p7833
aVhttp://dbpedia.org/resource/Combat
p7834
aasg18
(lp7835
Vreduced duration
p7836
aVincreased duration
p7837
aVno effect on duration of action
p7838
asg24
(lp7839
Vhttp://dbpedia.org/resource/Ester
p7840
aVhttp://dbpedia.org/resource/Data_type
p7841
aVhttp://dbpedia.org/resource/Local_anesthetic
p7842
aVhttp://dbpedia.org/resource/Duration_%28music%29
p7843
aVhttp://dbpedia.org/resource/Combat
p7844
aVhttp://dbpedia.org/resource/Patient
p7845
aVhttp://dbpedia.org/resource/Blood_plasma
p7846
aVhttp://dbpedia.org/resource/Cholinesterase
p7847
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7848
sg31
S'Effects on ester-type local anesthetic duration of action in patients with atypical plasma cholinesterase:'
p7849
sg33
I10
sg34
S'Q66#11'
p7850
sg36
I14
sg37
S'11'
p7851
sg38
I1
sg39
S'66'
p7852
sa(dp7853
g3
(lp7854
(lp7855
Vhttp://dbpedia.org/resource/Lidocaine
p7856
aVhttp://dbpedia.org/resource/Lidocaine
p7857
aa(lp7858
Vhttp://dbpedia.org/resource/Procaine
p7859
aVhttp://dbpedia.org/resource/Procaine
p7860
aasg18
(lp7861
Vlidocaine (Xylocaine)
p7862
aVbupivacaine (Marcaine)
p7863
aVmepivacaine (Carbocaine)
p7864
aVprilocaine (Citanest)
p7865
aVprocaine (Novocain)
p7866
asg24
(lp7867
Vhttp://dbpedia.org/resource/Local_anesthetic
p7868
aVhttp://dbpedia.org/resource/Cyanosis
p7869
aVhttp://dbpedia.org/resource/Secondary_school
p7870
aVhttp://dbpedia.org/resource/Oxygen
p7871
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7872
sg31
S'Local anesthetic which may cause cyanosis secondary to reduced oxygen transport'
p7873
sg33
I20
sg34
S'Q66#14'
p7874
sg36
I11
sg37
S'14'
p7875
sg38
I3
sg39
S'66'
p7876
sa(dp7877
g3
(lp7878
(lp7879
Vhttp://dbpedia.org/resource/Procaine
p7880
aVhttp://dbpedia.org/resource/Procaine
p7881
aasg18
(lp7882
Vmepivacaine (Carbocaine)
p7883
aVbupivacaine (Marcaine)
p7884
aVdibucaine (Nupercainal, generic)
p7885
aVprocaine (Novocain)
p7886
asg24
(lp7887
Vhttp://dbpedia.org/resource/Amide
p7888
aVhttp://dbpedia.org/resource/Derivative_%28chemistry%29
p7889
aVhttp://dbpedia.org/resource/Local_anesthetic
p7890
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions2/questionset2.htm'
p7891
sg31
S'Most slowly eliminated among amide derivative local anesthetics:'
p7892
sg33
I18
sg34
S'Q66#15'
p7893
sg36
I8
sg37
S'15'
p7894
sg38
I2
sg39
S'66'
p7895
sa(dp7896
g3
(lp7897
(lp7898
Vhttp://dbpedia.org/resource/Common_land
p7899
aa(lp7900
Vhttp://dbpedia.org/resource/Amide
p7901
aVhttp://dbpedia.org/resource/Type_system
p7902
aVhttp://dbpedia.org/resource/Agent_Orange
p7903
aa(lp7904
Vhttp://dbpedia.org/resource/Preservative
p7905
aasg18
(lp7906
Vcommon
p7907
aVmainly associated with amide-type agents
p7908
aVmay be caused by preservatives
p7909
asg24
(lp7910
Vhttp://dbpedia.org/resource/Allergy
p7911
aVhttp://dbpedia.org/resource/Local_anesthetic
p7912
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions3/questionset3.htm'
p7913
sg31
S'Allergic reactions to local anesthetics: characteristics'
p7914
sg33
I11
sg34
S'Q67#2'
p7915
sg36
I7
sg37
S'2'
sg38
I2
sg39
S'67'
p7916
sa(dp7917
g3
(lp7918
(lp7919
Vhttp://dbpedia.org/resource/Vagrancy_%28biology%29
p7920
aVhttp://dbpedia.org/resource/Direct_current
p7921
aVhttp://dbpedia.org/resource/Blood_vessel
p7922
aVhttp://dbpedia.org/resource/Injection_%28medicine%29
p7923
aa(lp7924
Vhttp://dbpedia.org/resource/Digestion
p7925
aVhttp://dbpedia.org/resource/Injection_%28medicine%29
p7926
aVhttp://dbpedia.org/resource/Ribosome
p7927
aasg18
(lp7928
Vdosage too high
p7929
aVaccidental direct intravascular injection during peripheral nerve block or epidural anesthesia
p7930
aVexcessive absorption from injection site
p7931
asg24
(lp7932
Vhttp://dbpedia.org/resource/Common_Cause
p7933
aVhttp://dbpedia.org/resource/Toxicity
p7934
aVhttp://dbpedia.org/resource/Blood_plasma
p7935
aVhttp://dbpedia.org/resource/Local_anesthetic
p7936
aVhttp://dbpedia.org/resource/Concentration
p7937
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions3/questionset3.htm'
p7938
sg31
S'Most common cause of toxic plasma local anesthetic concentrations'
p7939
sg33
I19
sg34
S'Q67#7'
p7940
sg36
I9
sg37
S'7'
sg38
I1
sg39
S'67'
p7941
sa(dp7942
g3
(lp7943
(lp7944
Vhttp://dbpedia.org/resource/Tongue
p7945
aVhttp://dbpedia.org/resource/Paresthesia
p7946
aa(lp7947
Vhttp://dbpedia.org/resource/Tinnitus
p7948
aVhttp://dbpedia.org/resource/Vertigo
p7949
aasg18
(lp7950
Vtonic-clonic seizures
p7951
aVskeletal muscle fasciculation
p7952
aVtongue and circumoral numbness
p7953
aVtinnitus, vertigo, restlessness
p7954
asg24
(lp7955
Vhttp://dbpedia.org/resource/Symptom
p7956
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions3/questionset3.htm'
p7957
sg31
S'Earliest symptom associated with local anesthetic toxicity'
p7958
sg33
I14
sg34
S'Q67#9'
p7959
sg36
I7
sg37
S'9'
sg38
I2
sg39
S'67'
p7960
sa(dp7961
g3
(lp7962
(lp7963
Vhttp://dbpedia.org/resource/Rates_%28tax%29
p7964
aVhttp://dbpedia.org/resource/Injection_%28medicine%29
p7965
aVhttp://dbpedia.org/resource/Injection_%28medicine%29
p7966
aVhttp://dbpedia.org/resource/Rates_%28tax%29
p7967
aVhttp://dbpedia.org/resource/Total_S.A.
p7968
aVhttp://dbpedia.org/resource/Quantity
p7969
aVhttp://dbpedia.org/resource/Drug
p7970
aa(lp7971
Vhttp://dbpedia.org/resource/Local_anesthetic
p7972
aVhttp://dbpedia.org/resource/Epileptic_seizure
p7973
aa(lp7974
Vhttp://dbpedia.org/resource/Hypokalemia
p7975
aa(lp7976
Vhttp://dbpedia.org/resource/Redox
p7977
aVhttp://dbpedia.org/resource/Lidocaine
p7978
aVhttp://dbpedia.org/resource/Lidocaine
p7979
aVhttp://dbpedia.org/resource/Toxicity
p7980
aVhttp://dbpedia.org/resource/Patient
p7981
aasg18
(lp7982
Vrate of injection -- injection rate more important than total amount of drug injected
p7983
aVdirect relationship between PaCO2 and local anesthetic seizure thresholds
p7984
aVhypokalemia: increased local anesthetic toxicity
p7985
aVReduced lidocaine (Xylocaine) toxicity in patients treated perioperatively with mexiletine (Mexitil)
p7986
asg24
(lp7987
Vhttp://dbpedia.org/resource/Local_anesthetic
p7988
aVhttp://dbpedia.org/resource/Central_nervous_system
p7989
aVhttp://dbpedia.org/resource/Toxicity
p7990
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions3/questionset3.htm'
p7991
sg31
S'Factors influencing local anesthetic CNS toxicity:'
p7992
sg33
I44
sg34
S'Q67#11'
p7993
sg36
I6
sg37
S'11'
p7994
sg38
I0
sg39
S'67'
p7995
sa(dp7996
g3
(lp7997
(lp7998
Vhttp://dbpedia.org/resource/Irritation
p7999
aa(lp8000
Vhttp://dbpedia.org/resource/Syndrome
p8001
aasg18
(lp8002
Vcauda equina syndrome
p8003
aVtransient radicular irritation
p8004
aVanterior spinal artery syndrome
p8005
asg24
(lp8006
Vhttp://dbpedia.org/resource/Local_anesthetic
p8007
aVhttp://dbpedia.org/resource/Neurotoxicity
p8008
aVhttp://dbpedia.org/resource/Symptom
p8009
aVhttp://dbpedia.org/resource/Moderate
p8010
aVhttp://dbpedia.org/resource/Buttocks
p8011
aVhttp://dbpedia.org/resource/Thigh
p8012
aVhttp://dbpedia.org/resource/Pain
p8013
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions3/questionset3.htm'
p8014
sg31
S'Local anesthetic Neurotoxicity symptoms: moderate/severe lower back, buttocks, posterior thigh pain'
p8015
sg33
I10
sg34
S'Q67#14'
p8016
sg36
I14
sg37
S'14'
p8017
sg38
I1
sg39
S'67'
p8018
sa(dp8019
g3
(lp8020
(lp8021
Vhttp://dbpedia.org/resource/Irritation
p8022
aa(lp8023
Vhttp://dbpedia.org/resource/Syndrome
p8024
aasg18
(lp8025
Vtransient radicular irritation
p8026
aVcauda equina syndrome
p8027
aVanterior spinal artery syndrome
p8028
asg24
(lp8029
Vhttp://dbpedia.org/resource/Local_anesthetic
p8030
aVhttp://dbpedia.org/resource/Neurotoxicity
p8031
aVhttp://dbpedia.org/resource/Symptom
p8032
aVhttp://dbpedia.org/resource/Sensory_neuron
p8033
aVhttp://dbpedia.org/resource/Anesthesia
p8034
aVhttp://dbpedia.org/resource/Intestine
p8035
aVhttp://dbpedia.org/resource/Urinary_bladder
p8036
aVhttp://dbpedia.org/resource/Sphincter
p8037
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions3/questionset3.htm'
p8038
sg31
S'Local anesthetic neurotoxicity symptoms: sensory anesthesia; bowel & bladder sphincter dysfunction'
p8039
sg33
I10
sg34
S'Q67#15'
p8040
sg36
I13
sg37
S'15'
p8041
sg38
I1
sg39
S'67'
p8042
sa(dp8043
g3
(lp8044
(lp8045
Vhttp://dbpedia.org/resource/Stimulation
p8046
aasg18
(lp8047
Vstimulation
p8048
aVinhibition
p8049
aVno effect
p8050
asg24
(lp8051
Vhttp://dbpedia.org/resource/Carbon_dioxide
p8052
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8053
sg31
S'Bupivacaine (Marcaine) effects on ventilatory response carbon dioxide:'
p8054
sg33
I4
sg34
S'Q68#4'
p8055
sg36
I10
sg37
S'4'
sg38
I0
sg39
S'68'
p8056
sa(dp8057
g3
(lp8058
(lp8059
Vhttp://dbpedia.org/resource/Preventive_medicine
p8060
aa(lp8061
Vhttp://dbpedia.org/resource/Management
p8062
aVhttp://dbpedia.org/resource/Intracranial_pressure
p8063
aa(lp8064
Vhttp://dbpedia.org/resource/Region
p8065
aa(lp8066
Vhttp://dbpedia.org/resource/Analgesic
p8067
aa(lp8068
Vhttp://dbpedia.org/resource/Management
p8069
aasg18
(lp8070
Vprevention and treatment of cardiac arrhythmias
p8071
aVmanagement of increased intracranial pressure
p8072
aVregional anesthetia
p8073
aVanalgesia
p8074
aVmanagement of grand mal seizure
p8075
asg24
(lp8076
Vhttp://dbpedia.org/resource/Local_anesthetic
p8077
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8078
sg31
S'Most frequent use of local anesthetics:'
p8079
sg33
I19
sg34
S'Q68#5'
p8080
sg36
I6
sg37
S'5'
sg38
I2
sg39
S'68'
p8081
sa(dp8082
g3
(lp8083
(lp8084
Vhttp://dbpedia.org/resource/Lidocaine
p8085
aVhttp://dbpedia.org/resource/Lidocaine
p8086
aa(lp8087
Vhttp://dbpedia.org/resource/Cocaine
p8088
aasg18
(lp8089
Vlidocaine (Xylocaine)
p8090
aVprilocaine (Citanest)
p8091
aVdyclonine (Dyclone)
p8092
aVcocaine
p8093
aVbupivacaine (Marcaine)
p8094
asg24
(lp8095
Vhttp://dbpedia.org/resource/Local_anesthetic
p8096
aVhttp://dbpedia.org/resource/Patient
p8097
aVhttp://dbpedia.org/resource/Allergy
p8098
aVhttp://dbpedia.org/resource/Procaine
p8099
aVhttp://dbpedia.org/resource/Procaine
p8100
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8101
sg31
S'Appropriate local anesthetic for patients allergic to bupivacaine (Marcaine) and procaine (Novocain):'
p8102
sg33
I17
sg34
S'Q68#16'
p8103
sg36
I17
sg37
S'16'
p8104
sg38
I2
sg39
S'68'
p8105
sa(dp8106
g3
(lp8107
(lp8108
Vhttp://dbpedia.org/resource/Lidocaine
p8109
aVhttp://dbpedia.org/resource/Lidocaine
p8110
aasg18
(lp8111
Vropivacaine (Naropin)
p8112
aVbupivacaine (Marcaine)
p8113
aVlidocaine (Xylocaine)
p8114
asg24
(lp8115
Vhttp://dbpedia.org/resource/Common_land
p8116
aVhttp://dbpedia.org/resource/Local_anesthetic
p8117
aVhttp://dbpedia.org/resource/Choice_of_law
p8118
aVhttp://dbpedia.org/resource/Local_anesthesia
p8119
aVhttp://dbpedia.org/resource/Infiltration_%28hydrology%29
p8120
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8121
sg31
S'Most common local anesthetic choice for local infiltration'
p8122
sg33
I12
sg34
S'Q68#17'
p8123
sg36
I8
sg37
S'17'
p8124
sg38
I2
sg39
S'68'
p8125
sa(dp8126
g3
(lp8127
(lp8128
Vhttp://dbpedia.org/resource/Motor_neuron
p8129
aa(lp8130
Vhttp://dbpedia.org/resource/Anatomy
p8131
aVhttp://dbpedia.org/resource/Location_%28geography%29
p8132
aasg18
(lp8133
Vmotor first
p8134
aVsensory first
p8135
aVdepended on anatomical locations within the nerve fiber
p8136
asg24
(lp8137
Vhttp://dbpedia.org/resource/Mixed_media
p8138
aVhttp://dbpedia.org/resource/Peripheral_nervous_system
p8139
aVhttp://dbpedia.org/resource/Motor_neuron
p8140
aVhttp://dbpedia.org/resource/Sequence
p8141
aVhttp://dbpedia.org/resource/Anesthesia
p8142
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8143
sg31
S'In mixed peripheral nerves (motor/sensory)-- sequence of anesthesia'
p8144
sg33
I12
sg34
S'Q68#19'
p8145
sg36
I11
sg37
S'19'
p8146
sg38
I2
sg39
S'68'
p8147
sa(dp8148
g3
(lp8149
(lp8150
Vhttp://dbpedia.org/resource/Lidocaine
p8151
aVhttp://dbpedia.org/resource/Lidocaine
p8152
aa(lp8153
Vhttp://dbpedia.org/resource/Subject_%28grammar%29
p8154
aVhttp://dbpedia.org/resource/Ester
p8155
aVhttp://dbpedia.org/resource/Hydrolysis
p8156
aa(lp8157
Vhttp://dbpedia.org/resource/Lidocaine
p8158
aVhttp://dbpedia.org/resource/Lidocaine
p8159
aVhttp://dbpedia.org/resource/Ionization
p8160
aVhttp://dbpedia.org/resource/Musical_form
p8161
aasg18
(lp8162
Vlidocaine (Xylocaine) is more lipophilic
p8163
aVbupivacaine (Marcaine) is subject to extensive ester hydrolysis
p8164
aVlidocaine (Xylocaine) is present to a greater extent in an un-ionized form
p8165
asg24
(lp8166
Vhttp://dbpedia.org/resource/Peripheral_nervous_system
p8167
aVhttp://dbpedia.org/resource/Blockade
p8168
aVhttp://dbpedia.org/resource/Lidocaine
p8169
aVhttp://dbpedia.org/resource/Lidocaine
p8170
aVhttp://dbpedia.org/resource/Wayne_Shorter
p8171
aVhttp://dbpedia.org/resource/Time
p8172
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8173
sg31
S'And peripheral nerve blockade, why lidocaine (Xylocaine) has a shorter time to onset compared to bupivacaine (Marcaine):'
p8174
sg33
I31
sg34
S'Q68#20'
p8175
sg36
I23
sg37
S'20'
p8176
sg38
I2
sg39
S'68'
p8177
sa(dp8178
g3
(lp8179
(lp8180
Vhttp://dbpedia.org/resource/Lidocaine
p8181
aVhttp://dbpedia.org/resource/Lidocaine
p8182
aasg18
(lp8183
Vropivacaine (Naropin)
p8184
aVbupivacaine (Marcaine)
p8185
aVtetracaine (pontocaine)
p8186
aVlidocaine (Xylocaine)
p8187
asg24
(lp8188
Vhttp://dbpedia.org/resource/Local_anesthetic
p8189
aVhttp://dbpedia.org/resource/Local_anesthesia
p8190
aVhttp://dbpedia.org/resource/Infiltration_%28hydrology%29
p8191
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8192
sg31
S' Local anesthetic not recommended for their block or for local infiltration:'
p8193
sg33
I16
sg34
S'Q68#21'
p8194
sg36
I11
sg37
S'21'
p8195
sg38
I2
sg39
S'68'
p8196
sa(dp8197
g3
(lp8198
(lp8199
Vhttp://dbpedia.org/resource/Lidocaine
p8200
aVhttp://dbpedia.org/resource/Lidocaine
p8201
aasg18
(lp8202
Vlidocaine (Xylocaine)
p8203
aVprilocaine (Citanest)
p8204
aVbupivacaine (Marcaine)
p8205
asg24
(lp8206
Vhttp://dbpedia.org/resource/Local_anesthetic
p8207
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8208
sg31
S'Local anesthetic not recommended for Bier block'
p8209
sg33
I12
sg34
S'Q68#22'
p8210
sg36
I7
sg37
S'22'
p8211
sg38
I2
sg39
S'68'
p8212
sa(dp8213
g3
(lp8214
sg18
(lp8215
Vtetracaine (pontocaine)
p8216
aVchloroprocaine (Nesacaine)
p8217
aVlidocaine (Xylocaine)
p8218
aV bupivacaine (Marcaine)
p8219
asg24
(lp8220
Vhttp://dbpedia.org/resource/Lidocaine
p8221
aVhttp://dbpedia.org/resource/Lidocaine
p8222
asg29
S'http://www.pharmacology2000.com/Central/Local_Anes/questions4/questionset4.htm'
p8223
sg31
S'Not suitable for spinal anesthesia:'
p8224
sg33
I16
sg34
S'Q68#31'
p8225
sg36
I5
sg37
S'31'
p8226
sg38
I1
sg39
S'68'
p8227
sa(dp8228
g3
(lp8229
(lp8230
Vhttp://dbpedia.org/resource/Chloral_hydrate
p8231
aVhttp://dbpedia.org/resource/Chloral_hydrate
p8232
aa(lp8233
Vhttp://dbpedia.org/resource/Haloperidol
p8234
aVhttp://dbpedia.org/resource/Haloperidol
p8235
aa(lp8236
Vhttp://dbpedia.org/resource/Lithium
p8237
aasg18
(lp8238
Vchloral hydrate (Noctec)
p8239
aVhaloperidol (Haldol)
p8240
aVlithium
p8241
aVmeprobamate (Miltown)
p8242
asg24
(lp8243
Vhttp://dbpedia.org/resource/Side_effect
p8244
aVhttp://dbpedia.org/resource/Anticholinergic
p8245
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8246
sg31
S'Side effects include anti-cholinergic, anti-adrenergic and extrapyramidal'
p8247
sg33
I14
sg34
S'Q69#0'
p8248
sg36
I8
sg37
S'0'
sg38
I1
sg39
S'69'
p8249
sa(dp8250
g3
(lp8251
(lp8252
Vhttp://dbpedia.org/resource/Glycine
p8253
aVhttp://dbpedia.org/resource/Metabolism
p8254
aa(lp8255
Vhttp://dbpedia.org/resource/Brain
p8256
aa(lp8257
Vhttp://dbpedia.org/resource/Dopaminergic
p8258
aa(lp8259
Vhttp://dbpedia.org/resource/Central_nervous_system
p8260
aasg18
(lp8261
Vabnormal glycine metabolism
p8262
aVdecreased brain GABA
p8263
aVdopaminergic abnormality
p8264
aVhigh levels of CNS VMA
p8265
asg24
(lp8266
Vhttp://dbpedia.org/resource/Schizophrenia
p8267
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8268
sg31
S'Neurochemical abnormality most closely associated with schizophrenia:'
p8269
sg33
I13
sg34
S'Q69#1'
p8270
sg36
I7
sg37
S'1'
sg38
I2
sg39
S'69'
p8271
sa(dp8272
g3
(lp8273
(lp8274
Vhttp://dbpedia.org/resource/Clozapine
p8275
aVhttp://dbpedia.org/resource/Clozapine
p8276
aa(lp8277
Vhttp://dbpedia.org/resource/Haloperidol
p8278
aVhttp://dbpedia.org/resource/Haloperidol
p8279
aa(lp8280
Vhttp://dbpedia.org/resource/Chlorpromazine
p8281
aVhttp://dbpedia.org/resource/Chlorpromazine
p8282
aasg18
(lp8283
Vclozapine (Clozaril)
p8284
aVthioridazine (Mellaril)
p8285
aVhaloperidol (Haldol)
p8286
aVchlorpromazine (Thorazine)
p8287
asg24
(lp8288
Vhttp://dbpedia.org/resource/Antipsychotic
p8289
aVhttp://dbpedia.org/resource/Patient
p8290
aVhttp://dbpedia.org/resource/Benign_prostatic_hyperplasia
p8291
aVhttp://dbpedia.org/resource/Chronic_%28medicine%29
p8292
aVhttp://dbpedia.org/resource/Constipation
p8293
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8294
sg31
S'Antipsychotic most appropriate in elderly patients with prostatic hypertrophy and chronic constipation.'
p8295
sg33
I16
sg34
S'Q69#2'
p8296
sg36
I13
sg37
S'2'
sg38
I2
sg39
S'69'
p8297
sa(dp8298
g3
(lp8299
(lp8300
Vhttp://dbpedia.org/resource/Clozapine
p8301
aVhttp://dbpedia.org/resource/Clozapine
p8302
aasg18
(lp8303
Vhaloperidol (Haldol)
p8304
aVloxapine (Loxitane)
p8305
aVclozapine (Clozaril)
p8306
asg24
(lp8307
Vhttp://dbpedia.org/resource/Haloperidol
p8308
aVhttp://dbpedia.org/resource/Haloperidol
p8309
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8310
sg31
S'Least extrapyramidal side effects:'
p8311
sg33
I12
sg34
S'Q69#3'
p8312
sg36
I4
sg37
S'3'
sg38
I2
sg39
S'69'
p8313
sa(dp8314
g3
(lp8315
(lp8316
Vhttp://dbpedia.org/resource/Clozapine
p8317
aVhttp://dbpedia.org/resource/Clozapine
p8318
aasg18
(lp8319
Vtrifluoperazine (Stelazine)
p8320
aVclozapine (Clozaril)
p8321
aVbenztropine (Cogentin)
p8322
aVmolindone (Moban)
p8323
asg24
(lp8324
Vhttp://dbpedia.org/resource/Schizophrenia
p8325
aVhttp://dbpedia.org/resource/Patient
p8326
aVhttp://dbpedia.org/resource/Haloperidol
p8327
aVhttp://dbpedia.org/resource/Lithium
p8328
aVhttp://dbpedia.org/resource/Delusion
p8329
aVhttp://dbpedia.org/resource/Drug
p8330
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8331
sg31
S'A schizophrenic patient has been treated with haloperidol, loxapine, thiothixene and lithium. If paranoid delusions persist, what other drug might be tried?'
p8332
sg33
I16
sg34
S'Q69#4'
p8333
sg36
I26
sg37
S'4'
sg38
I1
sg39
S'69'
p8334
sa(dp8335
g3
(lp8336
(lp8337
Vhttp://dbpedia.org/resource/Tardive_dyskinesia
p8338
aVhttp://dbpedia.org/resource/Redox
p8339
aa(lp8340
Vhttp://dbpedia.org/resource/Dystonia
p8341
aa(lp8342
Vhttp://dbpedia.org/resource/Dystonia
p8343
aVhttp://dbpedia.org/resource/L-DOPA
p8344
aa(lp8345
Vhttp://dbpedia.org/resource/Dystonia
p8346
aVhttp://dbpedia.org/resource/Diphenhydramine
p8347
aasg18
(lp8348
Vtardive dyskinesia: reduce fluphenazine (Prolixin) dosage
p8349
aVacute dystonia: benztropine (Cogentin)
p8350
aVacute dystonia:L-DOPA
p8351
aVacute dystonia: diphenhydramine (Benadryl)
p8352
asg24
(lp8353
Vhttp://dbpedia.org/resource/Patient
p8354
aVhttp://dbpedia.org/resource/Stiffness
p8355
aVhttp://dbpedia.org/resource/Neck
p8356
aVhttp://dbpedia.org/resource/Neurology
p8357
aVhttp://dbpedia.org/resource/Drug
p8358
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8359
sg31
S'Patient treated with fluphenazine presents the following day with a unilateral stiff , sore neck and back; What was the neurological reaction--which drug treatments might be appropriate?'
p8360
sg33
I27
sg34
S'Q69#5'
p8361
sg36
I31
sg37
S'5'
sg38
I3
sg39
S'69'
p8362
sa(dp8363
g3
(lp8364
(lp8365
Vhttp://dbpedia.org/resource/Tardive_dyskinesia
p8366
aa(lp8367
Vhttp://dbpedia.org/resource/Mouth
p8368
aVhttp://dbpedia.org/resource/Tremor
p8369
aa(lp8370
Vhttp://dbpedia.org/resource/Akathisia
p8371
aa(lp8372
Vhttp://dbpedia.org/resource/Parkinsonism
p8373
aasg18
(lp8374
Vtardive dyskinesia
p8375
aVperioral tremor
p8376
aVakathisia
p8377
aVpseudoparkinsonism
p8378
asg24
(lp8379
Vhttp://dbpedia.org/resource/Antipsychotic
p8380
aVhttp://dbpedia.org/resource/Neurology
p8381
aVhttp://dbpedia.org/resource/Side_effect
p8382
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8383
sg31
S'Most common antipsychotic neurological side effect:'
p8384
sg33
I6
sg34
S'Q69#6'
p8385
sg36
I6
sg37
S'6'
sg38
I2
sg39
S'69'
p8386
sa(dp8387
g3
(lp8388
(lp8389
Vhttp://dbpedia.org/resource/Chlorpromazine
p8390
aVhttp://dbpedia.org/resource/Chlorpromazine
p8391
aa(lp8392
Vhttp://dbpedia.org/resource/Carbamazepine
p8393
aVhttp://dbpedia.org/resource/Carbamazepine
p8394
aasg18
(lp8395
Vchlorpromazine (Thorazine)
p8396
aVcarbamazepine (Tegretol)
p8397
aVphenelzine (Nardil)
p8398
aVamantidine (Symmetrel)
p8399
asg24
(lp8400
Vhttp://dbpedia.org/resource/Alternative_medicine
p8401
aVhttp://dbpedia.org/resource/Patient
p8402
aVhttp://dbpedia.org/resource/Bipolar_disorder
p8403
aVhttp://dbpedia.org/resource/Lithium
p8404
asg29
S'http://www.pharmacology2000.com/Central/psychotics/questions/questions2/psycho1.htm'
p8405
sg31
S'Accepted first alternative for treating patients with bipolar disorder not adequately responsive to lithium.'
p8406
sg33
I16
sg34
S'Q69#9'
p8407
sg36
I15
sg37
S'9'
sg38
I1
sg39
S'69'
p8408
sa(dp8409
g3
(lp8410
(lp8411
Vhttp://dbpedia.org/resource/Chlorpromazine
p8412
aVhttp://dbpedia.org/resource/Chlorpromazine
p8413
aa(lp8414
Vhttp://dbpedia.org/resource/Haloperidol
p8415
aVhttp://dbpedia.org/resource/Haloperidol
p8416
aasg18
(lp8417
Vthioridazine (Mellaril)
p8418
aVchlorpromazine (Thorazine)
p8419
aVthiothixene (Navane)
p8420
aVhaloperidol (Haldol)
p8421
aVfluphenazine (Prolixin)
p8422
asg24
(lp8423
Vhttp://dbpedia.org/resource/Antipsychotic
p8424
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8425
sg31
S'Butyrophenone antipsychotic:'
p8426
sg33
I20
sg34
S'Q70#0'
p8427
sg36
I2
sg37
S'0'
sg38
I3
sg39
S'70'
p8428
sa(dp8429
g3
(lp8430
(lp8431
Vhttp://dbpedia.org/resource/Haloperidol
p8432
aVhttp://dbpedia.org/resource/Haloperidol
p8433
aa(lp8434
Vhttp://dbpedia.org/resource/Chlorpromazine
p8435
aVhttp://dbpedia.org/resource/Chlorpromazine
p8436
aa(lp8437
Vhttp://dbpedia.org/resource/Olanzapine
p8438
aVhttp://dbpedia.org/resource/Olanzapine
p8439
aasg18
(lp8440
Vthiothixene (Navane)
p8441
aVhaloperidol (Haldol)
p8442
aVchlorpromazine (Thorazine)
p8443
aVolanzapine (Zyprexa)
p8444
asg24
(lp8445
Vhttp://dbpedia.org/resource/Clinical_trial
p8446
aVhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p8447
aVhttp://dbpedia.org/resource/Degree_%28angle%29
p8448
aVhttp://dbpedia.org/resource/Sedation
p8449
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8450
sg31
S'Associated with a LOW clinical potency but HIGH degree of sedation:'
p8451
sg33
I16
sg34
S'Q70#3'
p8452
sg36
I11
sg37
S'3'
sg38
I2
sg39
S'70'
p8453
sa(dp8454
g3
(lp8455
(lp8456
Vhttp://dbpedia.org/resource/Haloperidol
p8457
aVhttp://dbpedia.org/resource/Haloperidol
p8458
aa(lp8459
Vhttp://dbpedia.org/resource/Clozapine
p8460
aVhttp://dbpedia.org/resource/Clozapine
p8461
aa(lp8462
Vhttp://dbpedia.org/resource/Chlorpromazine
p8463
aVhttp://dbpedia.org/resource/Chlorpromazine
p8464
aasg18
(lp8465
Vfluphenazine (Prolixin)
p8466
aVhaloperidol (Haldol)
p8467
aVclozapine (Clozaril)
p8468
aVthiothixene (Navane)
p8469
aVchlorpromazine (Thorazine)
p8470
asg24
(lp8471
Vhttp://dbpedia.org/resource/Antipsychotic
p8472
aVhttp://dbpedia.org/resource/Drug
p8473
aVhttp://dbpedia.org/resource/Toxicity
p8474
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8475
sg31
S'Antipsychotic drug with least extrapyramidal toxicity:'
p8476
sg33
I20
sg34
S'Q70#4'
p8477
sg36
I6
sg37
S'4'
sg38
I2
sg39
S'70'
p8478
sa(dp8479
g3
(lp8480
(lp8481
Vhttp://dbpedia.org/resource/Chlorpromazine
p8482
aVhttp://dbpedia.org/resource/Chlorpromazine
p8483
aa(lp8484
Vhttp://dbpedia.org/resource/Clozapine
p8485
aVhttp://dbpedia.org/resource/Clozapine
p8486
aa(lp8487
Vhttp://dbpedia.org/resource/Olanzapine
p8488
aVhttp://dbpedia.org/resource/Olanzapine
p8489
aa(lp8490
Vhttp://dbpedia.org/resource/Hypotension
p8491
aasg18
(lp8492
Vchlorpromazine (Thorazine)
p8493
aVthiothixene (Navane)
p8494
aVclozapine (Clozaril)
p8495
aVolanzapine (Zyprexa)
p8496
aVall about equal in hypotensive action
p8497
asg24
(lp8498
Vhttp://dbpedia.org/resource/Antipsychotic
p8499
aVhttp://dbpedia.org/resource/Drug
p8500
aVhttp://dbpedia.org/resource/Hypotension
p8501
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8502
sg31
S'Antipsychotic drug:least hypotensive effect:'
p8503
sg33
I22
sg34
S'Q70#5'
p8504
sg36
I6
sg37
S'5'
sg38
I3
sg39
S'70'
p8505
sa(dp8506
g3
(lp8507
(lp8508
Vhttp://dbpedia.org/resource/Chlorpromazine
p8509
aVhttp://dbpedia.org/resource/Chlorpromazine
p8510
aa(lp8511
Vhttp://dbpedia.org/resource/Haloperidol
p8512
aVhttp://dbpedia.org/resource/Haloperidol
p8513
aa(lp8514
Vhttp://dbpedia.org/resource/Olanzapine
p8515
aVhttp://dbpedia.org/resource/Olanzapine
p8516
aasg18
(lp8517
Vchlorpromazine (Thorazine)
p8518
aVhaloperidol (Haldol)
p8519
aVperphenazine (Trilafon)
p8520
aVolanzapine (Zyprexa)
p8521
aVthiothixene (Navane)
p8522
asg24
(lp8523
Vhttp://dbpedia.org/resource/Prolactin
p8524
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8525
sg31
S'Least likely to cause an increase in prolactin:'
p8526
sg33
I20
sg34
S'Q70#8'
p8527
sg36
I8
sg37
S'8'
sg38
I3
sg39
S'70'
p8528
sa(dp8529
g3
(lp8530
(lp8531
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p8532
aVhttp://dbpedia.org/resource/Cholinergic
p8533
aa(lp8534
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p8535
aa(lp8536
Vhttp://dbpedia.org/resource/Dopamine_receptor
p8537
aasg18
(lp8538
Vmuscarinic cholinergic
p8539
aValpha adrenergic
p8540
aVdopamine
p8541
aVserotonin
p8542
aVGABA
p8543
asg24
(lp8544
Vhttp://dbpedia.org/resource/Blockade
p8545
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p8546
aVhttp://dbpedia.org/resource/Side_effect
p8547
aVhttp://dbpedia.org/resource/Antipsychotic
p8548
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8549
sg31
S'Blockade of this receptor system most likely associated with akisthisia side effect of antipsychotic treatment:'
p8550
sg33
I7
sg34
S'Q70#10'
p8551
sg36
I15
sg37
S'10'
p8552
sg38
I2
sg39
S'70'
p8553
sa(dp8554
g3
(lp8555
(lp8556
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p8557
aa(lp8558
Vhttp://dbpedia.org/resource/Dopamine_receptor
p8559
aa(lp8560
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p8561
aVhttp://dbpedia.org/resource/Cholinergic
p8562
aa(lp8563
Vhttp://dbpedia.org/resource/Serotonergic
p8564
aasg18
(lp8565
Valpha-adrenergic
p8566
aVdopamine
p8567
aVmuscarinic cholinergic
p8568
aVserotonergic
p8569
aVnone-of the above
p8570
asg24
(lp8571
Vhttp://dbpedia.org/resource/Toxicity
p8572
aVhttp://dbpedia.org/resource/Antipsychotic
p8573
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p8574
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8575
sg31
S'Toxic-confusion states due to antipsychotic medication associated with effects on this receptor system'
p8576
sg33
I8
sg34
S'Q70#11'
p8577
sg36
I13
sg37
S'11'
p8578
sg38
I2
sg39
S'70'
p8579
sa(dp8580
g3
(lp8581
(lp8582
Vhttp://dbpedia.org/resource/Olanzapine
p8583
aVhttp://dbpedia.org/resource/Olanzapine
p8584
aa(lp8585
Vhttp://dbpedia.org/resource/Risperidone
p8586
aVhttp://dbpedia.org/resource/Risperidone
p8587
aa(lp8588
Vhttp://dbpedia.org/resource/Clozapine
p8589
aasg18
(lp8590
Volanzapine (Zyprexa)
p8591
aVrisperidone (Risperdal)
p8592
aVpimozide (Orap)
p8593
aVclozapine
p8594
asg24
(lp8595
Vhttp://dbpedia.org/resource/Antipsychotic
p8596
aVhttp://dbpedia.org/resource/Drug
p8597
aVhttp://dbpedia.org/resource/Agranulocytosis
p8598
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8599
sg31
S'Antipsychotic drug most likely to induce agranulocytosis (around 2% frequency)'
p8600
sg33
I13
sg34
S'Q70#12'
p8601
sg36
I13
sg37
S'12'
p8602
sg38
I3
sg39
S'70'
p8603
sa(dp8604
g3
(lp8605
(lp8606
Vhttp://dbpedia.org/resource/Antipsychotic
p8607
aVhttp://dbpedia.org/resource/Drug
p8608
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p8609
aa(lp8610
Vhttp://dbpedia.org/resource/Ang_Dating_Daan
p8611
aVhttp://dbpedia.org/resource/Tricyclic_antidepressant
p8612
aVhttp://dbpedia.org/resource/Drug
p8613
aa(lp8614
Vhttp://dbpedia.org/resource/Ang_Dating_Daan
p8615
aa(lp8616
Vhttp://dbpedia.org/resource/Starting_lineup
p8617
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p8618
aVhttp://dbpedia.org/resource/Diazepam
p8619
aVhttp://dbpedia.org/resource/Kilogram
p8620
aa(lp8621
Vhttp://dbpedia.org/resource/Pharmacology
p8622
aVhttp://dbpedia.org/resource/Intervention_%28counseling%29
p8623
aVhttp://dbpedia.org/resource/Tardive_dyskinesia
p8624
aVhttp://dbpedia.org/resource/Antipsychotic
p8625
aasg18
(lp8626
Vincrease antipsychotic drug dose
p8627
aVadd a tricyclic antidepressants to the drug regimen
p8628
aVadd benztropine (Cogentin)
p8629
aVstart high-dose diazepam (30-40 milligrams per day)
p8630
aVno pharmacological intervention is helpful after tardive dyskinesia is induced by antipsychotic treatment
p8631
asg24
(lp8632
Vhttp://dbpedia.org/resource/Reason
p8633
aVhttp://dbpedia.org/resource/Pharmacology
p8634
aVhttp://dbpedia.org/resource/Tardive_dyskinesia
p8635
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question2/questionset2.htm'
p8636
sg31
S'Reasonable pharmacological step(s) to treat tardive dyskinesia:'
p8637
sg33
I39
sg34
S'Q70#14'
p8638
sg36
I10
sg37
S'14'
p8639
sg38
I3
sg39
S'70'
p8640
sa(dp8641
g3
(lp8642
(lp8643
Vhttp://dbpedia.org/resource/Major_depressive_disorder
p8644
aa(lp8645
Vhttp://dbpedia.org/resource/Schizophrenia
p8646
aa(lp8647
Vhttp://dbpedia.org/resource/Anxiety_disorder
p8648
aa(lp8649
Vhttp://dbpedia.org/resource/Bipolar_disorder
p8650
aasg18
(lp8651
Vtypical rendogenous depression
p8652
aVschizophrenia
p8653
aVanxiety
p8654
aVbipolar disorder
p8655
aVenuresis
p8656
asg24
(lp8657
Vhttp://dbpedia.org/resource/Lithium_carbonate
p8658
aVhttp://dbpedia.org/resource/Preference
p8659
asg29
S'http://www.pharmacology2000.com/Central/psychotics/question5/questionset5.htm'
p8660
sg31
S'Lithium carbonate is the preferred treatment for:'
p8661
sg33
I8
sg34
S'Q71#1'
p8662
sg36
I7
sg37
S'1'
sg38
I3
sg39
S'71'
p8663
sa(dp8664
g3
(lp8665
(lp8666
Vhttp://dbpedia.org/resource/Diazepam
p8667
aa(lp8668
Vhttp://dbpedia.org/resource/Paroxetine
p8669
aa(lp8670
Vhttp://dbpedia.org/resource/Methylphenidate
p8671
aasg18
(lp8672
Vdiazepam
p8673
aVparoxetine
p8674
aVoxazepam
p8675
aVmethylphenidate
p8676
asg24
(lp8677
Vhttp://dbpedia.org/resource/Anxiety
p8678
aVhttp://dbpedia.org/resource/Major_depressive_disorder
p8679
asg29
S'http://www.pharmacology2000.com/Central/Antidepressant/questions2/dep1.htm'
p8680
sg31
S'Anxiety associated with depression:'
p8681
sg33
I4
sg34
S'Q72#2'
p8682
sg36
I4
sg37
S'2'
sg38
I1
sg39
S'72'
p8683
sa(dp8684
g3
(lp8685
(lp8686
Vhttp://dbpedia.org/resource/Imipramine
p8687
aa(lp8688
Vhttp://dbpedia.org/resource/Sertraline
p8689
aasg18
(lp8690
Vimipramine
p8691
aVamoxapine
p8692
aVsertraline
p8693
aVphenelzine
p8694
asg24
(lp8695
Vhttp://dbpedia.org/resource/Management
p8696
aVhttp://dbpedia.org/resource/Mild_ale
p8697
aVhttp://dbpedia.org/resource/Moderate
p8698
aVhttp://dbpedia.org/resource/Major_depressive_disorder
p8699
asg29
S'http://www.pharmacology2000.com/Central/Antidepressant/questions2/dep1.htm'
p8700
sg31
S'Most likely to be prescribed first for management of mild to moderate depression:'
p8701
sg33
I4
sg34
S'Q72#4'
p8702
sg36
I13
sg37
S'4'
sg38
I2
sg39
S'72'
p8703
sa(dp8704
g3
(lp8705
(lp8706
Vhttp://dbpedia.org/resource/Imipramine
p8707
aa(lp8708
Vhttp://dbpedia.org/resource/Fluoxetine
p8709
aa(lp8710
Vhttp://dbpedia.org/resource/Amitriptyline
p8711
aasg18
(lp8712
Vimipramine
p8713
aVfluoxetine
p8714
aVphenelzine
p8715
aVamitriptyline
p8716
asg24
(lp8717
Vhttp://dbpedia.org/resource/Old_age
p8718
aVhttp://dbpedia.org/resource/Male
p8719
aVhttp://dbpedia.org/resource/Medical_history
p8720
aVhttp://dbpedia.org/resource/Myocardial_infarction
p8721
aVhttp://dbpedia.org/resource/Major_depressive_disorder
p8722
aVhttp://dbpedia.org/resource/Antidepressant
p8723
asg29
S'http://www.pharmacology2000.com/Central/Antidepressant/questions2/dep1.htm'
p8724
sg31
S'An elderly male with a history of coronary vascular disease (myocardial infarction and second degree heart block) presents with endogenous depression. Appropriate antidepressant medication would be:'
p8725
sg33
I4
sg34
S'Q72#6'
p8726
sg36
I28
sg37
S'6'
sg38
I1
sg39
S'72'
p8727
sa(dp8728
g3
(lp8729
(lp8730
Vhttp://dbpedia.org/resource/Hypertension
p8731
aa(lp8732
Vhttp://dbpedia.org/resource/Beta_blocker
p8733
aa(lp8734
Vhttp://dbpedia.org/resource/Monoamine_oxidase_inhibitor
p8735
aVhttp://dbpedia.org/resource/Hypertension
p8736
aVhttp://dbpedia.org/resource/Patient
p8737
aVhttp://dbpedia.org/resource/Ingestion
p8738
aVhttp://dbpedia.org/resource/Tyramine
p8739
aVhttp://dbpedia.org/resource/Food
p8740
aa(lp8741
Vhttp://dbpedia.org/resource/Generation
p8742
aVhttp://dbpedia.org/resource/Hypertension
p8743
aVhttp://dbpedia.org/resource/Side_effect
p8744
aasg18
(lp8745
VNormally, tranylcypromine causes hypertension
p8746
aVTranylcypromine, a beta-blocker, unmasked essential hypertension.
p8747
aVTranylcypromine, an MAO inhibitor, can cause hypertensive reactions in patients who have ingested tyramine-containing foods.
p8748
aVTyanylcypromine, a first-generation tricyclic antdepressant, produces hypertensive responses as a side effect.
p8749
asg24
(lp8750
Vhttp://dbpedia.org/resource/Depression_%28mood%29
p8751
aVhttp://dbpedia.org/resource/Patient
p8752
aVhttp://dbpedia.org/resource/Emergency_department
p8753
aVhttp://dbpedia.org/resource/Headache
p8754
aVhttp://dbpedia.org/resource/Patient
p8755
aVhttp://dbpedia.org/resource/Dinner
p8756
aVhttp://dbpedia.org/resource/Meal
p8757
aVhttp://dbpedia.org/resource/Symptom
p8758
asg29
S'http://www.pharmacology2000.com/Central/Antidepressant/questions2/dep1.htm'
p8759
sg31
S'A depressed patient treated with tranylcypromine presents to the emergency department with a pounding headache. The patient had just eaten dinner, enjoying a red wine with the meal. Suggest possible cause for these symptoms:'
p8760
sg33
I45
sg34
S'Q72#7'
p8761
sg36
I35
sg37
S'7'
sg38
I2
sg39
S'72'
p8762
sa(dp8763
g3
(lp8764
(lp8765
Vhttp://dbpedia.org/resource/Fluvoxamine
p8766
aa(lp8767
Vhttp://dbpedia.org/resource/Imipramine
p8768
aasg18
(lp8769
Vclomipramine
p8770
aVfluvoxamine
p8771
aVimipramine
p8772
aVphenelzine
p8773
asg24
(lp8774
Vhttp://dbpedia.org/resource/Obsessive%E2%80%93compulsive_disorder
p8775
aVhttp://dbpedia.org/resource/Patient
p8776
aVhttp://dbpedia.org/resource/Cardiac_muscle
p8777
aVhttp://dbpedia.org/resource/Disease
p8778
asg29
S'http://www.pharmacology2000.com/Central/Antidepressant/questions2/dep1.htm'
p8779
sg31
S'Drug treatment for obsessive-compulsive disorder in a patient with significant myocardial disease.'
p8780
sg33
I4
sg34
S'Q72#9'
p8781
sg36
I13
sg37
S'9'
sg38
I1
sg39
S'72'
p8782
sa(dp8783
g3
(lp8784
(lp8785
Vhttp://dbpedia.org/resource/Lithium
p8786
aa(lp8787
Vhttp://dbpedia.org/resource/Lithium
p8788
aVhttp://dbpedia.org/resource/Sodium
p8789
aa(lp8790
Vhttp://dbpedia.org/resource/Lithium
p8791
aVhttp://dbpedia.org/resource/Carbonic_anhydrase
p8792
aa(lp8793
Vhttp://dbpedia.org/resource/Lithium
p8794
aasg18
(lp8795
Vlithium-induced osmotic diuresis, similar to mannitor
p8796
aVlithium inhibits sodium exchange in the ascending loop of Henle
p8797
aVlithium activates carbonic anhydrase
p8798
aVlithium inhibits ADH receptor.
p8799
asg24
(lp8800
Vhttp://dbpedia.org/resource/Polyuria
p8801
aVhttp://dbpedia.org/resource/Lithium
p8802
asg29
S'http://www.pharmacology2000.com/Central/Antidepressant/questions2/dep1.htm'
p8803
sg31
S'Polyuria associated with lithium caused by:'
p8804
sg33
I26
sg34
S'Q72#11'
p8805
sg36
I6
sg37
S'11'
p8806
sg38
I3
sg39
S'72'
p8807
sa(dp8808
g3
(lp8809
(lp8810
Vhttp://dbpedia.org/resource/Parkinson%27s_disease
p8811
aa(lp8812
Vhttp://dbpedia.org/resource/Wilson%27s_disease
p8813
aa(lp8814
Vhttp://dbpedia.org/resource/Huntington%27s_disease
p8815
aa(lp8816
Vhttp://dbpedia.org/resource/Tourette_syndrome
p8817
aa(lp8818
Vhttp://dbpedia.org/resource/Hyperthyroidism
p8819
aasg18
(lp8820
VParkinson\u005c
p8821
aVWilson\u005c
p8822
aVHuntington\u005c
p8823
aVTourette\u005c
p8824
aVThyrotoxicosis
p8825
asg24
(lp8826
Vhttp://dbpedia.org/resource/Neurology
p8827
aVhttp://dbpedia.org/resource/Dysfunctional_family
p8828
aVhttp://dbpedia.org/resource/Dominance_%28genetics%29
p8829
aVhttp://dbpedia.org/resource/Genetic_disorder
p8830
aVhttp://dbpedia.org/resource/Copper
p8831
aVhttp://dbpedia.org/resource/Metabolism
p8832
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/question1/questionset1.htm'
p8833
sg31
S'Neurologic dysfunction is associated with this recessively-inherited disorder of copper metabolism:'
p8834
sg33
I5
sg34
S'Q73#0'
p8835
sg36
I11
sg37
S'0'
sg38
I1
sg39
S'73'
p8836
sa(dp8837
g3
(lp8838
(lp8839
Vhttp://dbpedia.org/resource/Parkinsonism
p8840
aVhttp://dbpedia.org/resource/Syndrome
p8841
aa(lp8842
Vhttp://dbpedia.org/resource/Akathisia
p8843
aa(lp8844
Vhttp://dbpedia.org/resource/Tardive_dyskinesia
p8845
aa(lp8846
Vhttp://dbpedia.org/resource/Dystonia
p8847
aa(lp8848
Vhttp://dbpedia.org/resource/Mouth
p8849
aVhttp://dbpedia.org/resource/Tremor
p8850
aasg18
(lp8851
VParkinsonian syndrome
p8852
aVakathisia
p8853
aVtardive dyskinesia
p8854
aVacute dystonia
p8855
aVperioral tremor
p8856
asg24
(lp8857
Vhttp://dbpedia.org/resource/Drug
p8858
aVhttp://dbpedia.org/resource/Phenothiazine
p8859
aVhttp://dbpedia.org/resource/Antipsychotic
p8860
aVhttp://dbpedia.org/resource/Adult
p8861
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/question1/questionset1.htm'
p8862
sg31
S'A drug-induced dyskinesia -- typically induced by long-term use of phenothiazine antipsychotics;in adults, may not be reversible'
p8863
sg33
I9
sg34
S'Q73#1'
p8864
sg36
I20
sg37
S'1'
sg38
I2
sg39
S'73'
p8865
sa(dp8866
g3
(lp8867
(lp8868
Vhttp://dbpedia.org/resource/Wilson%27s_disease
p8869
aa(lp8870
Vhttp://dbpedia.org/resource/Tourette_syndrome
p8871
aa(lp8872
Vhttp://dbpedia.org/resource/Huntington%27s_disease
p8873
aa(lp8874
Vhttp://dbpedia.org/resource/Parkinsonism
p8875
aasg18
(lp8876
VWilson\u005c
p8877
aVTourette\u005c
p8878
aVHuntington\u005c
p8879
aVParkinsonism
p8880
asg24
(lp8881
Vhttp://dbpedia.org/resource/Dementia
p8882
aVhttp://dbpedia.org/resource/Dopaminergic
p8883
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/question1/questionset1.htm'
p8884
sg31
S'Dominantly-inherited: associated with progressive chorea & dementia, typically beginning in adulthood --possibly due to overactivity of dopaminergic nigrostriatal pathways'
p8885
sg33
I4
sg34
S'Q73#3'
p8886
sg36
I22
sg37
S'3'
sg38
I2
sg39
S'73'
p8887
sa(dp8888
g3
(lp8889
(lp8890
Vhttp://dbpedia.org/resource/GABAA_receptor
p8891
aa(lp8892
Vhttp://dbpedia.org/resource/Glutamate_receptor
p8893
aa(lp8894
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p8895
aa(lp8896
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p8897
aasg18
(lp8898
VGABA receptors
p8899
aVglutamate receptors
p8900
aVadrenergic receptors
p8901
aVadenosine receptors
p8902
aVmuscarinic receptors
p8903
asg24
(lp8904
Vhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p8905
aVhttp://dbpedia.org/resource/Physical_system
p8906
aVhttp://dbpedia.org/resource/Propranolol
p8907
aVhttp://dbpedia.org/resource/Syndrome
p8908
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/question1/questionset1.htm'
p8909
sg31
S'Essential tremor: receptor system most likely to be involved given that propranolol or metoprolol may improve the syndrome.'
p8910
sg33
I10
sg34
S'Q73#4'
p8911
sg36
I20
sg37
S'4'
sg38
I2
sg39
S'73'
p8912
sa(dp8913
g3
(lp8914
(lp8915
Vhttp://dbpedia.org/resource/Amitriptyline
p8916
aa(lp8917
Vhttp://dbpedia.org/resource/L-DOPA
p8918
aasg18
(lp8919
Vorphenadrine
p8920
aVamitriptyline
p8921
aVselegiline
p8922
aVamantadine
p8923
aVlevodopa
p8924
asg24
(lp8925
Vhttp://dbpedia.org/resource/Drug
p8926
aVhttp://dbpedia.org/resource/Talent_manager
p8927
aVhttp://dbpedia.org/resource/Parkinson%27s_disease
p8928
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/question1/questionset1.htm'
p8929
sg31
S"Antimuscarinic drug(s) used in management of Parkinson's disease include(s):"
p8930
sg33
I5
sg34
S'Q73#8'
p8931
sg36
I17
sg37
S'8'
sg38
I0
sg39
S'73'
p8932
sa(dp8933
g3
(lp8934
(lp8935
Vhttp://dbpedia.org/resource/L-DOPA
p8936
aa(lp8937
Vhttp://dbpedia.org/resource/Phenothiazine
p8938
aasg18
(lp8939
Vamantadine
p8940
aVlevodopa
p8941
aVbromocriptine
p8942
aVselegiline
p8943
aVphenothiazine
p8944
asg24
(lp8945
Vhttp://dbpedia.org/resource/Agent_Orange
p8946
aVhttp://dbpedia.org/resource/Treat_Williams
p8947
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/question1/questionset1.htm'
p8948
sg31
S'In lower doses, this agent can be used to treat hyperprolactinemia:'
p8949
sg33
I5
sg34
S'Q73#9'
p8950
sg36
I12
sg37
S'9'
sg38
I2
sg39
S'73'
p8951
sa(dp8952
g3
(lp8953
(lp8954
Vhttp://dbpedia.org/resource/Tremor
p8955
aasg18
(lp8956
Vrigidity
p8957
aVhyperkinesia
p8958
aVtremor
p8959
aVpostural disturbances.
p8960
asg24
(lp8961
Vhttp://dbpedia.org/resource/Neurology
p8962
aVhttp://dbpedia.org/resource/Presentation
p8963
aVhttp://dbpedia.org/resource/Parkinsonism
p8964
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/questions2/park1.htm'
p8965
sg31
S'Neurological presentations of Parkinsonism EXCEPT:'
p8966
sg33
I6
sg34
S'Q74#1'
p8967
sg36
I5
sg37
S'1'
sg38
I1
sg39
S'74'
p8968
sa(dp8969
g3
(lp8970
(lp8971
Vhttp://dbpedia.org/resource/Tremor
p8972
aasg18
(lp8973
Vtremor
p8974
aVrigidity
p8975
aVmicrographia
p8976
aVsialorrhea
p8977
asg24
(lp8978
Vhttp://dbpedia.org/resource/Autonomic_nervous_system
p8979
aVhttp://dbpedia.org/resource/Autonomic_nervous_system
p8980
aVhttp://dbpedia.org/resource/Parkinson%27s_disease
p8981
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/questions2/park1.htm'
p8982
sg31
S"ANS (autonomic nervous system) manifestations in Parkinson's disease:"
p8983
sg33
I4
sg34
S'Q74#2'
p8984
sg36
I11
sg37
S'2'
sg38
I3
sg39
S'74'
p8985
sa(dp8986
g3
(lp8987
(lp8988
Vhttp://dbpedia.org/resource/L-DOPA
p8989
aasg18
(lp8990
Vamantadine
p8991
aVL-DOPA
p8992
aVselegiline
p8993
aVpergolide
p8994
asg24
(lp8995
Vhttp://dbpedia.org/resource/Primary_school
p8996
aVhttp://dbpedia.org/resource/Drug
p8997
aVhttp://dbpedia.org/resource/Management
p8998
aVhttp://dbpedia.org/resource/Parkinson%27s_disease
p8999
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/questions2/park1.htm'
p9000
sg31
S"Primary drug used in managing Parkinson's disease"
p9001
sg33
I4
sg34
S'Q74#4'
p9002
sg36
I8
sg37
S'4'
sg38
I1
sg39
S'74'
p9003
sa(dp9004
g3
(lp9005
(lp9006
Vhttp://dbpedia.org/resource/Bioavailability
p9007
aa(lp9008
Vhttp://dbpedia.org/resource/Cross-dressing
p9009
aVhttp://dbpedia.org/resource/Blood-brain_barrier
p9010
aa(lp9011
Vhttp://dbpedia.org/resource/Initiation
p9012
aVhttp://dbpedia.org/resource/Early_Christianity
p9013
aa(lp9014
Vhttp://dbpedia.org/resource/Metabolism
p9015
aVhttp://dbpedia.org/resource/Brain
p9016
aVhttp://dbpedia.org/resource/Real_Presence
p9017
aasg18
(lp9018
Vnot itself pharmacologically active
p9019
aVcannot cross the blood-brain barrier
p9020
aVcan be curative if initiated early enough.
p9021
aVmetabolized only in the brain--due to the presence of a unique dopa-decarboxylase
p9022
asg24
(lp9023
Vhttp://dbpedia.org/resource/Pharmacology
p9024
aVhttp://dbpedia.org/resource/L-DOPA
p9025
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/questions2/park1.htm'
p9026
sg31
S'Pharmacological characteristics of L-DOPA'
p9027
sg33
I31
sg34
S'Q74#6'
p9028
sg36
I4
sg37
S'6'
sg38
I0
sg39
S'74'
p9029
sa(dp9030
g3
(lp9031
sg18
(lp9032
Vbenztropine
p9033
aVselegiline
p9034
aVbromocriptine
p9035
aVamantadine
p9036
asg24
(lp9037
Vhttp://dbpedia.org/resource/ANTI-
p9038
aVhttp://dbpedia.org/resource/Parkinson%27s_disease
p9039
aVhttp://dbpedia.org/resource/Drug
p9040
aVhttp://dbpedia.org/resource/Dopamine_receptor
p9041
aVhttp://dbpedia.org/resource/Simulation
p9042
asg29
S'http://www.pharmacology2000.com/Central/Parkinson/questions2/park1.htm'
p9043
sg31
S'Anti-Parkinson Drug that probably acts by direct dopamine receptor simulation.'
p9044
sg33
I4
sg34
S'Q74#7'
p9045
sg36
I11
sg37
S'7'
sg38
I2
sg39
S'74'
p9046
sa(dp9047
g3
(lp9048
(lp9049
Vhttp://dbpedia.org/resource/Phenytoin
p9050
aa(lp9051
Vhttp://dbpedia.org/resource/Diazepam
p9052
aasg18
(lp9053
Vprimidone
p9054
aVethosuximide
p9055
aVphenytoin
p9056
aVi.v. diazepam
p9057
asg24
(lp9058
Vhttp://dbpedia.org/resource/Drug
p9059
asg29
S'http://www.pharmacology2000.com/Central/Epilepsy/questions1/epi1.htm'
p9060
sg31
S'Drug of first choice for absence seizures'
p9061
sg33
I5
sg34
S'Q76#0'
p9062
sg36
I7
sg37
S'0'
sg38
I1
sg39
S'76'
p9063
sa(dp9064
g3
(lp9065
(lp9066
Vhttp://dbpedia.org/resource/Phenytoin
p9067
aVhttp://dbpedia.org/resource/Carbamazepine
p9068
aVhttp://dbpedia.org/resource/Phenobarbital
p9069
aa(lp9070
Vhttp://dbpedia.org/resource/Valproic_acid
p9071
aa(lp9072
Vhttp://dbpedia.org/resource/Carbamazepine
p9073
aVhttp://dbpedia.org/resource/Valproic_acid
p9074
aa(lp9075
Vhttp://dbpedia.org/resource/Valproic_acid
p9076
aVhttp://dbpedia.org/resource/Carbamazepine
p9077
aasg18
(lp9078
Vphenytoin, carbamazepine, phenobarbital
p9079
aVethosuximide, valproate, trimethadione
p9080
aVcarbamazepine, ethosuximide, valproate
p9081
aVvalproate, carbamazepine, trimethadione
p9082
asg24
(lp9083
Vhttp://dbpedia.org/resource/Drug
p9084
aVhttp://dbpedia.org/resource/Order_of_precedence
p9085
aVhttp://dbpedia.org/resource/Management
p9086
asg29
S'http://www.pharmacology2000.com/Central/Epilepsy/questions1/epi1.htm'
p9087
sg31
S'Drugs in order of preference for managing absence seizures:'
p9088
sg33
I20
sg34
S'Q76#3'
p9089
sg36
I9
sg37
S'3'
sg38
I1
sg39
S'76'
p9090
sa(dp9091
g3
(lp9092
(lp9093
Vhttp://dbpedia.org/resource/Pentazocine
p9094
aa(lp9095
Vhttp://dbpedia.org/resource/Triazolam
p9096
aasg18
(lp9097
Vtrimethadione
p9098
aVpentazocine
p9099
aVethosuximide
p9100
aVtriazolam
p9101
asg24
(lp9102
Vhttp://dbpedia.org/resource/Anticonvulsant
p9103
aVhttp://dbpedia.org/resource/Neutropenia
p9104
aVhttp://dbpedia.org/resource/Sedation
p9105
aVhttp://dbpedia.org/resource/Nausea
p9106
aVhttp://dbpedia.org/resource/Drug
p9107
aVhttp://dbpedia.org/resource/Choice
p9108
asg29
S'http://www.pharmacology2000.com/Central/Epilepsy/questions1/epi1.htm'
p9109
sg31
S'Antiepileptic drug: causes neutropenia (7%), sedation, nausea; a drug of choice in treating absence seizures.'
p9110
sg33
I4
sg34
S'Q76#4'
p9111
sg36
I23
sg37
S'4'
sg38
I2
sg39
S'76'
p9112
sa(dp9113
g3
(lp9114
sg18
(lp9115
Vpancuronium (Pavulon)
p9116
aVpipecuronium (Arduan)
p9117
aVatracurium (Tracrium)
p9118
aVgallamine (Flaxedil)
p9119
aVvecuronium (Norcuron)
p9120
asg24
(lp9121
Vhttp://dbpedia.org/resource/Derivative_%28chemistry%29
p9122
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions1/questionset1.htm'
p9123
sg31
S'isoquinoline derivative:'
p9124
sg33
I20
sg34
S'Q77#0'
p9125
sg36
I2
sg37
S'0'
sg38
I2
sg39
S'77'
p9126
sa(dp9127
g3
(lp9128
(lp9129
Vhttp://dbpedia.org/resource/Route_of_administration
p9130
aa(lp9131
Vhttp://dbpedia.org/resource/Peripheral
p9132
aVhttp://dbpedia.org/resource/Symptom
p9133
aVhttp://dbpedia.org/resource/Common_good
p9134
aa(lp9135
Vhttp://dbpedia.org/resource/Major_%28United_States%29
p9136
aVhttp://dbpedia.org/resource/Integrity
p9137
aVhttp://dbpedia.org/resource/Delivery_%28commerce%29
p9138
aVhttp://dbpedia.org/resource/Catheter
p9139
aa(lp9140
Vhttp://dbpedia.org/resource/Engineering_tolerance
p9141
aa(lp9142
Vhttp://dbpedia.org/resource/Quality_of_life
p9143
aasg18
(lp9144
VGenerally favored Route of Administration
p9145
aVperipheral symptoms common
p9146
aVmajor disadvantage is the maintenance of integrity of delivery catheter
p9147
aVtolerance does not develop
p9148
aVSignificant improvement of the quality of life is not seen
p9149
asg24
(lp9150
Vhttp://dbpedia.org/resource/Baclofen
p9151
aVhttp://dbpedia.org/resource/Baclofen
p9152
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions1/questionset1.htm'
p9153
sg31
S'Concerning intrathecal baclofen (Lioresal):'
p9154
sg33
I32
sg34
S'Q77#7'
p9155
sg36
I7
sg37
S'7'
sg38
I2
sg39
S'77'
p9156
sa(dp9157
g3
(lp9158
(lp9159
Vhttp://dbpedia.org/resource/Patient
p9160
aVhttp://dbpedia.org/resource/Spasticity
p9161
aa(lp9162
Vhttp://dbpedia.org/resource/Transmission_line
p9163
aa(lp9164
Vhttp://dbpedia.org/resource/Efficacy
p9165
aVhttp://dbpedia.org/resource/Diazepam
p9166
aVhttp://dbpedia.org/resource/Diazepam
p9167
aa(lp9168
Vhttp://dbpedia.org/resource/Adverse_effect
p9169
aVhttp://dbpedia.org/resource/Hypertension
p9170
aasg18
(lp9171
Vadvantages for patients with spasticity (several types)
p9172
aVfacilitates nociceptor transmission in dorsal horn
p9173
aVsignificantly more efficacious compared to diazepam (Valium)
p9174
aVadverse effects: hypertension
p9175
asg24
(lp9176
Vhttp://dbpedia.org/resource/Pharmacology
p9177
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions1/questionset1.htm'
p9178
sg31
S'Tizanidine (Zanaflex) pharmacology:'
p9179
sg33
I28
sg34
S'Q77#8'
p9180
sg36
I5
sg37
S'8'
sg38
I0
sg39
S'77'
p9181
sa(dp9182
g3
(lp9183
(lp9184
Vhttp://dbpedia.org/resource/Baclofen
p9185
aVhttp://dbpedia.org/resource/Baclofen
p9186
aasg18
(lp9187
Vbaclofen (Lioresal)
p9188
aVdantrolene (Dantrium)
p9189
aVtizanidine (Zanaflex)
p9190
asg24
(lp9191
Vhttp://dbpedia.org/resource/Interference_%28wave_propagation%29
p9192
aVhttp://dbpedia.org/resource/Coupling
p9193
aVhttp://dbpedia.org/resource/Mechanism_of_action
p9194
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions1/questionset1.htm'
p9195
sg31
S'Spasmolytic:: acts by interfering with muscle fiber excitation-coupling mechanism.'
p9196
sg33
I12
sg34
S'Q77#9'
p9197
sg36
I12
sg37
S'9'
sg38
I1
sg39
S'77'
p9198
sa(dp9199
g3
(lp9200
sg18
(lp9201
Vpancuronium (Pavulon)
p9202
aVvecuronium (Norcuron)
p9203
aVdoxacurium (Nuromax)
p9204
aVpipecuronium (Arduan)
p9205
aVroncuronium (Zemuron)
p9206
asg24
(lp9207
Vhttp://dbpedia.org/resource/Derivative_%28chemistry%29
p9208
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions2/questionset2.htm'
p9209
sg31
S'Isoquinoline derivative:'
p9210
sg33
I20
sg34
S'Q78#1'
p9211
sg36
I2
sg37
S'1'
sg38
I2
sg39
S'78'
p9212
sa(dp9213
g3
(lp9214
sg18
(lp9215
Vcisatracurium (Nimbex)
p9216
aVtubocurarine
p9217
aVmivacurium (Mivacron)
p9218
aVvecuronium (Norcuron)
p9219
asg24
(lp9220
Vhttp://dbpedia.org/resource/Derivation_%28linguistics%29
p9221
aVhttp://dbpedia.org/resource/Duration_%28music%29
p9222
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions2/questionset2.htm'
p9223
sg31
S'Isoquinoline derivative; shortest duration of action'
p9224
sg33
I13
sg34
S'Q78#5'
p9225
sg36
I7
sg37
S'5'
sg38
I2
sg39
S'78'
p9226
sa(dp9227
g3
(lp9228
sg18
(lp9229
Vpancuronium (Pavulon)
p9230
aVpipecuronium (Arduan)
p9231
aVtubocurarine
p9232
aVmivacurium (Mivacron)
p9233
asg24
(lp9234
Vhttp://dbpedia.org/resource/Duration_%28music%29
p9235
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions2/questionset2.htm'
p9236
sg31
S'Shortest duration of action among nondepolarizing neuromuscular blocking drugs:'
p9237
sg33
I13
sg34
S'Q78#10'
p9238
sg36
I9
sg37
S'10'
p9239
sg38
I3
sg39
S'78'
p9240
sa(dp9241
g3
(lp9242
(lp9243
Vhttp://dbpedia.org/resource/Reuptake
p9244
aVhttp://dbpedia.org/resource/Chemical_synapse
p9245
aa(lp9246
Vhttp://dbpedia.org/resource/Diffusion
p9247
aVhttp://dbpedia.org/resource/Chemical_synapse
p9248
aa(lp9249
Vhttp://dbpedia.org/resource/Metabolism
p9250
aVhttp://dbpedia.org/resource/Chemical_synapse
p9251
aVhttp://dbpedia.org/resource/Acetylcholinesterase
p9252
aasg18
(lp9253
Vreuptake into presynaptic vesicles
p9254
aVdiffusion away from postsynaptic receptors
p9255
aVmetabolism by postsynaptic acetylcholinesterase
p9256
asg24
(lp9257
Vhttp://dbpedia.org/resource/Mechanism_of_action
p9258
aVhttp://dbpedia.org/resource/Termination_of_employment
p9259
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions2/questionset2.htm'
p9260
sg31
S'Mechanism of termination of action of succinylcholine (Anectine):'
p9261
sg33
I13
sg34
S'Q78#11'
p9262
sg36
I11
sg37
S'11'
p9263
sg38
I1
sg39
S'78'
p9264
sa(dp9265
g3
(lp9266
sg18
(lp9267
V5-10 minutes
p9268
aV15-30 minutes
p9269
aV> 30 minutes
p9270
asg24
(lp9271
Vhttp://dbpedia.org/resource/Duration_%28music%29
p9272
aVhttp://dbpedia.org/resource/Firearm_action
p9273
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions2/questionset2.htm'
p9274
sg31
S'Succinylcholine (Anectine): duration of action'
p9275
sg33
I7
sg34
S'Q78#12'
p9276
sg36
I8
sg37
S'12'
p9277
sg38
I0
sg39
S'78'
p9278
sa(dp9279
g3
(lp9280
(lp9281
Vhttp://dbpedia.org/resource/Dysphagia
p9282
aVhttp://dbpedia.org/resource/Diplopia
p9283
aVhttp://dbpedia.org/resource/Ptosis_%28eyelid%29
p9284
aVhttp://dbpedia.org/resource/Difficulty_level
p9285
aVhttp://dbpedia.org/resource/Mandibular_nerve
p9286
aVhttp://dbpedia.org/resource/Muscle_weakness
p9287
aa(lp9288
Vhttp://dbpedia.org/resource/Mandibular_nerve
p9289
aVhttp://dbpedia.org/resource/Muscle_weakness
p9290
aVhttp://dbpedia.org/resource/Ptosis_%28eyelid%29
p9291
aVhttp://dbpedia.org/resource/Dysphagia
p9292
aVhttp://dbpedia.org/resource/Difficulty_level
p9293
aa(lp9294
Vhttp://dbpedia.org/resource/Difficulty_level
p9295
aVhttp://dbpedia.org/resource/Mandibular_nerve
p9296
aVhttp://dbpedia.org/resource/Muscle_weakness
p9297
aVhttp://dbpedia.org/resource/Ptosis_%28eyelid%29
p9298
aVhttp://dbpedia.org/resource/Diplopia
p9299
aVhttp://dbpedia.org/resource/Dysphagia
p9300
aa(lp9301
Vhttp://dbpedia.org/resource/Symptom
p9302
aasg18
(lp9303
Vdysphagia, diplopia, ptosis,difficulty in focusing, mandibular muscle weakness
p9304
aVmandibular muscle weakness, ptosis, dysphagia, difficulty in focusing
p9305
aVdifficulty in focusing, mandibular muscle weakness, ptosis, diplopia, dysphagia
p9306
aVall symptoms occur simultaneously
p9307
asg24
(lp9308
Vhttp://dbpedia.org/resource/Sequence_%28biology%29
p9309
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9310
aVhttp://dbpedia.org/resource/Blocking_%28American_football%29
p9311
aVhttp://dbpedia.org/resource/Injection_%28medicine%29
p9312
aVhttp://dbpedia.org/resource/Drug
p9313
aVhttp://dbpedia.org/resource/Patient
p9314
aVhttp://dbpedia.org/resource/Presentation
p9315
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions2/questionset2.htm'
p9316
sg31
S'Sequence of events following IV neuromuscular-blocking injection (nondepolarizing drug) to an awake patient:{first presentations to last}'
p9317
sg33
I41
sg34
S'Q78#16'
p9318
sg36
I22
sg37
S'16'
p9319
sg38
I2
sg39
S'78'
p9320
sa(dp9321
g3
(lp9322
(lp9323
Vhttp://dbpedia.org/resource/Long_%28finance%29
p9324
aVhttp://dbpedia.org/resource/Duration_%28music%29
p9325
aVhttp://dbpedia.org/resource/Firearm_action
p9326
aa(lp9327
Vhttp://dbpedia.org/resource/Mechanism_of_action
p9328
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9329
aVhttp://dbpedia.org/resource/Blocking_%28American_football%29
p9330
aVhttp://dbpedia.org/resource/Firearm_action
p9331
aVhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p9332
aVhttp://dbpedia.org/resource/Cholinergic
p9333
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p9334
aa(lp9335
Vhttp://dbpedia.org/resource/Chemical_synapse
p9336
aVhttp://dbpedia.org/resource/Biological_membrane
p9337
aVhttp://dbpedia.org/resource/Depolarization
p9338
aa(lp9339
Vhttp://dbpedia.org/resource/Quality_%28business%29
p9340
aasg18
(lp9341
Vrapid onset; long duration of action
p9342
aVmechanism for neuromuscular-blocking action: interacts with muscarinic, cholinergic receptors.
p9343
aVcauses postsynaptic membrane depolarization
p9344
aVquality above
p9345
asg24
(lp9346
Vhttp://dbpedia.org/resource/Pharmacology
p9347
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions3/questionset3.htm'
p9348
sg31
S'Succinylcholine (Anectine) pharmacology:'
p9349
sg33
I24
sg34
S'Q79#3'
p9350
sg36
I5
sg37
S'3'
sg38
I2
sg39
S'79'
p9351
sa(dp9352
g3
(lp9353
(lp9354
Vhttp://dbpedia.org/resource/Redox
p9355
aVhttp://dbpedia.org/resource/Duration_%28music%29
p9356
aVhttp://dbpedia.org/resource/Minute
p9357
aa(lp9358
Vhttp://dbpedia.org/resource/Duration_%28music%29
p9359
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9360
aVhttp://dbpedia.org/resource/Blockade
p9361
aa(lp9362
Vhttp://dbpedia.org/resource/Absenteeism
p9363
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9364
aVhttp://dbpedia.org/resource/Blockade
p9365
aa(lp9366
Vhttp://dbpedia.org/resource/Duration_%28music%29
p9367
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9368
aVhttp://dbpedia.org/resource/Blockade
p9369
aVhttp://dbpedia.org/resource/Hour
p9370
aasg18
(lp9371
Vreduced  duration of neuromuscular blockade (< one-minute)
p9372
aVincreased duration of neuromuscular-blockade (to 30 minutes)
p9373
aVabsence of neuromuscular-blockade
p9374
aVincreased duration of neuromuscular-blockade (1-3 hours)
p9375
asg24
(lp9376
Vhttp://dbpedia.org/resource/Consequences_Creed
p9377
aVhttp://dbpedia.org/resource/Patient
p9378
aVhttp://dbpedia.org/resource/Cholinesterase
p9379
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions3/questionset3.htm'
p9380
sg31
S'Consequence of normal succinylcholine (Anectine) dosage in a patient with atypical pseudocholinesterase'
p9381
sg33
I29
sg34
S'Q79#10'
p9382
sg36
I14
sg37
S'10'
p9383
sg38
I3
sg39
S'79'
p9384
sa(dp9385
g3
(lp9386
(lp9387
Vhttp://dbpedia.org/resource/Supraventricular_tachycardia
p9388
aasg18
(lp9389
Vventricular tachycardia
p9390
aVparoxysmal atrial tachycardia
p9391
aVTorsades de Pointes
p9392
aVsinus bradycardia
p9393
asg24
(lp9394
Vhttp://dbpedia.org/resource/Ventricular_tachycardia
p9395
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions3/questionset3.htm'
p9396
sg31
S'Most common cardiac arrhythmias associated with succinylcholine (Anectine):'
p9397
sg33
I10
sg34
S'Q79#14'
p9398
sg36
I11
sg37
S'14'
p9399
sg38
I3
sg39
S'79'
p9400
sa(dp9401
g3
(lp9402
(lp9403
Vhttp://dbpedia.org/resource/Duchenne_muscular_dystrophy
p9404
aa(lp9405
Vhttp://dbpedia.org/resource/Probability
p9406
aasg18
(lp9407
VDuchenne\u005c
p9408
aVBecker muscular dystrophy
p9409
aVequally probable
p9410
asg24
(lp9411
Vhttp://dbpedia.org/resource/Common_land
p9412
aVhttp://dbpedia.org/resource/Muscular_dystrophy
p9413
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions3/questionset3.htm'
p9414
sg31
S'More common muscular dystrophy:'
p9415
sg33
I6
sg34
S'Q79#17'
p9416
sg36
I4
sg37
S'17'
p9417
sg38
I0
sg39
S'79'
p9418
sa(dp9419
g3
(lp9420
sg18
(lp9421
V< 5%
p9422
aVabout 20%
p9423
aVabout 50%
p9424
aV> 80%-90%
p9425
asg24
(lp9426
Vhttp://dbpedia.org/resource/Nicotinic_acetylcholine_receptor
p9427
aVhttp://dbpedia.org/resource/Blockade
p9428
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9429
aVhttp://dbpedia.org/resource/Failure
p9430
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9431
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions4/questionset4.htm'
p9432
sg31
S'Extent of nicotinic receptor blockade required for neuromuscular transmission failure due to nondepolarizing neuromuscular blockers:'
p9433
sg33
I14
sg34
S'Q80#0'
p9434
sg36
I15
sg37
S'0'
sg38
I3
sg39
S'80'
p9435
sa(dp9436
g3
(lp9437
(lp9438
Vhttp://dbpedia.org/resource/Halothane
p9439
aVhttp://dbpedia.org/resource/Halothane
p9440
aa(lp9441
Vhttp://dbpedia.org/resource/Nitrous_oxide
p9442
aVhttp://dbpedia.org/resource/Opioid
p9443
aasg18
(lp9444
Vhalothane (Fluothane)
p9445
aVisoflurane (Forane)
p9446
aVnitrous oxide-opioid combinations
p9447
aVdesflurane (Suprane)
p9448
aVsevoflurane (Sevorane, Ultane)
p9449
asg24
(lp9450
Vhttp://dbpedia.org/resource/Magnitude_%28mathematics%29
p9451
aVhttp://dbpedia.org/resource/Duration_%28music%29
p9452
aVhttp://dbpedia.org/resource/Neuromuscular_junction
p9453
aVhttp://dbpedia.org/resource/Blockade
p9454
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions4/questionset4.htm'
p9455
sg31
S'Least likely to influence magnitude or duration of neuromuscular-blockade (caused by nondepolarizing agents):'
p9456
sg33
I21
sg34
S'Q80#7'
p9457
sg36
I16
sg37
S'7'
sg38
I2
sg39
S'80'
p9458
sa(dp9459
g3
(lp9460
sg18
(lp9461
Vatracurium (Tracrium)
p9462
aVroncuronium (Zemuron)
p9463
aVdoxacurium (Nuromax)
p9464
aVcisatracurium (Nimbex)
p9465
aVvecuronium (Norcuron)
p9466
asg24
(lp9467
Vhttp://dbpedia.org/resource/Reduction_%28complexity%29
p9468
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions4/questionset4.htm'
p9469
sg31
S'Most likely to require greater reduction in blocker dosage as a result of volatile anesthetic use:'
p9470
sg33
I20
sg34
S'Q80#9'
p9471
sg36
I16
sg37
S'9'
sg38
I2
sg39
S'80'
p9472
sa(dp9473
g3
(lp9474
sg18
(lp9475
Vpancuronium (Pavulon)
p9476
aVpipecuronium (Arduan)
p9477
aVcisatracurium (Nimbex)
p9478
aVdoxacurium (Nuromax)
p9479
aVsuccinylcholine (Anectine)
p9480
asg24
(lp9481
Vhttp://dbpedia.org/resource/Duration_%28music%29
p9482
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions4/questionset4.htm'
p9483
sg31
S'Intermediate-duration agent (category of nondepolarizing neuromuscular-blocking drug):'
p9484
sg33
I20
sg34
S'Q80#10'
p9485
sg36
I10
sg37
S'10'
p9486
sg38
I2
sg39
S'80'
p9487
sa(dp9488
g3
(lp9489
(lp9490
Vhttp://dbpedia.org/resource/Clarithromycin
p9491
aVhttp://dbpedia.org/resource/Clarithromycin
p9492
aa(lp9493
Vhttp://dbpedia.org/resource/Azithromycin
p9494
aasg18
(lp9495
Vchloramphenicol (Chloromycetin)
p9496
aVclarithromycin (Biaxin)
p9497
aVazithromycin (Zythromax)
p9498
aVtobramycin (Nebcin)
p9499
aVpenicillin V (Pen-Vee K, Veetids)
p9500
asg24
(lp9501
Vhttp://dbpedia.org/resource/Chloramphenicol
p9502
aVhttp://dbpedia.org/resource/Chloramphenicol
p9503
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions4/questionset4.htm'
p9504
sg31
S'Antibiotic most likely to have an effect on neuromuscular-blockade due to nondepolarizing agents:'
p9505
sg33
I24
sg34
S'Q80#11'
p9506
sg36
I13
sg37
S'11'
p9507
sg38
I3
sg39
S'80'
p9508
sa(dp9509
g3
(lp9510
(lp9511
Vhttp://dbpedia.org/resource/Management
p9512
aVhttp://dbpedia.org/resource/Plague_%28disease%29
p9513
aa(lp9514
Vhttp://dbpedia.org/resource/Management
p9515
aVhttp://dbpedia.org/resource/Tularemia
p9516
aa(lp9517
Vhttp://dbpedia.org/resource/Management
p9518
aVhttp://dbpedia.org/resource/Brucellosis
p9519
aa(lp9520
Vhttp://dbpedia.org/resource/Therapy
p9521
aVhttp://dbpedia.org/resource/Tuberculosis
p9522
aa(lp9523
Vhttp://dbpedia.org/resource/Streptococcus
p9524
aVhttp://dbpedia.org/resource/Endocarditis
p9525
aasg18
(lp9526
Vmanagement of plague
p9527
aVmanagement of tularemia
p9528
aVmanagement of brucellosis
p9529
aVsecond line treatment for tuberculosis
p9530
aVtreatment for viridans streptococcal endocarditis
p9531
asg24
(lp9532
Vhttp://dbpedia.org/resource/Spanish_Main
p9533
aVhttp://dbpedia.org/resource/Streptomycin
p9534
asg29
S'http://www.pharmacology2000.com/Central/NMJ/questions4/questionset4.htm'
p9535
sg31
S'Main use for streptomycin:'
p9536
sg33
I19
sg34
S'Q80#16'
p9537
sg36
I4
sg37
S'16'
p9538
sg38
I3
sg39
S'80'
p9539
sa(dp9540
g3
(lp9541
(lp9542
Vhttp://dbpedia.org/resource/Physical_exercise
p9543
aa(lp9544
Vhttp://dbpedia.org/resource/Aspirin
p9545
aasg18
(lp9546
Vexercise
p9547
aVaspirin
p9548
aVrespiratory infection
p9549
aVA, B, C
p9550
asg24
(lp9551
Vhttp://dbpedia.org/resource/Precipitation_%28chemistry%29
p9552
aVhttp://dbpedia.org/resource/Acute_%28medicine%29
p9553
aVhttp://dbpedia.org/resource/Asthma
p9554
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9555
sg31
S'May precipitate acute asthma:'
p9556
sg33
I9
sg34
S'Q81#0'
p9557
sg36
I4
sg37
S'0'
sg38
I3
sg39
S'81'
p9558
sa(dp9559
g3
(lp9560
(lp9561
Vhttp://dbpedia.org/resource/Placebo
p9562
aa(lp9563
Vhttp://dbpedia.org/resource/Efficacy
p9564
aa(lp9565
Vhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p9566
aasg18
(lp9567
Vthe placebo effect
p9568
aVcross-tolerance
p9569
aVefficacy
p9570
aVpotency
p9571
asg24
(lp9572
Vhttp://dbpedia.org/resource/Asthma
p9573
aVhttp://dbpedia.org/resource/Patient
p9574
aVhttp://dbpedia.org/resource/Exhibition
p9575
aVhttp://dbpedia.org/resource/Sensitivity_and_specificity
p9576
aVhttp://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug
p9577
aVhttp://dbpedia.org/resource/Administration_%28government%29
p9578
aVhttp://dbpedia.org/resource/Aspirin
p9579
aVhttp://dbpedia.org/resource/Aspirin
p9580
aVhttp://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug
p9581
aVhttp://dbpedia.org/resource/Phenomenon
p9582
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9583
sg31
S'Some asthmatic patients exhibit aspirin sensitivity (and sensitivity to other NSAIDS). Daily administration of aspirin causes desensitization not only to aspirin also to other NSAIDS. This phenomenon is:'
p9584
sg33
I6
sg34
S'Q81#1'
p9585
sg36
I31
sg37
S'1'
sg38
I1
sg39
S'81'
p9586
sa(dp9587
g3
(lp9588
(lp9589
Vhttp://dbpedia.org/resource/Beta_blocker
p9590
aVhttp://dbpedia.org/resource/Affect_%28psychology%29
p9591
aVhttp://dbpedia.org/resource/Patient
p9592
aa(lp9593
Vhttp://dbpedia.org/resource/Patient
p9594
aa(lp9595
Vhttp://dbpedia.org/resource/Exhalation
p9596
aVhttp://dbpedia.org/resource/Patient
p9597
aa(lp9598
Vhttp://dbpedia.org/resource/Patient
p9599
aasg18
(lp9600
VThe cardioselective beta-blocker, metoprolol, alleviated the arrhythmia and did not affect the patient\u005c
p9601
aVSince metoprolol is a beta agonist, the patient\u005c
p9602
aVThe expiratory component of the patient\u005c
p9603
aVMetoprolol increased airway obstruction, worsening the patient\u005c
p9604
asg24
(lp9605
Vhttp://dbpedia.org/resource/Asthma
p9606
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p9607
aVhttp://dbpedia.org/resource/Agonist
p9608
aVhttp://dbpedia.org/resource/Millennium
p9609
aVhttp://dbpedia.org/resource/Experience
p9610
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p9611
aVhttp://dbpedia.org/resource/Therapy
p9612
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9613
sg31
S'A thirty-eight year old asthmatic who has been using beta adrenergic agonists for several years began to experience arrhythmias, premature atrial contractions. In order to suppress the arrhythmias, high-dose metoprolol therapy was started. Suggest a likely consequence:'
p9614
sg33
I38
sg34
S'Q81#2'
p9615
sg36
I39
sg37
S'2'
sg38
I3
sg39
S'81'
p9616
sa(dp9617
g3
(lp9618
sg18
(lp9619
Vipratropium
p9620
aVterbutaline
p9621
aVcromolyn
p9622
aVmethoxamine
p9623
asg24
(lp9624
Vhttp://dbpedia.org/resource/Asthma
p9625
aVhttp://dbpedia.org/resource/Agency_%28philosophy%29
p9626
aVhttp://dbpedia.org/resource/Air_Corps_Tactical_School
p9627
aVhttp://dbpedia.org/resource/Lung
p9628
aVhttp://dbpedia.org/resource/Beta_cell
p9629
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p9630
aVhttp://dbpedia.org/resource/Camp_%28style%29
p9631
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9632
sg31
S'Anti-asthma agent that acts in part by activating pulmonary beta-receptors thus increasing cAMP'
p9633
sg33
I4
sg34
S'Q81#3'
p9634
sg36
I13
sg37
S'3'
sg38
I1
sg39
S'81'
p9635
sa(dp9636
g3
(lp9637
(lp9638
Vhttp://dbpedia.org/resource/Cardiac_output
p9639
aVhttp://dbpedia.org/resource/Pulmonary_artery
p9640
aVhttp://dbpedia.org/resource/Perfusion
p9641
aVhttp://dbpedia.org/resource/Lung
p9642
aa(lp9643
Vhttp://dbpedia.org/resource/Lung
p9644
aVhttp://dbpedia.org/resource/Vasodilation
p9645
aa(lp9646
Vhttp://dbpedia.org/resource/Relaxation_technique
p9647
aVhttp://dbpedia.org/resource/Ventilation_%28physiology%29
p9648
aasg18
(lp9649
VIncreased cardiac output increases pulmonary artery perfusion pressure in the lung
p9650
aVPulmonary vasodilation improves V/Q mismatching
p9651
aVBronchiolar relaxation improves ventilation.
p9652
aVActually, it is the use of supplimental oxygen that is more important than terbutaline.
p9653
asg24
(lp9654
Vhttp://dbpedia.org/resource/Ventilation_%28physiology%29
p9655
aVhttp://dbpedia.org/resource/Perfusion
p9656
aVhttp://dbpedia.org/resource/Asthma
p9657
aVhttp://dbpedia.org/resource/Inhalation
p9658
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9659
sg31
S'V/Q (ventilation/perfusion) mismatching which occurs in severe asthma results in hypoxemia. Terbutaline inhalation inproves the V/Q ratio. Why?'
p9660
sg33
I36
sg34
S'Q81#5'
p9661
sg36
I21
sg37
S'5'
sg38
I2
sg39
S'81'
p9662
sa(dp9663
g3
(lp9664
(lp9665
Vhttp://dbpedia.org/resource/Theophylline
p9666
aVhttp://dbpedia.org/resource/Liver
p9667
aVhttp://dbpedia.org/resource/Redox
p9668
aa(lp9669
Vhttp://dbpedia.org/resource/Salbutamol
p9670
aVhttp://dbpedia.org/resource/Adrenergic
p9671
aa(lp9672
Vhttp://dbpedia.org/resource/Quaternary_ammonium_cation
p9673
aVhttp://dbpedia.org/resource/Anticholinergic
p9674
aVhttp://dbpedia.org/resource/Xerostomia
p9675
aa(lp9676
Vhttp://dbpedia.org/resource/Drug
p9677
aVhttp://dbpedia.org/resource/Effectiveness
p9678
aVhttp://dbpedia.org/resource/Beta_cell
p9679
aVhttp://dbpedia.org/resource/Adrenergic
p9680
aasg18
(lp9681
Vtheophylline: hepatic oxidation and demethylation
p9682
aValbuterol: beta2 adrenergic blocker
p9683
aVipratropium bromide: well-absorbed quaternary anticholinergic; associated with dry mouth
p9684
aVBeclomethasone: enhances release of chemical mediators of bronchospasm which diminishes effectiveness of beta-2 adrenergic agonists.
p9685
asg24
(lp9686
Vhttp://dbpedia.org/resource/Drug
p9687
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9688
sg31
S'Correct drug:property combination'
p9689
sg33
I39
sg34
S'Q81#6'
p9690
sg36
I5
sg37
S'6'
sg38
I3
sg39
S'81'
p9691
sa(dp9692
g3
(lp9693
(lp9694
Vhttp://dbpedia.org/resource/Corticosteroid
p9695
aa(lp9696
Vhttp://dbpedia.org/resource/Corticosteroid
p9697
aVhttp://dbpedia.org/resource/Inflammation
p9698
aa(lp9699
Vhttp://dbpedia.org/resource/Corticosteroid
p9700
aVhttp://dbpedia.org/resource/Redox
p9701
aVhttp://dbpedia.org/resource/Patient
p9702
aa(lp9703
Vhttp://dbpedia.org/resource/Acute_%28medicine%29
p9704
aVhttp://dbpedia.org/resource/Asthma
p9705
aVhttp://dbpedia.org/resource/Corticosteroid
p9706
aVhttp://dbpedia.org/resource/Corticosteroid
p9707
aVhttp://dbpedia.org/resource/Chronic_%28medicine%29
p9708
aasg18
(lp9709
VCorticosteroids relax smooth muscle
p9710
aVCorticosteroids inhibit the inflammatory response.
p9711
aVCorticosteroids reduce patient responsiveness to beta agonists
p9712
aVIn acute asthma, corticosteroids increase airway obstruction; therefore corticosteroids should only be used for chronic treatment.
p9713
asg24
(lp9714
Vhttp://dbpedia.org/resource/Corticosteroid
p9715
aVhttp://dbpedia.org/resource/Asthma
p9716
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9717
sg31
S'Corticosteroids and the treatment of asthma:'
p9718
sg33
I35
sg34
S'Q81#7'
p9719
sg36
I6
sg37
S'7'
sg38
I1
sg39
S'81'
p9720
sa(dp9721
g3
(lp9722
(lp9723
Vhttp://dbpedia.org/resource/Ciclosporin
p9724
aasg18
(lp9725
Vipratropium bromide
p9726
aVaminophylline
p9727
aVmetaproterenol
p9728
aVcyclosporine
p9729
asg24
(lp9730
Vhttp://dbpedia.org/resource/Phosphodiesterase
p9731
aVhttp://dbpedia.org/resource/Asthma
p9732
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9733
sg31
S'Phosphodiesterase-inhibitor used in asthma therapy:'
p9734
sg33
I5
sg34
S'Q81#8'
p9735
sg36
I5
sg37
S'8'
sg38
I1
sg39
S'81'
p9736
sa(dp9737
g3
(lp9738
(lp9739
Vhttp://dbpedia.org/resource/Salbutamol
p9740
aasg18
(lp9741
Vbeclomethasone
p9742
aVcromolyn
p9743
aVmetaproterenol
p9744
aValbuterol
p9745
asg24
(lp9746
Vhttp://dbpedia.org/resource/Drug
p9747
aVhttp://dbpedia.org/resource/Mast_cell
p9748
asg29
S'http://www.pharmacology2000.com/Pulmonary/questions2/pul1.htm'
p9749
sg31
S'Prophylactic antiasthmatic drug probably acts by preventing release of bronchoconstrictive mediators from mast cells:'
p9750
sg33
I4
sg34
S'Q81#9'
p9751
sg36
I14
sg37
S'9'
sg38
I1
sg39
S'81'
p9752
sa(dp9753
g3
(lp9754
(lp9755
Vhttp://dbpedia.org/resource/Acetazolamide
p9756
aVhttp://dbpedia.org/resource/Acetazolamide
p9757
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9758
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9759
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9760
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9761
aa(lp9762
Vhttp://dbpedia.org/resource/Hydrochlorothiazide
p9763
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9764
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9765
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9766
aVhttp://dbpedia.org/resource/Furosemide
p9767
aVhttp://dbpedia.org/resource/Furosemide
p9768
aVhttp://dbpedia.org/resource/Acetazolamide
p9769
aVhttp://dbpedia.org/resource/Acetazolamide
p9770
aa(lp9771
Vhttp://dbpedia.org/resource/Acetazolamide
p9772
aVhttp://dbpedia.org/resource/Acetazolamide
p9773
aa(lp9774
Vhttp://dbpedia.org/resource/Furosemide
p9775
aVhttp://dbpedia.org/resource/Furosemide
p9776
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9777
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9778
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9779
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p9780
aVhttp://dbpedia.org/resource/Acetazolamide
p9781
aVhttp://dbpedia.org/resource/Acetazolamide
p9782
aasg18
(lp9783
Vbumetanide (Bumex) > acetazolamide (Diamox) > hydrochlorothiazide (HCTZ, Esidrix, HydroDIURIL)
p9784
aVhydrochlorothiazide (HCTZ, Esidrix, HydroDIURIL) >  furosemide (Lasix) > acetazolamide (Diamox)
p9785
aV acetazolamide (Diamox) > chlorthalidone (Hygroton) > ethacrynic acid (Edecrin)
p9786
aV furosemide (Lasix) >hydrochlorothiazide (HCTZ, Esidrix, HydroDIURIL) > acetazolamide (Diamox)
p9787
asg24
(lp9788
Vhttp://dbpedia.org/resource/Diuretic
p9789
asg29
S'http://www.pharmacology2000.com/Renal/questions1/ren1.htm'
p9790
sg31
S'DECREASING diuretic efficiency'
p9791
sg33
I69
sg34
S'Q83#2'
p9792
sg36
I3
sg37
S'2'
sg38
I3
sg39
S'83'
p9793
sa(dp9794
g3
(lp9795
(lp9796
Vhttp://dbpedia.org/resource/Furosemide
p9797
aVhttp://dbpedia.org/resource/Furosemide
p9798
aasg18
(lp9799
Vethacrynic acid (Edecrin)
p9800
aVfurosemide (Lasix)
p9801
aVtriamterene (Dyrenium)
p9802
asg24
(lp9803
Vhttp://dbpedia.org/resource/Diuretic
p9804
aVhttp://dbpedia.org/resource/Produce
p9805
aVhttp://dbpedia.org/resource/Hypokalemia
p9806
asg29
S'http://www.pharmacology2000.com/Renal/questions1/ren1.htm'
p9807
sg31
S'Diuretic least likely to produce hypokalemia:'
p9808
sg33
I13
sg34
S'Q83#3'
p9809
sg36
I6
sg37
S'3'
sg38
I2
sg39
S'83'
p9810
sa(dp9811
g3
(lp9812
(lp9813
Vhttp://dbpedia.org/resource/Furosemide
p9814
aVhttp://dbpedia.org/resource/Furosemide
p9815
aasg18
(lp9816
Vfurosemide (Lasix)
p9817
aVtriamterene (Dyrenium)
p9818
aVchlorothiazide (Diuril)
p9819
aVbumetanide (Bumex)
p9820
asg24
(lp9821
Vhttp://dbpedia.org/resource/Patient
p9822
aVhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p9823
aVhttp://dbpedia.org/resource/Pulmonary_edema
p9824
aVhttp://dbpedia.org/resource/Blood_serum
p9825
aVhttp://dbpedia.org/resource/Creatinine
p9826
aVhttp://dbpedia.org/resource/Potassium
p9827
aVhttp://dbpedia.org/resource/Medical_diagnosis
p9828
aVhttp://dbpedia.org/resource/Renal_failure
p9829
aVhttp://dbpedia.org/resource/Diuretic
p9830
aVhttp://dbpedia.org/resource/Patient
p9831
aVhttp://dbpedia.org/resource/Heart
p9832
aVhttp://dbpedia.org/resource/Electrical_conduction_system_of_the_heart
p9833
aVhttp://dbpedia.org/resource/Cardiac_arrest
p9834
aVhttp://dbpedia.org/resource/Diuretic
p9835
asg29
S'http://www.pharmacology2000.com/Renal/questions1/ren1.htm'
p9836
sg31
S'A patient with Type I diabetes presents with significant water retention and pulmonary congestion. Serum creatinine, BUN and potassium were significantly elevated. The diagnosis was advanced renal failure. A diuretic was given to treat water retention, but shortly thereafter the patient exhibited cardiac conduction changes which progressed to heart block and cardiac arrest. The diuretic which was determined to cause this event was probably:'
p9837
sg33
I16
sg34
S'Q83#4'
p9838
sg36
I66
sg37
S'4'
sg38
I1
sg39
S'83'
p9839
sa(dp9840
g3
(lp9841
(lp9842
Vhttp://dbpedia.org/resource/Furosemide
p9843
aVhttp://dbpedia.org/resource/Furosemide
p9844
aa(lp9845
Vhttp://dbpedia.org/resource/Mannitol
p9846
aasg18
(lp9847
Vfurosemide (Lasix)
p9848
aVbumetanide (Bumex)
p9849
aVmannitol (Osmitrol)
p9850
aVthiazides
p9851
asg24
(lp9852
Vhttp://dbpedia.org/resource/Osmosis
p9853
aVhttp://dbpedia.org/resource/Diuretic
p9854
asg29
S'http://www.pharmacology2000.com/Renal/questions1/ren1.htm'
p9855
sg31
S'Osmotic diuretic'
p9856
sg33
I13
sg34
S'Q83#5'
p9857
sg36
I2
sg37
S'5'
sg38
I2
sg39
S'83'
p9858
sa(dp9859
g3
(lp9860
sg18
(lp9861
Vchlorothiazide (Diuril)
p9862
aVbumetanide (Bumex)
p9863
aVmannitol (Osmitrol)
p9864
aVtriamterene (Dyrenium)
p9865
asg24
(lp9866
Vhttp://dbpedia.org/resource/Diuretic
p9867
aVhttp://dbpedia.org/resource/Acting
p9868
asg29
S'http://www.pharmacology2000.com/Renal/questions1/ren1.htm'
p9869
sg31
S'Diuretic acting primarily on the thick ascending limb of the loop of Henle:'
p9870
sg33
I16
sg34
S'Q83#6'
p9871
sg36
I13
sg37
S'6'
sg38
I1
sg39
S'83'
p9872
sa(dp9873
g3
(lp9874
(lp9875
Vhttp://dbpedia.org/resource/Acetazolamide
p9876
aVhttp://dbpedia.org/resource/Acetazolamide
p9877
aasg18
(lp9878
Vchlorothiazide (Diuril)
p9879
aVacetazolamide (Diamox)
p9880
aVmetolazone (Zaroxolyn, Mykrox)
p9881
aVbumetanide (Bumex)
p9882
asg24
(lp9883
Vhttp://dbpedia.org/resource/Diuretic
p9884
aVhttp://dbpedia.org/resource/Epilepsy
p9885
aVhttp://dbpedia.org/resource/Altitude_sickness
p9886
aVhttp://dbpedia.org/resource/Glaucoma
p9887
asg29
S'http://www.pharmacology2000.com/Renal/questions1/ren1.htm'
p9888
sg31
S'Diuretic that may be used to treat epilepsy, acute mountain sickness and open-angle glaucoma'
p9889
sg33
I18
sg34
S'Q83#7'
p9890
sg36
I15
sg37
S'7'
sg38
I1
sg39
S'83'
p9891
sa(dp9892
g3
(lp9893
(lp9894
Vhttp://dbpedia.org/resource/Bicarbonate
p9895
aa(lp9896
Vhttp://dbpedia.org/resource/Secretion
p9897
aVhttp://dbpedia.org/resource/Bicarbonate
p9898
aVhttp://dbpedia.org/resource/Ciliary_body
p9899
aVhttp://dbpedia.org/resource/Eye
p9900
aa(lp9901
Vhttp://dbpedia.org/resource/Effectiveness
p9902
aVhttp://dbpedia.org/resource/In_Treatment
p9903
aa(lp9904
Vhttp://dbpedia.org/resource/Major_%28United_States%29
p9905
aVhttp://dbpedia.org/resource/Application_software
p9906
aVhttp://dbpedia.org/resource/Kidney
p9907
aVhttp://dbpedia.org/resource/Produce
p9908
aVhttp://dbpedia.org/resource/Bicarbonate
p9909
aa(lp9910
Vhttp://dbpedia.org/resource/Main_%28river%29
p9911
aVhttp://dbpedia.org/resource/Kidney
p9912
aVhttp://dbpedia.org/resource/Ribosome
p9913
aVhttp://dbpedia.org/resource/Karma
p9914
aasg18
(lp9915
Vincreases bicarbonate reabsorption in the proximal tubule
p9916
aVincreases secretion of bicarbonate by the ciliary body of the eye into aqueous humor
p9917
aVmay be effective in treatment metabolic alkalosis
p9918
aVmajor clincial application is the kidney--to produce a bicarbonate-driven diuresis
p9919
aVmain renal site of action is the thick ascending loop of Henle
p9920
asg24
(lp9921
Vhttp://dbpedia.org/resource/Acetazolamide
p9922
aVhttp://dbpedia.org/resource/Acetazolamide
p9923
asg29
S'http://www.pharmacology2000.com/Renal/questions2/renal2.htm'
p9924
sg31
S'Acetazolamide (Diamox)'
p9925
sg33
I52
sg34
S'Q84#0'
p9926
sg36
I4
sg37
S'0'
sg38
I2
sg39
S'84'
p9927
sa(dp9928
g3
(lp9929
(lp9930
Vhttp://dbpedia.org/resource/Secretion
p9931
aa(lp9932
Vhttp://dbpedia.org/resource/Excretion
p9933
aa(lp9934
Vhttp://dbpedia.org/resource/Distal_convoluted_tubule
p9935
aasg18
(lp9936
Vnot secreted
p9937
aVexcreted by the S2 segment of the proximal tubule
p9938
aVcollecting duct
p9939
aVdistal convoluted tubule
p9940
aVascending Loop of Henle
p9941
asg24
(lp9942
Vhttp://dbpedia.org/resource/Acetazolamide
p9943
aVhttp://dbpedia.org/resource/Acetazolamide
p9944
aVhttp://dbpedia.org/resource/Secretion
p9945
asg29
S'http://www.pharmacology2000.com/Renal/questions2/renal2.htm'
p9946
sg31
S'Acetazolamide (Diamox) secretion:'
p9947
sg33
I20
sg34
S'Q84#2'
p9948
sg36
I5
sg37
S'2'
sg38
I1
sg39
S'84'
p9949
sa(dp9950
g3
(lp9951
(lp9952
Vhttp://dbpedia.org/resource/Acetazolamide
p9953
aVhttp://dbpedia.org/resource/Acetazolamide
p9954
aa(lp9955
Vhttp://dbpedia.org/resource/Furosemide
p9956
aVhttp://dbpedia.org/resource/Furosemide
p9957
aasg18
(lp9958
Vacetazolamide (Diamox)
p9959
aVfurosemide (Lasix)
p9960
aVchlorothiazide (Diuril)
p9961
aVdorzolamide (Trusopf)
p9962
aVbumetanide (Bumex)
p9963
asg24
(lp9964
Vhttp://dbpedia.org/resource/Topical
p9965
aVhttp://dbpedia.org/resource/Bioavailability
p9966
asg29
S'http://www.pharmacology2000.com/Renal/questions2/renal2.htm'
p9967
sg31
S'Topically-active carbonic anhydrase inhibitor for ocular use:'
p9968
sg33
I20
sg34
S'Q84#3'
p9969
sg36
I7
sg37
S'3'
sg38
I3
sg39
S'84'
p9970
sa(dp9971
g3
(lp9972
(lp9973
Vhttp://dbpedia.org/resource/Distal_convoluted_tubule
p9974
aa(lp9975
Vhttp://dbpedia.org/resource/Thin_Lizzy
p9976
aa(lp9977
Vhttp://dbpedia.org/resource/Ribosome
p9978
aVhttp://dbpedia.org/resource/Renal_function
p9979
aasg18
(lp9980
Vdistal tubule
p9981
aVcollecting duct
p9982
aVthin descending limb of the loop of Henle
p9983
aVthick ascending limb of the loop of Henle
p9984
aVat the site of glomerular filtration
p9985
asg24
(lp9986
Vhttp://dbpedia.org/resource/Primary_school
p9987
aVhttp://dbpedia.org/resource/Ribosome
p9988
aVhttp://dbpedia.org/resource/Action_%28physics%29
p9989
asg29
S'http://www.pharmacology2000.com/Renal/questions3/renal3.htm'
p9990
sg31
S'Primary site of action of loop diuretics:'
p9991
sg33
I26
sg34
S'Q85#0'
p9992
sg36
I7
sg37
S'0'
sg38
I3
sg39
S'85'
p9993
sa(dp9994
g3
(lp9995
(lp9996
Vhttp://dbpedia.org/resource/Kidney
p9997
aVhttp://dbpedia.org/resource/Secretion
p9998
aa(lp9999
Vhttp://dbpedia.org/resource/Renal_function
p10000
aa(lp10001
Vhttp://dbpedia.org/resource/Interstitial_fluid
p10002
aVhttp://dbpedia.org/resource/Cell_%28biology%29
p10003
aa(lp10004
Vhttp://dbpedia.org/resource/Highland_Clearances
p10005
aasg18
(lp10006
Vrapidly absorbed
p10007
aVeliminated by renal secretion only
p10008
aVeliminated by glomerular filtration only
p10009
aVloop diuretics act on the interstitial side of the principal cell
p10010
aVindomethacin (Indocin) increases loop diuretic clearance
p10011
asg24
(lp10012
Vhttp://dbpedia.org/resource/Pharmacokinetics
p10013
asg29
S'http://www.pharmacology2000.com/Renal/questions3/renal3.htm'
p10014
sg31
S'Loop diuretics: Pharmacokinetics'
p10015
sg33
I31
sg34
S'Q85#2'
p10016
sg36
I4
sg37
S'2'
sg38
I0
sg39
S'85'
p10017
sa(dp10018
g3
(lp10019
(lp10020
Vhttp://dbpedia.org/resource/Mannitol
p10021
aa(lp10022
Vhttp://dbpedia.org/resource/Spironolactone
p10023
aVhttp://dbpedia.org/resource/Spironolactone
p10024
aasg18
(lp10025
Vchlorothiazide (Diuril)
p10026
aVmannitol (Osmitrol)
p10027
aVbumetanide (Bumex)
p10028
aVcarbonic anhydrase inhibitor
p10029
aVspironolactone (Aldactone)
p10030
asg24
(lp10031
Vhttp://dbpedia.org/resource/Efficacy
p10032
aVhttp://dbpedia.org/resource/Diuretic
p10033
aVhttp://dbpedia.org/resource/Pulmonary_edema
p10034
aVhttp://dbpedia.org/resource/Heart_failure
p10035
asg29
S'http://www.pharmacology2000.com/Renal/questions3/renal3.htm'
p10036
sg31
S'Most efficacious diuretic in management of acute pulmonary edema secondary to congestive heart failure.'
p10037
sg33
I19
sg34
S'Q85#5'
p10038
sg36
I15
sg37
S'5'
sg38
I2
sg39
S'85'
p10039
sa(dp10040
g3
(lp10041
sg18
(lp10042
Vototoxicity
p10043
aVhypouricemia
p10044
aVhypermagnesemia
p10045
aVsevere fluid overload
p10046
aVhypernatremia
p10047
asg24
(lp10048
Vhttp://dbpedia.org/resource/Furosemide
p10049
aVhttp://dbpedia.org/resource/Furosemide
p10050
aVhttp://dbpedia.org/resource/Toxicity
p10051
asg29
S'http://www.pharmacology2000.com/Renal/questions3/renal3.htm'
p10052
sg31
S'Furosemide (Lasix) toxicity:'
p10053
sg33
I7
sg34
S'Q85#7'
p10054
sg36
I5
sg37
S'7'
sg38
I0
sg39
S'85'
p10055
sa(dp10056
g3
(lp10057
(lp10058
Vhttp://dbpedia.org/resource/Furosemide
p10059
aVhttp://dbpedia.org/resource/Furosemide
p10060
aa(lp10061
Vhttp://dbpedia.org/resource/Acetazolamide
p10062
aVhttp://dbpedia.org/resource/Acetazolamide
p10063
aa(lp10064
Vhttp://dbpedia.org/resource/Mannitol
p10065
aasg18
(lp10066
Vfurosemide (Lasix)
p10067
aVbumetanide (Bumex)
p10068
aVacetazolamide (Diamox)
p10069
aVtriamterene (Dyrenium)
p10070
aVmannitol
p10071
asg24
(lp10072
Vhttp://dbpedia.org/resource/Prototype_%28video_game%29
p10073
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10074
sg31
S'Prototype carbonic anhydrase inhibitor:'
p10075
sg33
I17
sg34
S'Q86#0'
p10076
sg36
I4
sg37
S'0'
sg38
I2
sg39
S'86'
p10077
sa(dp10078
g3
(lp10079
(lp10080
Vhttp://dbpedia.org/resource/Furosemide
p10081
aVhttp://dbpedia.org/resource/Furosemide
p10082
aa(lp10083
Vhttp://dbpedia.org/resource/Spironolactone
p10084
aVhttp://dbpedia.org/resource/Spironolactone
p10085
aa(lp10086
Vhttp://dbpedia.org/resource/Mannitol
p10087
aasg18
(lp10088
Vfurosemide (Lasix)
p10089
aVtriamterene (Dyrenium)
p10090
aVspironolactone (Aldactone)
p10091
aVmannitol
p10092
asg24
(lp10093
Vhttp://dbpedia.org/resource/Pharmacology
p10094
aVhttp://dbpedia.org/resource/Mineralocorticoid
p10095
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p10096
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10097
sg31
S'Pharmacologic antagonism that mineralocorticoid receptors:'
p10098
sg33
I13
sg34
S'Q86#5'
p10099
sg36
I5
sg37
S'5'
sg38
I2
sg39
S'86'
p10100
sa(dp10101
g3
(lp10102
sg18
(lp10103
Vchlorothiazide (Diuril)
p10104
aVtorsemide (Demadex)
p10105
aVtriamterene (Dyrenium)
p10106
aVbumetanide (Bumex)
p10107
aVacetazolamide (Diamox)
p10108
asg24
(lp10109
Vhttp://dbpedia.org/resource/Acetazolamide
p10110
aVhttp://dbpedia.org/resource/Acetazolamide
p10111
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10112
sg31
S'Example(s) of potassium-sparing diuretics:'
p10113
sg33
I20
sg34
S'Q86#6'
p10114
sg36
I7
sg37
S'6'
sg38
I2
sg39
S'86'
p10115
sa(dp10116
g3
(lp10117
(lp10118
Vhttp://dbpedia.org/resource/Distal_convoluted_tubule
p10119
aasg18
(lp10120
Vdistal  tubule
p10121
aVcollecting duct
p10122
aVdescending loop of Henle
p10123
aVascending loop of Henle
p10124
aVproximal tubule
p10125
asg24
(lp10126
Vhttp://dbpedia.org/resource/Primary_school
p10127
aVhttp://dbpedia.org/resource/Ribosome
p10128
aVhttp://dbpedia.org/resource/Karma
p10129
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10130
sg31
S'Primary site of action of bumetanide (Bumex):'
p10131
sg33
I14
sg34
S'Q86#12'
p10132
sg36
I10
sg37
S'12'
p10133
sg38
I3
sg39
S'86'
p10134
sa(dp10135
g3
(lp10136
(lp10137
Vhttp://dbpedia.org/resource/Mannitol
p10138
aa(lp10139
Vhttp://dbpedia.org/resource/Acetazolamide
p10140
aVhttp://dbpedia.org/resource/Acetazolamide
p10141
aasg18
(lp10142
Vmannitol
p10143
aVtriamterene (Dyrenium)
p10144
aVbumetanide (Bumex)
p10145
aVacetazolamide (Diamox)
p10146
asg24
(lp10147
Vhttp://dbpedia.org/resource/Effectiveness
p10148
aVhttp://dbpedia.org/resource/Diuretic
p10149
aVhttp://dbpedia.org/resource/In_Treatment
p10150
aVhttp://dbpedia.org/resource/Acute_%28medicine%29
p10151
aVhttp://dbpedia.org/resource/Heart_failure
p10152
aVhttp://dbpedia.org/resource/Magnitude_%28mathematics%29
p10153
aVhttp://dbpedia.org/resource/Intravenous_therapy
p10154
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10155
sg31
S'Most effective diuretic in treatment of acute congestive heart failure -- in terms of magnitude of induced diuresis following IV administration:'
p10156
sg33
I13
sg34
S'Q86#13'
p10157
sg36
I21
sg37
S'13'
p10158
sg38
I2
sg39
S'86'
p10159
sa(dp10160
g3
(lp10161
(lp10162
Vhttp://dbpedia.org/resource/Hyperkalemia
p10163
aVhttp://dbpedia.org/resource/Metabolic_acidosis
p10164
aasg18
(lp10165
Vhyperkalemic metabolic acidosis
p10166
aVototoxicity
p10167
aVhypouricemia
p10168
aVhypermagnesemia
p10169
asg24
(lp10170
Vhttp://dbpedia.org/resource/Toxicity
p10171
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10172
sg31
S'Toxicities/toxicity associated with loop diuretics:'
p10173
sg33
I6
sg34
S'Q86#16'
p10174
sg36
I5
sg37
S'16'
p10175
sg38
I1
sg39
S'86'
p10176
sa(dp10177
g3
(lp10178
(lp10179
Vhttp://dbpedia.org/resource/Thin_Lizzy
p10180
aa(lp10181
Vhttp://dbpedia.org/resource/Distal_convoluted_tubule
p10182
aasg18
(lp10183
Vthin descending loop of Henle
p10184
aVthick ascending loop of Henle
p10185
aVdistal convoluted tubule
p10186
aVproximal tubule
p10187
aVcollecting duct
p10188
asg24
(lp10189
Vhttp://dbpedia.org/resource/Primary_school
p10190
aVhttp://dbpedia.org/resource/Ribosome
p10191
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p10192
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p10193
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p10194
aVhttp://dbpedia.org/resource/Hydrochlorothiazide
p10195
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10196
sg31
S'Primary site of action of hydrochlorothiazide (HCTZ, Esidrix, HydroDIURIL):'
p10197
sg33
I17
sg34
S'Q86#17'
p10198
sg36
I14
sg37
S'17'
p10199
sg38
I2
sg39
S'86'
p10200
sa(dp10201
g3
(lp10202
(lp10203
Vhttp://dbpedia.org/resource/Hyperkalemia
p10204
aa(lp10205
Vhttp://dbpedia.org/resource/Hyponatremia
p10206
aasg18
(lp10207
Vhyperkalemic states
p10208
aVhypouricemia
p10209
aVhypolipidemia
p10210
aVhyponatremia
p10211
asg24
(lp10212
Vhttp://dbpedia.org/resource/Toxicity
p10213
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10214
sg31
S'Toxicities/toxicity associated with thiazide diuretics:'
p10215
sg33
I5
sg34
S'Q86#20'
p10216
sg36
I5
sg37
S'20'
p10217
sg38
I3
sg39
S'86'
p10218
sa(dp10219
g3
(lp10220
(lp10221
Vhttp://dbpedia.org/resource/ACE_inhibitor
p10222
aa(lp10223
Vhttp://dbpedia.org/resource/Calcium_channel_blocker
p10224
aa(lp10225
Vhttp://dbpedia.org/resource/Beta_blocker
p10226
aa(lp10227
Vhttp://dbpedia.org/resource/Vasodilation
p10228
aasg18
(lp10229
VACE inhibitor
p10230
aVcalcium channel blocker
p10231
aVbeta-blocker
p10232
aVthiazide
p10233
aVvasodilator
p10234
asg24
(lp10235
Vhttp://dbpedia.org/resource/Pharmacology
p10236
aVhttp://dbpedia.org/resource/Mild_ale
p10237
aVhttp://dbpedia.org/resource/Hypertension
p10238
asg29
S'http://www.pharmacology2000.com/Renal/questions4/questionset4.htm'
p10239
sg31
S'Least likely to be used initially in the pharmacological treatment of mild hypertension:'
p10240
sg33
I8
sg34
S'Q86#22'
p10241
sg36
I13
sg37
S'22'
p10242
sg38
I4
sg39
S'86'
p10243
sa(dp10244
g3
(lp10245
(lp10246
Vhttp://dbpedia.org/resource/Atropine
p10247
aa(lp10248
Vhttp://dbpedia.org/resource/Scopolamine
p10249
aa(lp10250
Vhttp://dbpedia.org/resource/Produce
p10251
aVhttp://dbpedia.org/resource/Equality_%28mathematics%29
p10252
aVhttp://dbpedia.org/resource/Side_effect
p10253
aasg18
(lp10254
Vatropine
p10255
aVscopolamine
p10256
aVpirenzepine
p10257
aVall produce about equal side effects.
p10258
asg24
(lp10259
Vhttp://dbpedia.org/resource/Talent_manager
p10260
aVhttp://dbpedia.org/resource/Acid
p10261
aVhttp://dbpedia.org/resource/Peptic_ulcer
p10262
aVhttp://dbpedia.org/resource/Produce
p10263
aVhttp://dbpedia.org/resource/Side_effect
p10264
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10265
sg31
S'Used in management of acid-peptic ulcer disease: Least likely to produce side effects.'
p10266
sg33
I10
sg34
S'Q87#2'
p10267
sg36
I15
sg37
S'2'
sg38
I2
sg39
S'87'
p10268
sa(dp10269
g3
(lp10270
(lp10271
Vhttp://dbpedia.org/resource/Gastric_acid
p10272
aVhttp://dbpedia.org/resource/Pump
p10273
aa(lp10274
Vhttp://dbpedia.org/resource/Block_%28sailing%29
p10275
aVhttp://dbpedia.org/resource/Camping
p10276
aVhttp://dbpedia.org/resource/Action_game
p10277
aa(lp10278
Vhttp://dbpedia.org/resource/Histamine
p10279
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p10280
aa(lp10281
Vhttp://dbpedia.org/resource/Gastrin
p10282
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p10283
aasg18
(lp10284
Vinterferes with the gastric acid pump
p10285
aVblocks cAMP action by preventing protein phosphorylation
p10286
aVcompetes with histamine for H-2 receptor sites
p10287
aVcompetes with gastrin for H-2 receptor sites
p10288
asg24
(lp10289
Vhttp://dbpedia.org/resource/Mechanism_of_action
p10290
aVhttp://dbpedia.org/resource/Cimetidine
p10291
aVhttp://dbpedia.org/resource/Gastric_acid
p10292
aVhttp://dbpedia.org/resource/Secretion
p10293
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10294
sg31
S'Mechanism by which cimetidine decrease gastric acid secretion:'
p10295
sg33
I27
sg34
S'Q87#3'
p10296
sg36
I8
sg37
S'3'
sg38
I2
sg39
S'87'
p10297
sa(dp10298
g3
(lp10299
(lp10300
Vhttp://dbpedia.org/resource/Cimetidine
p10301
aVhttp://dbpedia.org/resource/Cimetidine
p10302
aa(lp10303
Vhttp://dbpedia.org/resource/Atropine
p10304
aa(lp10305
Vhttp://dbpedia.org/resource/Omeprazole
p10306
aVhttp://dbpedia.org/resource/Omeprazole
p10307
aasg18
(lp10308
Vranitidine (Zantac)
p10309
aVthe cimetidine (Tagamet)
p10310
aVatropine
p10311
aVomeprazole (Prilosec)
p10312
asg24
(lp10313
Vhttp://dbpedia.org/resource/Gynecomastia
p10314
aVhttp://dbpedia.org/resource/Breast_implant
p10315
aVhttp://dbpedia.org/resource/Patient
p10316
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10317
sg31
S'Antiulcer medication that has an antiadrogenic effect--may cause gynecomastia (breast enlargement) in some patients:'
p10318
sg33
I14
sg34
S'Q87#4'
p10319
sg36
I18
sg37
S'4'
sg38
I1
sg39
S'87'
p10320
sa(dp10321
g3
(lp10322
(lp10323
Vhttp://dbpedia.org/resource/Bismuth
p10324
aa(lp10325
Vhttp://dbpedia.org/resource/Viscosity
p10326
aVhttp://dbpedia.org/resource/Lidocaine
p10327
aasg18
(lp10328
Vbismuth compounds
p10329
aVmisoprostol (Cytotec)
p10330
aVsucralfate (Carafate)
p10331
aVviscous lidocaine
p10332
asg24
(lp10333
Vhttp://dbpedia.org/resource/Peptic_ulcer
p10334
aVhttp://dbpedia.org/resource/Drug
p10335
aVhttp://dbpedia.org/resource/Mucous_membrane
p10336
aVhttp://dbpedia.org/resource/Protein
p10337
aVhttp://dbpedia.org/resource/Substrate_%28chemistry%29
p10338
aVhttp://dbpedia.org/resource/Gel_electrophoresis
p10339
aVhttp://dbpedia.org/resource/Ulcer_%28dermatology%29
p10340
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10341
sg31
S'Anti-gastric ulcer drug that binds to mucosal protein substrate and then forms a gel that coats the ulcer.'
p10342
sg33
I12
sg34
S'Q87#6'
p10343
sg36
I19
sg37
S'6'
sg38
I2
sg39
S'87'
p10344
sa(dp10345
g3
(lp10346
(lp10347
Vhttp://dbpedia.org/resource/Omeprazole
p10348
aVhttp://dbpedia.org/resource/Omeprazole
p10349
aa(lp10350
Vhttp://dbpedia.org/resource/Bismuth
p10351
aasg18
(lp10352
Vsucralfate
p10353
aVomeprazole (Prilosec)
p10354
aVranitidine (Zantac)
p10355
aVbismuth compounds
p10356
asg24
(lp10357
Vhttp://dbpedia.org/resource/Ulcer_%28dermatology%29
p10358
aVhttp://dbpedia.org/resource/Proton
p10359
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10360
sg31
S'Anti-ulcer agent that blocks proton gnerations by parietal cells:'
p10361
sg33
I11
sg34
S'Q87#7'
p10362
sg36
I9
sg37
S'7'
sg38
I1
sg39
S'87'
p10363
sa(dp10364
g3
(lp10365
(lp10366
Vhttp://dbpedia.org/resource/Omeprazole
p10367
aVhttp://dbpedia.org/resource/Omeprazole
p10368
aa(lp10369
Vhttp://dbpedia.org/resource/Cimetidine
p10370
aVhttp://dbpedia.org/resource/Cimetidine
p10371
aasg18
(lp10372
Vranitidine (Zantac)
p10373
aVomeprazole (Prilosec)
p10374
aVcimetidine (Tagamet)
p10375
aVsucralfate
p10376
asg24
(lp10377
Vhttp://dbpedia.org/resource/Produce
p10378
aVhttp://dbpedia.org/resource/Hyperplasia
p10379
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10380
sg31
S'may produce hyperplasia of enterochromaffin-like cells:'
p10381
sg33
I13
sg34
S'Q87#8'
p10382
sg36
I6
sg37
S'8'
sg38
I1
sg39
S'87'
p10383
sa(dp10384
g3
(lp10385
(lp10386
Vhttp://dbpedia.org/resource/Cimetidine
p10387
aVhttp://dbpedia.org/resource/Cimetidine
p10388
aasg18
(lp10389
Vfamotidine (Pepcid)
p10390
aVterfenadine (Seldane)
p10391
aVnizatidine (Axid)
p10392
aVcimetidine (Tagamet)
p10393
asg24
(lp10394
Vhttp://dbpedia.org/resource/Classified_%28rapper%29
p10395
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p10396
aVhttp://dbpedia.org/resource/Dan_Blocker
p10397
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10398
sg31
S'NOT classified as an H-2 receptor blocker:'
p10399
sg33
I16
sg34
S'Q87#9'
p10400
sg36
I7
sg37
S'9'
sg38
I1
sg39
S'87'
p10401
sa(dp10402
g3
(lp10403
(lp10404
Vhttp://dbpedia.org/resource/Omeprazole
p10405
aVhttp://dbpedia.org/resource/Omeprazole
p10406
aasg18
(lp10407
Vsucralfate (Carafate)
p10408
aVomeprazole (Prilosec)
p10409
aVfamotidine (Pepcid)
p10410
aVmisoprostol (Cytotec)
p10411
asg24
(lp10412
Vhttp://dbpedia.org/resource/Effectiveness
p10413
aVhttp://dbpedia.org/resource/Syndrome
p10414
aVhttp://dbpedia.org/resource/Gastrin
p10415
aVhttp://dbpedia.org/resource/Tumor
p10416
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10417
sg31
S'Most effective in treating Zollinger-Ellison syndrome (caused by gastrin secreting tumors)'
p10418
sg33
I16
sg34
S'Q87#11'
p10419
sg36
I13
sg37
S'11'
p10420
sg38
I1
sg39
S'87'
p10421
sa(dp10422
g3
(lp10423
(lp10424
Vhttp://dbpedia.org/resource/Lidocaine
p10425
aa(lp10426
Vhttp://dbpedia.org/resource/Chlorpromazine
p10427
aVhttp://dbpedia.org/resource/Chlorpromazine
p10428
aasg18
(lp10429
Vviscous lidocaine
p10430
aVchlorpromazine (Thorazine)
p10431
aVbismuth subsalicylate
p10432
aVcholestyramine (Questran, Questran Light)
p10433
asg24
(lp10434
Vhttp://dbpedia.org/resource/Acting
p10435
aVhttp://dbpedia.org/resource/Antiemetic
p10436
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10437
sg31
S'Centrally-acting anti-emetic:'
p10438
sg33
I15
sg34
S'Q87#12'
p10439
sg36
I2
sg37
S'12'
p10440
sg38
I1
sg39
S'87'
p10441
sa(dp10442
g3
(lp10443
(lp10444
Vhttp://dbpedia.org/resource/Cimetidine
p10445
aVhttp://dbpedia.org/resource/Cimetidine
p10446
aa(lp10447
Vhttp://dbpedia.org/resource/Omeprazole
p10448
aVhttp://dbpedia.org/resource/Omeprazole
p10449
aasg18
(lp10450
Vfamotidine (Pepcid)
p10451
aVcimetidine (Tagamet)
p10452
aVomeprazole (Prilosec)
p10453
aVsucralfate (Carafate)
p10454
asg24
(lp10455
Vhttp://dbpedia.org/resource/Gastroesophageal_reflux_disease
p10456
asg29
S'http://www.pharmacology2000.com/Gastrointestinal/questions2/GI1.htm'
p10457
sg31
S'Reflux esophagitis responds best to:'
p10458
sg33
I16
sg34
S'Q87#14'
p10459
sg36
I5
sg37
S'14'
p10460
sg38
I2
sg39
S'87'
p10461
sa(dp10462
g3
(lp10463
(lp10464
Vhttp://dbpedia.org/resource/Diagnosis
p10465
aVhttp://dbpedia.org/resource/Adrenal_gland
p10466
aVhttp://dbpedia.org/resource/Function_%28mathematics%29
p10467
aa(lp10468
Vhttp://dbpedia.org/resource/Adrenal_gland
p10469
aVhttp://dbpedia.org/resource/Function_%28mathematics%29
p10470
aa(lp10471
Vhttp://dbpedia.org/resource/Immunology
p10472
aasg18
(lp10473
Vdiagnosis of adrenal function disorders
p10474
aVtreatment of adrenal function disorders
p10475
aVtreatment of inflammatory/immunologic disorders
p10476
asg24
(lp10477
Vhttp://dbpedia.org/resource/Nature
p10478
aVhttp://dbpedia.org/resource/Synthetic_fiber
p10479
aVhttp://dbpedia.org/resource/Corticosteroid
p10480
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question1/questionset1.htm'
p10481
sg31
S'Natural and synthetic corticosteroids are mainly used for:'
p10482
sg33
I14
sg34
S'Q88#1'
p10483
sg36
I8
sg37
S'1'
sg38
I2
sg39
S'88'
p10484
sa(dp10485
g3
(lp10486
(lp10487
Vhttp://dbpedia.org/resource/Angiotensin
p10488
aVhttp://dbpedia.org/resource/Stop_consonant
p10489
aa(lp10490
Vhttp://dbpedia.org/resource/Renin
p10491
aa(lp10492
Vhttp://dbpedia.org/resource/Calcitonin
p10493
aa(lp10494
Vhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p10495
aa(lp10496
Vhttp://dbpedia.org/resource/Vasopressin
p10497
aasg18
(lp10498
Vangiotensin release
p10499
aVrenin
p10500
aVcalcitonin
p10501
aVcorticotropin
p10502
aVvasopressin
p10503
asg24
(lp10504
Vhttp://dbpedia.org/resource/Adrenal_cortex
p10505
aVhttp://dbpedia.org/resource/Steroid
p10506
aVhttp://dbpedia.org/resource/Secretion
p10507
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question1/questionset1.htm'
p10508
sg31
S'Adrenocortical steroid secretion is mainly controlled by:'
p10509
sg33
I6
sg34
S'Q88#2'
p10510
sg36
I7
sg37
S'2'
sg38
I3
sg39
S'88'
p10511
sa(dp10512
g3
(lp10513
(lp10514
Vhttp://dbpedia.org/resource/Gluconeogenesis
p10515
aVhttp://dbpedia.org/resource/Diabetes_mellitus
p10516
aa(lp10517
Vhttp://dbpedia.org/resource/Amino_acid
p10518
aVhttp://dbpedia.org/resource/Liver
p10519
aa(lp10520
Vhttp://dbpedia.org/resource/Amino_acid
p10521
aVhttp://dbpedia.org/resource/Kidney
p10522
aa(lp10523
Vhttp://dbpedia.org/resource/Activity_%28chemistry%29
p10524
aVhttp://dbpedia.org/resource/Liver
p10525
aa(lp10526
Vhttp://dbpedia.org/resource/Glucose
p10527
aVhttp://dbpedia.org/resource/Protein
p10528
aasg18
(lp10529
Vgluconeogenesis in diabetics
p10530
aVdecreased amino acid uptake in the liver
p10531
aVdecreased amino acid uptake in the kidney
p10532
aVdecreased glycogen synthase activity in the liver
p10533
aVdecreased glucose production for protein
p10534
asg24
(lp10535
Vhttp://dbpedia.org/resource/Glucocorticoid
p10536
aVhttp://dbpedia.org/resource/Metabolism
p10537
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question1/questionset1.htm'
p10538
sg31
S'Glucocorticoid metabolic effects:'
p10539
sg33
I29
sg34
S'Q88#9'
p10540
sg36
I3
sg37
S'9'
sg38
I0
sg39
S'88'
p10541
sa(dp10542
g3
(lp10543
(lp10544
Vhttp://dbpedia.org/resource/Prednisolone
p10545
aa(lp10546
Vhttp://dbpedia.org/resource/Dexamethasone
p10547
aVhttp://dbpedia.org/resource/Dexamethasone
p10548
aasg18
(lp10549
Vtriamcinolone (Aristocort)
p10550
aVfluprednisolone
p10551
aVprednisolone (Prelone)
p10552
aVfludrocortisone (Florinef)
p10553
aVdexamethasone (Decadron)
p10554
asg24
(lp10555
Vhttp://dbpedia.org/resource/Medium_%28TV_series%29
p10556
aVhttp://dbpedia.org/resource/Acting
p10557
aVhttp://dbpedia.org/resource/Glucocorticoid
p10558
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question1/questionset1.htm'
p10559
sg31
S'Example of short-to medium-acting glucocorticoid'
p10560
sg33
I17
sg34
S'Q88#14'
p10561
sg36
I5
sg37
S'14'
p10562
sg38
I2
sg39
S'88'
p10563
sa(dp10564
g3
(lp10565
(lp10566
Vhttp://dbpedia.org/resource/Cortisone
p10567
aasg18
(lp10568
Vcortisone
p10569
aVfluprednisolone
p10570
aVtriamcinolone (Aristocort)
p10571
aVbetamethasone (Celestone)
p10572
aVdesoxycorticosterone acetate
p10573
asg24
(lp10574
Vhttp://dbpedia.org/resource/Long_%28finance%29
p10575
aVhttp://dbpedia.org/resource/Acting
p10576
aVhttp://dbpedia.org/resource/Glucocorticoid
p10577
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question1/questionset1.htm'
p10578
sg31
S'Long-acting glucocorticoid'
p10579
sg33
I12
sg34
S'Q88#15'
p10580
sg36
I2
sg37
S'15'
p10581
sg38
I3
sg39
S'88'
p10582
sa(dp10583
g3
(lp10584
(lp10585
Vhttp://dbpedia.org/resource/Dexamethasone
p10586
aa(lp10587
Vhttp://dbpedia.org/resource/Acetate
p10588
aa(lp10589
Vhttp://dbpedia.org/resource/Cortisol
p10590
aVhttp://dbpedia.org/resource/Cortisol
p10591
aasg18
(lp10592
Vdexamethasone
p10593
aVtriamcinolone
p10594
aVdesoxycorticosterone acetate
p10595
aVhydrocortisone (cortisol)
p10596
aVfludrocortisone
p10597
asg24
(lp10598
Vhttp://dbpedia.org/resource/Mineralocorticoid
p10599
aVhttp://dbpedia.org/resource/Acute_%28medicine%29
p10600
aVhttp://dbpedia.org/resource/Adrenal_insufficiency
p10601
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question2/questionset2.htm'
p10602
sg31
S'Most appropriate mineralocorticoids following management of acute adrenocortical insufficiency:'
p10603
sg33
I9
sg34
S'Q89#2'
p10604
sg36
I9
sg37
S'2'
sg38
I4
sg39
S'89'
p10605
sa(dp10606
g3
(lp10607
(lp10608
Vhttp://dbpedia.org/resource/Infection
p10609
aVhttp://dbpedia.org/resource/AIDS
p10610
aa(lp10611
Vhttp://dbpedia.org/resource/Idiopathic
p10612
aVhttp://dbpedia.org/resource/Atrophy
p10613
aa(lp10614
Vhttp://dbpedia.org/resource/Congenital_adrenal_hyperplasia
p10615
aa(lp10616
Vhttp://dbpedia.org/resource/Hypothalamus
p10617
aVhttp://dbpedia.org/resource/Pituitary_gland
p10618
aVhttp://dbpedia.org/resource/Steroid
p10619
aa(lp10620
Vhttp://dbpedia.org/resource/Mutation
p10621
aVhttp://dbpedia.org/resource/Gene
p10622
aasg18
(lp10623
Vinfection -- especially in AIDS patients
p10624
aVidiopathic atrophy
p10625
aVcongenital adrenal hyperplasia
p10626
aVsuppression of hypothalamic-pituitary axis by endogenous steroid
p10627
aVmutation in ACTH receptor gene
p10628
asg24
(lp10629
Vhttp://dbpedia.org/resource/Secondary_school
p10630
aVhttp://dbpedia.org/resource/Adrenal_insufficiency
p10631
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question2/questionset2.htm'
p10632
sg31
S'Secondary adrenal insufficiency:'
p10633
sg33
I23
sg34
S'Q89#5'
p10634
sg36
I3
sg37
S'5'
sg38
I3
sg39
S'89'
p10635
sa(dp10636
g3
(lp10637
(lp10638
Vhttp://dbpedia.org/resource/Hypotension
p10639
aa(lp10640
Vhttp://dbpedia.org/resource/Weakness
p10641
aa(lp10642
Vhttp://dbpedia.org/resource/Hypoglycemia
p10643
aasg18
(lp10644
Vhyperpigmentation
p10645
aVarteriole hypotension
p10646
aVasthenia
p10647
aVabnormal Gi function
p10648
aVhypoglycemia
p10649
asg24
(lp10650
Vhttp://dbpedia.org/resource/Symptom
p10651
aVhttp://dbpedia.org/resource/Addison%27s_disease
p10652
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question2/questionset2.htm'
p10653
sg31
S"Cardinal symptom of Addison's disease:"
p10654
sg33
I8
sg34
S'Q89#7'
p10655
sg36
I6
sg37
S'7'
sg38
I2
sg39
S'89'
p10656
sa(dp10657
g3
(lp10658
(lp10659
Vhttp://dbpedia.org/resource/Cortisol
p10660
aa(lp10661
Vhttp://dbpedia.org/resource/Spironolactone
p10662
aasg18
(lp10663
Vcortisol
p10664
aVspironolactone
p10665
aVmitotane
p10666
aVmitoxantrone
p10667
aVaminoglutethimide
p10668
asg24
(lp10669
Vhttp://dbpedia.org/resource/Cushing%27s_syndrome
p10670
aVhttp://dbpedia.org/resource/Adrenal_gland
p10671
aVhttp://dbpedia.org/resource/Neoplasm
p10672
aVhttp://dbpedia.org/resource/Drug
p10673
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question2/questionset2.htm'
p10674
sg31
S"In Cushing's syndrome due to adrenal neoplasm:most common drug for treating adrenocortical carcinoma:"
p10675
sg33
I5
sg34
S'Q89#15'
p10676
sg36
I16
sg37
S'15'
p10677
sg38
I2
sg39
S'89'
p10678
sa(dp10679
g3
(lp10680
(lp10681
Vhttp://dbpedia.org/resource/Addison%27s_disease
p10682
aa(lp10683
Vhttp://dbpedia.org/resource/Cushing%27s_syndrome
p10684
aasg18
(lp10685
VAddison\u005c
p10686
aVCushing\u005c
p10687
aVConn\u005c
p10688
asg24
(lp10689
Vhttp://dbpedia.org/resource/Aldosterone
p10690
asg29
S'http://www.pharmacology2000.com/Adrenocorticosteroids/question2/questionset2.htm'
p10691
sg31
S'Primary aldosteronism -- aldosterone-producing adrenal adenoma'
p10692
sg33
I3
sg34
S'Q89#17'
p10693
sg36
I6
sg37
S'17'
p10694
sg38
I2
sg39
S'89'
p10695
sa(dp10696
g3
(lp10697
(lp10698
Vhttp://dbpedia.org/resource/Adult
p10699
aa(lp10700
Vhttp://dbpedia.org/resource/Anabolism
p10701
aVhttp://dbpedia.org/resource/Inborn_error_of_metabolism
p10702
aa(lp10703
Vhttp://dbpedia.org/resource/Insulin
p10704
aVhttp://dbpedia.org/resource/Absenteeism
p10705
aa(lp10706
Vhttp://dbpedia.org/resource/Glucagon
p10707
aasg18
(lp10708
Vmost often presents in adults
p10709
aVanabolic metabolic disorder
p10710
aVcirculating insulin is virtually absent
p10711
aVglucagon levels are low
p10712
aVketoacidosis is rarely seen
p10713
asg24
(lp10714
Vhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p10715
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10716
sg31
S'Type I diabetes:'
p10717
sg33
I21
sg34
S'Q91#2'
p10718
sg36
I3
sg37
S'2'
sg38
I2
sg39
S'91'
p10719
sa(dp10720
g3
(lp10721
(lp10722
Vhttp://dbpedia.org/resource/Absenteeism
p10723
aVhttp://dbpedia.org/resource/Insulin
p10724
aa(lp10725
Vhttp://dbpedia.org/resource/Tissue_%28biology%29
p10726
aVhttp://dbpedia.org/resource/Insulin
p10727
aa(lp10728
Vhttp://dbpedia.org/resource/Patient
p10729
aVhttp://dbpedia.org/resource/Obesity
p10730
aa(lp10731
Vhttp://dbpedia.org/resource/Hyperactivity
p10732
aVhttp://dbpedia.org/resource/Beta_cell
p10733
aVhttp://dbpedia.org/resource/Insulin
p10734
aasg18
(lp10735
Vabsence of endogenous insulin
p10736
aVtissue supersensitivity to insulin
p10737
aVmost patients are obese
p10738
aVhyper-responsiveness of pancreatic B cell-response to insulin
p10739
aVketoacidosis
p10740
asg24
(lp10741
Vhttp://dbpedia.org/resource/Characteristic_%28algebra%29
p10742
aVhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p10743
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10744
sg31
S'Characteristic(s) of Type II diabetes'
p10745
sg33
I20
sg34
S'Q91#6'
p10746
sg36
I8
sg37
S'6'
sg38
I2
sg39
S'91'
p10747
sa(dp10748
g3
(lp10749
(lp10750
Vhttp://dbpedia.org/resource/Beta_cell
p10751
aa(lp10752
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p10753
aasg18
(lp10754
Valpha cells
p10755
aVbeta cells
p10756
aVdelta cells
p10757
aVF cells
p10758
asg24
(lp10759
Vhttp://dbpedia.org/resource/Somatostatin
p10760
aVhttp://dbpedia.org/resource/Secretion
p10761
aVhttp://dbpedia.org/resource/Islets_of_Langerhans
p10762
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10763
sg31
S'Somatostatin -- secreted from this pancreatic islets cell type:'
p10764
sg33
I8
sg34
S'Q91#7'
p10765
sg36
I9
sg37
S'7'
sg38
I2
sg39
S'91'
p10766
sa(dp10767
g3
(lp10768
(lp10769
Vhttp://dbpedia.org/resource/Potassium
p10770
aa(lp10771
Vhttp://dbpedia.org/resource/Sodium
p10772
aa(lp10773
Vhttp://dbpedia.org/resource/Calcium
p10774
aa(lp10775
Vhttp://dbpedia.org/resource/Magnesium
p10776
aa(lp10777
Vhttp://dbpedia.org/resource/Chloride
p10778
aasg18
(lp10779
Vpotassium
p10780
aVsodium
p10781
aVcalcium
p10782
aVmagnesium
p10783
aVchloride
p10784
asg24
(lp10785
Vhttp://dbpedia.org/resource/Ion
p10786
aVhttp://dbpedia.org/resource/Insulin
p10787
aVhttp://dbpedia.org/resource/Secretion
p10788
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10789
sg31
S'Ion influx mow strictly associated with insulin secretion:'
p10790
sg33
I5
sg34
S'Q91#10'
p10791
sg36
I8
sg37
S'10'
p10792
sg38
I2
sg39
S'91'
p10793
sa(dp10794
g3
(lp10795
(lp10796
Vhttp://dbpedia.org/resource/Liver
p10797
aa(lp10798
Vhttp://dbpedia.org/resource/Kidney
p10799
aVhttp://dbpedia.org/resource/Pancreas
p10800
aa(lp10801
Vhttp://dbpedia.org/resource/Pancreas
p10802
aVhttp://dbpedia.org/resource/Liver
p10803
aa(lp10804
Vhttp://dbpedia.org/resource/Liver
p10805
aVhttp://dbpedia.org/resource/Kidney
p10806
aa(lp10807
Vhttp://dbpedia.org/resource/Kidney
p10808
aasg18
(lp10809
Vliver and GI tract
p10810
aVkidney and pancreas
p10811
aVpancreas and liver
p10812
aVliver and kidney
p10813
aVGI tract and kidney
p10814
asg24
(lp10815
Vhttp://dbpedia.org/resource/Organ_%28anatomy%29
p10816
aVhttp://dbpedia.org/resource/Insulin
p10817
aVhttp://dbpedia.org/resource/Circulatory_system
p10818
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10819
sg31
S'The two main organs that remove insulin from circulation:'
p10820
sg33
I17
sg34
S'Q91#11'
p10821
sg36
I9
sg37
S'11'
p10822
sg38
I3
sg39
S'91'
p10823
sa(dp10824
g3
(lp10825
(lp10826
Vhttp://dbpedia.org/resource/Liver
p10827
aa(lp10828
Vhttp://dbpedia.org/resource/Kidney
p10829
aa(lp10830
Vhttp://dbpedia.org/resource/Pancreas
p10831
aa(lp10832
Vhttp://dbpedia.org/resource/Lung
p10833
aasg18
(lp10834
Vliver
p10835
aVkidney
p10836
aVpancreas
p10837
aVGI tract
p10838
aVlung
p10839
asg24
(lp10840
Vhttp://dbpedia.org/resource/Secretion
p10841
aVhttp://dbpedia.org/resource/Insulin
p10842
aVhttp://dbpedia.org/resource/Blood_sugar
p10843
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10844
sg31
S'Most of ENDOGENOUSLY secreted insulin is cleared from the blood by:'
p10845
sg33
I6
sg34
S'Q91#12'
p10846
sg36
I11
sg37
S'12'
p10847
sg38
I0
sg39
S'91'
p10848
sa(dp10849
g3
(lp10850
(lp10851
Vhttp://dbpedia.org/resource/Liver
p10852
aa(lp10853
Vhttp://dbpedia.org/resource/Kidney
p10854
aa(lp10855
Vhttp://dbpedia.org/resource/Pancreas
p10856
aa(lp10857
Vhttp://dbpedia.org/resource/Lung
p10858
aasg18
(lp10859
Vliver
p10860
aVkidney
p10861
aVGI tract
p10862
aVpancreas
p10863
aVlung
p10864
asg24
(lp10865
Vhttp://dbpedia.org/resource/Erogenous_zone
p10866
aVhttp://dbpedia.org/resource/Insulin
p10867
aVhttp://dbpedia.org/resource/Blood_sugar
p10868
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10869
sg31
S'Most of EXOGENOUSLY administered insulin is cleared from the blood by:'
p10870
sg33
I6
sg34
S'Q91#13'
p10871
sg36
I11
sg37
S'13'
p10872
sg38
I1
sg39
S'91'
p10873
sa(dp10874
g3
(lp10875
sg18
(lp10876
VGLUT-1
p10877
aVGLUT-2
p10878
aVGLUT-3
p10879
aVGLUT 4
p10880
aVGLUT-5
p10881
asg24
(lp10882
Vhttp://dbpedia.org/resource/Blood_sugar
p10883
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10884
sg31
S'Glucose transporter is most important to in terms of lowering blood glucose:'
p10885
sg33
I6
sg34
S'Q91#14'
p10886
sg36
I12
sg37
S'14'
p10887
sg38
I3
sg39
S'91'
p10888
sa(dp10889
g3
(lp10890
sg18
(lp10891
Vpyruvate carboxylase
p10892
aVglucose 6-phosphatase
p10893
aVglucokinase
p10894
aVfructose bisphosphatase
p10895
aVphosphoenolpyruvate carboxykinase
p10896
asg24
(lp10897
Vhttp://dbpedia.org/resource/Insulin
p10898
asg29
S'http://www.pharmacology2000.com/Diabetes/question1/questionset1.htm'
p10899
sg31
S'Postprandial insulin release induces phosphorylations which activate:'
p10900
sg33
I9
sg34
S'Q91#15'
p10901
sg36
I7
sg37
S'15'
p10902
sg38
I2
sg39
S'91'
p10903
sa(dp10904
g3
(lp10905
(lp10906
Vhttp://dbpedia.org/resource/Hypotension
p10907
aa(lp10908
Vhttp://dbpedia.org/resource/Gallstone
p10909
aa(lp10910
Vhttp://dbpedia.org/resource/Hypoglycemia
p10911
aa(lp10912
Vhttp://dbpedia.org/resource/Retinopathy
p10913
aasg18
(lp10914
Vlipodystrophies
p10915
aVhypotension
p10916
aVgallstones
p10917
aVhypoglycemia
p10918
aVretinopathy
p10919
asg24
(lp10920
Vhttp://dbpedia.org/resource/Complication_%28medicine%29
p10921
asg29
S'http://www.pharmacology2000.com/Diabetes/question3/questionset3.htm'
p10922
sg31
S'Most common complication insulin therapy:'
p10923
sg33
I5
sg34
S'Q93#0'
p10924
sg36
I5
sg37
S'0'
sg38
I3
sg39
S'93'
p10925
sa(dp10926
g3
(lp10927
(lp10928
Vhttp://dbpedia.org/resource/Muscarinic_acetylcholine_receptor
p10929
aa(lp10930
Vhttp://dbpedia.org/resource/Calcium_channel
p10931
aa(lp10932
Vhttp://dbpedia.org/resource/Potassium_channel
p10933
aa(lp10934
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p10935
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p10936
aa(lp10937
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p10938
aasg18
(lp10939
Vmuscarinic receptor
p10940
aVcalcium channel
p10941
aVpotassium channel
p10942
aVbeta adrenergic receptor
p10943
aValpha adrenergic receptor
p10944
asg24
(lp10945
Vhttp://dbpedia.org/resource/Sulfonylurea
p10946
aVhttp://dbpedia.org/resource/Hypoglycemia
p10947
aVhttp://dbpedia.org/resource/Drug
p10948
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p10949
asg29
S'http://www.pharmacology2000.com/Diabetes/question3/questionset3.htm'
p10950
sg31
S'Sulfonylurea hypoglycemic drug:receptor sites'
p10951
sg33
I12
sg34
S'Q93#8'
p10952
sg36
I6
sg37
S'8'
sg38
I2
sg39
S'93'
p10953
sa(dp10954
g3
(lp10955
sg18
(lp10956
Vchlorpropamide (Diabinese)
p10957
aVtolazamide (Tolinase)
p10958
aVacetohexamide
p10959
aVglipizide (Glucotrol)
p10960
aVTolbutamide (Orinase)
p10961
asg24
(lp10962
Vhttp://dbpedia.org/resource/Sulfonylurea
p10963
asg29
S'http://www.pharmacology2000.com/Diabetes/question3/questionset3.htm'
p10964
sg31
S'Second generation sulfonylurea:'
p10965
sg33
I17
sg34
S'Q93#10'
p10966
sg36
I3
sg37
S'10'
p10967
sg38
I3
sg39
S'93'
p10968
sa(dp10969
g3
(lp10970
(lp10971
Vhttp://dbpedia.org/resource/Metformin
p10972
aVhttp://dbpedia.org/resource/Metformin
p10973
aasg18
(lp10974
Vchlorpropamide (Diabinese)
p10975
aVglyburide (Micronase, DiaBeta)
p10976
aVglipizide (Glucotrol)
p10977
aVglimepiride (Amaryl)
p10978
aVmetformin (Glucophage)
p10979
asg24
(lp10980
Vhttp://dbpedia.org/resource/Sulfonylurea
p10981
aVhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p10982
asg29
S'http://www.pharmacology2000.com/Diabetes/question3/questionset3.htm'
p10983
sg31
S'Second-generation sulfonylurea approved for once-daily use as monotherapy in management of Type II diabetes:'
p10984
sg33
I22
sg34
S'Q93#11'
p10985
sg36
I14
sg37
S'11'
p10986
sg38
I3
sg39
S'93'
p10987
sa(dp10988
g3
(lp10989
(lp10990
Vhttp://dbpedia.org/resource/Metformin
p10991
aVhttp://dbpedia.org/resource/Metformin
p10992
aasg18
(lp10993
Vacetohexamide
p10994
aVchlorpropamide (Diabinese)
p10995
aVglyburide (Micronase, DiaBeta)
p10996
aVmetformin (Glucophage)
p10997
aVTolbutamide (Orinase)
p10998
asg24
(lp10999
Vhttp://dbpedia.org/resource/Patient
p11000
aVhttp://dbpedia.org/resource/Refractory
p11001
aVhttp://dbpedia.org/resource/Obesity
p11002
aVhttp://dbpedia.org/resource/Metabolic_syndrome
p11003
asg29
S'http://www.pharmacology2000.com/Diabetes/question3/questionset3.htm'
p11004
sg31
S'Oral hypoglycemic agent most likely to be prescribed for patients with refractory obesity and who exhibit insulin resistance syndrome: in'
p11005
sg33
I19
sg34
S'Q93#12'
p11006
sg36
I21
sg37
S'12'
p11007
sg38
I3
sg39
S'93'
p11008
sa(dp11009
g3
(lp11010
(lp11011
Vhttp://dbpedia.org/resource/Acetazolamide
p11012
aVhttp://dbpedia.org/resource/Acetazolamide
p11013
aasg18
(lp11014
Vmetformin (Glucophage)
p11015
aVacetazolamide (Diamox)
p11016
aVTolbutamide (Orinase)
p11017
aVacarbose (Precose)
p11018
aVtroglitazone (Rezulin)
p11019
asg24
(lp11020
Vhttp://dbpedia.org/resource/Metformin
p11021
aVhttp://dbpedia.org/resource/Metformin
p11022
asg29
S'http://www.pharmacology2000.com/Diabetes/question3/questionset3.htm'
p11023
sg31
S'Aldose reductase inhibitor:'
p11024
sg33
I20
sg34
S'Q93#13'
p11025
sg36
I3
sg37
S'13'
p11026
sg38
I3
sg39
S'93'
p11027
sa(dp11028
g3
(lp11029
(lp11030
Vhttp://dbpedia.org/resource/Adult
p11031
aa(lp11032
Vhttp://dbpedia.org/resource/Blood_plasma
p11033
aVhttp://dbpedia.org/resource/Glucagon
p11034
aa(lp11035
Vhttp://dbpedia.org/resource/Insulin
p11036
aVhttp://dbpedia.org/resource/Absenteeism
p11037
aa(lp11038
Vhttp://dbpedia.org/resource/Beta_cell
p11039
aasg18
(lp11040
Vtypically adult onset
p11041
aVlow plasma glucagon
p11042
aVinsulin nearly absent
p11043
aVpancreatic B cell is responsive to insulinogenic stimuli
p11044
asg24
(lp11045
Vhttp://dbpedia.org/resource/Diabetes_mellitus_type_1
p11046
asg29
S'http://www.pharmacology2000.com/Diabetes/question4/questionset4.htm'
p11047
sg31
S'Characteristics of Type I diabetes:'
p11048
sg33
I17
sg34
S'Q94#4'
p11049
sg36
I5
sg37
S'4'
sg38
I2
sg39
S'94'
p11050
sa(dp11051
g3
(lp11052
(lp11053
Vhttp://dbpedia.org/resource/Developed_country
p11054
aa(lp11055
Vhttp://dbpedia.org/resource/Exhibition
p11056
aVhttp://dbpedia.org/resource/Volume
p11057
aa(lp11058
Vhttp://dbpedia.org/resource/Central_nervous_system
p11059
aVhttp://dbpedia.org/resource/Symptom
p11060
aa(lp11061
Vhttp://dbpedia.org/resource/Exhibition
p11062
aasg18
(lp11063
Vusually developed ketoacidosis
p11064
aVexhibits volume excess
p11065
aVCNS symptoms
p11066
aVexhibits hypo-osmolality
p11067
asg24
(lp11068
Vhttp://dbpedia.org/resource/Physical_examination
p11069
asg29
S'http://www.pharmacology2000.com/Diabetes/question4/questionset4.htm'
p11070
sg31
S'Clinical presentation: NIDDM'
p11071
sg33
I10
sg34
S'Q94#13'
p11072
sg36
I4
sg37
S'13'
p11073
sg38
I2
sg39
S'94'
p11074
sa(dp11075
g3
(lp11076
(lp11077
Vhttp://dbpedia.org/resource/Weight_loss
p11078
aa(lp11079
Vhttp://dbpedia.org/resource/Diet_%28nutrition%29
p11080
aa(lp11081
Vhttp://dbpedia.org/resource/Insulin
p11082
aa(lp11083
Vhttp://dbpedia.org/resource/Sulfonylurea
p11084
aVhttp://dbpedia.org/resource/Drug
p11085
aasg18
(lp11086
Vweight reduction
p11087
aVdiet
p11088
aVinsulin
p11089
aVsulfonylurea drugs
p11090
aVall the both
p11091
asg24
(lp11092
Vhttp://dbpedia.org/resource/Diabetes_mellitus_type_2
p11093
asg29
S'http://www.pharmacology2000.com/Diabetes/question4/questionset4.htm'
p11094
sg31
S'Type II diabetes treatment --'
p11095
sg33
I9
sg34
S'Q94#16'
p11096
sg36
I5
sg37
S'16'
p11097
sg38
I4
sg39
S'94'
p11098
sa(dp11099
g3
(lp11100
(lp11101
Vhttp://dbpedia.org/resource/Appetite
p11102
aa(lp11103
Vhttp://dbpedia.org/resource/Tachycardia
p11104
aVhttp://dbpedia.org/resource/Palpitation
p11105
aVhttp://dbpedia.org/resource/Sympathetic_nervous_system
p11106
aa(lp11107
Vhttp://dbpedia.org/resource/Hypoglycemia
p11108
aasg18
(lp11109
Vexcessive appetite
p11110
aVtachycardia, palpitations -- sympathetic overactivity
p11111
aVhypoglycemia
p11112
asg24
(lp11113
Vhttp://dbpedia.org/resource/Complication_%28medicine%29
p11114
aVhttp://dbpedia.org/resource/Insulin
p11115
asg29
S'http://www.pharmacology2000.com/Diabetes/question4/questionset4.htm'
p11116
sg31
S'Most common complication of insulin treatment'
p11117
sg33
I9
sg34
S'Q94#19'
p11118
sg36
I6
sg37
S'19'
p11119
sg38
I2
sg39
S'94'
p11120
sa(dp11121
g3
(lp11122
(lp11123
Vhttp://dbpedia.org/resource/Thyroxine
p11124
aa(lp11125
Vhttp://dbpedia.org/resource/Triiodothyronine
p11126
aa(lp11127
Vhttp://dbpedia.org/resource/Parenteral
p11128
aasg18
(lp11129
Vthyroxine
p11130
aVtriiodothyronine
p11131
aVboth equally absorbed
p11132
aVneither absorbed orally, requires parenteral administration
p11133
asg24
(lp11134
Vhttp://dbpedia.org/resource/Thyroid_hormone
p11135
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11136
sg31
S'Thyroid hormone more likely to be completely absorbed following oral administration:'
p11137
sg33
I12
sg34
S'Q95#0'
p11138
sg36
I11
sg37
S'0'
sg38
I1
sg39
S'95'
p11139
sa(dp11140
g3
(lp11141
(lp11142
Vhttp://dbpedia.org/resource/Menopause
p11143
aasg18
(lp11144
Vincreased
p11145
aVdecreased
p11146
aVno change
p11147
asg24
(lp11148
Vhttp://dbpedia.org/resource/Effectiveness
p11149
aVhttp://dbpedia.org/resource/Hyperthyroidism
p11150
aVhttp://dbpedia.org/resource/Thyroxine
p11151
aVhttp://dbpedia.org/resource/Metabolism
p11152
aVhttp://dbpedia.org/resource/Highland_Clearances
p11153
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11154
sg31
S'Effective hyperthyroidism on thyroxine (T4) metabolic clearance:'
p11155
sg33
I4
sg34
S'Q95#1'
p11156
sg36
I9
sg37
S'1'
sg38
I0
sg39
S'95'
p11157
sa(dp11158
g3
(lp11159
(lp11160
Vhttp://dbpedia.org/resource/Dopamine_transporter
p11161
aa(lp11162
Vhttp://dbpedia.org/resource/Salicylic_acid
p11163
aasg18
(lp11164
Vrifampin
p11165
aViopanoic acid
p11166
aVdopamine
p11167
aVcholestyramine
p11168
aVsalicylates
p11169
asg24
(lp11170
Vhttp://dbpedia.org/resource/Rifampicin
p11171
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11172
sg31
S"Associated with 5'-deiodinase inhibition:"
p11173
sg33
I6
sg34
S'Q95#5'
p11174
sg36
I4
sg37
S'5'
sg38
I1
sg39
S'95'
p11175
sa(dp11176
g3
(lp11177
(lp11178
Vhttp://dbpedia.org/resource/Interleukin_2
p11179
aa(lp11180
Vhttp://dbpedia.org/resource/Amiodarone
p11181
aa(lp11182
Vhttp://dbpedia.org/resource/Estrogen
p11183
aasg18
(lp11184
Vandrogens
p11185
aVcolestipol
p11186
aVinterleukin 2
p11187
aVamiodarone
p11188
aVestrogens
p11189
asg24
(lp11190
Vhttp://dbpedia.org/resource/Androgen
p11191
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11192
sg31
S'Associated with increased TBG (thyroxine-binding globulin):'
p11193
sg33
I6
sg34
S'Q95#6'
p11194
sg36
I9
sg37
S'6'
sg38
I4
sg39
S'95'
p11195
sa(dp11196
g3
(lp11197
(lp11198
Vhttp://dbpedia.org/resource/Equality_%28mathematics%29
p11199
aVhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p11200
aasg18
(lp11201
VT4
p11202
aVT3
p11203
aVequal potent
p11204
asg24
(lp11205
Vhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p11206
aVhttp://dbpedia.org/resource/Thyroid_hormone
p11207
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11208
sg31
S'More potent thyroid hormone:'
p11209
sg33
I4
sg34
S'Q95#14'
p11210
sg36
I4
sg37
S'14'
p11211
sg38
I1
sg39
S'95'
p11212
sa(dp11213
g3
(lp11214
(lp11215
Vhttp://dbpedia.org/resource/Thyroid
p11216
aa(lp11217
Vhttp://dbpedia.org/resource/Propylthiouracil
p11218
aasg18
(lp11219
Vdessicated thyroid
p11220
aVliothyronine
p11221
aVlevothyroxine
p11222
aVpropylthiouracil
p11223
aVmethimazole
p11224
asg24
(lp11225
Vhttp://dbpedia.org/resource/Thyroid
p11226
aVhttp://dbpedia.org/resource/The_Replacements_%28band%29
p11227
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11228
sg31
S'Preparation of choice for thyroid replacement.'
p11229
sg33
I6
sg34
S'Q95#16'
p11230
sg36
I7
sg37
S'16'
p11231
sg38
I2
sg39
S'95'
p11232
sa(dp11233
g3
(lp11234
(lp11235
Vhttp://dbpedia.org/resource/Propylthiouracil
p11236
aa(lp11237
Vhttp://dbpedia.org/resource/Perchlorate
p11238
aasg18
(lp11239
Vmethimazole
p11240
aVpropylthiouracil
p11241
aViopanoic acid
p11242
aVperchlorate
p11243
aVliothyronine
p11244
asg24
(lp11245
Vhttp://dbpedia.org/resource/Liver
p11246
aVhttp://dbpedia.org/resource/Kidney
p11247
aVhttp://dbpedia.org/resource/Pituitary_gland
p11248
aVhttp://dbpedia.org/resource/Brain
p11249
aVhttp://dbpedia.org/resource/Hyperthyroidism
p11250
aVhttp://dbpedia.org/resource/Radiography
p11251
aVhttp://dbpedia.org/resource/Contrast_medium
p11252
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11253
sg31
S'Inhibits conversion T4 to T3 in the liver, kidney, pituitary gland, brain;may be useful in treating hyperthyroidism; routinely used as a radiographic contrast agent'
p11254
sg33
I6
sg34
S'Q95#17'
p11255
sg36
I30
sg37
S'17'
p11256
sg38
I2
sg39
S'95'
p11257
sa(dp11258
g3
(lp11259
(lp11260
Vhttp://dbpedia.org/resource/Propylthiouracil
p11261
aasg18
(lp11262
Vmethimazole
p11263
aVpropylthiouracil
p11264
aVboth are equally likely
p11265
asg24
(lp11266
Vhttp://dbpedia.org/resource/Cross
p11267
aVhttp://dbpedia.org/resource/Placenta
p11268
asg29
S'http://www.pharmacology2000.com/Thyroid/question3/questionset3.htm'
p11269
sg31
S'Thioamide less likely to cross the placental barrier:'
p11270
sg33
I6
sg34
S'Q95#18'
p11271
sg36
I8
sg37
S'18'
p11272
sg38
I1
sg39
S'95'
p11273
sa(dp11274
g3
(lp11275
(lp11276
Vhttp://dbpedia.org/resource/Nervous_system
p11277
aVhttp://dbpedia.org/resource/Amygdala
p11278
aa(lp11279
Vhttp://dbpedia.org/resource/Gonad
p11280
aa(lp11281
Vhttp://dbpedia.org/resource/Pituitary_gland
p11282
aVhttp://dbpedia.org/resource/Hypothalamus
p11283
aVhttp://dbpedia.org/resource/Gonadotropin
p11284
aVhttp://dbpedia.org/resource/Hormone
p11285
aasg18
(lp11286
Vmaturation of neural centers (e.g.,amygdala)
p11287
aVmaturation of the gonad
p11288
aVresponsiveness of the pituitary to hypothalamic gonadotropin-releasing hormones
p11289
asg24
(lp11290
Vhttp://dbpedia.org/resource/Mechanism_of_action
p11291
aVhttp://dbpedia.org/resource/Ovary
p11292
aVhttp://dbpedia.org/resource/Function_%28mathematics%29
p11293
aVhttp://dbpedia.org/resource/Time
p11294
aVhttp://dbpedia.org/resource/Puberty
p11295
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11296
sg31
S'Mechanism responsible for onset of ovarian function of the time of puberty:'
p11297
sg33
I21
sg34
S'Q96#0'
p11298
sg36
I12
sg37
S'0'
sg38
I0
sg39
S'96'
p11299
sa(dp11300
g3
(lp11301
(lp11302
Vhttp://dbpedia.org/resource/Follicle-stimulating_hormone
p11303
aVhttp://dbpedia.org/resource/Follicle-stimulating_hormone
p11304
aa(lp11305
Vhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11306
aVhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11307
aa(lp11308
Vhttp://dbpedia.org/resource/Dehydroepiandrosterone
p11309
aasg18
(lp11310
Vhuman menopausal gonadotropin (hMG)
p11311
aVfollicle-stimulating hormone (FSH)
p11312
aVadrenocorticotropic hormone (ACTH)
p11313
aVsex hormone-binding globulin (SHBG)
p11314
aVdehydroepiandrosterone (DAG a)
p11315
asg24
(lp11316
Vhttp://dbpedia.org/resource/Human
p11317
aVhttp://dbpedia.org/resource/Menopause
p11318
aVhttp://dbpedia.org/resource/Gonadotropin
p11319
aVhttp://dbpedia.org/resource/HMG-CoA_reductase
p11320
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11321
sg31
S'At the beginning of each cycle, some vesicular follicles enlarge in response to:'
p11322
sg33
I27
sg34
S'Q96#2'
p11323
sg36
I14
sg37
S'2'
sg38
I1
sg39
S'96'
p11324
sa(dp11325
g3
(lp11326
(lp11327
Vhttp://dbpedia.org/resource/Follicle-stimulating_hormone
p11328
aasg18
(lp11329
Vsex hormone-binding globulin
p11330
aVluteinizing hormone
p11331
aVfollicle-stimulating hormone
p11332
aVcorticosteroid-binding globulin (transcortin)
p11333
aVaspartate aminotransferase
p11334
asg24
(lp11335
Vhttp://dbpedia.org/resource/Luteinizing_hormone
p11336
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11337
sg31
S'Granulosa cells in the one of several vesicular follicles that begins to develop more rapidly than the others do so under the influence of:'
p11338
sg33
I14
sg34
S'Q96#3'
p11339
sg36
I24
sg37
S'3'
sg38
I1
sg39
S'96'
p11340
sa(dp11341
g3
(lp11342
(lp11343
Vhttp://dbpedia.org/resource/Early_modern_Europe
p11344
aVhttp://dbpedia.org/resource/Hitting_for_the_cycle
p11345
aa(lp11346
Vhttp://dbpedia.org/resource/Hitting_for_the_cycle
p11347
aasg18
(lp11348
Vearly cycle
p11349
aVjust before midcycle
p11350
aVlate in cycle
p11351
asg24
(lp11352
Vhttp://dbpedia.org/resource/Peak_Practice
p11353
aVhttp://dbpedia.org/resource/Time
p11354
aVhttp://dbpedia.org/resource/Estrogen
p11355
aVhttp://dbpedia.org/resource/Secretion
p11356
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11357
sg31
S'Peak time of estrogen secretion:'
p11358
sg33
I8
sg34
S'Q96#6'
p11359
sg36
I5
sg37
S'6'
sg38
I1
sg39
S'96'
p11360
sa(dp11361
g3
(lp11362
(lp11363
Vhttp://dbpedia.org/resource/Pregnancy
p11364
aVhttp://dbpedia.org/resource/Mare
p11365
aa(lp11366
Vhttp://dbpedia.org/resource/Stallion
p11367
aa(lp11368
Vhttp://dbpedia.org/resource/Pregnancy
p11369
aasg18
(lp11370
Vpregnant mare
p11371
aVstallion
p11372
aVpregnant woman
p11373
asg24
(lp11374
Vhttp://dbpedia.org/resource/Natural_product
p11375
aVhttp://dbpedia.org/resource/Estrogen
p11376
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11377
sg31
S'Most prolific natural source of estrogenic substances:'
p11378
sg33
I5
sg34
S'Q96#11'
p11379
sg36
I7
sg37
S'11'
p11380
sg38
I1
sg39
S'96'
p11381
sa(dp11382
g3
(lp11383
(lp11384
Vhttp://dbpedia.org/resource/Androstenedione
p11385
aa(lp11386
Vhttp://dbpedia.org/resource/Progesterone
p11387
aa(lp11388
Vhttp://dbpedia.org/resource/Dehydroepiandrosterone
p11389
aasg18
(lp11390
Vestriol
p11391
aVandrostenedione
p11392
aVprogesterone
p11393
aVdehydroepiandrosterone
p11394
aVpregnenolone
p11395
asg24
(lp11396
Vhttp://dbpedia.org/resource/Estrone
p11397
aVhttp://dbpedia.org/resource/Testosterone
p11398
aVhttp://dbpedia.org/resource/Precursor_%28chemistry%29
p11399
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11400
sg31
S'Immediate estrone and testosterone precursor:'
p11401
sg33
I5
sg34
S'Q96#13'
p11402
sg36
I5
sg37
S'13'
p11403
sg38
I1
sg39
S'96'
p11404
sa(dp11405
g3
(lp11406
(lp11407
Vhttp://dbpedia.org/resource/Diethylstilbestrol
p11408
aa(lp11409
Vhttp://dbpedia.org/resource/Estrone
p11410
aa(lp11411
Vhttp://dbpedia.org/resource/Estradiol
p11412
aasg18
(lp11413
Vdiethylstilbestrol
p11414
aVestrone
p11415
aVestradiol
p11416
aVethinyl estradiol
p11417
aVmethallenestril
p11418
asg24
(lp11419
Vhttp://dbpedia.org/resource/Steroid
p11420
aVhttp://dbpedia.org/resource/Chemical_synthesis
p11421
aVhttp://dbpedia.org/resource/Estrogen
p11422
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p11423
asg29
S'http://www.pharmacology2000.com/Gonadal/question1/questionset1.htm'
p11424
sg31
S'Example of a steroidal, synthetic compound with estrogenic activity'
p11425
sg33
I6
sg34
S'Q96#14'
p11426
sg36
I10
sg37
S'14'
p11427
sg38
I3
sg39
S'96'
p11428
sa(dp11429
g3
(lp11430
(lp11431
Vhttp://dbpedia.org/resource/Progesterone
p11432
aa(lp11433
Vhttp://dbpedia.org/resource/Androstenedione
p11434
aa(lp11435
Vhttp://dbpedia.org/resource/Estrone
p11436
aasg18
(lp11437
Vprogesterone
p11438
aVandrostenedione
p11439
aVethinyl estradiol
p11440
aVestriol
p11441
aVestrone
p11442
asg24
(lp11443
Vhttp://dbpedia.org/resource/Initiation
p11444
aVhttp://dbpedia.org/resource/Primary_school
p11445
aVhttp://dbpedia.org/resource/Hypogonadism
p11446
asg29
S'http://www.pharmacology2000.com/Gonadal/question2/questionset2.htm'
p11447
sg31
S'Useful for initiation of treatment of primary hypogonadism:'
p11448
sg33
I6
sg34
S'Q97#0'
p11449
sg36
I8
sg37
S'0'
sg38
I2
sg39
S'97'
p11450
sa(dp11451
g3
(lp11452
(lp11453
Vhttp://dbpedia.org/resource/Blood_plasma
p11454
aVhttp://dbpedia.org/resource/Cholesterol
p11455
aa(lp11456
Vhttp://dbpedia.org/resource/Low-density_lipoprotein
p11457
aVhttp://dbpedia.org/resource/Blood_serum
p11458
aa(lp11459
Vhttp://dbpedia.org/resource/High-density_lipoprotein
p11460
aa(lp11461
Vhttp://dbpedia.org/resource/Triglyceride
p11462
aasg18
(lp11463
Vdecrease in plasma cholesterol
p11464
aVdecrease in LDL receptors
p11465
aVincrease in LDL serum levels
p11466
aVsignificant increase in HDL
p11467
aVsignificant increase in triglyceride levels
p11468
asg24
(lp11469
Vhttp://dbpedia.org/resource/Lipid
p11470
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p11471
asg29
S'http://www.pharmacology2000.com/Gonadal/question2/questionset2.htm'
p11472
sg31
S'Lipid profile/receptor changes associated with oophorectomy:'
p11473
sg33
I22
sg34
S'Q97#2'
p11474
sg36
I6
sg37
S'2'
sg38
I2
sg39
S'97'
p11475
sa(dp11476
g3
(lp11477
(lp11478
Vhttp://dbpedia.org/resource/Estradiol
p11479
aa(lp11480
Vhttp://dbpedia.org/resource/Diethylstilbestrol
p11481
aasg18
(lp11482
Vestradiol
p11483
aVethinyl estradiol
p11484
aVdiethylstilbestrol
p11485
aVquinestrol
p11486
aVestriol
p11487
asg24
(lp11488
Vhttp://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug
p11489
aVhttp://dbpedia.org/resource/Synthetic_rubber
p11490
aVhttp://dbpedia.org/resource/Agent_Orange
p11491
aVhttp://dbpedia.org/resource/Estrogen
p11492
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p11493
asg29
S'http://www.pharmacology2000.com/Gonadal/question2/questionset2.htm'
p11494
sg31
S'Nonsteroidal, synthetic agent with estrogenic activity:'
p11495
sg33
I6
sg34
S'Q97#5'
p11496
sg36
I7
sg37
S'5'
sg38
I2
sg39
S'97'
p11497
sa(dp11498
g3
(lp11499
(lp11500
Vhttp://dbpedia.org/resource/Lipoprotein
p11501
aVhttp://dbpedia.org/resource/Lipase
p11502
aa(lp11503
Vhttp://dbpedia.org/resource/Malachi_Favors
p11504
aVhttp://dbpedia.org/resource/Adipose_tissue
p11505
aa(lp11506
Vhttp://dbpedia.org/resource/Glucose
p11507
aasg18
(lp11508
Vdramatically increases protein metabolism
p11509
aVinhibits lipoproteins lipase
p11510
aVfavor fat deposition
p11511
aVblunts insulin response to glucose
p11512
aVinhibits ketogenesis
p11513
asg24
(lp11514
Vhttp://dbpedia.org/resource/Progesterone
p11515
asg29
S'http://www.pharmacology2000.com/Gonadal/question2/questionset2.htm'
p11516
sg31
S'Progesterone effect(s):'
p11517
sg33
I17
sg34
S'Q97#10'
p11518
sg36
I6
sg37
S'10'
p11519
sg38
I2
sg39
S'97'
p11520
sa(dp11521
g3
(lp11522
(lp11523
Vhttp://dbpedia.org/resource/Progesterone
p11524
aasg18
(lp11525
Vdesogestrel
p11526
aVdimethisterone
p11527
aVprogesterone
p11528
aVmegestrol acetate
p11529
aVhydroxyprogesterone
p11530
asg24
(lp11531
Vhttp://dbpedia.org/resource/Progestin
p11532
asg29
S'http://www.pharmacology2000.com/Gonadal/question2/questionset2.htm'
p11533
sg31
S'Most important human progestin:'
p11534
sg33
I6
sg34
S'Q97#13'
p11535
sg36
I4
sg37
S'13'
p11536
sg38
I2
sg39
S'97'
p11537
sa(dp11538
g3
(lp11539
(lp11540
Vhttp://dbpedia.org/resource/Tamoxifen
p11541
aVhttp://dbpedia.org/resource/Tamoxifen
p11542
aasg18
(lp11543
Vdanazol (Donocrine)
p11544
aVMedroxyprogesterone acetate
p11545
aVclomiphene (Clomid)
p11546
aVL-Norgestrel
p11547
aVtamoxifen (Nolvadex)
p11548
asg24
(lp11549
Vhttp://dbpedia.org/resource/Ovulation
p11550
aVhttp://dbpedia.org/resource/Patient
p11551
asg29
S'http://www.pharmacology2000.com/Gonadal/question3/questionset3.htm'
p11552
sg31
S'Primarily used to promote ovulation in patients wishing to become pregnant:'
p11553
sg33
I15
sg34
S'Q98#0'
p11554
sg36
I11
sg37
S'0'
sg38
I2
sg39
S'98'
p11555
sa(dp11556
g3
(lp11557
sg18
(lp11558
Vbreakthrough bleeding
p11559
aVchanges in serum  proteins
p11560
aVgastrointestinal disorders
p11561
asg24
(lp11562
Vhttp://dbpedia.org/resource/Adverse_effect
p11563
aVhttp://dbpedia.org/resource/Birth_control
p11564
asg29
S'http://www.pharmacology2000.com/Gonadal/question3/questionset3.htm'
p11565
sg31
S'Considered a severe adverse effect associated with contraceptive agents:'
p11566
sg33
I8
sg34
S'Q98#1'
p11567
sg36
I9
sg37
S'1'
sg38
I2
sg39
S'98'
p11568
sa(dp11569
g3
(lp11570
(lp11571
Vhttp://dbpedia.org/resource/Ketoconazole
p11572
aa(lp11573
Vhttp://dbpedia.org/resource/Stanozolol
p11574
aasg18
(lp11575
Vketoconazole (Nizoral)
p11576
aVmethyltestosterone
p11577
aVleuprolide acetate
p11578
aVstanozolol
p11579
asg24
(lp11580
Vhttp://dbpedia.org/resource/Prostate_cancer
p11581
aVhttp://dbpedia.org/resource/Continuous_function
p11582
aVhttp://dbpedia.org/resource/Gonad
p11583
aVhttp://dbpedia.org/resource/Suppression_of_the_Society_of_Jesus
p11584
aVhttp://dbpedia.org/resource/Gonadotropin-releasing_hormone
p11585
aVhttp://dbpedia.org/resource/Structural_analog
p11586
asg29
S'http://www.pharmacology2000.com/Gonadal/question5/questionset5.htm'
p11587
sg31
S'Used for treating advanced prostatic carcinoma; works by producing continuous gonadal suppression; is a gonadotropin-releasing hormone analog'
p11588
sg33
I8
sg34
S'Q100#1'
p11589
sg36
I19
sg37
S'1'
sg38
I2
sg39
S'100'
p11590
sa(dp11591
g3
(lp11592
(lp11593
Vhttp://dbpedia.org/resource/Testosterone
p11594
aa(lp11595
Vhttp://dbpedia.org/resource/Testosterone
p11596
aa(lp11597
Vhttp://dbpedia.org/resource/Testosterone
p11598
aa(lp11599
Vhttp://dbpedia.org/resource/Testosterone
p11600
aasg18
(lp11601
Vtestosterone propionate
p11602
aVtestosterone
p11603
aVtestosterone enanthate
p11604
aVtestosterone undecanoate
p11605
aVtestosterone cypionate
p11606
asg24
(lp11607
Vhttp://dbpedia.org/resource/Testosterone
p11608
asg29
S'http://www.pharmacology2000.com/Gonadal/question5/questionset5.htm'
p11609
sg31
S'Most rapidly absorbed:'
p11610
sg33
I9
sg34
S'Q100#2'
p11611
sg36
I3
sg37
S'2'
sg38
I1
sg39
S'100'
p11612
sa(dp11613
g3
(lp11614
sg18
(lp11615
Vdanazol (Donocrine)
p11616
aVclomiphene (Clomid)
p11617
aVanastrozole (Arimidex)
p11618
aVnorethindrone (Aygestin)
p11619
asg24
(lp11620
Vhttp://dbpedia.org/resource/Functional_selectivity
p11621
asg29
S'http://www.pharmacology2000.com/Gonadal/question5/questionset5.htm'
p11622
sg31
S'Aromatase inhibitor -- selective nonsteroidal form'
p11623
sg33
I16
sg34
S'Q100#5'
p11624
sg36
I6
sg37
S'5'
sg38
I2
sg39
S'100'
p11625
sa(dp11626
g3
(lp11627
(lp11628
Vhttp://dbpedia.org/resource/Blood_plasma
p11629
aVhttp://dbpedia.org/resource/Renin
p11630
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p11631
aa(lp11632
Vhttp://dbpedia.org/resource/Aldosterone
p11633
aVhttp://dbpedia.org/resource/Secretion
p11634
aa(lp11635
Vhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11636
aa(lp11637
Vhttp://dbpedia.org/resource/Thyroxine
p11638
aasg18
(lp11639
Vincreases corticosteroid-binding globulin
p11640
aVincreases plasma renin activity
p11641
aVincreases aldosterone secretion
p11642
aVincreases ACTH response to metyrapone
p11643
aVincreases thyroxine levels
p11644
asg24
(lp11645
Vhttp://dbpedia.org/resource/Endocrine_system
p11646
asg29
S'http://www.pharmacology2000.com/Gonadal/question5/questionset5.htm'
p11647
sg31
S'Oral contraceptive effects on endocrine function except:'
p11648
sg33
I18
sg34
S'Q100#7'
p11649
sg36
I7
sg37
S'7'
sg38
I3
sg39
S'100'
p11650
sa(dp11651
g3
(lp11652
(lp11653
Vhttp://dbpedia.org/resource/Androstenedione
p11654
aa(lp11655
Vhttp://dbpedia.org/resource/Dehydroepiandrosterone
p11656
aa(lp11657
Vhttp://dbpedia.org/resource/Testosterone
p11658
aasg18
(lp11659
Vandrostenedione
p11660
aVdehydroepiandrosterone
p11661
aVdehydroepiandrosterone sulfate
p11662
aVtestosterone
p11663
asg24
(lp11664
Vhttp://dbpedia.org/resource/Quantity
p11665
aVhttp://dbpedia.org/resource/Testicle
p11666
asg29
S'http://www.pharmacology2000.com/Gonadal/question5/questionset5.htm'
p11667
sg31
S'Most likely to be produced in quantity in the testes:'
p11668
sg33
I5
sg34
S'Q100#8'
p11669
sg36
I10
sg37
S'8'
sg38
I3
sg39
S'100'
p11670
sa(dp11671
g3
(lp11672
(lp11673
Vhttp://dbpedia.org/resource/Liver
p11674
aa(lp11675
Vhttp://dbpedia.org/resource/Adrenal_cortex
p11676
aa(lp11677
Vhttp://dbpedia.org/resource/Thyroid
p11678
aa(lp11679
Vhttp://dbpedia.org/resource/Gonad
p11680
aa(lp11681
Vhttp://dbpedia.org/resource/Breast
p11682
aasg18
(lp11683
Vliver
p11684
aVadrenal cortex
p11685
aVthyroid
p11686
aVgonads
p11687
aVbreast
p11688
asg24
(lp11689
Vhttp://dbpedia.org/resource/Primary_school
p11690
aVhttp://dbpedia.org/resource/Organ_%28anatomy%29
p11691
aVhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11692
aVhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11693
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question1/questionset1.htm'
p11694
sg31
S'Primary target organ for adrenocorticotropin (ACTH):'
p11695
sg33
I6
sg34
S'Q101#1'
p11696
sg36
I9
sg37
S'1'
sg38
I1
sg39
S'101'
p11697
sa(dp11698
g3
(lp11699
(lp11700
Vhttp://dbpedia.org/resource/Liver
p11701
aa(lp11702
Vhttp://dbpedia.org/resource/Adrenal_cortex
p11703
aa(lp11704
Vhttp://dbpedia.org/resource/Thyroid
p11705
aa(lp11706
Vhttp://dbpedia.org/resource/Gonad
p11707
aasg18
(lp11708
Vliver
p11709
aVadrenal cortex
p11710
aVthyroid
p11711
aVgonads
p11712
aVbreast
p11713
asg24
(lp11714
Vhttp://dbpedia.org/resource/Primary_school
p11715
aVhttp://dbpedia.org/resource/Organ_%28anatomy%29
p11716
aVhttp://dbpedia.org/resource/Luteinizing_hormone
p11717
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question1/questionset1.htm'
p11718
sg31
S'Primary target organ for leutinizing hormone:'
p11719
sg33
I6
sg34
S'Q101#2'
p11720
sg36
I6
sg37
S'2'
sg38
I3
sg39
S'101'
p11721
sa(dp11722
g3
(lp11723
(lp11724
Vhttp://dbpedia.org/resource/Corticotropin-releasing_hormone
p11725
aa(lp11726
Vhttp://dbpedia.org/resource/Dopamine
p11727
aa(lp11728
Vhttp://dbpedia.org/resource/Gonadotropin-releasing_hormone
p11729
aa(lp11730
Vhttp://dbpedia.org/resource/Growth_hormone
p11731
aVhttp://dbpedia.org/resource/Hormone
p11732
aVhttp://dbpedia.org/resource/Somatostatin
p11733
aasg18
(lp11734
Vgrowth hormone releasing hormone
p11735
aVcorticotropin-releasing hormone
p11736
aVdopamine
p11737
aVgonadotropin-releasing hormone
p11738
aVsomatotropin release-inhibiting hormone (somatostatin, SRIH)
p11739
asg24
(lp11740
Vhttp://dbpedia.org/resource/Hypothalamus
p11741
aVhttp://dbpedia.org/resource/Hormone
p11742
aVhttp://dbpedia.org/resource/Pituitary_gland
p11743
aVhttp://dbpedia.org/resource/Hormone
p11744
aVhttp://dbpedia.org/resource/Prolactin
p11745
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question1/questionset1.htm'
p11746
sg31
S'Hypothalamic hormone linked to the pituitary hormone prolactin'
p11747
sg33
I17
sg34
S'Q101#3'
p11748
sg36
I8
sg37
S'3'
sg38
I2
sg39
S'101'
p11749
sa(dp11750
g3
(lp11751
(lp11752
Vhttp://dbpedia.org/resource/Pituitary_gland
p11753
aVhttp://dbpedia.org/resource/Region
p11754
aVhttp://dbpedia.org/resource/Disease
p11755
aa(lp11756
Vhttp://dbpedia.org/resource/Hypothalamus
p11757
aVhttp://dbpedia.org/resource/Growth_hormone
p11758
aa(lp11759
Vhttp://dbpedia.org/resource/Blood_serum
p11760
aVhttp://dbpedia.org/resource/Growth_hormone
p11761
aVhttp://dbpedia.org/resource/Antibody
p11762
aasg18
(lp11763
Vcraniopharyngiomas and other hypophyseal-pituitary region disease
p11764
aVlack of hypothalamic growth hormone-releasing factors
p11765
aVhigh-level of serum growth hormone antibodies
p11766
asg24
(lp11767
Vhttp://dbpedia.org/resource/Common_Cause
p11768
aVhttp://dbpedia.org/resource/Congenital_disorder
p11769
aVhttp://dbpedia.org/resource/Growth_hormone_deficiency
p11770
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question1/questionset1.htm'
p11771
sg31
S'Most common cause of congenital growth hormone deficiency:'
p11772
sg33
I18
sg34
S'Q101#8'
p11773
sg36
I8
sg37
S'8'
sg38
I1
sg39
S'101'
p11774
sa(dp11775
g3
(lp11776
(lp11777
Vhttp://dbpedia.org/resource/Activation_energy
p11778
aVhttp://dbpedia.org/resource/Thyroid
p11779
aVhttp://dbpedia.org/resource/Cell_%28biology%29
p11780
aVhttp://dbpedia.org/resource/System
p11781
aa(lp11782
Vhttp://dbpedia.org/resource/Activation_energy
p11783
aVhttp://dbpedia.org/resource/System
p11784
aa(lp11785
Vhttp://dbpedia.org/resource/Activation_energy
p11786
aVhttp://dbpedia.org/resource/Adenylate_cyclase
p11787
aVhttp://dbpedia.org/resource/System
p11788
aa(lp11789
Vhttp://dbpedia.org/resource/Blockade
p11790
aVhttp://dbpedia.org/resource/Adrenergic_receptor
p11791
aa(lp11792
Vhttp://dbpedia.org/resource/Adrenergic_receptor
p11793
aasg18
(lp11794
Vactivation of thyroid cell  IP3 system
p11795
aVactivation of guanylyl cyclase system
p11796
aVactivation of adenylyl cyclase system
p11797
aVblockade of beta adrenergic receptors
p11798
aVthrough alpha adrenergic receptor antagonism
p11799
asg24
(lp11800
Vhttp://dbpedia.org/resource/Mechanism_of_action
p11801
aVhttp://dbpedia.org/resource/Thyroid-stimulating_hormone
p11802
aVhttp://dbpedia.org/resource/Action_game
p11803
aVhttp://dbpedia.org/resource/Thyroid_hormone
p11804
aVhttp://dbpedia.org/resource/Production_line
p11805
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question2/questionset2.htm'
p11806
sg31
S'Mechanism of thyrotropin action -- results in ultimately increased thyroid hormone production:'
p11807
sg33
I26
sg34
S'Q102#6'
p11808
sg36
I12
sg37
S'6'
sg38
I2
sg39
S'102'
p11809
sa(dp11810
g3
(lp11811
(lp11812
Vhttp://dbpedia.org/resource/Liver
p11813
aa(lp11814
Vhttp://dbpedia.org/resource/Kidney
p11815
aa(lp11816
Vhttp://dbpedia.org/resource/Excretion
p11817
aasg18
(lp11818
Vliver
p11819
aVkidney
p11820
aVexcreted unchanged; no degradation
p11821
asg24
(lp11822
Vhttp://dbpedia.org/resource/Primary_mirror
p11823
aVhttp://dbpedia.org/resource/Thyroid-stimulating_hormone
p11824
aVhttp://dbpedia.org/resource/Thyroid-stimulating_hormone
p11825
aVhttp://dbpedia.org/resource/Ribosome
p11826
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question2/questionset2.htm'
p11827
sg31
S'Primary thyrotropin (TSH) degradation site:'
p11828
sg33
I7
sg34
S'Q102#7'
p11829
sg36
I7
sg37
S'7'
sg38
I1
sg39
S'102'
p11830
sa(dp11831
g3
(lp11832
(lp11833
Vhttp://dbpedia.org/resource/Thyroid-stimulating_hormone
p11834
aa(lp11835
Vhttp://dbpedia.org/resource/Corticotropin-releasing_hormone
p11836
aa(lp11837
Vhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11838
aasg18
(lp11839
VTRH
p11840
aVTSH
p11841
aVCRH
p11842
aVadrenocorticotropin
p11843
asg24
(lp11844
Vhttp://dbpedia.org/resource/Hypothalamus
p11845
aVhttp://dbpedia.org/resource/Hormone
p11846
aVhttp://dbpedia.org/resource/Pituitary_gland
p11847
aVhttp://dbpedia.org/resource/Stop_consonant
p11848
aVhttp://dbpedia.org/resource/Endorphin
p11849
aVhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11850
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question2/questionset2.htm'
p11851
sg31
S'Hypothalamic hormone causing pituitary release of beta-endorphins and ACTH:'
p11852
sg33
I4
sg34
S'Q102#8'
p11853
sg36
I9
sg37
S'8'
sg38
I2
sg39
S'102'
p11854
sa(dp11855
g3
(lp11856
(lp11857
Vhttp://dbpedia.org/resource/Cholesterol
p11858
aVhttp://dbpedia.org/resource/Esterase
p11859
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p11860
aa(lp11861
Vhttp://dbpedia.org/resource/Redox
p11862
aVhttp://dbpedia.org/resource/Mineralocorticoid
p11863
aVhttp://dbpedia.org/resource/Production_line
p11864
aa(lp11865
Vhttp://dbpedia.org/resource/Adrenal_gland
p11866
aVhttp://dbpedia.org/resource/Atrophy
p11867
aa(lp11868
Vhttp://dbpedia.org/resource/Skin
p11869
aasg18
(lp11870
Vcholesterol esterases activity
p11871
aVreduced mineralocorticoid production
p11872
aVadrenal atrophy
p11873
aVskin depigmentation
p11874
asg24
(lp11875
Vhttp://dbpedia.org/resource/Adrenocorticotropic_hormone
p11876
aVhttp://dbpedia.org/resource/Adrenal_cortex
p11877
aVhttp://dbpedia.org/resource/Stimulation
p11878
asg29
S'http://www.pharmacology2000.com/Hypothalamic/question2/questionset2.htm'
p11879
sg31
S'ACTH adrenocortical stimulation results in:'
p11880
sg33
I10
sg34
S'Q102#9'
p11881
sg36
I5
sg37
S'9'
sg38
I0
sg39
S'102'
p11882
sa(dp11883
g3
(lp11884
(lp11885
Vhttp://dbpedia.org/resource/Cyclophosphamide
p11886
aVhttp://dbpedia.org/resource/Cyclophosphamide
p11887
aasg18
(lp11888
Vcyclophosphamide (Cytoxan)
p11889
aVbusulfan (Myleran)
p11890
aVthiopeta (Thioplex)
p11891
aVdacarbazine (DTIC)
p11892
asg24
(lp11893
Vhttp://dbpedia.org/resource/Alkylation
p11894
aVhttp://dbpedia.org/resource/Chronic_myelogenous_leukemia
p11895
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p11896
sg31
S'Polyfunctional alkylating agent used specifically for chronic myeloid leukemia:'
p11897
sg33
I16
sg34
S'Q104#2'
p11898
sg36
I9
sg37
S'2'
sg38
I1
sg39
S'104'
p11899
sa(dp11900
g3
(lp11901
(lp11902
Vhttp://dbpedia.org/resource/Alopecia
p11903
aa(lp11904
Vhttp://dbpedia.org/resource/Kidney
p11905
aVhttp://dbpedia.org/resource/Damages
p11906
aa(lp11907
Vhttp://dbpedia.org/resource/Liver_failure
p11908
aasg18
(lp11909
Valopecia
p11910
aVmyelosuppression
p11911
aVrenal damage
p11912
aVhepatic failure
p11913
asg24
(lp11914
Vhttp://dbpedia.org/resource/Major_%28United_States%29
p11915
aVhttp://dbpedia.org/resource/Toxicity
p11916
aVhttp://dbpedia.org/resource/Alkylation
p11917
aVhttp://dbpedia.org/resource/Drug
p11918
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p11919
sg31
S'Major toxicity of alkylating drugs:'
p11920
sg33
I6
sg34
S'Q104#3'
p11921
sg36
I5
sg37
S'3'
sg38
I1
sg39
S'104'
p11922
sa(dp11923
g3
(lp11924
sg18
(lp11925
Vmelphalan (Alkeran)
p11926
aVcyclophosphamide (Cytoxan)
p11927
aVlomustine (CCNU,CeeNU)
p11928
aVthiopeta (Thioplex)
p11929
asg24
(lp11930
Vhttp://dbpedia.org/resource/Cyclophosphamide
p11931
aVhttp://dbpedia.org/resource/Cyclophosphamide
p11932
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p11933
sg31
S'Most useful alkylating drug currently available:'
p11934
sg33
I18
sg34
S'Q104#4'
p11935
sg36
I6
sg37
S'4'
sg38
I1
sg39
S'104'
p11936
sa(dp11937
g3
(lp11938
sg18
(lp11939
Vlomustine (CCNU,CeeNU)
p11940
aVcarmustine (BNCU,BiCNU)
p11941
aVstreptozocin (Zanosar)
p11942
aVprocarbazine (Matulane)
p11943
asg24
(lp11944
Vhttp://dbpedia.org/resource/Bone
p11945
aVhttp://dbpedia.org/resource/Pancreas
p11946
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p11947
sg31
S'Nitrosourea with minimal bone-marrow suppression and effective in treating pancreatic, islet cell carcinoma.'
p11948
sg33
I20
sg34
S'Q104#7'
p11949
sg36
I15
sg37
S'7'
sg38
I2
sg39
S'104'
p11950
sa(dp11951
g3
(lp11952
(lp11953
Vhttp://dbpedia.org/resource/Cisplatin
p11954
aVhttp://dbpedia.org/resource/Cisplatin
p11955
aa(lp11956
Vhttp://dbpedia.org/resource/Methotrexate
p11957
aasg18
(lp11958
Valtretamine (Hexalen)
p11959
aVcisplatin (Platinol)
p11960
aVprocarbazine (Matulane)
p11961
aVmethotrexate
p11962
asg24
(lp11963
Vhttp://dbpedia.org/resource/Bleomycin
p11964
aVhttp://dbpedia.org/resource/Major_%28United_Kingdom%29
p11965
aVhttp://dbpedia.org/resource/Testicular_cancer
p11966
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p11967
sg31
S'Used in combination with vinblastine and bleomycin: a major advance in treating nonseminomatous testicular cancer:'
p11968
sg33
I13
sg34
S'Q104#8'
p11969
sg36
I16
sg37
S'8'
sg38
I1
sg39
S'104'
p11970
sa(dp11971
g3
(lp11972
(lp11973
Vhttp://dbpedia.org/resource/Methotrexate
p11974
aasg18
(lp11975
Vmercaptomurine (6-MP)
p11976
aVmethotrexate
p11977
aVprocarbazine (Matulane)
p11978
aVallopurinol (Zyloprim, Purinol)
p11979
asg24
(lp11980
Vhttp://dbpedia.org/resource/Drug
p11981
aVhttp://dbpedia.org/resource/Psoriasis
p11982
aVhttp://dbpedia.org/resource/Rheumatoid_arthritis
p11983
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p11984
sg31
S'Anticancer drug that is also used to treat psoriasis and rheumatoid arthritis:'
p11985
sg33
I15
sg34
S'Q104#10'
p11986
sg36
I12
sg37
S'10'
p11987
sg38
I1
sg39
S'104'
p11988
sa(dp11989
g3
(lp11990
sg18
(lp11991
V6-thioguanine
p11992
aVflurouracil (5-FU)
p11993
aV6-mercaptopurine
p11994
aVazatadine (Optimine)
p11995
asg24
(lp11996
Vhttp://dbpedia.org/resource/Combination
p11997
aVhttp://dbpedia.org/resource/Drug
p11998
aVhttp://dbpedia.org/resource/Toxicity
p11999
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p12000
sg31
S'Combination of allopurinol with this anticancer drug can cause an increase in toxicity:'
p12001
sg33
I10
sg34
S'Q104#11'
p12002
sg36
I13
sg37
S'11'
p12003
sg38
I2
sg39
S'104'
p12004
sa(dp12005
g3
(lp12006
sg18
(lp12007
Vmethotrexate
p12008
aVcladribine (Leustatin)
p12009
aVvinblastine (Velban) 
p12010
aVcytarabine (ara-C)
p12011
asg24
(lp12012
Vhttp://dbpedia.org/resource/Methotrexate
p12013
asg29
S'http://www.pharmacology2000.com/Anticancer/questions1/antic1.htm'
p12014
sg31
S'Recommended for treating hairy cell leukemia'
p12015
sg33
I13
sg34
S'Q104#12'
p12016
sg36
I6
sg37
S'12'
p12017
sg38
I1
sg39
S'104'
p12018
sa(dp12019
g3
(lp12020
(lp12021
Vhttp://dbpedia.org/resource/Cisplatin
p12022
aVhttp://dbpedia.org/resource/Cisplatin
p12023
aa(lp12024
Vhttp://dbpedia.org/resource/Methotrexate
p12025
aasg18
(lp12026
Valtretamine (Hexalen)
p12027
aVcisplatin (Platinol)
p12028
aVmethotrexate
p12029
aVfludarabine (Fludara)
p12030
asg24
(lp12031
Vhttp://dbpedia.org/resource/Folic_acid
p12032
aVhttp://dbpedia.org/resource/Receptor_antagonist
p12033
aVhttp://dbpedia.org/resource/Active_site
p12034
asg29
S'http://www.pharmacology2000.com/Anticancer/questions2/antic2.htm'
p12035
sg31
S'Folic acid antagonist: binds to catalytic site of dihydrofolate reductase-'
p12036
sg33
I13
sg34
S'Q105#0'
p12037
sg36
I11
sg37
S'0'
sg38
I2
sg39
S'105'
p12038
sa(dp12039
g3
(lp12040
(lp12041
Vhttp://dbpedia.org/resource/GCE_Advanced_Level
p12042
aa(lp12043
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p12044
aVhttp://dbpedia.org/resource/Active_transport
p12045
aa(lp12046
Vhttp://dbpedia.org/resource/Activity_%28chemistry%29
p12047
aa(lp12048
Vhttp://dbpedia.org/resource/Formation_%28stratigraphy%29
p12049
aasg18
(lp12050
Vincreased levels of dihydrofolate reductase (DHFR)
p12051
aVincreased drug efflux from the cells by increased active transport
p12052
aVdecreased HGPRT activity
p12053
aVdecreased polyglutamate formation
p12054
asg24
(lp12055
Vhttp://dbpedia.org/resource/Common_land
p12056
aVhttp://dbpedia.org/resource/Mechanism_of_action
p12057
aVhttp://dbpedia.org/resource/Drug_resistance
p12058
asg29
S'http://www.pharmacology2000.com/Anticancer/questions2/antic2.htm'
p12059
sg31
S'Most common mechanism of resistance to both 6-MP (6-mercaptopurine) and 6-TG (6-thioguanine):'
p12060
sg33
I24
sg34
S'Q105#2'
p12061
sg36
I17
sg37
S'2'
sg38
I2
sg39
S'105'
p12062
sa(dp12063
g3
(lp12064
sg18
(lp12065
Vcytarabine (ARA-C)
p12066
aVvinblastine (Velban)
p12067
aVfluorouracil (5-FU)
p12068
aVcladribine (Leustatin)
p12069
asg24
(lp12070
Vhttp://dbpedia.org/resource/Adenocarcinoma
p12071
aVhttp://dbpedia.org/resource/Topical
p12072
aVhttp://dbpedia.org/resource/Skin
p12073
aVhttp://dbpedia.org/resource/Cancer
p12074
aVhttp://dbpedia.org/resource/Transcription_%28genetics%29
p12075
asg29
S'http://www.pharmacology2000.com/Anticancer/questions2/antic2.htm'
p12076
sg31
S'This pyrimidine analog is used systemically to treat adenocarcinomas, topically for skin cancer and works through inhibition of DNA synthesis.'
p12077
sg33
I16
sg34
S'Q105#3'
p12078
sg36
I22
sg37
S'3'
sg38
I2
sg39
S'105'
p12079
sa(dp12080
g3
(lp12081
(lp12082
Vhttp://dbpedia.org/resource/Methotrexate
p12083
aasg18
(lp12084
Vbusulfan (Myleran)
p12085
aVmercaptopurine (Purinethol)
p12086
aVmethotrexate
p12087
aVdaunorubicin (DaunoXome)
p12088
asg24
(lp12089
Vhttp://dbpedia.org/resource/Rescue
p12090
asg29
S'http://www.pharmacology2000.com/Anticancer/questions2/antic2.htm'
p12091
sg31
S' Leucovorin "rescue"'
p12092
sg33
I13
sg34
S'Q105#4'
p12093
sg36
I4
sg37
S'4'
sg38
I2
sg39
S'105'
p12094
sa(dp12095
g3
(lp12096
sg18
(lp12097
Vthioguanine
p12098
aVmercaptopurine (Purinethol)
p12099
aVcytarabine (ARA-C)
p12100
aVfludarabine (Fludara)
p12101
asg24
(lp12102
Vhttp://dbpedia.org/resource/Drug
p12103
aVhttp://dbpedia.org/resource/Toxicity
p12104
asg29
S'http://www.pharmacology2000.com/Anticancer/questions2/antic2.htm'
p12105
sg31
S'Administrate of this drug concurrently with allopurinol can result in excessive toxicity;'
p12106
sg33
I13
sg34
S'Q105#5'
p12107
sg36
I13
sg37
S'5'
sg38
I1
sg39
S'105'
p12108
sa(dp12109
g3
(lp12110
(lp12111
Vhttp://dbpedia.org/resource/Methotrexate
p12112
aasg18
(lp12113
Vazatadine (Optimine)
p12114
aVvinblastine (Velban)
p12115
aVcladribine (Leustatin)
p12116
aVmethotrexate
p12117
asg24
(lp12118
Vhttp://dbpedia.org/resource/Foreign_Agents_Registration_Act
p12119
aVhttp://dbpedia.org/resource/Microtubule
p12120
asg29
S'http://www.pharmacology2000.com/Anticancer/questions3/antic3.htm'
p12121
sg31
S'Anticancer agent that works by depolymerization of microtubules:'
p12122
sg33
I13
sg34
S'Q106#0'
p12123
sg36
I8
sg37
S'0'
sg38
I1
sg39
S'106'
p12124
sa(dp12125
g3
(lp12126
(lp12127
Vhttp://dbpedia.org/resource/Vincristine
p12128
aVhttp://dbpedia.org/resource/Vincristine
p12129
aa(lp12130
Vhttp://dbpedia.org/resource/Prednisone
p12131
aasg18
(lp12132
Vtopotecan (Hycamtin)
p12133
aVvincristine (Oncovin)
p12134
aVvinblastine (Velban)
p12135
aVprednisone (Deltasone)
p12136
asg24
(lp12137
Vhttp://dbpedia.org/resource/Administration_%28government%29
p12138
aVhttp://dbpedia.org/resource/Plant
p12139
aVhttp://dbpedia.org/resource/Alkaloid
p12140
aVhttp://dbpedia.org/resource/Agent_Orange
p12141
aVhttp://dbpedia.org/resource/Neurotoxicity
p12142
asg29
S'http://www.pharmacology2000.com/Anticancer/questions3/antic3.htm'
p12143
sg31
S'Administration of this plant alkaloid anticancer agent is associated with significant incidence of neurotoxicity.'
p12144
sg33
I16
sg34
S'Q106#1'
p12145
sg36
I15
sg37
S'1'
sg38
I1
sg39
S'106'
p12146
sa(dp12147
g3
(lp12148
(lp12149
Vhttp://dbpedia.org/resource/Vincristine
p12150
aVhttp://dbpedia.org/resource/Vincristine
p12151
aa(lp12152
Vhttp://dbpedia.org/resource/Paclitaxel
p12153
aVhttp://dbpedia.org/resource/Paclitaxel
p12154
aa(lp12155
Vhttp://dbpedia.org/resource/Etoposide
p12156
aVhttp://dbpedia.org/resource/Etoposide
p12157
aVhttp://dbpedia.org/resource/Sid_James
p12158
aasg18
(lp12159
Vvincristine (Oncovin) 
p12160
aVpaclitaxel (Taxol)
p12161
aVirinotecan (Camptosar)
p12162
aVetoposide (VP-16,VePe-sid)
p12163
asg24
(lp12164
Vhttp://dbpedia.org/resource/Derivative_%28chemistry%29
p12165
aVhttp://dbpedia.org/resource/Taxus_baccata
p12166
aVhttp://dbpedia.org/resource/Drug
p12167
aVhttp://dbpedia.org/resource/Tubulin
p12168
aVhttp://dbpedia.org/resource/Polymerization
p12169
asg29
S'http://www.pharmacology2000.com/Anticancer/questions3/antic3.htm'
p12170
sg31
S'Derivative from the Western Yew and European Yew tree, this anticancer drug acts by enhacing tubulin polymerization.'
p12171
sg33
I18
sg34
S'Q106#2'
p12172
sg36
I19
sg37
S'2'
sg38
I1
sg39
S'106'
p12173
sa(dp12174
g3
(lp12175
(lp12176
Vhttp://dbpedia.org/resource/Vincristine
p12177
aVhttp://dbpedia.org/resource/Vincristine
p12178
aa(lp12179
Vhttp://dbpedia.org/resource/Doxorubicin
p12180
aVhttp://dbpedia.org/resource/Doxorubicin
p12181
aasg18
(lp12182
Vvincristine (Oncovin)
p12183
aVtopotecan (Hycamtin)
p12184
aVdoxorubicin (Adriamycin)
p12185
aVmitomycin (Mutamycin)
p12186
asg24
(lp12187
Vhttp://dbpedia.org/resource/Metastasis
p12188
aVhttp://dbpedia.org/resource/Ovarian_cancer
p12189
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p12190
aVhttp://dbpedia.org/resource/Adverse_effect
p12191
aVhttp://dbpedia.org/resource/Neutropenia
p12192
aVhttp://dbpedia.org/resource/Anemia
p12193
asg29
S'http://www.pharmacology2000.com/Anticancer/questions3/antic3.htm'
p12194
sg31
S"May be useful in control of metastatic ovarian cancer, this topoisomerase I inhibitor's dose-limiting adverse effects include: neutropenia, thromobcytopenia and anemia."
p12195
sg33
I16
sg34
S'Q106#3'
p12196
sg36
I26
sg37
S'3'
sg38
I1
sg39
S'106'
p12197
sa(dp12198
g3
(lp12199
(lp12200
Vhttp://dbpedia.org/resource/Vincristine
p12201
aVhttp://dbpedia.org/resource/Vincristine
p12202
aa(lp12203
Vhttp://dbpedia.org/resource/Paclitaxel
p12204
aVhttp://dbpedia.org/resource/Paclitaxel
p12205
aa(lp12206
Vhttp://dbpedia.org/resource/Etoposide
p12207
aVhttp://dbpedia.org/resource/Etoposide
p12208
aasg18
(lp12209
Vvincristine (Oncovin)
p12210
aVpaclitaxel (Taxol)
p12211
aVtopotecan (Hycamtin)
p12212
aVetoposide (VP-16,VePe-sid)
p12213
asg24
(lp12214
Vhttp://dbpedia.org/resource/Bioavailability
p12215
aVhttp://dbpedia.org/resource/G1_phase
p12216
aVhttp://dbpedia.org/resource/Mechanism_of_action
p12217
aVhttp://dbpedia.org/resource/Derivative_%28chemistry%29
p12218
aVhttp://dbpedia.org/resource/Drug
p12219
asg29
S'http://www.pharmacology2000.com/Anticancer/questions3/antic3.htm'
p12220
sg31
S'Active in late S-G2 phase of the cell cycle, the mechanism of this semisynthetic derivative of podophyllotoxin anticancer drug is through inhibition of topoisomerase II.'
p12221
sg33
I18
sg34
S'Q106#4'
p12222
sg36
I27
sg37
S'4'
sg38
I3
sg39
S'106'
p12223
sa(dp12224
g3
(lp12225
(lp12226
Vhttp://dbpedia.org/resource/Vincristine
p12227
aVhttp://dbpedia.org/resource/Vincristine
p12228
aa(lp12229
Vhttp://dbpedia.org/resource/Paclitaxel
p12230
aVhttp://dbpedia.org/resource/Paclitaxel
p12231
aasg18
(lp12232
Vvincristine (Oncovin)
p12233
aVirinotecan (Camptosar)
p12234
aVpaclitaxel (Taxol)
p12235
aVdocetaxel (Taxotere)
p12236
asg24
(lp12237
Vhttp://dbpedia.org/resource/Patient
p12238
aVhttp://dbpedia.org/resource/Colorectal_cancer
p12239
aVhttp://dbpedia.org/resource/Prodrug
p12240
aVhttp://dbpedia.org/resource/Patient
p12241
aVhttp://dbpedia.org/resource/Diarrhea
p12242
aVhttp://dbpedia.org/resource/Hypovolemia
p12243
aVhttp://dbpedia.org/resource/Drug
p12244
asg29
S'http://www.pharmacology2000.com/Anticancer/questions3/antic3.htm'
p12245
sg31
S'A patient with fluorouracil-nonresponsive colon cancer is given this prodrug which following activation is a topoisomerase I inhibitor. Following administration, the patient experiences very severe diarrhea which causes hypovolemia. This drug probably was:'
p12246
sg33
I16
sg34
S'Q106#5'
p12247
sg36
I34
sg37
S'5'
sg38
I1
sg39
S'106'
p12248
sa(dp12249
g3
(lp12250
(lp12251
Vhttp://dbpedia.org/resource/Bleomycin
p12252
aVhttp://dbpedia.org/resource/Bleomycin
p12253
aa(lp12254
Vhttp://dbpedia.org/resource/Doxorubicin
p12255
aVhttp://dbpedia.org/resource/Doxorubicin
p12256
aasg18
(lp12257
Vdactinomycin  (Cosmegen)
p12258
aVbleomycin (Blenoxane)
p12259
aVdaunorubicin (DaunoXome)
p12260
aVdoxorubicin (Adriamycin)
p12261
asg24
(lp12262
Vhttp://dbpedia.org/resource/Clinic
p12263
aVhttp://dbpedia.org/resource/Antibacterial
p12264
aVhttp://dbpedia.org/resource/In_Treatment
p12265
asg29
S'http://www.pharmacology2000.com/Anticancer/questions4/antic4.htm'
p12266
sg31
S'Major clinical use of this antracycline anticancer, antibiotic is in treatment of acute leukemia.'
p12267
sg33
I16
sg34
S'Q107#1'
p12268
sg36
I16
sg37
S'1'
sg38
I2
sg39
S'107'
p12269
sa(dp12270
g3
(lp12271
(lp12272
Vhttp://dbpedia.org/resource/Doxorubicin
p12273
aVhttp://dbpedia.org/resource/Doxorubicin
p12274
aa(lp12275
Vhttp://dbpedia.org/resource/Bleomycin
p12276
aVhttp://dbpedia.org/resource/Bleomycin
p12277
aasg18
(lp12278
Vplicamycin (Mithramycin)
p12279
aVdactinomycin  (Cosmegen)
p12280
aVdoxorubicin (Adriamycin)
p12281
aVbleomycin (Blenoxane)
p12282
asg24
(lp12283
Vhttp://dbpedia.org/resource/Antibacterial
p12284
asg29
S'http://www.pharmacology2000.com/Anticancer/questions4/antic4.htm'
p12285
sg31
S'Among anticancer antibiotics: most toxic--'
p12286
sg33
I16
sg34
S'Q107#2'
p12287
sg36
I7
sg37
S'2'
sg38
I2
sg39
S'107'
p12288
sa(dp12289
g3
(lp12290
(lp12291
Vhttp://dbpedia.org/resource/Doxorubicin
p12292
aVhttp://dbpedia.org/resource/Doxorubicin
p12293
aa(lp12294
Vhttp://dbpedia.org/resource/Vincristine
p12295
aVhttp://dbpedia.org/resource/Vincristine
p12296
aasg18
(lp12297
Vdoxorubicin (Adriamycin)
p12298
aVmitomycin (Mutamycin)
p12299
aVvincristine (Oncovin)
p12300
aVplicamycin (Mithramycin)
p12301
asg24
(lp12302
Vhttp://dbpedia.org/resource/Antibacterial
p12303
aVhttp://dbpedia.org/resource/Drug
p12304
aVhttp://dbpedia.org/resource/Alkylation
p12305
aVhttp://dbpedia.org/resource/Tumor
p12306
aVhttp://dbpedia.org/resource/Stem_cell
p12307
asg29
S'http://www.pharmacology2000.com/Anticancer/questions4/antic4.htm'
p12308
sg31
S'Antibiotic anticancer drug that is bioactivated to an alkylating agent. Hypoxic solid tumor stem cells may be most susceptible.'
p12309
sg33
I16
sg34
S'Q107#3'
p12310
sg36
I20
sg37
S'3'
sg38
I1
sg39
S'107'
p12311
sa(dp12312
g3
(lp12313
(lp12314
Vhttp://dbpedia.org/resource/Bleomycin
p12315
aVhttp://dbpedia.org/resource/Bleomycin
p12316
aa(lp12317
Vhttp://dbpedia.org/resource/Paclitaxel
p12318
aVhttp://dbpedia.org/resource/Paclitaxel
p12319
aasg18
(lp12320
Vplicamycin (Mithramycin)
p12321
aVidarubicin (Idamycin)
p12322
aVbleomycin (Blenoxane)
p12323
aVpaclitaxel (Taxol)
p12324
asg24
(lp12325
Vhttp://dbpedia.org/resource/Analogy
p12326
aVhttp://dbpedia.org/resource/Acute_myeloid_leukemia
p12327
aVhttp://dbpedia.org/resource/Produce
p12328
aVhttp://dbpedia.org/resource/Patient
p12329
aVhttp://dbpedia.org/resource/Acute_myeloid_leukemia
p12330
asg29
S'http://www.pharmacology2000.com/Anticancer/questions4/antic4.htm'
p12331
sg31
S'Anthracycline analog useful in treating acute myeloid leukemia; In combination with cytarabine (ARA-C), it can produce complete remissions in patients with acute myelogenous leukemia.'
p12332
sg33
I16
sg34
S'Q107#4'
p12333
sg36
I29
sg37
S'4'
sg38
I1
sg39
S'107'
p12334
sa(dp12335
g3
(lp12336
(lp12337
Vhttp://dbpedia.org/resource/Doxorubicin
p12338
aVhttp://dbpedia.org/resource/Doxorubicin
p12339
aa(lp12340
Vhttp://dbpedia.org/resource/Bleomycin
p12341
aVhttp://dbpedia.org/resource/Bleomycin
p12342
aasg18
(lp12343
Vdactinomycin  (Cosmegen)
p12344
aVdoxorubicin (Adriamycin)
p12345
aVbleomycin (Blenoxane)
p12346
aVplicamycin (Mithramycin)
p12347
asg24
(lp12348
Vhttp://dbpedia.org/resource/Drug
p12349
aVhttp://dbpedia.org/resource/Osteoclast
p12350
aVhttp://dbpedia.org/resource/Blood_serum
p12351
aVhttp://dbpedia.org/resource/Chemotherapy
p12352
asg29
S'http://www.pharmacology2000.com/Anticancer/questions4/antic4.htm'
p12353
sg31
S'Anticancer drug: acts on osteoclasts to decrease serum calcium levels (independent of its antitumor action)'
p12354
sg33
I16
sg34
S'Q107#5'
p12355
sg36
I18
sg37
S'5'
sg38
I3
sg39
S'107'
p12356
sa(dp12357
g3
(lp12358
sg18
(lp12359
V5%
p12360
aV15%
p12361
aV25%
p12362
aV50%
p12363
aV75%
p12364
asg24
(lp12365
Vhttp://dbpedia.org/resource/Cure
p12366
aVhttp://dbpedia.org/resource/Cancer_%28astrology%29
p12367
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12368
sg31
S'Cure rate for cancer (1998):'
p12369
sg33
I10
sg34
S'Q108#2'
p12370
sg36
I8
sg37
S'2'
sg38
I3
sg39
S'108'
p12371
sa(dp12372
g3
(lp12373
(lp12374
Vhttp://dbpedia.org/resource/Colorectal_cancer
p12375
aa(lp12376
Vhttp://dbpedia.org/resource/Testicular_cancer
p12377
aasg18
(lp12378
Vdiffuse large cell lymphoma
p12379
aVWilm\u005c
p12380
aVchoriocarcinoma
p12381
aVcolon cancer
p12382
aVtesticular cancer
p12383
asg24
(lp12384
Vhttp://dbpedia.org/resource/Cancer
p12385
aVhttp://dbpedia.org/resource/Movable_type
p12386
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12387
sg31
S'Cancer type relatively resistant to treatment:'
p12388
sg33
I10
sg34
S'Q108#3'
p12389
sg36
I6
sg37
S'3'
sg38
I3
sg39
S'108'
p12390
sa(dp12391
g3
(lp12392
(lp12393
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p12394
aa(lp12395
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p12396
aa(lp12397
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p12398
aa(lp12399
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p12400
aa(lp12401
Vhttp://dbpedia.org/resource/Cell_%28biology%29
p12402
aasg18
(lp12403
V10^4 cells
p12404
aV10^6 cells
p12405
aV10^8 cells
p12406
aV10^10 cells
p12407
aV10^12 cells
p12408
asg24
(lp12409
Vhttp://dbpedia.org/resource/Chris_Burden
p12410
aVhttp://dbpedia.org/resource/Disease
p12411
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12412
sg31
S' Cancer cell burden associated with widespread disease'
p12413
sg33
I10
sg34
S'Q108#4'
p12414
sg36
I7
sg37
S'4'
sg38
I4
sg39
S'108'
p12415
sa(dp12416
g3
(lp12417
(lp12418
Vhttp://dbpedia.org/resource/Drug
p12419
aVhttp://dbpedia.org/resource/Law
p12420
aVhttp://dbpedia.org/resource/Maxima_and_minima
p12421
aVhttp://dbpedia.org/resource/Frequency
p12422
aa(lp12423
Vhttp://dbpedia.org/resource/Drug
p12424
aVhttp://dbpedia.org/resource/Maxima_and_minima
p12425
aVhttp://dbpedia.org/resource/Side_effect
p12426
aa(lp12427
Vhttp://dbpedia.org/resource/Drug
p12428
aVhttp://dbpedia.org/resource/Major_%28United_States%29
p12429
aa(lp12430
Vhttp://dbpedia.org/resource/Drug
p12431
aVhttp://dbpedia.org/resource/Effectiveness
p12432
aasg18
(lp12433
Vdrug should be administered at law or the maximum doses but with increased frequency
p12434
aVdrug should be administered infrequently to minimize side effects
p12435
aVdrugs more beneficial if major toxicities are nonoverlapping
p12436
aVdrugs rarely effective in combination
p12437
asg24
(lp12438
Vhttp://dbpedia.org/resource/Chemotherapy
p12439
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12440
sg31
S'Chemotherapeutic (anticancer) dosing principles:'
p12441
sg33
I36
sg34
S'Q108#8'
p12442
sg36
I6
sg37
S'8'
sg38
I2
sg39
S'108'
p12443
sa(dp12444
g3
(lp12445
(lp12446
Vhttp://dbpedia.org/resource/Cyclophosphamide
p12447
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12448
aasg18
(lp12449
Vchlorambucil (Leukeran)
p12450
aVmechlorethamine (Mustargen)
p12451
aVthiopeta (Thioplex)
p12452
aVmelphalan (Alkeran)
p12453
aVcyclophosphamide (Cytoxan)
p12454
asg24
(lp12455
Vhttp://dbpedia.org/resource/Secondary_school
p12456
aVhttp://dbpedia.org/resource/Alkylation
p12457
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12458
sg31
S'"Secondary" alkylating agent:'
p12459
sg33
I20
sg34
S'Q108#10'
p12460
sg36
I5
sg37
S'10'
p12461
sg38
I2
sg39
S'108'
p12462
sa(dp12463
g3
(lp12464
(lp12465
Vhttp://dbpedia.org/resource/Cyclophosphamide
p12466
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12467
aasg18
(lp12468
Vmelphalan (Alkeran)
p12469
aVchlorambucil (Leukeran)
p12470
aVlomustine (CCNU,CeeNU)
p12471
aVcyclophosphamide (Cytoxan)
p12472
aVifofamide (Ifex)
p12473
asg24
(lp12474
Vhttp://dbpedia.org/resource/Alkylation
p12475
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12476
sg31
S'Nitrosourea-alkylating agent'
p12477
sg33
I22
sg34
S'Q108#12'
p12478
sg36
I2
sg37
S'12'
p12479
sg38
I2
sg39
S'108'
p12480
sa(dp12481
g3
(lp12482
(lp12483
Vhttp://dbpedia.org/resource/Methyl_group
p12484
aa(lp12485
Vhttp://dbpedia.org/resource/Cyclophosphamide
p12486
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12487
aasg18
(lp12488
Vchlorambucil (Leukeran)
p12489
aVsemustine (methyl CCNU)
p12490
aV thiopeta (Thioplex)
p12491
aVcyclophosphamide (Cytoxan)
p12492
aVmechlorethamine (Mustargen)
p12493
asg24
(lp12494
Vhttp://dbpedia.org/resource/Prodrug
p12495
aVhttp://dbpedia.org/resource/Activation_energy
p12496
aVhttp://dbpedia.org/resource/Enzyme
p12497
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12498
sg31
S'Prodrug-requires activation by microsomal enzyme system:'
p12499
sg33
I21
sg34
S'Q108#15'
p12500
sg36
I6
sg37
S'15'
p12501
sg38
I3
sg39
S'108'
p12502
sa(dp12503
g3
(lp12504
(lp12505
Vhttp://dbpedia.org/resource/Cyclophosphamide
p12506
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12507
aasg18
(lp12508
Vbusulfan (Myleran)
p12509
aVmelphalan (Alkeran)
p12510
aVmechlorethamine (Mustargen)
p12511
aVcyclophosphamide (Cytoxan)
p12512
aVthiopeta (Thioplex)
p12513
asg24
(lp12514
Vhttp://dbpedia.org/resource/Alkylation
p12515
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12516
sg31
S' Most useful alkylating agent at present'
p12517
sg33
I20
sg34
S'Q108#18'
p12518
sg36
I6
sg37
S'18'
p12519
sg38
I3
sg39
S'108'
p12520
sa(dp12521
g3
(lp12522
(lp12523
Vhttp://dbpedia.org/resource/Liver
p12524
aa(lp12525
Vhttp://dbpedia.org/resource/Lung
p12526
aa(lp12527
Vhttp://dbpedia.org/resource/Kidney
p12528
aasg18
(lp12529
Vhepatic
p12530
aVpulmonary
p12531
aVrenal
p12532
asg24
(lp12533
Vhttp://dbpedia.org/resource/Highway
p12534
aVhttp://dbpedia.org/resource/Elimination_reaction
p12535
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12536
sg31
S'Major route of elimination for nitrosoureas:'
p12537
sg33
I3
sg34
S'Q108#21'
p12538
sg36
I6
sg37
S'21'
p12539
sg38
I2
sg39
S'108'
p12540
sa(dp12541
g3
(lp12542
(lp12543
Vhttp://dbpedia.org/resource/Cyclophosphamide
p12544
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12545
aasg18
(lp12546
Vbusulfan (Myleran)
p12547
aVmechlorethamine (Mustargen)
p12548
aVcyclophosphamide (Cytoxan)
p12549
aVstreptozocin (Zanosar)
p12550
aVthiopeta (Thioplex)
p12551
asg24
(lp12552
Vhttp://dbpedia.org/resource/Insulin
p12553
aVhttp://dbpedia.org/resource/Islets_of_Langerhans
p12554
aVhttp://dbpedia.org/resource/Pancreatic_cancer
p12555
aVhttp://dbpedia.org/resource/Non-Hodgkin_lymphoma
p12556
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12557
sg31
S"Most likely to be effective in insulin-secreting islet cell pancreatic carcinoma and sometimes in non-Hodgkin's lymphoma:"
p12558
sg33
I20
sg34
S'Q108#23'
p12559
sg36
I17
sg37
S'23'
p12560
sg38
I3
sg39
S'108'
p12561
sa(dp12562
g3
(lp12563
(lp12564
Vhttp://dbpedia.org/resource/Cisplatin
p12565
aVhttp://dbpedia.org/resource/Cisplatin
p12566
aasg18
(lp12567
Vdacarbazine (DTIC)
p12568
aVprocarbazine (Matulane)
p12569
aVcisplatin (Platinol)
p12570
aValtretamine (Hexalen)
p12571
asg24
(lp12572
Vhttp://dbpedia.org/resource/The_Combination
p12573
aVhttp://dbpedia.org/resource/Bleomycin
p12574
aVhttp://dbpedia.org/resource/Bleomycin
p12575
aVhttp://dbpedia.org/resource/Testicular_cancer
p12576
asg29
S'http://www.pharmacology2000.com/Anticancer/questions7/questionset7.htm'
p12577
sg31
S'In combination with bleomycin (Blenoxane) and vinblastine (Velban)-curative for nonseminomatous testicular cancer:'
p12578
sg33
I16
sg34
S'Q108#24'
p12579
sg36
I17
sg37
S'24'
p12580
sg38
I2
sg39
S'108'
p12581
sa(dp12582
g3
(lp12583
(lp12584
Vhttp://dbpedia.org/resource/Kidney
p12585
aVhttp://dbpedia.org/resource/Dysfunctional_family
p12586
aa(lp12587
Vhttp://dbpedia.org/resource/Nausea
p12588
aVhttp://dbpedia.org/resource/Vomiting
p12589
aa(lp12590
Vhttp://dbpedia.org/resource/Vestibulocochlear_nerve
p12591
aVhttp://dbpedia.org/resource/Dysfunctional_family
p12592
aasg18
(lp12593
Vbone marrow depression
p12594
aVrenal dysfunction
p12595
aVnausea and vomiting
p12596
aVacoustic nerve dysfunction
p12597
asg24
(lp12598
Vhttp://dbpedia.org/resource/Acute_%28medicine%29
p12599
aVhttp://dbpedia.org/resource/Side_effect
p12600
aVhttp://dbpedia.org/resource/Cisplatin
p12601
aVhttp://dbpedia.org/resource/Cisplatin
p12602
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12603
sg31
S'major acute side effect of cisplatin (Platinol)'
p12604
sg33
I11
sg34
S'Q109#2'
p12605
sg36
I9
sg37
S'2'
sg38
I2
sg39
S'109'
p12606
sa(dp12607
g3
(lp12608
(lp12609
Vhttp://dbpedia.org/resource/Kidney
p12610
aVhttp://dbpedia.org/resource/Dysfunctional_family
p12611
aa(lp12612
Vhttp://dbpedia.org/resource/Liver_failure
p12613
aa(lp12614
Vhttp://dbpedia.org/resource/Neurotoxicity
p12615
aa(lp12616
Vhttp://dbpedia.org/resource/Alopecia
p12617
aasg18
(lp12618
Vrenal dysfunction
p12619
aVhepatic failure
p12620
aVneurotoxicity
p12621
aVbone marrow suppression
p12622
aValopecia
p12623
asg24
(lp12624
Vhttp://dbpedia.org/resource/Toxicity
p12625
aVhttp://dbpedia.org/resource/Alkylation
p12626
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12627
sg31
S'Most important toxic effect associated with alkylating agents:'
p12628
sg33
I9
sg34
S'Q109#3'
p12629
sg36
I8
sg37
S'3'
sg38
I3
sg39
S'109'
p12630
sa(dp12631
g3
(lp12632
(lp12633
Vhttp://dbpedia.org/resource/Cyclophosphamide
p12634
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12635
aa(lp12636
Vhttp://dbpedia.org/resource/Oral_rehydration_therapy
p12637
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12638
aVhttp://dbpedia.org/resource/Cyclophosphamide
p12639
aasg18
(lp12640
VIV cyclophosphamide (Cytoxan)
p12641
aVoral cyclophosphamide (Cytoxan)
p12642
aVequally likely
p12643
asg24
(lp12644
Vhttp://dbpedia.org/resource/Nausea
p12645
aVhttp://dbpedia.org/resource/Vomiting
p12646
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12647
sg31
S'More likely to cause nausea and vomiting:'
p12648
sg33
I12
sg34
S'Q109#5'
p12649
sg36
I7
sg37
S'5'
sg38
I0
sg39
S'109'
p12650
sa(dp12651
g3
(lp12652
(lp12653
Vhttp://dbpedia.org/resource/Gout
p12654
aa(lp12655
Vhttp://dbpedia.org/resource/Hepatotoxicity
p12656
aa(lp12657
Vhttp://dbpedia.org/resource/Bone
p12658
aVhttp://dbpedia.org/resource/Calcium
p12659
aasg18
(lp12660
Vcardiotoxicity
p12661
aVretroperitoneal fibrosis
p12662
aVnephrotoxicity and gout
p12663
aVhepatotoxicity
p12664
aVdepletion of bone calcium
p12665
asg24
(lp12666
Vhttp://dbpedia.org/resource/Hematology
p12667
aVhttp://dbpedia.org/resource/Chemotherapy
p12668
aVhttp://dbpedia.org/resource/Purine
p12669
aVhttp://dbpedia.org/resource/Receptor_antagonist
p12670
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12671
sg31
S' In hematologic cancer chemotherapy with purine antagonists, allopurinol (Zyloprim, Purinol) coadministration is used to prevent:'
p12672
sg33
I11
sg34
S'Q109#12'
p12673
sg36
I19
sg37
S'12'
p12674
sg38
I2
sg39
S'109'
p12675
sa(dp12676
g3
(lp12677
(lp12678
Vhttp://dbpedia.org/resource/Testicular_cancer
p12679
aasg18
(lp12680
Vmonocytic leukemia
p12681
aVlymphoma
p12682
aV testicular cancer
p12683
aVoat cell carcinoma
p12684
asg24
(lp12685
Vhttp://dbpedia.org/resource/Lymphoma
p12686
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12687
sg31
S'Clinical use teniposide (Vumon)'
p12688
sg33
I8
sg34
S'Q109#16'
p12689
sg36
I6
sg37
S'16'
p12690
sg38
I1
sg39
S'109'
p12691
sa(dp12692
g3
(lp12693
(lp12694
Vhttp://dbpedia.org/resource/Neurotoxicity
p12695
aa(lp12696
Vhttp://dbpedia.org/resource/Equality_%28mathematics%29
p12697
aVhttp://dbpedia.org/resource/Frequency
p12698
aasg18
(lp12699
Vbone marrow depression
p12700
aVneurotoxicity
p12701
aVequal frequency
p12702
asg24
(lp12703
Vhttp://dbpedia.org/resource/Frequency
p12704
aVhttp://dbpedia.org/resource/Adverse_effect
p12705
aVhttp://dbpedia.org/resource/Vincristine
p12706
aVhttp://dbpedia.org/resource/Vincristine
p12707
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12708
sg31
S'Significant frequency-adverse effect associated with vincristine (Oncovin)'
p12709
sg33
I6
sg34
S'Q109#18'
p12710
sg36
I9
sg37
S'18'
p12711
sg38
I1
sg39
S'109'
p12712
sa(dp12713
g3
(lp12714
(lp12715
Vhttp://dbpedia.org/resource/Diarrhea
p12716
aa(lp12717
Vhttp://dbpedia.org/resource/Nausea
p12718
aa(lp12719
Vhttp://dbpedia.org/resource/Vomiting
p12720
aasg18
(lp12721
Vdiarrhea
p12722
aVnausea
p12723
aVvomiting
p12724
aVmyelosuppression
p12725
asg24
(lp12726
Vhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p12727
aVhttp://dbpedia.org/resource/Adverse_effect
p12728
asg29
S'http://www.pharmacology2000.com/Anticancer/questions8/questionset8.htm'
p12729
sg31
S'Dose-limiting adverse effect for irinotecan (Camptosar):'
p12730
sg33
I4
sg34
S'Q109#21'
p12731
sg36
I9
sg37
S'21'
p12732
sg38
I3
sg39
S'109'
p12733
sa(dp12734
g3
(lp12735
(lp12736
Vhttp://dbpedia.org/resource/Neomycin
p12737
aa(lp12738
Vhttp://dbpedia.org/resource/Penicillin
p12739
aa(lp12740
Vhttp://dbpedia.org/resource/Streptomycin
p12741
aasg18
(lp12742
Vneomycin
p12743
aVpenicillin
p12744
aVkanamycin (Kantrex)
p12745
aVstreptomycin
p12746
asg24
(lp12747
Vhttp://dbpedia.org/resource/Topical
p12748
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12749
sg31
S'Topical use:'
p12750
sg33
I7
sg34
S'Q110#0'
p12751
sg36
I2
sg37
S'0'
sg38
I0
sg39
S'110'
p12752
sa(dp12753
g3
(lp12754
(lp12755
Vhttp://dbpedia.org/resource/Penicillin
p12756
aa(lp12757
Vhttp://dbpedia.org/resource/Streptomycin
p12758
aasg18
(lp12759
Vaspirin
p12760
aVcephalothin (Keflin)
p12761
aVpenicillin
p12762
aVstreptomycin
p12763
asg24
(lp12764
Vhttp://dbpedia.org/resource/Renal_function
p12765
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12766
sg31
S'Glomerular filtration:'
p12767
sg33
I7
sg34
S'Q110#2'
p12768
sg36
I2
sg37
S'2'
sg38
I3
sg39
S'110'
p12769
sa(dp12770
g3
(lp12771
(lp12772
Vhttp://dbpedia.org/resource/Block_%28sailing%29
p12773
aVhttp://dbpedia.org/resource/Cell_wall
p12774
aVhttp://dbpedia.org/resource/S_phase
p12775
aa(lp12776
Vhttp://dbpedia.org/resource/Protein_biosynthesis
p12777
aa(lp12778
Vhttp://dbpedia.org/resource/Folic_acid
p12779
aVhttp://dbpedia.org/resource/S_phase
p12780
aa(lp12781
Vhttp://dbpedia.org/resource/Nucleic_acid
p12782
aVhttp://dbpedia.org/resource/S_phase
p12783
aasg18
(lp12784
Vblocks cell wall synthesis
p12785
aVinhibits protein synthesis
p12786
aVfolic acid synthesis inhibitor
p12787
aVnucleic acid synthesis inhibitor
p12788
asg24
(lp12789
Vhttp://dbpedia.org/resource/Mechanism_of_action
p12790
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12791
sg31
S'Mechanism of bacteriocidal action: kanamycin (Kantrex)'
p12792
sg33
I15
sg34
S'Q110#4'
p12793
sg36
I9
sg37
S'4'
sg38
I1
sg39
S'110'
p12794
sa(dp12795
g3
(lp12796
sg18
(lp12797
Vamikacin (Amikin)
p12798
aVpenicillin G
p12799
aVamphotericin B (Fungizone, Amphotec) been
p12800
aVcefotaxime (Claforan)
p12801
asg24
(lp12802
Vhttp://dbpedia.org/resource/Amphotericin_B
p12803
aVhttp://dbpedia.org/resource/Amphotericin_B
p12804
aVhttp://dbpedia.org/resource/Amphotericin_B
p12805
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12806
sg31
S'Neuromuscular blockade at high dosages:'
p12807
sg33
I18
sg34
S'Q110#5'
p12808
sg36
I5
sg37
S'5'
sg38
I0
sg39
S'110'
p12809
sa(dp12810
g3
(lp12811
(lp12812
Vhttp://dbpedia.org/resource/Clindamycin
p12813
aVhttp://dbpedia.org/resource/Clindamycin
p12814
aasg18
(lp12815
Vpenicillin G
p12816
aVkanamycin (Kantrex)
p12817
aVtobramycin (Nebcin)
p12818
aVclindamycin (Cleocin)
p12819
asg24
(lp12820
Vhttp://dbpedia.org/resource/Pseudomonas
p12821
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12822
sg31
S'Pseudomonas strains resistant to carbenicillin may be sensitive to:'
p12823
sg33
I14
sg34
S'Q110#7'
p12824
sg36
I9
sg37
S'7'
sg38
I2
sg39
S'110'
p12825
sa(dp12826
g3
(lp12827
(lp12828
Vhttp://dbpedia.org/resource/Treat_Williams
p12829
aVhttp://dbpedia.org/resource/Sepsis
p12830
aVhttp://dbpedia.org/resource/Gram-negative_bacteria
p12831
aVhttp://dbpedia.org/resource/Pseudomonas
p12832
aa(lp12833
Vhttp://dbpedia.org/resource/Endocarditis
p12834
aa(lp12835
Vhttp://dbpedia.org/resource/Agent_Orange
p12836
aVhttp://dbpedia.org/resource/Treat_Williams
p12837
aVhttp://dbpedia.org/resource/Staphylococcus
p12838
aa(lp12839
Vhttp://dbpedia.org/resource/Cephalosporin
p12840
aVhttp://dbpedia.org/resource/Immunodeficiency
p12841
aVhttp://dbpedia.org/resource/Patient
p12842
aasg18
(lp12843
Vto treat sepsis caused by gram-negative bacteria such as Pseudomonas.
p12844
aVin combination with Penicillin G for endocarditis due to viridans streptococci
p12845
aVas a single agent to treat staphylococcal infections.
p12846
aVin combination with cephalosporin in immunocompromised patients.
p12847
asg24
(lp12848
Vhttp://dbpedia.org/resource/Gentamicin
p12849
aVhttp://dbpedia.org/resource/Gentamicin
p12850
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12851
sg31
S'Gentamicin (Garamycin) should NOT be used:'
p12852
sg33
I37
sg34
S'Q110#9'
p12853
sg36
I8
sg37
S'9'
sg38
I2
sg39
S'110'
p12854
sa(dp12855
g3
(lp12856
(lp12857
Vhttp://dbpedia.org/resource/Streptomycin
p12858
aa(lp12859
Vhttp://dbpedia.org/resource/Neomycin
p12860
aa(lp12861
Vhttp://dbpedia.org/resource/Doxycycline
p12862
aVhttp://dbpedia.org/resource/Doxycycline
p12863
aVhttp://dbpedia.org/resource/Doxycycline
p12864
aasg18
(lp12865
Vstreptomycin
p12866
aVamikacin (Amikin)
p12867
aVneomycin
p12868
aVdoxycycline (Vibramycin, Doryx)
p12869
asg24
(lp12870
Vhttp://dbpedia.org/resource/Derivative_%28chemistry%29
p12871
aVhttp://dbpedia.org/resource/Toxin
p12872
aVhttp://dbpedia.org/resource/Effectiveness
p12873
aVhttp://dbpedia.org/resource/Organism
p12874
aVhttp://dbpedia.org/resource/Gentamicin
p12875
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12876
sg31
S'Semisynthetic derivative of kanamycin: less toxin than kanamycin; may be effective against organisms resistant to gentamicin and tobramycin.'
p12877
sg33
I12
sg34
S'Q110#10'
p12878
sg36
I21
sg37
S'10'
p12879
sg38
I1
sg39
S'110'
p12880
sa(dp12881
g3
(lp12882
(lp12883
Vhttp://dbpedia.org/resource/Penicillin
p12884
aa(lp12885
Vhttp://dbpedia.org/resource/Streptomycin
p12886
aa(lp12887
Vhttp://dbpedia.org/resource/Gentamicin
p12888
aVhttp://dbpedia.org/resource/Gentamicin
p12889
aasg18
(lp12890
Vpenicillin
p12891
aVstreptomycin
p12892
aVgentamicin (Garamycin)
p12893
aVtobramycin (Nebcin)
p12894
asg24
(lp12895
Vhttp://dbpedia.org/resource/Therapy
p12896
aVhttp://dbpedia.org/resource/Tuberculosis
p12897
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions3/amino1.htm'
p12898
sg31
S'Main use: second-line treatment of tuberculosis'
p12899
sg33
I10
sg34
S'Q110#11'
p12900
sg36
I7
sg37
S'11'
p12901
sg38
I1
sg39
S'110'
p12902
sa(dp12903
g3
(lp12904
(lp12905
Vhttp://dbpedia.org/resource/Infection
p12906
aVhttp://dbpedia.org/resource/Beta-lactamase
p12907
aVhttp://dbpedia.org/resource/Staphylococcus
p12908
aa(lp12909
Vhttp://dbpedia.org/resource/Bile_duct
p12910
aVhttp://dbpedia.org/resource/Secretion
p12911
aVhttp://dbpedia.org/resource/Patient
p12912
aVhttp://dbpedia.org/resource/Kidney
p12913
aasg18
(lp12914
Vlow cost
p12915
aVinfection by beta-lactamase-producing staphylococci
p12916
aVbiliary secretion for patients with renal disease
p12917
asg24
(lp12918
Vhttp://dbpedia.org/resource/Indication_%28medicine%29
p12919
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions4/ques4.htm'
p12920
sg31
S'Primary, possibly sole-indication for use of methicillin (Staphcillin), nafcillin (Nafcil, Unipen), and cloxacillin (Cloxapen):'
p12921
sg33
I13
sg34
S'Q111#6'
p12922
sg36
I25
sg37
S'6'
sg38
I1
sg39
S'111'
p12923
sa(dp12924
g3
(lp12925
(lp12926
Vhttp://dbpedia.org/resource/Penicillin
p12927
aVhttp://dbpedia.org/resource/The_Combination
p12928
aVhttp://dbpedia.org/resource/Aminoglycoside
p12929
aasg18
(lp12930
Vticarcillin (Ticar)
p12931
aVpiperacillin (Pipracil)
p12932
aVantipseudomonal penicillin in combination with an aminoglycoside
p12933
aVA and B
p12934
aVA,  B and C
p12935
asg24
(lp12936
Vhttp://dbpedia.org/resource/Pseudomonas
p12937
aVhttp://dbpedia.org/resource/Infection
p12938
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions4/ques4.htm'
p12939
sg31
S'Pseudomonal infections:'
p12940
sg33
I23
sg34
S'Q111#8'
p12941
sg36
I2
sg37
S'8'
sg38
I4
sg39
S'111'
p12942
sa(dp12943
g3
(lp12944
(lp12945
Vhttp://dbpedia.org/resource/Renal_failure
p12946
aa(lp12947
Vhttp://dbpedia.org/resource/Hypersensitivity
p12948
aa(lp12949
Vhttp://dbpedia.org/resource/Liver_failure
p12950
aa(lp12951
Vhttp://dbpedia.org/resource/Neutropenia
p12952
aasg18
(lp12953
Vrenal failure
p12954
aVcardiotoxicity
p12955
aVhypersensitivity reactions
p12956
aVhepatic failure
p12957
aVneutropenia
p12958
asg24
(lp12959
Vhttp://dbpedia.org/resource/Adverse_effect
p12960
aVhttp://dbpedia.org/resource/Penicillin
p12961
asg29
S'http://www.pharmacology2000.com/Antibacterial/questions4/ques4.htm'
p12962
sg31
S'Most serious adverse effect associated with penicillins:'
p12963
sg33
I8
sg34
S'Q111#9'
p12964
sg36
I7
sg37
S'9'
sg38
I2
sg39
S'111'
p12965
sa(dp12966
g3
(lp12967
(lp12968
Vhttp://dbpedia.org/resource/Ribavirin
p12969
aa(lp12970
Vhttp://dbpedia.org/resource/Interferon
p12971
aasg18
(lp12972
Vribavirin (Virazole,Rebetron)
p12973
aVinterferon
p12974
aVganciclovir (DHPG, Cytovene)
p12975
aVvidarabine (Vira-A)
p12976
asg24
(lp12977
Vhttp://dbpedia.org/resource/Group_selection
p12978
aVhttp://dbpedia.org/resource/Protein
p12979
aVhttp://dbpedia.org/resource/Exhibition
p12980
aVhttp://dbpedia.org/resource/Antiviral_drug
p12981
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p12982
sg31
S'Group of endogenous proteins that exhibit antiviral activities;'
p12983
sg33
I17
sg34
S'Q119#0'
p12984
sg36
I9
sg37
S'0'
sg38
I1
sg39
S'119'
p12985
sa(dp12986
g3
(lp12987
(lp12988
Vhttp://dbpedia.org/resource/Zidovudine
p12989
aVhttp://dbpedia.org/resource/Zidovudine
p12990
aVhttp://dbpedia.org/resource/Zidovudine
p12991
aVhttp://dbpedia.org/resource/Zidovudine
p12992
aasg18
(lp12993
Vfoscarnet (Foscavir)
p12994
aVzidovudine (Retrovir, AZT, azidothymidine)
p12995
aVamantidine (Symmetrel)
p12996
aVindinavir (Crixivan)
p12997
asg24
(lp12998
Vhttp://dbpedia.org/resource/Reverse_transcriptase
p12999
aVhttp://dbpedia.org/resource/Drug
p13000
aVhttp://dbpedia.org/resource/HIV
p13001
aVhttp://dbpedia.org/resource/Thymidine
p13002
aVhttp://dbpedia.org/resource/Structural_analog
p13003
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13004
sg31
S'First available reverse transcriptase drug for treatment of HIV-1; a deoxythymidine analogue'
p13005
sg33
I20
sg34
S'Q119#1'
p13006
sg36
I13
sg37
S'1'
sg38
I1
sg39
S'119'
p13007
sa(dp13008
g3
(lp13009
sg18
(lp13010
Vzalcitabine (Hivid, ddc)
p13011
aVtrifluridine (Viroptic)
p13012
aVdidanosine (Videx, ddI)
p13013
aVfoscarnet (Foscavir)
p13014
asg24
(lp13015
Vhttp://dbpedia.org/resource/Structural_analog
p13016
aVhttp://dbpedia.org/resource/Bioavailability
p13017
aVhttp://dbpedia.org/resource/HIV
p13018
aVhttp://dbpedia.org/resource/Reverse_transcriptase
p13019
aVhttp://dbpedia.org/resource/Zidovudine
p13020
aVhttp://dbpedia.org/resource/Clinical_trial
p13021
aVhttp://dbpedia.org/resource/Toxicity
p13022
aVhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p13023
aVhttp://dbpedia.org/resource/Pancreatitis
p13024
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13025
sg31
S'Synthetic analog of deoxyadenosine; active triphosphate form inhibits viral replication by competitively inhibiting HIV reverse transcriptase and by chain termination;may be prescribed concurrently with zidovudine or given as monotherapy; major clinical toxicity is a dose-dependent pancreatitis.'
p13026
sg33
I20
sg34
S'Q119#2'
p13027
sg36
I41
sg37
S'2'
sg38
I2
sg39
S'119'
p13028
sa(dp13029
g3
(lp13030
(lp13031
Vhttp://dbpedia.org/resource/Ribavirin
p13032
aasg18
(lp13033
Vrimantadine (Flumadine)
p13034
aVribavirin (Virazole,Rebetron)
p13035
aVsaquinavir (Invirase)
p13036
aVstavudine (Zerit, d4T)
p13037
asg24
(lp13038
Vhttp://dbpedia.org/resource/Protease_inhibitor_%28pharmacology%29
p13039
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13040
sg31
S'HIV protease inhibitor'
p13041
sg33
I20
sg34
S'Q119#4'
p13042
sg36
I3
sg37
S'4'
sg38
I2
sg39
S'119'
p13043
sa(dp13044
g3
(lp13045
(lp13046
Vhttp://dbpedia.org/resource/Zidovudine
p13047
aVhttp://dbpedia.org/resource/Zidovudine
p13048
aVhttp://dbpedia.org/resource/Zidovudine
p13049
aVhttp://dbpedia.org/resource/Zidovudine
p13050
aasg18
(lp13051
Vdidanosine (Videx, ddI)
p13052
aVzidovudine (Retrovir, AZT, azidothymidine)
p13053
aVzalcitabine (Hivid, ddc)
p13054
aVsaquinavir (Invirase)
p13055
asg24
(lp13056
Vhttp://dbpedia.org/resource/HIV
p13057
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13058
sg31
S'Most likely to cause additive myelosuppresion in an HIV patient also receiving ganciclovir for CMV retinitis:'
p13059
sg33
I24
sg34
S'Q119#6'
p13060
sg36
I16
sg37
S'6'
sg38
I1
sg39
S'119'
p13061
sa(dp13062
g3
(lp13063
sg18
(lp13064
Vamantidine (Symmetrel)
p13065
aVritonavir (Norvir)
p13066
aVdidanosine (Videx, ddI)
p13067
aVlamivudine (Epivir, 3TC)
p13068
asg24
(lp13069
Vhttp://dbpedia.org/resource/HIV
p13070
aVhttp://dbpedia.org/resource/Blood_serum
p13071
aVhttp://dbpedia.org/resource/Concentration
p13072
aVhttp://dbpedia.org/resource/Fluoxetine
p13073
aVhttp://dbpedia.org/resource/Fluoxetine
p13074
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13075
sg31
S'HIV drug treatment most likely to chang serum concentrations of fluoxetine (Prozac). '
p13076
sg33
I20
sg34
S'Q119#7'
p13077
sg36
I15
sg37
S'7'
sg38
I1
sg39
S'119'
p13078
sa(dp13079
g3
(lp13080
(lp13081
Vhttp://dbpedia.org/resource/Zidovudine
p13082
aVhttp://dbpedia.org/resource/Zidovudine
p13083
aVhttp://dbpedia.org/resource/Zidovudine
p13084
aVhttp://dbpedia.org/resource/Zidovudine
p13085
aa(lp13086
Vhttp://dbpedia.org/resource/Interferon
p13087
aa(lp13088
Vhttp://dbpedia.org/resource/Ribavirin
p13089
aasg18
(lp13090
Vzidovudine (Retrovir, AZT, azidothymidine)
p13091
aVacyclovir (Zovirax)
p13092
aVinterferon
p13093
aVribavirin (Virazole,Rebetron)
p13094
asg24
(lp13095
Vhttp://dbpedia.org/resource/Herpes_simplex_virus
p13096
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13097
sg31
S'Used to treat HSV:'
p13098
sg33
I19
sg34
S'Q119#8'
p13099
sg36
I4
sg37
S'8'
sg38
I1
sg39
S'119'
p13100
sa(dp13101
g3
(lp13102
sg18
(lp13103
Vritonavir (Norvir)
p13104
aVdidanosine (Videx, ddI)
p13105
aVindinavir (Crixivan)
p13106
aVsaquinavir (Invirase)
p13107
asg24
(lp13108
Vhttp://dbpedia.org/resource/HIV
p13109
asg29
S'http://www.pharmacology2000.com/Antiviral/questions4/virus2.htm'
p13110
sg31
S'HIV reverse transcriptase inhibitor'
p13111
sg33
I18
sg34
S'Q119#9'
p13112
sg36
I4
sg37
S'9'
sg38
I1
sg39
S'119'
p13113
sa(dp13114
g3
(lp13115
sg18
(lp13116
Vstavudine (Zerit, d4T)
p13117
aVefavirenz (EFV; Sustiva)
p13118
aVzalcitabine (Hivid, ddc)
p13119
aVindinavir (Crixivan)
p13120
asg24
(lp13121
Vhttp://dbpedia.org/resource/AIDS
p13122
asg29
S'http://www.pharmacology2000.com/Antiviral/questions5/virq5.htm'
p13123
sg31
S'Once daily anti-HIV/AIDS non-nucleoside reverse transcriptase inhibitor'
p13124
sg33
I22
sg34
S'Q120#0'
p13125
sg36
I7
sg37
S'0'
sg38
I1
sg39
S'120'
p13126
sa(dp13127
g3
(lp13128
(lp13129
Vhttp://dbpedia.org/resource/Zidovudine
p13130
aVhttp://dbpedia.org/resource/Zidovudine
p13131
aa(lp13132
Vhttp://dbpedia.org/resource/Zidovudine
p13133
aVhttp://dbpedia.org/resource/Zidovudine
p13134
aa(lp13135
Vhttp://dbpedia.org/resource/Zidovudine
p13136
aVhttp://dbpedia.org/resource/Zidovudine
p13137
aVhttp://dbpedia.org/resource/Zidovudine
p13138
aVhttp://dbpedia.org/resource/Zidovudine
p13139
aasg18
(lp13140
Vindinavir (Crixivan) + AZT (zidovudine) + ddI
p13141
aVAZT (zidovudine) + ddI
p13142
aVzidovudine (Retrovir, AZT, azidothymidine)
p13143
aVddC + 3TC
p13144
asg24
(lp13145
Vhttp://dbpedia.org/resource/HIV
p13146
asg29
S'http://www.pharmacology2000.com/Antiviral/questions5/virq5.htm'
p13147
sg31
S'Reasonable initial HIV treatment protocols'
p13148
sg33
I28
sg34
S'Q120#3'
p13149
sg36
I5
sg37
S'3'
sg38
I0
sg39
S'120'
p13150
sa(dp13151
g3
(lp13152
(lp13153
Vhttp://dbpedia.org/resource/Clindamycin
p13154
aVhttp://dbpedia.org/resource/Clindamycin
p13155
aa(lp13156
Vhttp://dbpedia.org/resource/Amphotericin_B
p13157
aVhttp://dbpedia.org/resource/Amphotericin_B
p13158
aVhttp://dbpedia.org/resource/Amphotericin_B
p13159
aa(lp13160
Vhttp://dbpedia.org/resource/Oral_rehydration_therapy
p13161
aVhttp://dbpedia.org/resource/Itraconazole
p13162
aVhttp://dbpedia.org/resource/Itraconazole
p13163
aasg18
(lp13164
Vclindamycin (Cleocin)
p13165
aVtrimethoprim-sulfamethoxazole (Bactrim)
p13166
aVamphotericin B (Fungizone, Amphotec) + flucytosine (Ancobon)
p13167
aVoral itraconazole (Sporanox)
p13168
asg24
(lp13169
Vhttp://dbpedia.org/resource/Acute_%28medicine%29
p13170
aVhttp://dbpedia.org/resource/Infection
p13171
aVhttp://dbpedia.org/resource/HIV
p13172
aVhttp://dbpedia.org/resource/Patient
p13173
asg29
S'http://www.pharmacology2000.com/Antiviral/questions5/virq5.htm'
p13174
sg31
S'Acute treatment of cryptococcal infections in HIV patients'
p13175
sg33
I25
sg34
S'Q120#6'
p13176
sg36
I8
sg37
S'6'
sg38
I2
sg39
S'120'
p13177
sa(dp13178
g3
(lp13179
sg18
(lp13180
Vacyclovir (Zovirax)
p13181
aVfamciclovir (Famvir)
p13182
aVvalacyclovir (Valtrex)
p13183
aVcidofovir (Vistide)
p13184
asg24
(lp13185
Vhttp://dbpedia.org/resource/Misuse_of_Drugs_Act_1971
p13186
aVhttp://dbpedia.org/resource/Bioavailability
p13187
aVhttp://dbpedia.org/resource/Musical_form
p13188
asg29
S'http://www.pharmacology2000.com/Antiviral/questions6/antiv6.htm'
p13189
sg31
S'First-pass metabolism of this drug results in the active form, penciclovir (Denavir):'
p13190
sg33
I16
sg34
S'Q121#2'
p13191
sg36
I16
sg37
S'2'
sg38
I1
sg39
S'121'
p13192
sa(dp13193
g3
(lp13194
sg18
(lp13195
Vganciclovir (DHPG, Cytovene)
p13196
aVfoscarnet (Foscavir)
p13197
aVcidofovir (Vistide)
p13198
aVvalacyclovir (Valtrex)
p13199
asg24
(lp13200
Vhttp://dbpedia.org/resource/Antiviral_drug
p13201
aVhttp://dbpedia.org/resource/Catalysis
p13202
aVhttp://dbpedia.org/resource/Virus
p13203
aVhttp://dbpedia.org/resource/Protein_kinase
p13204
aVhttp://dbpedia.org/resource/Cytomegalovirus
p13205
aVhttp://dbpedia.org/resource/Cell_%28biology%29
p13206
aVhttp://dbpedia.org/resource/Herpes_simplex_virus
p13207
aVhttp://dbpedia.org/resource/Cell_%28biology%29
p13208
asg29
S'http://www.pharmacology2000.com/Antiviral/questions6/antiv6.htm'
p13209
sg31
S'Monophosphorylation of this antiviral drug is catalyzed by virus-specified protein kinase phophotransferase in CMV-infected cells and by viral thymidine kinase in HSV-infected cells.'
p13210
sg33
I18
sg34
S'Q121#3'
p13211
sg36
I24
sg37
S'3'
sg38
I0
sg39
S'121'
p13212
sa(dp13213
g3
(lp13214
sg18
(lp13215
Vfoscarnet (Foscavir)
p13216
aVfamciclovir (Famvir)
p13217
aVcidofovir (Vistide)
p13218
aVvidarabine (Vira-A)
p13219
asg24
(lp13220
Vhttp://dbpedia.org/resource/Dose_%28biochemistry%29
p13221
aVhttp://dbpedia.org/resource/Toxicity
p13222
aVhttp://dbpedia.org/resource/Drug
p13223
aVhttp://dbpedia.org/resource/Dan_Blocker
p13224
asg29
S'http://www.pharmacology2000.com/Antiviral/questions6/antiv6.htm'
p13225
sg31
S' Nephrotoxicity, the major dose-limiting toxicity associated with i.v. use of this drug can be prevented by probenecid (Benemid) (a blocker of tubular secretion)'
p13226
sg33
I16
sg34
S'Q121#4'
p13227
sg36
I28
sg37
S'4'
sg38
I2
sg39
S'121'
p13228
sa(dp13229
g3
(lp13230
(lp13231
Vhttp://dbpedia.org/resource/Zidovudine
p13232
aVhttp://dbpedia.org/resource/Zidovudine
p13233
aVhttp://dbpedia.org/resource/Zidovudine
p13234
aVhttp://dbpedia.org/resource/Zidovudine
p13235
aasg18
(lp13236
Vvidarabine (Vira-A)
p13237
aVganciclovir (DHPG, Cytovene)
p13238
aVfoscarnet (Foscavir)
p13239
aVzidovudine (Retrovir, AZT, azidothymidine)
p13240
asg24
(lp13241
Vhttp://dbpedia.org/resource/Kidney
p13242
aVhttp://dbpedia.org/resource/Metabolite
p13243
aVhttp://dbpedia.org/resource/Antiviral_drug
p13244
aVhttp://dbpedia.org/resource/Effectiveness
p13245
aVhttp://dbpedia.org/resource/Topical
p13246
aVhttp://dbpedia.org/resource/Herpes_simplex_virus
p13247
aVhttp://dbpedia.org/resource/Encephalitis
p13248
asg29
S'http://www.pharmacology2000.com/Antiviral/questions6/antiv6.htm'
p13249
sg31
S'Mainly eliminated by renal mechanisms as the hypoxanthine metabolite, this antiviral agent is effective for treating acute keratoconjunctivitis (ointment) and HSV encephalitis (i.v.)'
p13250
sg33
I22
sg34
S'Q121#5'
p13251
sg36
I29
sg37
S'5'
sg38
I0
sg39
S'121'
p13252
sa(dp13253
g3
(lp13254
(lp13255
Vhttp://dbpedia.org/resource/Interferon
p13256
aasg18
(lp13257
Vinterferon
p13258
aVamantidine (Symmetrel)
p13259
aVdidanosine (Videx, ddI)
p13260
aVsaquinavir (Invirase)
p13261
asg24
(lp13262
Vhttp://dbpedia.org/resource/HIV
p13263
aVhttp://dbpedia.org/resource/Reverse_transcriptase
p13264
asg29
S'http://www.pharmacology2000.com/Antiviral/questions6/antiv6.htm'
p13265
sg31
S'Inhibition of viral replication by: (1) Competitive inhibition of HIV reverse transcriptase and (2) by chain termination.'
p13266
sg33
I15
sg34
S'Q121#6'
p13267
sg36
I23
sg37
S'6'
sg38
I2
sg39
S'121'
p13268
sa(dp13269
g3
(lp13270
(lp13271
Vhttp://dbpedia.org/resource/Zidovudine
p13272
aVhttp://dbpedia.org/resource/Zidovudine
p13273
aVhttp://dbpedia.org/resource/Zidovudine
p13274
aVhttp://dbpedia.org/resource/Zidovudine
p13275
aa(lp13276
Vhttp://dbpedia.org/resource/Interferon
p13277
aasg18
(lp13278
Vzidovudine (Retrovir, AZT, azidothymidine)
p13279
aVinterferon
p13280
aVamantidine (Symmetrel)
p13281
aVritonavir (Norvir)
p13282
asg24
(lp13283
Vhttp://dbpedia.org/resource/Protease_inhibitor_%28pharmacology%29
p13284
asg29
S'http://www.pharmacology2000.com/Antiviral/questions6/antiv6.htm'
p13285
sg31
S'HIV protease inhibitor'
p13286
sg33
I17
sg34
S'Q121#9'
p13287
sg36
I3
sg37
S'9'
sg38
I3
sg39
S'121'
p13288
sa(dp13289
g3
(lp13290
(lp13291
Vhttp://dbpedia.org/resource/Ketoconazole
p13292
aa(lp13293
Vhttp://dbpedia.org/resource/Amphotericin_B
p13294
aasg18
(lp13295
Vketoconazole
p13296
aVamphotericin B
p13297
aVflucytosine
p13298
aVgrisefulvin
p13299
aVclotrimazole
p13300
asg24
(lp13301
Vhttp://dbpedia.org/resource/Macrolide
p13302
aVhttp://dbpedia.org/resource/Fungus
p13303
aVhttp://dbpedia.org/resource/Ergosterol
p13304
aVhttp://dbpedia.org/resource/Cellular_%28film%29
p13305
aVhttp://dbpedia.org/resource/Permeability_%28earth_sciences%29
p13306
asg29
S'http://www.pharmacology2000.com/Antifungal/questions1/fung1.htm'
p13307
sg31
S'Antifungal polyene macrolide that preferentially binds to fungal ergosterol which alters cellular permeability.'
p13308
sg33
I6
sg34
S'Q122#0'
p13309
sg36
I14
sg37
S'0'
sg38
I1
sg39
S'122'
p13310
sa(dp13311
g3
(lp13312
(lp13313
Vhttp://dbpedia.org/resource/Nystatin
p13314
aa(lp13315
Vhttp://dbpedia.org/resource/Fluconazole
p13316
aasg18
(lp13317
Vmiconazole
p13318
aVterbinafine
p13319
aVnystatin
p13320
aVfluconazole
p13321
aVflucytosine
p13322
asg24
(lp13323
Vhttp://dbpedia.org/resource/Macrolide
p13324
aVhttp://dbpedia.org/resource/Topical
p13325
aVhttp://dbpedia.org/resource/Systemic_lupus_erythematosus
p13326
aVhttp://dbpedia.org/resource/Toxicity
p13327
aVhttp://dbpedia.org/resource/Bioavailability
p13328
aVhttp://dbpedia.org/resource/Suppression_of_the_Society_of_Jesus
p13329
aVhttp://dbpedia.org/resource/Local_government
p13330
aVhttp://dbpedia.org/resource/Candida_albicans
p13331
aVhttp://dbpedia.org/resource/Infection
p13332
asg29
S'http://www.pharmacology2000.com/Antifungal/questions1/fung1.htm'
p13333
sg31
S'Polyene macrolide only used topically, due to systemic toxicity; active against most Candida species--most commonly used for suppression of local candidal infection.'
p13334
sg33
I5
sg34
S'Q122#2'
p13335
sg36
I27
sg37
S'2'
sg38
I2
sg39
S'122'
p13336
sa(dp13337
g3
(lp13338
(lp13339
Vhttp://dbpedia.org/resource/Ketoconazole
p13340
aa(lp13341
Vhttp://dbpedia.org/resource/Itraconazole
p13342
aa(lp13343
Vhttp://dbpedia.org/resource/Fluconazole
p13344
aasg18
(lp13345
Vketoconazole
p13346
aVitraconazole
p13347
aVfluconazole
p13348
asg24
(lp13349
Vhttp://dbpedia.org/resource/Ketoconazole
p13350
aVhttp://dbpedia.org/resource/Itraconazole
p13351
aVhttp://dbpedia.org/resource/Fluconazole
p13352
asg29
S'http://www.pharmacology2000.com/Antifungal/questions1/fung1.htm'
p13353
sg31
S'Of ketoconazole, itraconazole, and fluconazole--most likely to cause increased arrhythmogenic effects of astemizole or terphidine'
p13354
sg33
I3
sg34
S'Q122#3'
p13355
sg36
I19
sg37
S'3'
sg38
I0
sg39
S'122'
p13356
sa(dp13357
g3
(lp13358
(lp13359
Vhttp://dbpedia.org/resource/Fluconazole
p13360
aa(lp13361
Vhttp://dbpedia.org/resource/Itraconazole
p13362
aa(lp13363
Vhttp://dbpedia.org/resource/Ketoconazole
p13364
aasg18
(lp13365
Vfluconazole
p13366
aVitraconazole
p13367
aVketoconazole
p13368
asg24
(lp13369
Vhttp://dbpedia.org/resource/Potency_%28pharmacology%29
p13370
asg29
S'http://www.pharmacology2000.com/Antifungal/questions1/fung1.htm'
p13371
sg31
S'Most potent of the presently available anti-fungal azoles:'
p13372
sg33
I3
sg34
S'Q122#6'
p13373
sg36
I8
sg37
S'6'
sg38
I1
sg39
S'122'
p13374
sa(dp13375
g3
(lp13376
(lp13377
Vhttp://dbpedia.org/resource/Ketoconazole
p13378
aa(lp13379
Vhttp://dbpedia.org/resource/Itraconazole
p13380
aa(lp13381
Vhttp://dbpedia.org/resource/Fluconazole
p13382
aasg18
(lp13383
Vketoconazole
p13384
aVitraconazole
p13385
aVfluconazole
p13386
asg24
(lp13387
Vhttp://dbpedia.org/resource/Cerebrospinal_fluid
p13388
aVhttp://dbpedia.org/resource/California_Scholarship_Federation
p13389
asg29
S'http://www.pharmacology2000.com/Antifungal/questions1/fung1.htm'
p13390
sg31
S'Azole most likely to get into the cerebral spinal fluid (CSF):'
p13391
sg33
I3
sg34
S'Q122#7'
p13392
sg36
I14
sg37
S'7'
sg38
I2
sg39
S'122'
p13393
sa(dp13394
g3
(lp13395
(lp13396
Vhttp://dbpedia.org/resource/Ketoconazole
p13397
aa(lp13398
Vhttp://dbpedia.org/resource/Itraconazole
p13399
aa(lp13400
Vhttp://dbpedia.org/resource/Amphotericin_B
p13401
aa(lp13402
Vhttp://dbpedia.org/resource/Nystatin
p13403
aasg18
(lp13404
Vketoconazole
p13405
aVitraconazole
p13406
aVflucytosine
p13407
aVamphotericin B
p13408
aVnystatin
p13409
asg24
(lp13410
Vhttp://dbpedia.org/resource/Administration_%28government%29
p13411
aVhttp://dbpedia.org/resource/Drug
p13412
aVhttp://dbpedia.org/resource/Life
p13413
aVhttp://dbpedia.org/resource/Infection
p13414
aVhttp://dbpedia.org/resource/Inductive_reasoning
p13415
asg29
S'http://www.pharmacology2000.com/Antifungal/questions1/fung1.htm'
p13416
sg31
S'Given by i.v. administration, the drug of choice for nearly all life-threatening mycotic infections--usually used as the initial induction regimen'
p13417
sg33
I6
sg34
S'Q122#8'
p13418
sg36
I23
sg37
S'8'
sg38
I3
sg39
S'122'
p13419
sa(dp13420
g3
(lp13421
(lp13422
Vhttp://dbpedia.org/resource/Platelet
p13423
aa(lp13424
Vhttp://dbpedia.org/resource/Redox
p13425
aVhttp://dbpedia.org/resource/Blood_flow
p13426
aa(lp13427
Vhttp://dbpedia.org/resource/Plasmodium_falciparum
p13428
aVhttp://dbpedia.org/resource/Parasitism
p13429
aVhttp://dbpedia.org/resource/Vascular
p13430
aVhttp://dbpedia.org/resource/Epithelium
p13431
aa(lp13432
Vhttp://dbpedia.org/resource/Plasmodium_falciparum
p13433
aVhttp://dbpedia.org/resource/Parasitism
p13434
aVhttp://dbpedia.org/resource/Thrombocytopenia
p13435
aa(lp13436
Vhttp://dbpedia.org/resource/Plasmodium_falciparum
p13437
aVhttp://dbpedia.org/resource/Parasitism
p13438
aVhttp://dbpedia.org/resource/Polycythemia_vera
p13439
aasg18
(lp13440
Vincreased platelet count
p13441
aVreduced blood flow
p13442
aVstickiness of falciparum parasites to the vascular epithelium
p13443
aVfalciparum parasite-induced thrombocytopenic purpura
p13444
aVfalciparum parasite induced polycythemia vera
p13445
asg24
(lp13446
Vhttp://dbpedia.org/resource/Brain
p13447
aVhttp://dbpedia.org/resource/Organ_%28anatomy%29
p13448
aVhttp://dbpedia.org/resource/Plasmodium_falciparum
p13449
aVhttp://dbpedia.org/resource/Parasitism
p13450
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13451
sg31
S'Microhemorrhages in the brain and other organs associated with Falciparum parasites mainly due to:'
p13452
sg33
I23
sg34
S'Q126#0'
p13453
sg36
I14
sg37
S'0'
sg38
I2
sg39
S'126'
p13454
sa(dp13455
g3
(lp13456
(lp13457
Vhttp://dbpedia.org/resource/Blood_transfusion
p13458
aa(lp13459
Vhttp://dbpedia.org/resource/Traveller_%28role-playing_game%29
p13460
aasg18
(lp13461
Vtransfusion recipients
p13462
aVtravelers
p13463
aVIV drug users
p13464
asg24
(lp13465
Vhttp://dbpedia.org/resource/United_States
p13466
aVhttp://dbpedia.org/resource/Case_Western_Reserve_University
p13467
aVhttp://dbpedia.org/resource/Malaria
p13468
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13469
sg31
S'Most U.S. cases of malaria are found in:'
p13470
sg33
I6
sg34
S'Q126#2'
p13471
sg36
I8
sg37
S'2'
sg38
I1
sg39
S'126'
p13472
sa(dp13473
g3
(lp13474
(lp13475
Vhttp://dbpedia.org/resource/Plasmodium_falciparum
p13476
aa(lp13477
Vhttp://dbpedia.org/resource/Plasmodium_vivax
p13478
aasg18
(lp13479
VPlasmodium malariae
p13480
aVPlasmodium falciparum
p13481
aVPlasmodium vivax
p13482
aVPlasmodium ovale
p13483
asg24
(lp13484
Vhttp://dbpedia.org/resource/Species
p13485
aVhttp://dbpedia.org/resource/Plasmodium
p13486
aVhttp://dbpedia.org/resource/Species
p13487
aVhttp://dbpedia.org/resource/Causative
p13488
aVhttp://dbpedia.org/resource/Human_%28Dungeons_&_Dragons%29
p13489
aVhttp://dbpedia.org/resource/Malaria
p13490
aVhttp://dbpedia.org/resource/Complication_%28medicine%29
p13491
aVhttp://dbpedia.org/resource/Death_%28Discworld%29
p13492
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13493
sg31
S'Of about 156 species of plasmodium,this species, causative of human malaria, produces the most serious complications, including death:'
p13494
sg33
I8
sg34
S'Q126#4'
p13495
sg36
I23
sg37
S'4'
sg38
I1
sg39
S'126'
p13496
sa(dp13497
g3
(lp13498
(lp13499
Vhttp://dbpedia.org/resource/Common_cold
p13500
aVhttp://dbpedia.org/resource/Phase_%28waves%29
p13501
aVhttp://dbpedia.org/resource/Hot_%28Israel%29
p13502
aVhttp://dbpedia.org/resource/Phase_%28waves%29
p13503
aa(lp13504
Vhttp://dbpedia.org/resource/Viral_video
p13505
aVhttp://dbpedia.org/resource/48_Hours_%28TV_series%29
p13506
aVhttp://dbpedia.org/resource/Major_%28United_States%29
p13507
aVhttp://dbpedia.org/resource/Symptom
p13508
aa(lp13509
Vhttp://dbpedia.org/resource/Direct_current
p13510
aVhttp://dbpedia.org/resource/Observation
p13511
aVhttp://dbpedia.org/resource/Parasitism
p13512
aVhttp://dbpedia.org/resource/Thin_Lizzy
p13513
aa(lp13514
Vhttp://dbpedia.org/resource/Patient
p13515
aVhttp://dbpedia.org/resource/Drug
p13516
aVhttp://dbpedia.org/resource/Travel
p13517
aasg18
(lp13518
Vpresence of both cold phase & hot phase
p13519
aVmild, "viral"-like prodrome preceding by  24-48 hours major symptoms
p13520
aVdirect observation of intraerythrocytic parasites in thick/thin smears
p13521
aVthe patient has or has not taken prophylactic drugs during travel
p13522
asg24
(lp13523
Vhttp://dbpedia.org/resource/Diagnosis
p13524
aVhttp://dbpedia.org/resource/Malaria
p13525
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13526
sg31
S'Definitive diagnosis of malaria:'
p13527
sg33
I40
sg34
S'Q126#7'
p13528
sg36
I4
sg37
S'7'
sg38
I2
sg39
S'126'
p13529
sa(dp13530
g3
(lp13531
(lp13532
Vhttp://dbpedia.org/resource/Day
p13533
aa(lp13534
Vhttp://dbpedia.org/resource/Day
p13535
aasg18
(lp13536
V1-2 days
p13537
aV8-10 days
p13538
aVthree weeks
p13539
aVsix weeks
p13540
asg24
(lp13541
Vhttp://dbpedia.org/resource/Malaria
p13542
aVhttp://dbpedia.org/resource/Incubation_period
p13543
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13544
sg31
S'Malaria-incubation period'
p13545
sg33
I8
sg34
S'Q126#8'
p13546
sg36
I2
sg37
S'8'
sg38
I1
sg39
S'126'
p13547
sa(dp13548
g3
(lp13549
(lp13550
Vhttp://dbpedia.org/resource/Plasmodium_falciparum
p13551
aasg18
(lp13552
VP vivax &  P ovale
p13553
aVP falciparum & P.  malariae
p13554
aVall four species
p13555
asg24
(lp13556
Vhttp://dbpedia.org/resource/Parasitism
p13557
aVhttp://dbpedia.org/resource/Liver
p13558
aVhttp://dbpedia.org/resource/Red_blood_cell
p13559
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13560
sg31
S'Treatment must eliminate parasites from both liver erythrocytes:'
p13561
sg33
I13
sg34
S'Q126#16'
p13562
sg36
I8
sg37
S'16'
p13563
sg38
I0
sg39
S'126'
p13564
sa(dp13565
g3
(lp13566
sg18
(lp13567
Vmitotic spindle inhibitors
p13568
aVDNA gyrase inhibitors
p13569
aVdihydrofolate reductase inhibitors
p13570
asg24
(lp13571
Vhttp://dbpedia.org/resource/Biological_classification
p13572
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13573
sg31
S'Antimalarial drug classification:'
p13574
sg33
I9
sg34
S'Q126#17'
p13575
sg36
I3
sg37
S'17'
p13576
sg38
I2
sg39
S'126'
p13577
sa(dp13578
g3
(lp13579
sg18
(lp13580
Vpyrimethamine (Daraprim)
p13581
aVsulfadiazine
p13582
aVdoxycycline (Vibramycin, Doryx)
p13583
aVmefloquine (Lariam)
p13584
asg24
(lp13585
Vhttp://dbpedia.org/resource/Doxycycline
p13586
aVhttp://dbpedia.org/resource/Doxycycline
p13587
aVhttp://dbpedia.org/resource/Doxycycline
p13588
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions2/questionset2.htm'
p13589
sg31
S'An example of a 4-aminoquinoline antimalarial drug:'
p13590
sg33
I15
sg34
S'Q126#18'
p13591
sg36
I7
sg37
S'18'
p13592
sg38
I3
sg39
S'126'
p13593
sa(dp13594
g3
(lp13595
(lp13596
Vhttp://dbpedia.org/resource/Dog
p13597
aa(lp13598
Vhttp://dbpedia.org/resource/Rodent
p13599
aa(lp13600
Vhttp://dbpedia.org/resource/Bird
p13601
aa(lp13602
Vhttp://dbpedia.org/resource/Cat
p13603
aa(lp13604
Vhttp://dbpedia.org/resource/Mosquito
p13605
aasg18
(lp13606
Vdogs
p13607
aVrodents
p13608
aVbirds
p13609
aVcats
p13610
aVmosquitoes
p13611
asg24
(lp13612
Vhttp://dbpedia.org/resource/Host_%28biology%29
p13613
aVhttp://dbpedia.org/resource/Stage_%28theatre%29
p13614
aVhttp://dbpedia.org/resource/Toxoplasma_gondii
p13615
aVhttp://dbpedia.org/resource/Toxoplasmosis
p13616
aVhttp://dbpedia.org/resource/Toxoplasma_gondii
p13617
aVhttp://dbpedia.org/resource/Main_Page
p13618
aVhttp://dbpedia.org/resource/Resource
p13619
aVhttp://dbpedia.org/resource/Infection
p13620
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions4/questionset4.htm'
p13621
sg31
S'Only known definitive host for the sexual stages of T. gondii (Toxoplasmosis gondii)-main resource of infection'
p13622
sg33
I5
sg34
S'Q127#5'
p13623
sg36
I19
sg37
S'5'
sg38
I3
sg39
S'127'
p13624
sa(dp13625
g3
(lp13626
(lp13627
Vhttp://dbpedia.org/resource/Activity_%28chemistry%29
p13628
aVhttp://dbpedia.org/resource/Plasmodium_falciparum
p13629
aVhttp://dbpedia.org/resource/Species
p13630
aa(lp13631
Vhttp://dbpedia.org/resource/Bioavailability
p13632
aVhttp://dbpedia.org/resource/Liver
p13633
aVhttp://dbpedia.org/resource/Time
p13634
aa(lp13635
Vhttp://dbpedia.org/resource/Rapid
p13636
aa(lp13637
Vhttp://dbpedia.org/resource/Minimalism
p13638
aVhttp://dbpedia.org/resource/Side_effect
p13639
aasg18
(lp13640
VBlood schizonticidal activity against P falciparum (some species)
p13641
aVSignificant effects against blood schizonts of P vivax
p13642
aVActive against immunocytes or liver stages of P falciparumor P vivax
p13643
aVrapid onset of action
p13644
aVminimal side effects
p13645
asg24
(lp13646
Vhttp://dbpedia.org/resource/Sulfonamide_%28medicine%29
p13647
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p13648
asg29
S'http://www.pharmacology2000.com/Antiparasitic/questions4/questionset4.htm'
p13649
sg31
S'Concerning sulfonamides & sulfones and antimalarial activity: the'
p13650
sg33
I36
sg34
S'Q127#9'
p13651
sg36
I9
sg37
S'9'
sg38
I0
sg39
S'127'
p13652
sa(dp13653
g3
(lp13654
(lp13655
Vhttp://dbpedia.org/resource/Metamorphosis
p13656
aa(lp13657
Vhttp://dbpedia.org/resource/Hemostasis
p13658
aa(lp13659
Vhttp://dbpedia.org/resource/Fibrinolysis
p13660
aa(lp13661
Vhttp://dbpedia.org/resource/Coagulation
p13662
aasg18
(lp13663
Vvasospasm
p13664
aVviscous metamorphosis
p13665
aVhemostasis
p13666
aVfibrinolysis
p13667
aVcoagulation
p13668
asg24
(lp13669
Vhttp://dbpedia.org/resource/Spontaneous_generation
p13670
aVhttp://dbpedia.org/resource/Bleeding
p13671
aVhttp://dbpedia.org/resource/Blood_vessel
p13672
asg29
S'http://www.pharmacology2000.com/Coagulation/question1/questionset1.htm'
p13673
sg31
S'Spontaneous arresting of bleeding from blood vessel:'
p13674
sg33
I6
sg34
S'Q129#0'
p13675
sg36
I7
sg37
S'0'
sg38
I2
sg39
S'129'
p13676
sa(dp13677
g3
(lp13678
(lp13679
Vhttp://dbpedia.org/resource/Platelet
p13680
aa(lp13681
Vhttp://dbpedia.org/resource/Fibrinolysis
p13682
aa(lp13683
Vhttp://dbpedia.org/resource/Platelet
p13684
aVhttp://dbpedia.org/resource/Adhesion
p13685
aasg18
(lp13686
Vvasospasm
p13687
aVplatelet aggregation
p13688
aVfibrinolysis
p13689
aVplatelet adhesion
p13690
asg24
(lp13691
Vhttp://dbpedia.org/resource/Platelet
p13692
aVhttp://dbpedia.org/resource/Damage_%28comics%29
p13693
aVhttp://dbpedia.org/resource/Blood_vessel
p13694
aVhttp://dbpedia.org/resource/Collagen
p13695
asg29
S'http://www.pharmacology2000.com/Coagulation/question1/questionset1.htm'
p13696
sg31
S'Platelet sticking to exposed damage blood vessel collagen:'
p13697
sg33
I6
sg34
S'Q129#1'
p13698
sg36
I8
sg37
S'1'
sg38
I3
sg39
S'129'
p13699
sa(dp13700
g3
(lp13701
(lp13702
Vhttp://dbpedia.org/resource/Crohn%27s_disease
p13703
aa(lp13704
Vhttp://dbpedia.org/resource/Myocardial_infarction
p13705
aa(lp13706
Vhttp://dbpedia.org/resource/Wilson%27s_disease
p13707
aa(lp13708
Vhttp://dbpedia.org/resource/Factor_IX
p13709
aasg18
(lp13710
VCrohn\u005c
p13711
aVmyocardial infarction
p13712
aVabruptio placentae
p13713
aVWilson\u005c
p13714
aVChristmas factor deficiency
p13715
asg24
(lp13716
Vhttp://dbpedia.org/resource/Disseminated_intravascular_coagulation
p13717
aVhttp://dbpedia.org/resource/Disseminated_intravascular_coagulation
p13718
asg29
S'http://www.pharmacology2000.com/Coagulation/question1/questionset1.htm'
p13719
sg31
S'Expectable cause of disseminated intravascular coagulation (DIC):'
p13720
sg33
I9
sg34
S'Q129#7'
p13721
sg36
I10
sg37
S'7'
sg38
I2
sg39
S'129'
p13722
sa(dp13723
g3
(lp13724
(lp13725
Vhttp://dbpedia.org/resource/Tissue_plasminogen_activator
p13726
aasg18
(lp13727
Vt-PA
p13728
aVurokinase
p13729
aVstreptokinase
p13730
aVaminocaproic acid
p13731
asg24
(lp13732
Vhttp://dbpedia.org/resource/Fibrinolysis
p13733
asg29
S'http://www.pharmacology2000.com/Coagulation/question1/questionset1.htm'
p13734
sg31
S'Inhibitor of fibrinolysis'
p13735
sg33
I5
sg34
S'Q129#8'
p13736
sg36
I3
sg37
S'8'
sg38
I3
sg39
S'129'
p13737
sa(dp13738
g3
(lp13739
(lp13740
Vhttp://dbpedia.org/resource/Factor_IX
p13741
aa(lp13742
Vhttp://dbpedia.org/resource/Factor_X
p13743
aasg18
(lp13744
Vplasminogen
p13745
aVproaccelerin
p13746
aVplasmin
p13747
aVChristmas factor
p13748
aVStuart-Prower factor
p13749
asg24
(lp13750
Vhttp://dbpedia.org/resource/Thrombosis
p13751
aVhttp://dbpedia.org/resource/Proteolysis
p13752
aVhttp://dbpedia.org/resource/Fibrin
p13753
aVhttp://dbpedia.org/resource/Digestion
p13754
asg29
S'http://www.pharmacology2000.com/Coagulation/question1/questionset1.htm'
p13755
sg31
S'Limits thrombosis extension by proteolytic fibrin digestion:'
p13756
sg33
I7
sg34
S'Q129#9'
p13757
sg36
I7
sg37
S'9'
sg38
I2
sg39
S'129'
p13758
sa(dp13759
g3
(lp13760
(lp13761
Vhttp://dbpedia.org/resource/Air_Corps_Tactical_School
p13762
aVhttp://dbpedia.org/resource/Platelet
p13763
aa(lp13764
Vhttp://dbpedia.org/resource/Preventive_medicine
p13765
aVhttp://dbpedia.org/resource/Deep_vein_thrombosis
p13766
aVhttp://dbpedia.org/resource/Hip_replacement
p13767
aasg18
(lp13768
Vhigh-molecular-weight heparin fraction
p13769
aVacts by preventing platelet degranulation
p13770
aVprimary prevention of deep venous thrombosis after hip replacement surgery
p13771
asg24
(lp13772
Vhttp://dbpedia.org/resource/Molecule
p13773
aVhttp://dbpedia.org/resource/Weight
p13774
aVhttp://dbpedia.org/resource/Heparin
p13775
asg29
S'http://www.pharmacology2000.com/Coagulation/question2/questionset2.htm'
p13776
sg31
S'Enoxaparin:'
p13777
sg33
I18
sg34
S'Q130#0'
p13778
sg36
I1
sg37
S'0'
sg38
I2
sg39
S'130'
p13779
sa(dp13780
g3
(lp13781
(lp13782
Vhttp://dbpedia.org/resource/Osteoporosis
p13783
aa(lp13784
Vhttp://dbpedia.org/resource/Alopecia
p13785
aa(lp13786
Vhttp://dbpedia.org/resource/Bleeding
p13787
aa(lp13788
Vhttp://dbpedia.org/resource/Spontaneous_combustion
p13789
aVhttp://dbpedia.org/resource/Fracture
p13790
aa(lp13791
Vhttp://dbpedia.org/resource/Redox
p13792
aVhttp://dbpedia.org/resource/Renal_function
p13793
aasg18
(lp13794
Vosteoporosis
p13795
aValopecia
p13796
aVbleeding
p13797
aVspontaneous fractures
p13798
aVreduced glomerular filtration
p13799
asg24
(lp13800
Vhttp://dbpedia.org/resource/Adverse_effect
p13801
aVhttp://dbpedia.org/resource/Heparin
p13802
asg29
S'http://www.pharmacology2000.com/Coagulation/question2/questionset2.htm'
p13803
sg31
S'Major adverse effect of heparin:'
p13804
sg33
I8
sg34
S'Q130#1'
p13805
sg36
I5
sg37
S'1'
sg38
I2
sg39
S'130'
p13806
sa(dp13807
g3
(lp13808
(lp13809
Vhttp://dbpedia.org/resource/Heparin
p13810
aasg18
(lp13811
Vheparin
p13812
aVenoxaparin
p13813
aVdalteparin and danaproid
p13814
asg24
(lp13815
Vhttp://dbpedia.org/resource/ANTI-
p13816
aVhttp://dbpedia.org/resource/Factor_X
p13817
aVhttp://dbpedia.org/resource/Unit_%28ring_theory%29
p13818
asg29
S'http://www.pharmacology2000.com/Coagulation/question2/questionset2.htm'
p13819
sg31
S'Specified in anti-factor Xa units:'
p13820
sg33
I5
sg34
S'Q130#4'
p13821
sg36
I5
sg37
S'4'
sg38
I2
sg39
S'130'
p13822
sa(dp13823
g3
(lp13824
(lp13825
Vhttp://dbpedia.org/resource/Fibrinogen
p13826
aa(lp13827
Vhttp://dbpedia.org/resource/Platelet
p13828
aa(lp13829
Vhttp://dbpedia.org/resource/Tissue_plasminogen_activator
p13830
aasg18
(lp13831
Vfibrinogen
p13832
aVplatelets
p13833
aVantithrombin III
p13834
aVaminocaproic acid
p13835
aVtissue plasminogen activator
p13836
asg24
(lp13837
Vhttp://dbpedia.org/resource/Heparin
p13838
aVhttp://dbpedia.org/resource/Biological_activity
p13839
asg29
S'http://www.pharmacology2000.com/Coagulation/question2/questionset2.htm'
p13840
sg31
S'Heparin biological activity depends most directly on:'
p13841
sg33
I9
sg34
S'Q130#5'
p13842
sg36
I7
sg37
S'5'
sg38
I2
sg39
S'130'
p13843
sa(dp13844
g3
(lp13845
(lp13846
Vhttp://dbpedia.org/resource/Warfarin
p13847
aVhttp://dbpedia.org/resource/Cross
p13848
aVhttp://dbpedia.org/resource/Placenta
p13849
aa(lp13850
Vhttp://dbpedia.org/resource/Ossification
p13851
aa(lp13852
Vhttp://dbpedia.org/resource/Limited_company
p13853
aVhttp://dbpedia.org/resource/Warfarin
p13854
aVhttp://dbpedia.org/resource/Fetus
p13855
aasg18
(lp13856
Vnone-Warfarin does not cross the placental barrier
p13857
aVcauses abnormal bone formation
p13858
aVdespite limited Warfarin effects on the fetus, it may be used at low dosages
p13859
asg24
(lp13860
Vhttp://dbpedia.org/resource/Warfarin
p13861
aVhttp://dbpedia.org/resource/Fetus
p13862
asg29
S'http://www.pharmacology2000.com/Coagulation/question2/questionset2.htm'
p13863
sg31
S'Warfarin effects on the fetus:'
p13864
sg33
I26
sg34
S'Q130#9'
p13865
sg36
I5
sg37
S'9'
sg38
I1
sg39
S'130'
p13866
sa(dp13867
g3
(lp13868
(lp13869
Vhttp://dbpedia.org/resource/Air_Corps_Tactical_School
p13870
aVhttp://dbpedia.org/resource/Platelet
p13871
aa(lp13872
Vhttp://dbpedia.org/resource/Preventive_medicine
p13873
aVhttp://dbpedia.org/resource/Deep_vein_thrombosis
p13874
aVhttp://dbpedia.org/resource/Hip_replacement
p13875
aasg18
(lp13876
Vhigh-molecular-weight heparin fraction
p13877
aVacts by preventing platelet degranulation
p13878
aVprimary prevention of deep venous thrombosis after hip replacement surgery
p13879
asg24
(lp13880
Vhttp://dbpedia.org/resource/Molecule
p13881
aVhttp://dbpedia.org/resource/Weight
p13882
aVhttp://dbpedia.org/resource/Heparin
p13883
asg29
S'http://www.pharmacology2000.com/Coagulation/question3/questionset3.htm'
p13884
sg31
S'Enoxaparin:'
p13885
sg33
I18
sg34
S'Q131#0'
p13886
sg36
I1
sg37
S'0'
sg38
I2
sg39
S'131'
p13887
sa(dp13888
g3
(lp13889
(lp13890
Vhttp://dbpedia.org/resource/Osteoporosis
p13891
aa(lp13892
Vhttp://dbpedia.org/resource/Alopecia
p13893
aa(lp13894
Vhttp://dbpedia.org/resource/Bleeding
p13895
aa(lp13896
Vhttp://dbpedia.org/resource/Spontaneous_combustion
p13897
aVhttp://dbpedia.org/resource/Fracture
p13898
aa(lp13899
Vhttp://dbpedia.org/resource/Redox
p13900
aVhttp://dbpedia.org/resource/Renal_function
p13901
aasg18
(lp13902
Vosteoporosis
p13903
aValopecia
p13904
aVbleeding
p13905
aVspontaneous fractures
p13906
aVreduced glomerular filtration
p13907
asg24
(lp13908
Vhttp://dbpedia.org/resource/Adverse_effect
p13909
aVhttp://dbpedia.org/resource/Heparin
p13910
asg29
S'http://www.pharmacology2000.com/Coagulation/question3/questionset3.htm'
p13911
sg31
S'Major adverse effect of heparin:'
p13912
sg33
I8
sg34
S'Q131#1'
p13913
sg36
I5
sg37
S'1'
sg38
I2
sg39
S'131'
p13914
sa(dp13915
g3
(lp13916
(lp13917
Vhttp://dbpedia.org/resource/Heparin
p13918
aasg18
(lp13919
Vheparin
p13920
aVenoxaparin
p13921
aVdalteparin and danaproid
p13922
asg24
(lp13923
Vhttp://dbpedia.org/resource/ANTI-
p13924
aVhttp://dbpedia.org/resource/Factor_X
p13925
aVhttp://dbpedia.org/resource/Unit_%28ring_theory%29
p13926
asg29
S'http://www.pharmacology2000.com/Coagulation/question3/questionset3.htm'
p13927
sg31
S'Specified in anti-factor Xa units:'
p13928
sg33
I5
sg34
S'Q131#4'
p13929
sg36
I5
sg37
S'4'
sg38
I2
sg39
S'131'
p13930
sa(dp13931
g3
(lp13932
(lp13933
Vhttp://dbpedia.org/resource/Fibrinogen
p13934
aa(lp13935
Vhttp://dbpedia.org/resource/Platelet
p13936
aa(lp13937
Vhttp://dbpedia.org/resource/Tissue_plasminogen_activator
p13938
aasg18
(lp13939
Vfibrinogen
p13940
aVplatelets
p13941
aVantithrombin III
p13942
aVaminocaproic acid
p13943
aVtissue plasminogen activator
p13944
asg24
(lp13945
Vhttp://dbpedia.org/resource/Heparin
p13946
aVhttp://dbpedia.org/resource/Biological_activity
p13947
asg29
S'http://www.pharmacology2000.com/Coagulation/question3/questionset3.htm'
p13948
sg31
S'Heparin biological activity depends most directly on:'
p13949
sg33
I9
sg34
S'Q131#5'
p13950
sg36
I7
sg37
S'5'
sg38
I2
sg39
S'131'
p13951
sa(dp13952
g3
(lp13953
(lp13954
Vhttp://dbpedia.org/resource/Warfarin
p13955
aVhttp://dbpedia.org/resource/Cross
p13956
aVhttp://dbpedia.org/resource/Placenta
p13957
aa(lp13958
Vhttp://dbpedia.org/resource/Ossification
p13959
aa(lp13960
Vhttp://dbpedia.org/resource/Limited_company
p13961
aVhttp://dbpedia.org/resource/Warfarin
p13962
aVhttp://dbpedia.org/resource/Fetus
p13963
aasg18
(lp13964
Vnone-Warfarin does not cross the placental barrier
p13965
aVcauses abnormal bone formation
p13966
aVdespite limited Warfarin effects on the fetus, it may be used at low dosages
p13967
asg24
(lp13968
Vhttp://dbpedia.org/resource/Warfarin
p13969
aVhttp://dbpedia.org/resource/Fetus
p13970
asg29
S'http://www.pharmacology2000.com/Coagulation/question3/questionset3.htm'
p13971
sg31
S'Warfarin effects on the fetus:'
p13972
sg33
I26
sg34
S'Q131#9'
p13973
sg36
I5
sg37
S'9'
sg38
I1
sg39
S'131'
p13974
sa(dp13975
g3
(lp13976
(lp13977
Vhttp://dbpedia.org/resource/Aspirin
p13978
aasg18
(lp13979
Vcryoprecipitate
p13980
aVtranexamic acid
p13981
aVdesmopressin acetate
p13982
aVurokinase
p13983
aVaspirin
p13984
asg24
(lp13985
Vhttp://dbpedia.org/resource/Factor_VIII
p13986
aVhttp://dbpedia.org/resource/Factor_VIII
p13987
aVhttp://dbpedia.org/resource/Activity_%28chemistry%29
p13988
aVhttp://dbpedia.org/resource/Patient
p13989
aVhttp://dbpedia.org/resource/Mild_ale
p13990
asg29
S'http://www.pharmacology2000.com/Coagulation/question4/questionset4.htm'
p13991
sg31
S'Not factor VIII, but increases factor VIII activity in patients with mild hemophilia A:'
p13992
sg33
I7
sg34
S'Q132#0'
p13993
sg36
I15
sg37
S'0'
sg38
I2
sg39
S'132'
p13994
sa(dp13995
g3
(lp13996
(lp13997
Vhttp://dbpedia.org/resource/Tissue_plasminogen_activator
p13998
aasg18
(lp13999
Valteplase
p14000
aVreteplase
p14001
aVanistreplase
p14002
aVdicumarol
p14003
aVprotamine sulfate
p14004
asg24
(lp14005
Vhttp://dbpedia.org/resource/Coordination_complex
p14006
aVhttp://dbpedia.org/resource/Bacteria
p14007
asg29
S'http://www.pharmacology2000.com/Coagulation/question4/questionset4.htm'
p14008
sg31
S'Complex of purified human plasminogen and bacterial streptokinase'
p14009
sg33
I6
sg34
S'Q132#1'
p14010
sg36
I8
sg37
S'1'
sg38
I2
sg39
S'132'
p14011
sa(dp14012
g3
(lp14013
(lp14014
Vhttp://dbpedia.org/resource/Adenylate_cyclase
p14015
aa(lp14016
Vhttp://dbpedia.org/resource/Cyclooxygenase
p14017
aasg18
(lp14018
Vadenylyl cyclase
p14019
aVguanylyl cyclase
p14020
aVadenosine deaminase
p14021
aVcyclooxygenase
p14022
aVstreptokinase
p14023
asg24
(lp14024
Vhttp://dbpedia.org/resource/Aspirin
p14025
aVhttp://dbpedia.org/resource/Enzyme
p14026
asg29
S'http://www.pharmacology2000.com/Coagulation/question4/questionset4.htm'
p14027
sg31
S'Aspirin irreversibly inhibits this enzyme, preventing thromboxane A2 synthesis.'
p14028
sg33
I8
sg34
S'Q132#6'
p14029
sg36
I11
sg37
S'6'
sg38
I3
sg39
S'132'
p14030
sa(dp14031
g3
(lp14032
(lp14033
Vhttp://dbpedia.org/resource/Aspirin
p14034
aa(lp14035
Vhttp://dbpedia.org/resource/Antidepressant
p14036
aasg18
(lp14037
Vthromboxane A2
p14038
aVaspirin
p14039
aVabciximab
p14040
aVADP
p14041
aVstreptokinase
p14042
asg24
(lp14043
Vhttp://dbpedia.org/resource/Block_%28sailing%29
p14044
aVhttp://dbpedia.org/resource/Platelet
p14045
aVhttp://dbpedia.org/resource/Receptor_%28biochemistry%29
p14046
asg29
S'http://www.pharmacology2000.com/Coagulation/question4/questionset4.htm'
p14047
sg31
S'Blocks GPIIb/IIIa platelet receptors:'
p14048
sg33
I6
sg34
S'Q132#9'
p14049
sg36
I4
sg37
S'9'
sg38
I2
sg39
S'132'
p14050
sa(dp14051
g3
(lp14052
(lp14053
Vhttp://dbpedia.org/resource/Interleukin_2
p14054
aa(lp14055
Vhttp://dbpedia.org/resource/Tumor_necrosis_factors
p14056
aVhttp://dbpedia.org/resource/Beta_cell
p14057
aa(lp14058
Vhttp://dbpedia.org/resource/Interferon-gamma
p14059
aasg18
(lp14060
Vinterleukin-2
p14061
aVtumor necrosis factor beta
p14062
aVinterferon-gamma
p14063
aVIL-4
p14064
aVIL-6
p14065
asg24
(lp14066
Vhttp://dbpedia.org/resource/T_helper_cell
p14067
aVhttp://dbpedia.org/resource/T_helper_cell
p14068
aVhttp://dbpedia.org/resource/Cellular_%28film%29
p14069
asg29
S'http://www.pharmacology2000.com/Immunosupression/question1/questionset1.htm'
p14070
sg31
S'T helper lymphocytes -- regulate each other; this substance produced by TH1cells inhibits TH2 cellular proliferation:'
p14071
sg33
I8
sg34
S'Q133#5'
p14072
sg36
I17
sg37
S'5'
sg38
I2
sg39
S'133'
p14073
sa(dp14074
g3
(lp14075
(lp14076
Vhttp://dbpedia.org/resource/Hank_Williams_III
p14077
aasg18
(lp14078
VType I
p14079
aVType II
p14080
aVType III
p14081
asg24
(lp14082
Vhttp://dbpedia.org/resource/Hypersensitivity
p14083
aVhttp://dbpedia.org/resource/Cross-link
p14084
aVhttp://dbpedia.org/resource/Biological_membrane
p14085
aVhttp://dbpedia.org/resource/Blood_plasma
p14086
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p14087
aVhttp://dbpedia.org/resource/Mast_cell
p14088
aVhttp://dbpedia.org/resource/Antigen
p14089
asg29
S'http://www.pharmacology2000.com/Immunosupression/question1/questionset1.htm'
p14090
sg31
S'Hypersensitivity: cross-linking of membrane-bound IgE on blood basophils or tissue mast cells by antigen'
p14091
sg33
I6
sg34
S'Q133#9'
p14092
sg36
I15
sg37
S'9'
sg38
I0
sg39
S'133'
p14093
sa(dp14094
g3
(lp14095
sg18
(lp14096
VImmediate Hypersensitivity Type  I
p14097
aVDelayed Hypersensitivity
p14098
aVImmediate Hypersensitivity Type II
p14099
aVImmediate Hypersensitivity Type III
p14100
asg24
(lp14101
Vhttp://dbpedia.org/resource/Led_Zeppelin_III
p14102
asg29
S'http://www.pharmacology2000.com/Immunosupression/question1/questionset1.htm'
p14103
sg31
S'Hemolytic disease of the newborn:'
p14104
sg33
I14
sg34
S'Q133#10'
p14105
sg36
I5
sg37
S'10'
p14106
sg38
I2
sg39
S'133'
p14107
sa(dp14108
g3
(lp14109
sg18
(lp14110
VImmediate Hypersensitivity Type III
p14111
aVImmediate Hypersensitivity Type II
p14112
aVDelayed Hypersensitivity
p14113
aVImmediate Hypersensitivity Type I
p14114
asg24
(lp14115
Vhttp://dbpedia.org/resource/Elevated_railway
p14116
aVhttp://dbpedia.org/resource/Antigen
p14117
aVhttp://dbpedia.org/resource/Antibody
p14118
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p14119
aVhttp://dbpedia.org/resource/Damage_%28comics%29
p14120
aVhttp://dbpedia.org/resource/Complement_system
p14121
aVhttp://dbpedia.org/resource/Activation_energy
p14122
aVhttp://dbpedia.org/resource/Chemotaxis
p14123
asg29
S'http://www.pharmacology2000.com/Immunosupression/question1/questionset1.htm'
p14124
sg31
S'Associated with elevated levels of antigen-antibody complexes, which cause tissue damage; complement activation results in anaphylatoxic and chemotactic activities:'
p14125
sg33
I14
sg34
S'Q133#11'
p14126
sg36
I21
sg37
S'11'
p14127
sg38
I0
sg39
S'133'
p14128
sa(dp14129
g3
(lp14130
(lp14131
Vhttp://dbpedia.org/resource/Movable_type
p14132
aa(lp14133
Vhttp://dbpedia.org/resource/Movable_type
p14134
aa(lp14135
Vhttp://dbpedia.org/resource/Movable_type
p14136
aVhttp://dbpedia.org/resource/Led_Zeppelin_III
p14137
aasg18
(lp14138
VImmediate Hypersensitivity Type I
p14139
aVImmediate Hypersensitivity Type II
p14140
aVImmediate Hypersensitivity Type III
p14141
asg24
(lp14142
Vhttp://dbpedia.org/resource/Administration_%28government%29
p14143
aVhttp://dbpedia.org/resource/Penicillin
p14144
aVhttp://dbpedia.org/resource/Allergy
p14145
aVhttp://dbpedia.org/resource/Patient
p14146
asg29
S'http://www.pharmacology2000.com/Immunosupression/question1/questionset1.htm'
p14147
sg31
S'Administration of penicillin to allergic patients:'
p14148
sg33
I12
sg34
S'Q133#12'
p14149
sg36
I6
sg37
S'12'
p14150
sg38
I1
sg39
S'133'
p14151
sa(dp14152
g3
(lp14153
(lp14154
Vhttp://dbpedia.org/resource/Type_%28biology%29
p14155
aa(lp14156
Vhttp://dbpedia.org/resource/Type_%28biology%29
p14157
aa(lp14158
Vhttp://dbpedia.org/resource/Type_%28biology%29
p14159
aasg18
(lp14160
VImmediate Hypersensitivity Type I
p14161
aVImmediate Hypersensitivity Type II
p14162
aVImmediate Hypersensitivity Type III
p14163
aVDelayed Hypersensitivity
p14164
asg24
(lp14165
Vhttp://dbpedia.org/resource/Effectiveness
p14166
aVhttp://dbpedia.org/resource/Infection
p14167
aVhttp://dbpedia.org/resource/Intracellular
p14168
aVhttp://dbpedia.org/resource/Pathogen
p14169
aVhttp://dbpedia.org/resource/Leishmania
p14170
aVhttp://dbpedia.org/resource/Species
p14171
asg29
S'http://www.pharmacology2000.com/Immunosupression/question1/questionset1.htm'
p14172
sg31
S'Effective in eliminating infections caused by intracellular pathogens such as Leishmania species:'
p14173
sg33
I14
sg34
S'Q133#13'
p14174
sg36
I12
sg37
S'13'
p14175
sg38
I3
sg39
S'133'
p14176
sa(dp14177
g3
(lp14178
(lp14179
Vhttp://dbpedia.org/resource/Tacrolimus
p14180
aa(lp14181
Vhttp://dbpedia.org/resource/Ciclosporin
p14182
aVhttp://dbpedia.org/resource/Ciclosporin
p14183
aVhttp://dbpedia.org/resource/Ciclosporin
p14184
aa(lp14185
Vhttp://dbpedia.org/resource/Prednisone
p14186
aa(lp14187
Vhttp://dbpedia.org/resource/Methotrexate
p14188
aasg18
(lp14189
Vtacrolimus
p14190
aVcyclosporine (Sandimmune, Neoral)
p14191
aVprednisone (Deltasone)
p14192
aVdactinomycin  (Cosmegen)
p14193
aVmethotrexate
p14194
asg24
(lp14195
Vhttp://dbpedia.org/resource/Sports_agent
p14196
aVhttp://dbpedia.org/resource/Ribosome
p14197
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p14198
aVhttp://dbpedia.org/resource/Injury
p14199
aVhttp://dbpedia.org/resource/Figure_skating
p14200
asg29
S'http://www.pharmacology2000.com/Immunosupression/question2/questionset2.htm'
p14201
sg31
S'Agent acts directly at site 6 to diminish tissue injury: (see figure)'
p14202
sg33
I16
sg34
S'Q134#0'
p14203
sg36
I15
sg37
S'0'
sg38
I2
sg39
S'134'
p14204
sa(dp14205
g3
(lp14206
(lp14207
Vhttp://dbpedia.org/resource/Prednisone
p14208
aa(lp14209
Vhttp://dbpedia.org/resource/Cyclophosphamide
p14210
aVhttp://dbpedia.org/resource/Cyclophosphamide
p14211
aa(lp14212
Vhttp://dbpedia.org/resource/Methotrexate
p14213
aa(lp14214
Vhttp://dbpedia.org/resource/Azathioprine
p14215
aVhttp://dbpedia.org/resource/Azathioprine
p14216
aasg18
(lp14217
Vprednisone (Deltasone)
p14218
aVcyclophosphamide (Cytoxan)
p14219
aVdactinomycin  (Cosmegen)
p14220
aVmethotrexate
p14221
aVazathioprine (Imuran)
p14222
asg24
(lp14223
Vhttp://dbpedia.org/resource/Cellular_differentiation
p14224
aVhttp://dbpedia.org/resource/S_phase
p14225
asg29
S'http://www.pharmacology2000.com/Immunosupression/question2/questionset2.htm'
p14226
sg31
S'Inhibit(s) at differentiation/synthesis step (see figure):'
p14227
sg33
I17
sg34
S'Q134#2'
p14228
sg36
I12
sg37
S'2'
sg38
I2
sg39
S'134'
p14229
sa(dp14230
g3
(lp14231
(lp14232
Vhttp://dbpedia.org/resource/Prednisone
p14233
aa(lp14234
Vhttp://dbpedia.org/resource/Tacrolimus
p14235
aa(lp14236
Vhttp://dbpedia.org/resource/Azathioprine
p14237
aVhttp://dbpedia.org/resource/Azathioprine
p14238
aa(lp14239
Vhttp://dbpedia.org/resource/Cyclophosphamide
p14240
aVhttp://dbpedia.org/resource/Cyclophosphamide
p14241
aasg18
(lp14242
Vprednisone (Deltasone)
p14243
aVtacrolimus
p14244
aVazathioprine (Imuran)
p14245
aVRHo(D) immune globulin
p14246
aVcyclophosphamide (Cytoxan)
p14247
asg24
(lp14248
Vhttp://dbpedia.org/resource/Antigen
p14249
asg29
S'http://www.pharmacology2000.com/Immunosupression/question2/questionset2.htm'
p14250
sg31
S'Acts at antigen recognition site: (see figure)'
p14251
sg33
I19
sg34
S'Q134#5'
p14252
sg36
I10
sg37
S'5'
sg38
I3
sg39
S'134'
p14253
sa(dp14254
g3
(lp14255
(lp14256
Vhttp://dbpedia.org/resource/Ciclosporin
p14257
aa(lp14258
Vhttp://dbpedia.org/resource/Prednisone
p14259
aa(lp14260
Vhttp://dbpedia.org/resource/Tacrolimus
p14261
aa(lp14262
Vhttp://dbpedia.org/resource/Interferon
p14263
aVhttp://dbpedia.org/resource/Alpha_helix
p14264
aa(lp14265
Vhttp://dbpedia.org/resource/Thalidomide
p14266
aasg18
(lp14267
Vcyclosporine
p14268
aVprednisone (Deltasone)
p14269
aVtacrolimus
p14270
aVIFN-alpha
p14271
aVthalidomide
p14272
asg24
(lp14273
Vhttp://dbpedia.org/resource/First_class_%28aviation%29
p14274
aVhttp://dbpedia.org/resource/Hormone
p14275
aVhttp://dbpedia.org/resource/Agent_Orange
p14276
aVhttp://dbpedia.org/resource/Lipolysis
p14277
aVhttp://dbpedia.org/resource/Property
p14278
asg29
S'http://www.pharmacology2000.com/Immunosupression/question3/questionset3.htm'
p14279
sg31
S'Example of first-class of hormonal agents noted to have lipolytic properties:'
p14280
sg33
I8
sg34
S'Q135#0'
p14281
sg36
I11
sg37
S'0'
sg38
I1
sg39
S'135'
p14282
sa(dp14283
g3
(lp14284
(lp14285
Vhttp://dbpedia.org/resource/Tacrolimus
p14286
aa(lp14287
Vhttp://dbpedia.org/resource/Interferon
p14288
aa(lp14289
Vhttp://dbpedia.org/resource/Ciclosporin
p14290
aVhttp://dbpedia.org/resource/Ciclosporin
p14291
aVhttp://dbpedia.org/resource/Ciclosporin
p14292
aa(lp14293
Vhttp://dbpedia.org/resource/Prednisone
p14294
aa(lp14295
Vhttp://dbpedia.org/resource/Thalidomide
p14296
aasg18
(lp14297
Vtacrolimus
p14298
aVinterferon
p14299
aVcyclosporine (Sandimmune, Neoral)
p14300
aVprednisone (Deltasone) and
p14301
aVthalidomide
p14302
asg24
(lp14303
Vhttp://dbpedia.org/resource/Child
p14304
aVhttp://dbpedia.org/resource/Diabetes_mellitus
p14305
aVhttp://dbpedia.org/resource/Symptom
p14306
aVhttp://dbpedia.org/resource/End-of-life_%28product%29
p14307
aVhttp://dbpedia.org/resource/Redox
p14308
aVhttp://dbpedia.org/resource/Insulin
p14309
aVhttp://dbpedia.org/resource/Drug
p14310
asg29
S'http://www.pharmacology2000.com/Immunosupression/question3/questionset3.htm'
p14311
sg31
S'About two-thirds of children with early diabetic symptoms can discontinue or reduce insulin treatment within about six weeks after starting treatment with this drug:'
p14312
sg33
I14
sg34
S'Q135#4'
p14313
sg36
I24
sg37
S'4'
sg38
I2
sg39
S'135'
p14314
sa(dp14315
g3
(lp14316
(lp14317
Vhttp://dbpedia.org/resource/Penicillin
p14318
aa(lp14319
Vhttp://dbpedia.org/resource/Sulfonamide_%28medicine%29
p14320
aa(lp14321
Vhttp://dbpedia.org/resource/Iodide
p14322
aa(lp14323
Vhttp://dbpedia.org/resource/Phenytoin
p14324
aVhttp://dbpedia.org/resource/Phenytoin
p14325
aasg18
(lp14326
Vpenicillin
p14327
aVsulfonamides
p14328
aViodides
p14329
aVphenytoin (Dilantin)
p14330
aVhydralazine (Apresoline)
p14331
asg24
(lp14332
Vhttp://dbpedia.org/resource/Autoimmunity
p14333
aVhttp://dbpedia.org/resource/Adverse_drug_reaction
p14334
asg29
S'http://www.pharmacology2000.com/Immunosupression/question3/questionset3.htm'
p14335
sg31
S'Autoimmune (Type II) drug reaction:'
p14336
sg33
I11
sg34
S'Q135#6'
p14337
sg36
I7
sg37
S'6'
sg38
I4
sg39
S'135'
p14338
sa(dp14339
g3
(lp14340
(lp14341
Vhttp://dbpedia.org/resource/Bacillus_Calmette-Gu%C3%A9rin
p14342
aasg18
(lp14343
Vinosiplex
p14344
aVthymopoietin
p14345
aVlevamisole
p14346
aVBCG
p14347
aVIGIV
p14348
asg24
(lp14349
Vhttp://dbpedia.org/resource/Parasitism
p14350
aVhttp://dbpedia.org/resource/Infection
p14351
aVhttp://dbpedia.org/resource/Drug
p14352
aVhttp://dbpedia.org/resource/Food_and_Drug_Administration
p14353
aVhttp://dbpedia.org/resource/Clinic
p14354
aVhttp://dbpedia.org/resource/Colorectal_cancer
p14355
aVhttp://dbpedia.org/resource/Surgery
p14356
asg29
S'http://www.pharmacology2000.com/Immunosupression/question3/questionset3.htm'
p14357
sg31
S'For synthesized for treating parasitic infections, this drug is now FDA approved for clinical use in the treatment of Dukes class C colorectal cancer after surgery:'
p14358
sg33
I5
sg34
S'Q135#10'
p14359
sg36
I27
sg37
S'10'
p14360
sg38
I2
sg39
S'135'
p14361
sa(dp14362
g3
(lp14363
(lp14364
Vhttp://dbpedia.org/resource/Pedicel_%28botany%29
p14365
aVhttp://dbpedia.org/resource/Cross-link
p14366
aVhttp://dbpedia.org/resource/Biological_membrane
p14367
aVhttp://dbpedia.org/resource/Blood_serum
p14368
aVhttp://dbpedia.org/resource/Tissue_%28biology%29
p14369
aVhttp://dbpedia.org/resource/Mast_cell
p14370
aVhttp://dbpedia.org/resource/Antigen
p14371
aa(lp14372
Vhttp://dbpedia.org/resource/Formation_%28stratigraphy%29
p14373
aVhttp://dbpedia.org/resource/Antigen
p14374
aVhttp://dbpedia.org/resource/Antibody
p14375
aVhttp://dbpedia.org/resource/Foreign_policy
p14376
aVhttp://dbpedia.org/resource/Antigen
p14377
aVhttp://dbpedia.org/resource/Antibody
p14378
aa(lp14379
Vhttp://dbpedia.org/resource/Tissue_%28biology%29
p14380
aVhttp://dbpedia.org/resource/Damages
p14381
aVhttp://dbpedia.org/resource/Antigen
p14382
aVhttp://dbpedia.org/resource/Cell_%28biology%29
p14383
aVhttp://dbpedia.org/resource/Macrophage
p14384
aVhttp://dbpedia.org/resource/Neutrophil_granulocyte
p14385
aasg18
(lp14386
Vdue to elevated levels of antigen-antibody complexes
p14387
aVstems from cross-linking of membrane-bound IgE on blood basophils or tissue mast cells by antigen
p14388
aVfollows from formation of antigen- antibody complexes between foreign antigen and IgM or IgG immunoglobulins
p14389
aVtissue damage due to influx of antigen-nonspecific inflammatory cells (macrophages and neutrophils)
p14390
asg24
(lp14391
Vhttp://dbpedia.org/resource/Antigen
p14392
aVhttp://dbpedia.org/resource/Antibody
p14393
asg29
S'http://www.pharmacology2000.com/Immunosupression/question3/questionset3.htm'
p14394
sg31
S'Type 1 immediate hypersensitivity:'
p14395
sg33
I51
sg34
S'Q135#13'
p14396
sg36
I4
sg37
S'13'
p14397
sg38
I1
sg39
S'135'
p14398
sa(dp14399
g3
(lp14400
(lp14401
Vhttp://dbpedia.org/resource/Rheumatoid_arthritis
p14402
aa(lp14403
Vhttp://dbpedia.org/resource/Systemic_lupus_erythematosus
p14404
aa(lp14405
Vhttp://dbpedia.org/resource/Diabetes_mellitus_type_1
p14406
aasg18
(lp14407
Vrheumatoid arthritis
p14408
aVsystemic lupus erythematosus
p14409
aVinsulin dependent diabetes
p14410
asg24
(lp14411
Vhttp://dbpedia.org/resource/Autoimmune_disease
p14412
aVhttp://dbpedia.org/resource/Antibody
p14413
aVhttp://dbpedia.org/resource/DNA
p14414
aVhttp://dbpedia.org/resource/Red_blood_cell
p14415
aVhttp://dbpedia.org/resource/Histone
p14416
aVhttp://dbpedia.org/resource/Platelet
p14417
asg29
S'http://www.pharmacology2000.com/Immunosupression/question3/questionset3.htm'
p14418
sg31
S'Autoimmune disorder: associated with antibodies made against self DNA, red blood cells, histones, platelets'
p14419
sg33
I8
sg34
S'Q135#14'
p14420
sg36
I18
sg37
S'14'
p14421
sg38
I1
sg39
S'135'
p14422
sa(dp14423
g3
(lp14424
(lp14425
Vhttp://dbpedia.org/resource/Histamine
p14426
aa(lp14427
Vhttp://dbpedia.org/resource/Bradykinin
p14428
aa(lp14429
Vhttp://dbpedia.org/resource/Neuropeptide
p14430
aa(lp14431
Vhttp://dbpedia.org/resource/Serotonin
p14432
aasg18
(lp14433
Vhistamine
p14434
aVinterleukin 1
p14435
aVbradykinin
p14436
aVneuropeptides
p14437
aVserotonin
p14438
asg24
(lp14439
Vhttp://dbpedia.org/resource/Chronic_%28medicine%29
p14440
aVhttp://dbpedia.org/resource/Inflammation
p14441
aVhttp://dbpedia.org/resource/Rheumatoid_arthritis
p14442
asg29
S'http://www.pharmacology2000.com/Inflammation/question1/questionset1.htm'
p14443
sg31
S'Mediator of chronic inflammation (for example rheumatoid arthritis)'
p14444
sg33
I6
sg34
S'Q137#6'
p14445
sg36
I10
sg37
S'6'
sg38
I1
sg39
S'137'
p14446
sa(dp14447
g3
(lp14448
(lp14449
Vhttp://dbpedia.org/resource/Glucocorticoid
p14450
aa(lp14451
Vhttp://dbpedia.org/resource/Aspirin
p14452
aa(lp14453
Vhttp://dbpedia.org/resource/Diclofenac
p14454
aasg18
(lp14455
Vglucocorticoids
p14456
aVaspirin
p14457
aVdiclofenac
p14458
aVindomethacin
p14459
aVphenylbutazone
p14460
asg24
(lp14461
Vhttp://dbpedia.org/resource/Drug
p14462
aVhttp://dbpedia.org/resource/Choice
p14463
aVhttp://dbpedia.org/resource/Safety
p14464
aVhttp://dbpedia.org/resource/Efficacy
p14465
asg29
S'http://www.pharmacology2000.com/Inflammation/question1/questionset1.htm'
p14466
sg31
S'Initial drug of choice for treating most articular and musculoskeletal disorders (because of low-cost, safety, and efficacy)'
p14467
sg33
I5
sg34
S'Q137#8'
p14468
sg36
I21
sg37
S'8'
sg38
I1
sg39
S'137'
p14469
sa(dp14470
g3
(lp14471
(lp14472
Vhttp://dbpedia.org/resource/Colchicine
p14473
aa(lp14474
Vhttp://dbpedia.org/resource/Paracetamol
p14475
aVhttp://dbpedia.org/resource/Tylenol
p14476
aasg18
(lp14477
Vallopurinol (Zyloprim, Purinol)
p14478
aVcolchicine
p14479
aVprobenecid (Benemid)
p14480
aVsulfinpyrazone (Anturane)
p14481
aVacetaminophen (Tylenol, Panadol)
p14482
asg24
(lp14483
Vhttp://dbpedia.org/resource/Drug
p14484
aVhttp://dbpedia.org/resource/Inflammation
p14485
aVhttp://dbpedia.org/resource/Gout
p14486
aVhttp://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug
p14487
aVhttp://dbpedia.org/resource/Diarrhea
p14488
aVhttp://dbpedia.org/resource/Pharmaceutical_drug
p14489
asg29
S'http://www.pharmacology2000.com/Inflammation/question3/questionset3.htm'
p14490
sg31
S'Previously most popular drug for treating inflammation of acute gouty arthritis -- NSAIDs now more commonly used because of diarrhea associated with earlier medication:'
p14491
sg33
I21
sg34
S'Q139#3'
p14492
sg36
I24
sg37
S'3'
sg38
I1
sg39
S'139'
p14493
sa(dp14494
g3
(lp14495
(lp14496
Vhttp://dbpedia.org/resource/Paracetamol
p14497
aVhttp://dbpedia.org/resource/Tylenol
p14498
aasg18
(lp14499
Vpenicillamine (Cuprimine)
p14500
aVsulfasalazine (Azulfidine)
p14501
aVacetaminophen (Tylenol, Panadol)
p14502
aVetodolac (Lodine)
p14503
aVpiroxicam (Feldene)
p14504
asg24
(lp14505
Vhttp://dbpedia.org/resource/Effectiveness
p14506
aVhttp://dbpedia.org/resource/Mild_ale
p14507
aVhttp://dbpedia.org/resource/Moderate
p14508
aVhttp://dbpedia.org/resource/Pain
p14509
aVhttp://dbpedia.org/resource/Anti-inflammatory
p14510
asg29
S'http://www.pharmacology2000.com/Inflammation/question3/questionset3.htm'
p14511
sg31
S'effective in management of mild to moderate pain, when anti-inflammatory action is not necessary'
p14512
sg33
I22
sg34
S'Q139#4'
p14513
sg36
I15
sg37
S'4'
sg38
I2
sg39
S'139'
p14514
sa(dp14515
g3
(lp14516
(lp14517
Vhttp://dbpedia.org/resource/Granulocyte
p14518
aVhttp://dbpedia.org/resource/Rearrangement_reaction
p14519
aVhttp://dbpedia.org/resource/Joint
p14520
aa(lp14521
Vhttp://dbpedia.org/resource/Monocyte
p14522
aVhttp://dbpedia.org/resource/Phagocyte
p14523
aVhttp://dbpedia.org/resource/Macrophage
p14524
aa(lp14525
Vhttp://dbpedia.org/resource/Uric_acid
p14526
aVhttp://dbpedia.org/resource/Crystal
p14527
aVhttp://dbpedia.org/resource/Phagocytosis
p14528
aa(lp14529
Vhttp://dbpedia.org/resource/Prostaglandin
p14530
aVhttp://dbpedia.org/resource/Lysosome
p14531
aVhttp://dbpedia.org/resource/Interleukin
p14532
aasg18
(lp14533
Vpolymorphonuclear leukocytes migration into the joint
p14534
aVincreased numbers of mononuclear phagocytes (macrophages)
p14535
aVurate crystals phagocytosis by synoviocytes
p14536
aVprostaglandin, lysosomal &, interleukin 1 release
p14537
asg24
(lp14538
Vhttp://dbpedia.org/resource/Steps_%28group%29
p14539
aVhttp://dbpedia.org/resource/Gout
p14540
aVhttp://dbpedia.org/resource/September_11_attacks
p14541
asg29
S'http://www.pharmacology2000.com/Inflammation/question3/questionset3.htm'
p14542
sg31
S'Probably the initial step in acute gouty arthritis attack:'
p14543
sg33
I27
sg34
S'Q139#5'
p14544
sg36
I9
sg37
S'5'
sg38
I2
sg39
S'139'
p14545
sa(dp14546
g3
(lp14547
(lp14548
Vhttp://dbpedia.org/resource/Colchicine
p14549
aasg18
(lp14550
Vcolchicine
p14551
aVprobenecid (Benemid)
p14552
aVsulfinpyrazone (Anturane)
p14553
aVallopurinol (Zyloprim, Purinol)
p14554
aVoxaprozin (Daypro)
p14555
asg24
(lp14556
Vhttp://dbpedia.org/resource/Uric_acid
p14557
aVhttp://dbpedia.org/resource/Chemical_synthesis
p14558
aVhttp://dbpedia.org/resource/Gout
p14559
asg29
S'http://www.pharmacology2000.com/Inflammation/question3/questionset3.htm'
p14560
sg31
S'Reduces uric acid synthesis: for management of gout--'
p14561
sg33
I19
sg34
S'Q139#8'
p14562
sg36
I10
sg37
S'8'
sg38
I3
sg39
S'139'
p14563
sa.